data_1jv8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jv8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.538 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 21.1 p90 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.199 0.523 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.548 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 1.4 m -85.3 -21.98 28.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 25' ' ' ALA . 48.1 mt -74.06 -24.37 59.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.356 -0.84 . . . . 0.0 108.807 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.513 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -79.74 164.02 55.5 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.606 -0.684 . . . . 0.0 109.466 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.513 ' HD2' ' CG ' ' A' ' 7' ' ' GLU . 46.5 Cg_endo -74.03 167.36 27.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.736 1.387 . . . . 0.0 109.965 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.5 Cg_endo -70.17 172.34 13.23 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.785 1.413 . . . . 0.0 110.127 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.548 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 36.1 t80 -140.76 93.59 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.406 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.451 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -52.67 -23.12 6.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.548 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 65.53 -170.23 27.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -72.71 -155.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.092 1.575 . . . . 0.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 23.0 m 62.29 -168.69 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.243 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.42 20.78 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.232 -0.918 . . . . 0.0 109.985 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.24 167.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -142.36 69.2 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.841 . . . . 0.0 109.811 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -107.32 148.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.445 HG23 ' HB ' ' A' ' 32' ' ' THR . 17.9 mm -94.33 78.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 109.865 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HG3' ' CB ' ' A' ' 35' ' ' TYR . 4.1 mmt180 -83.53 -176.55 6.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 109.886 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -118.55 144.45 46.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.976 -1.077 . . . . 0.0 111.276 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -139.43 163.36 32.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CG ' ' HB3' ' A' ' 5' ' ' CYS . 57.2 t80 -93.44 117.2 29.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.003 -1.061 . . . . 0.0 111.837 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' ALA . 42.9 t-20 -91.07 92.17 8.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.856 . . . . 0.0 108.86 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.464 ' HB2' HD23 ' A' ' 6' ' ' LEU . . . -44.58 -29.5 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.891 -1.131 . . . . 0.0 110.183 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -75.2 -23.93 57.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.811 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -92.96 -16.83 24.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 110.507 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.13 -5.72 75.15 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -145.84 -143.43 0.14 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -1.162 . . . . 0.0 109.286 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.3 m -117.44 163.33 16.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 111.687 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 5.9 mt-30 -143.8 166.56 24.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.445 ' HB ' HG23 ' A' ' 19' ' ' ILE . 82.5 p -82.97 144.29 30.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 110.555 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.538 ' HB3' ' CD1' ' A' ' 22' ' ' PHE . 7.6 p90 -145.45 171.73 14.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 109.659 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.4 t -85.71 122.54 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.7 t80 -99.77 148.88 23.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.523 -0.736 . . . . 0.0 109.911 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -96.89 -3.9 59.06 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.641 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.604 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.41 -2.81 2.49 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.184 -1.186 . . . . 0.0 111.066 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.432 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 26.0 p -139.81 152.49 46.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.886 -1.134 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 49.04 42.99 21.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.379 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -70.81 149.87 46.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -101.1 -164.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.538 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 12.2 mtt-85 -82.79 -12.81 57.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.047 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 6.7 t-20 -95.48 54.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.585 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 15.7 t-20 -152.73 84.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.819 . . . . 0.0 109.303 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 14.7 m-85 -98.5 154.67 17.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.813 . . . . 0.0 110.156 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -81.69 -18.64 43.72 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 110.611 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.402 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 95.3 p -142.18 155.67 45.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.53 70.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.93 -23.83 55.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 44.6 t0 -74.29 -33.98 63.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -71.69 -48.51 46.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.3 mmt -56.01 -57.55 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.141 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -24.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.986 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.8 m -99.54 -63.72 1.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.487 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 56.7 m . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.584 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.579 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 53.5 p90 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.139 0.495 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.577 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 97.9 m -77.07 -24.2 51.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HA ' HD22 ' A' ' 6' ' ' LEU . 22.8 mt -83.63 -19.46 35.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.536 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.04 163.97 50.64 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.79 . . . . 0.0 109.938 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.75 160.25 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.856 1.45 . . . . 0.0 110.294 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.567 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.1 Cg_endo -71.4 -178.39 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.939 1.494 . . . . 0.0 110.546 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 86.1 t80 -132.15 93.35 3.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 110.128 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.27 -23.03 66.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.9 176.5 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.8 Cg_endo -79.9 -93.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.927 1.488 . . . . 0.0 110.357 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.5 m 42.77 -168.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.632 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -138.72 13.09 2.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.067 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.58 164.35 11.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 109.959 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -128.85 71.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.504 HD13 ' CB ' ' A' ' 37' ' ' ALA . 68.0 mt -77.88 151.9 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.772 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.4 ' HA ' HD12 ' A' ' 19' ' ' ILE . 26.2 mm -96.38 89.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.671 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -90.06 172.98 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.833 . . . . 0.0 110.327 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.512 ' CE1' HG22 ' A' ' 32' ' ' THR . 7.6 m-85 -114.41 144.73 42.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -144.7 154.2 42.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.649 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 67.3 t80 -83.0 112.87 20.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.382 -0.824 . . . . 0.0 110.876 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' A' ' 27' ' ' ALA . 61.1 t-20 -84.81 86.07 7.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.059 -1.025 . . . . 0.0 109.98 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.29 -25.39 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.06 -1.025 . . . . 0.0 109.741 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -76.07 -26.01 56.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.55 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' HD23 ' A' ' 29' ' ' LEU . . . -94.12 -25.49 17.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.161 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.77 78.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.528 HD23 ' CB ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -137.99 -145.16 0.19 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.138 -1.213 . . . . 0.0 109.588 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 95.5 m -119.16 150.6 39.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 111.048 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.408 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 24.7 mt-30 -140.48 160.4 40.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.512 HG22 ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -89.2 146.87 24.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.069 -1.019 . . . . 0.0 110.588 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.567 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.8 p90 -138.08 162.27 34.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.045 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 11' ' ' THR . 97.5 t -74.26 106.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 10.4 t80 -88.17 148.86 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.368 -0.833 . . . . 0.0 109.992 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -86.84 -1.35 85.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 75.42 -6.23 2.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.463 -1.022 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 p -136.07 165.76 24.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.893 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 4.7 mtt180 45.75 52.81 9.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.013 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -72.79 156.73 38.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.269 -0.895 . . . . 0.0 110.55 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -119.53 -162.62 0.93 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.872 . . . . 0.0 110.292 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.579 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 17.7 mtm180 -81.03 -26.07 36.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.002 -1.061 . . . . 0.0 109.964 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -93.0 53.92 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.7 t-20 -146.56 74.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.518 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 8.6 m-85 -92.95 163.6 13.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 0.0 110.586 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -91.45 -14.69 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -0.995 . . . . 0.0 110.086 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.4 p -145.95 160.46 41.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 110.212 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.63 -22.45 64.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.72 -26.4 59.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.102 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.415 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 65.1 m-20 -83.01 -30.69 27.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 109.37 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.5 t -74.2 -44.04 54.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.699 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -57.04 8.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.18 -21.36 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.1 -1.0 . . . . 0.0 110.231 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.505 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 2.1 m -101.39 -39.71 7.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 110.048 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 65.4 m . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.126 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.636 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 3.5 p90 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.274 0.559 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.578 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 4.6 m -71.23 -31.14 67.2 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.33 -16.07 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -79.87 162.01 64.04 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.13 170.53 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.414 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.59 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 41.0 Cg_endo -72.01 172.03 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.002 1.527 . . . . 0.0 110.598 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.461 ' CD2' ' HD2' ' A' ' 41' ' ' LYS . 17.7 t80 -130.84 94.31 3.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 110.683 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -51.74 -23.11 4.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 72.69 151.3 1.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.98 93.3 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.073 1.565 . . . . 0.0 110.222 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -154.76 -163.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -127.32 -6.95 5.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.324 -0.86 . . . . 0.0 110.189 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.11 -176.8 6.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 109.776 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -155.01 76.26 0.98 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.02 -1.05 . . . . 0.0 110.674 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.486 HG21 HD13 ' A' ' 18' ' ' ILE . 19.6 mt -90.44 164.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.627 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.2 mm -105.31 92.7 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.993 . . . . 0.0 110.785 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.74 177.87 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.58 ' CE2' HG23 ' A' ' 32' ' ' THR . 67.1 m-85 -114.88 151.9 33.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.935 -1.103 . . . . 0.0 111.124 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -144.62 153.77 42.11 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.52 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 30.3 t80 -76.11 100.25 4.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.171 -0.956 . . . . 0.0 111.15 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.7 t-20 -75.28 71.67 2.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.804 -1.185 . . . . 0.0 109.081 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.428 ' HB1' ' CE2' ' A' ' 23' ' ' TYR . . . -47.74 -24.53 0.97 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.042 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -70.55 -31.31 68.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -92.15 -21.7 20.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.466 -0.771 . . . . 0.0 109.583 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.2 5.18 60.81 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -150.72 -142.5 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.058 -1.26 . . . . 0.0 109.713 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.458 ' O ' HD12 ' A' ' 29' ' ' LEU . 92.1 m -125.14 147.79 48.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 110.346 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -135.83 178.06 7.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.491 -0.756 . . . . 0.0 109.256 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.58 HG23 ' CE2' ' A' ' 21' ' ' TYR . 1.5 p -101.78 144.21 30.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.096 . . . . 0.0 110.633 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.59 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 24.2 p90 -133.04 162.89 30.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.454 ' O ' ' OG1' ' A' ' 11' ' ' THR . 94.0 t -75.4 97.21 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 0.0 111.146 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CD2' ' HG3' ' A' ' 20' ' ' ARG . 11.4 t80 -80.06 145.63 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.606 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -83.48 1.29 88.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.581 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 79.74 -27.33 0.15 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.622 -0.928 . . . . 0.0 110.852 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -127.23 169.63 13.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.96 -1.087 . . . . 0.0 109.672 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 17.1 mmt180 57.27 33.76 23.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.414 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . . . -69.87 161.31 30.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HD2' ' CD2' ' A' ' 10' ' ' TYR . 17.0 mtpt -137.04 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.004 . . . . 0.0 110.419 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.636 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.1 ptp180 -66.99 -32.04 73.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.835 . . . . 0.0 111.452 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.4 t-20 -90.63 61.72 4.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.731 -1.23 . . . . 0.0 109.748 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.563 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 33.1 t-20 -161.92 76.19 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 24.6 m-85 -85.69 134.56 33.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.388 -0.82 . . . . 0.0 110.155 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 20' ' ' ARG . 39.3 mttt -65.23 -16.49 63.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.6 p -149.6 159.34 44.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.34 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -20.36 66.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.007 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -31.9 64.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.226 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.66 -33.98 53.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.88 . . . . 0.0 109.625 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.584 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 18.6 t -72.85 -44.61 61.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 109.066 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.1 tpp -69.61 -44.49 70.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.547 -0.721 . . . . 0.0 109.389 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -60.26 -24.03 64.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.873 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.418 HG23 ' SG ' ' A' ' 5' ' ' CYS . 4.5 m -85.38 -51.6 6.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 109.945 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 73.1 m . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.221 -0.924 . . . . 0.0 110.545 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.578 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 6.0 p90 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.423 0.63 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 23' ' ' TYR . 1.7 m -78.63 -22.64 46.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 110.354 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.06 -10.29 39.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.677 -1.264 . . . . 0.0 109.592 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.76 156.57 82.68 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 0.0 110.074 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 47.2 Cg_endo -73.85 174.4 12.39 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.93 1.489 . . . . 0.0 110.221 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.594 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 45.4 Cg_endo -72.97 -178.36 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.02 1.537 . . . . 0.0 110.357 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.422 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 14.4 t80 -155.25 94.18 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -53.5 -23.2 9.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.8 152.4 2.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 60.88 4.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.951 1.5 . . . . 0.0 110.08 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.415 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 15.5 m -123.03 -164.53 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -122.5 0.24 9.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.69 171.49 15.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.436 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.9 ttt-85 -149.21 69.22 1.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.447 HD12 HG22 ' A' ' 18' ' ' ILE . 12.8 mt -95.52 163.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.875 . . . . 0.0 109.988 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.458 ' CG2' ' HB ' ' A' ' 32' ' ' THR . 15.4 mm -104.98 86.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.254 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -88.93 179.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.845 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.576 ' CE1' HG21 ' A' ' 32' ' ' THR . 36.6 m-85 -115.3 149.3 38.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 110.942 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 14.2 p90 -144.11 -179.03 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.57 -0.706 . . . . 0.0 109.771 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.66 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.7 OUTLIER -95.8 98.53 10.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.927 -1.108 . . . . 0.0 110.92 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.5 t-20 -81.46 63.92 5.97 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.149 177.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -47.25 -26.98 1.35 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.324 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -35.42 80.9 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -88.09 -17.89 30.06 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.23 10.73 60.62 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.479 ' CD2' ' N ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -163.19 -179.13 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -1.217 . . . . 0.0 108.951 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 85.3 m -82.5 150.45 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.566 -0.709 . . . . 0.0 110.019 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -140.78 169.11 18.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.576 HG21 ' CE1' ' A' ' 21' ' ' TYR . 19.6 p -88.64 144.38 26.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 110.098 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.594 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.1 p90 -140.02 165.28 27.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' THR . 24.4 t -74.68 124.96 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 110.221 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.3 t80 -109.46 147.43 32.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -0.848 . . . . 0.0 109.985 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -93.77 -2.08 65.22 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.964 -1.085 . . . . 0.0 110.406 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.79 -0.83 3.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.123 -1.222 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 152.29 28.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 0.0 109.923 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.69 29.97 16.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -75.27 175.06 8.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.526 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 22.2 mtpt -121.46 -174.38 2.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 109.548 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.578 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.5 mtt-85 -70.26 -16.76 63.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.077 . . . . 0.0 109.3 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 2.1 t-20 -93.45 62.96 3.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.512 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 8.7 t-20 -154.84 80.22 1.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 17.1 m-85 -95.5 155.64 16.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -22.8 48.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.332 -0.855 . . . . 0.0 110.33 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 98.9 p -134.17 157.97 44.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 110.591 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.04 -24.38 59.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -74.97 -17.57 60.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.482 -0.761 . . . . 0.0 110.032 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.459 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.2 t0 -93.5 -30.2 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.207 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 1.7 t -66.89 -52.57 41.68 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.458 ' O ' ' C ' ' A' ' 53' ' ' ARG . 3.4 tpt -66.04 -49.43 67.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.641 -0.662 . . . . 0.0 109.846 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -41.47 -41.25 2.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 m -91.83 -45.22 8.51 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.835 0.826 . . . . 0.0 109.131 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.66 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 72.8 m . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.742 -0.598 . . . . 0.0 111.396 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.735 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 4.1 p90 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.152 0.501 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.566 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.33 -14.31 46.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.927 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.438 HD22 ' HB3' ' A' ' 25' ' ' ALA . 54.6 mt -75.51 -27.93 58.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.965 -1.084 . . . . 0.0 110.182 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.445 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -64.68 166.57 11.35 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 110.283 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 7' ' ' GLU . 46.2 Cg_endo -74.7 168.68 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.121 1.59 . . . . 0.0 110.448 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.7 Cg_endo -71.54 -170.41 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.02 1.537 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CD1' ' HE3' ' A' ' 41' ' ' LYS . 43.0 t80 -145.62 93.39 2.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 110.611 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.462 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.4 m -64.73 -22.89 67.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.23 158.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.14 81.1 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.036 1.545 . . . . 0.0 110.582 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -147.45 167.37 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 0.0 110.235 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -107.53 14.53 25.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.26 152.66 23.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.37 77.89 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 20' ' ' ARG . 70.0 mt -103.13 138.13 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.479 HG22 ' HB ' ' A' ' 32' ' ' THR . 42.8 mm -86.57 81.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.082 -1.011 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HG3' ' CB ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -86.54 173.25 9.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.563 ' CE2' ' HB1' ' A' ' 48' ' ' ALA . 61.9 m-85 -114.24 154.29 28.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.145 -0.972 . . . . 0.0 111.373 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 9.1 p90 -150.56 156.97 42.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.566 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 49.5 t80 -83.14 115.69 22.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.135 -0.978 . . . . 0.0 111.266 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.498 ' ND2' ' HB1' ' A' ' 27' ' ' ALA . 60.5 t-20 -91.91 87.78 6.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.438 ' HB3' HD22 ' A' ' 6' ' ' LEU . . . -45.37 -25.42 0.4 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.052 -1.03 . . . . 0.0 109.721 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -24.02 52.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.498 ' HB1' ' ND2' ' A' ' 24' ' ' ASN . . . -95.52 -33.54 12.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 110.492 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.428 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 102.12 -10.69 56.96 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HG ' ' C ' ' A' ' 28' ' ' GLY . 1.1 mt -134.45 -143.99 0.21 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.387 -1.066 . . . . 0.0 109.092 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.2 m -120.24 145.68 46.8 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 109.76 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -129.24 161.05 31.07 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 6.3 p -86.98 144.48 26.9 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.504 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.4 p90 -140.44 161.89 36.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.589 -0.694 . . . . 0.0 109.933 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 11' ' ' THR . 63.5 t -74.47 111.08 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.499 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.602 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.2 t80 -91.94 147.65 22.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -85.8 -4.12 85.25 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.602 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 68.59 12.48 8.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 110.089 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.2 p -147.3 147.31 30.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 110.454 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 51.89 44.77 29.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -67.78 146.13 54.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.579 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' HE3' ' CD1' ' A' ' 10' ' ' TYR . 26.5 mttm -109.55 -160.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.653 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.735 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -80.87 -22.21 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.042 -1.036 . . . . 0.0 110.351 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 9.6 t-20 -91.31 53.32 2.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.906 0.86 . . . . 0.0 109.048 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.5 t-20 -159.82 75.41 0.62 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 23.4 m-85 -85.18 134.23 34.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.524 -0.735 . . . . 0.0 110.414 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.1 tptm -60.42 -20.85 61.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.77 . . . . 0.0 111.325 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.4 p -142.52 162.22 36.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.976 -1.077 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.563 ' HB1' ' CE2' ' A' ' 21' ' ' TYR . . . -66.32 -27.04 67.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 82.1 mt-10 -75.26 -28.04 59.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.21 -31.27 58.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.493 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 54.0 t -80.58 -44.01 19.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -45.89 59.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 110.246 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -60.81 -15.15 26.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.976 -1.078 . . . . 0.0 109.141 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.9 m -94.99 -54.79 3.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 0.0 110.144 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.688 -179.452 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 4.1 p90 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.61 0.719 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 4.5 t -78.68 -29.76 45.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.595 -0.691 . . . . 0.0 109.734 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.7 mt -95.47 -9.02 33.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 109.631 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 3.9 mm-40 -75.1 160.85 79.46 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.913 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.89 162.13 39.93 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.916 1.482 . . . . 0.0 110.266 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.5 Cg_endo -70.15 171.76 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.034 1.544 . . . . 0.0 110.342 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.577 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 37.4 t80 -133.24 94.45 3.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.133 -0.979 . . . . 0.0 111.019 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -59.55 -22.91 62.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.577 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 70.85 143.97 0.27 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.92 60.95 5.51 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.049 1.552 . . . . 0.0 110.348 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.13 -169.75 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -105.71 -31.7 8.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.16 154.77 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.402 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 12.7 ptt85 -143.05 77.6 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 mt -92.14 160.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.455 HD13 HG22 ' A' ' 19' ' ' ILE . 46.7 mm -91.93 83.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.834 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.581 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -80.82 175.49 10.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.054 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.559 ' CE1' HG22 ' A' ' 32' ' ' THR . 51.3 m-85 -115.25 147.72 40.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 110.95 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 15.3 p90 -147.39 156.26 42.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 72.8 t80 -81.42 114.57 20.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.294 -0.878 . . . . 0.0 110.808 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 27' ' ' ALA . 30.6 t-20 -82.06 82.11 7.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.794 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.67 -26.61 0.65 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.993 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.462 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 36.8 mmtm -78.05 -23.04 48.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.861 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -98.28 -26.83 14.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.227 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -3.1 57.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -141.58 -142.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 99.2 m -121.74 159.45 26.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.496 -0.753 . . . . 0.0 110.731 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 4.7 mt-30 -143.2 169.08 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.509 -0.745 . . . . 0.0 109.32 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.559 HG22 ' CE1' ' A' ' 21' ' ' TYR . 1.5 p -91.54 144.27 25.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.386 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 14.1 p90 -143.39 166.57 24.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' THR . 65.1 t -74.41 128.3 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.452 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.609 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -112.27 145.83 39.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.064 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.49 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -96.93 7.98 65.17 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.046 -1.073 . . . . 0.0 110.742 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.609 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 58.99 12.47 2.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.283 . . . . 0.0 110.899 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 39' ' ' ARG . 17.9 p -152.34 164.58 37.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.043 -1.036 . . . . 0.0 110.494 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 98.7 mtt180 42.56 38.43 1.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.922 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.447 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -79.88 157.58 26.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -122.02 -168.15 1.66 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.369 -0.832 . . . . 0.0 109.63 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.519 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.6 mtm-85 -71.56 -19.16 62.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.022 -1.049 . . . . 0.0 110.152 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 5.1 t-20 -86.23 54.7 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.536 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -163.03 80.87 0.48 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.837 . . . . 0.0 109.227 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 19.8 m-85 -87.8 146.34 25.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.79 -25.45 62.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.758 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.5 p -140.47 160.4 40.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.563 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.57 67.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 0.0 109.666 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.57 -28.69 61.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.988 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 1.1 m-20 -80.83 -30.62 35.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.616 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 42.7 t -79.37 -44.64 21.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 109.333 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 6.7 ttm -67.45 -50.28 59.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 109.48 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -58.32 -19.06 31.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.889 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -90.72 -47.48 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -179.71 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.616 ' CB ' ' CD ' ' A' ' 42' ' ' ARG . 52.1 p90 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.155 0.502 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.552 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 53.4 m -68.15 -29.47 68.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 109.31 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -77.09 -13.64 59.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.69 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.428 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -79.48 165.01 51.02 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.405 -0.81 . . . . 0.0 110.286 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD2' ' OE1' ' A' ' 7' ' ' GLU . 44.4 Cg_endo -71.97 160.19 48.29 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.995 1.524 . . . . 0.0 110.15 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.6 Cg_endo -70.2 166.56 27.75 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.975 1.513 . . . . 0.0 110.612 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -117.49 94.1 4.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -0.911 . . . . 0.0 110.692 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -63.3 -22.75 67.07 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.54 169.34 1.35 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -75.01 -93.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.961 1.506 . . . . 0.0 110.453 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 40.37 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HD3' ' C ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -143.13 18.24 1.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.68 172.3 6.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.449 ' HG2' HG13 ' A' ' 34' ' ' VAL . 8.4 ttp180 -134.74 73.06 1.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.845 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.524 HD11 ' CB ' ' A' ' 37' ' ' ALA . 97.1 mt -88.56 155.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.383 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.456 HG21 ' HB ' ' A' ' 32' ' ' THR . 15.4 mm -102.01 92.15 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.6 mmp_? -92.48 -179.92 5.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.696 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 45' ' ' PHE . 47.6 m-85 -112.26 150.25 31.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -151.74 157.75 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 47.0 t80 -83.8 110.99 18.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 110.951 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 27' ' ' ALA . 41.7 t-20 -88.52 87.52 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.844 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.16 -33.82 2.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 109.411 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -28.95 69.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 109.549 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -94.87 -17.57 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.38 -9.5 70.22 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.519 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 0.6 OUTLIER -135.19 -143.11 0.19 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.228 -1.16 . . . . 0.0 109.426 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.4 m -116.95 145.39 43.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 110.621 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 mt-30 -128.86 162.79 26.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.795 . . . . 0.0 109.595 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.456 ' HB ' HG21 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -86.38 148.9 25.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 0.0 110.88 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.6 p90 -143.59 161.74 37.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.994 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 11' ' ' THR . 70.1 t -74.92 97.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.327 -0.858 . . . . 0.0 110.857 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.582 ' CD2' ' HG3' ' A' ' 20' ' ' ARG . 7.9 t80 -79.26 146.45 33.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.367 -0.833 . . . . 0.0 110.356 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -80.0 0.58 82.68 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 36' ' ' GLY . . . 73.95 -1.39 3.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.441 -1.035 . . . . 0.0 110.995 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 p -143.6 168.94 18.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.917 -1.115 . . . . 0.0 110.708 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 48.97 37.87 11.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.64 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.429 ' HB1' ' CZ ' ' A' ' 35' ' ' TYR . . . -65.31 144.55 57.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 109.672 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -127.68 -155.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.953 . . . . 0.0 110.704 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.616 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 14.7 ptp180 -70.69 -30.6 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.858 . . . . 0.0 111.829 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.7 t-20 -93.92 54.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.64 -1.288 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.4 t-20 -164.12 79.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.603 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 40.1 m-85 -85.46 148.78 25.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 110.041 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 15.3 mttt -97.02 7.03 47.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.037 -1.04 . . . . 0.0 110.665 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.539 ' OG ' ' CB ' ' A' ' 50' ' ' ASP . 51.7 p -134.97 161.44 35.26 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.2 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.77 27.44 0.63 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.583 0.706 . . . . 0.0 111.069 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -160.6 -16.66 0.05 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.602 -0.686 . . . . 0.0 111.616 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.539 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 12.1 t0 -70.76 -25.11 62.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.711 -1.243 . . . . 0.0 108.055 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.603 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.8 t -71.49 -43.91 65.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.519 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 7.7 mtt -67.9 -50.82 54.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.65 -0.656 . . . . 0.0 109.764 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.83 -19.35 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -104.5 -43.51 5.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 56.7 m . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 110.514 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.573 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 49.0 p90 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.046 0.451 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 26.5 m -70.29 -30.35 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.6 mt -75.77 -23.08 55.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.703 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.31 160.93 78.82 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 109.715 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.46 169.36 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.832 1.438 . . . . 0.0 109.958 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.4 Cg_endo -71.13 173.86 11.54 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.898 1.472 . . . . 0.0 110.461 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 36.6 t80 -135.07 94.08 3.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.62 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -62.52 -23.29 66.88 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.51 -163.44 3.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 48.8 Cg_endo -74.92 -156.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.152 1.606 . . . . 0.0 110.493 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 20.2 m 63.09 147.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 10.79 39.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.472 ' CB ' ' HB3' ' A' ' 37' ' ' ALA . . . -51.91 165.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.942 . . . . 0.0 110.558 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -146.61 65.98 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.909 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.427 HD12 HG22 ' A' ' 18' ' ' ILE . 29.1 mt -97.53 152.18 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.745 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 19' ' ' ILE . 39.2 mm -89.25 84.62 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 110.462 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -85.0 168.14 15.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.801 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.491 ' CE2' HG22 ' A' ' 32' ' ' THR . 37.1 m-85 -110.04 149.8 29.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.952 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -152.67 160.57 43.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.581 -0.7 . . . . 0.0 109.501 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 5' ' ' CYS . 72.6 t80 -90.09 127.82 36.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.285 -0.884 . . . . 0.0 110.654 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.468 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 43.7 t-20 -101.78 87.55 3.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.68 -24.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 109.665 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.06 -26.41 59.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.779 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 24' ' ' ASN . . . -96.56 -37.05 10.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.86 -11.31 38.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.0 mp -133.97 -144.17 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -1.202 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 65.9 m -116.36 156.43 26.73 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.438 -0.789 . . . . 0.0 110.903 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 18.2 mt-30 -144.62 167.59 22.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.505 -0.747 . . . . 0.0 109.575 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.4 p -96.41 144.9 26.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.784 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 24.0 p90 -139.37 165.42 27.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.441 -0.787 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' ' OG1' ' A' ' 11' ' ' THR . 30.1 t -75.72 113.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.475 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 8.6 t80 -93.42 148.0 22.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.328 -0.857 . . . . 0.0 109.855 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -89.95 -2.24 75.23 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.43 8.34 5.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.063 -1.257 . . . . 0.0 110.541 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.447 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 25.4 p -153.16 174.08 14.69 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.294 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.7 32.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 0.0 110.36 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' CB ' ' OH ' ' A' ' 35' ' ' TYR . . . -64.01 157.52 24.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.5 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 79.7 mttt -126.71 -159.45 0.93 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 109.683 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.56 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -77.54 -19.24 56.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.689 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.2 t-20 -92.94 64.48 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 0.0 109.711 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 31.1 t-20 -169.18 80.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.568 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.8 m-85 -91.71 157.59 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.076 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -85.82 -15.17 42.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 0.0 110.536 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.2 p -144.5 158.4 43.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.9 -24.14 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.784 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 32.6 mm-40 -75.2 -29.83 60.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.394 -0.816 . . . . 0.0 110.184 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -76.58 -32.58 58.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.525 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.568 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 35.9 t -75.02 -43.73 52.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 109.238 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -37.28 77.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.63 -0.669 . . . . 0.0 110.529 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 12.6 mtp85 -70.83 -20.95 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -102.25 -42.45 6.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.271 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.2 m . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.254 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.643 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 4.0 p90 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.046 0.45 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 3.9 m -68.25 -32.88 73.37 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.465 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.497 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 7.5 mt -84.56 -12.08 54.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.44 168.1 28.06 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.818 . . . . 0.0 110.206 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.14 159.18 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.926 1.488 . . . . 0.0 110.371 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.4 Cg_endo -70.78 174.1 10.89 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.006 1.529 . . . . 0.0 110.335 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.569 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 89.7 t80 -121.85 93.81 4.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 0.0 110.696 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.519 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.05 -23.12 67.21 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.569 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 64.09 147.56 0.03 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -76.9 81.95 2.46 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.141 1.6 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.92 168.56 19.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.066 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.45 3.76 54.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.91 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . -89.7 163.24 15.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 16' ' ' ALA . 27.1 mtp180 -142.75 73.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.507 HG23 ' CZ ' ' A' ' 20' ' ' ARG . 51.5 mt -86.95 155.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 32' ' ' THR . 27.4 mm -97.71 87.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 109.993 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' CZ ' HG23 ' A' ' 18' ' ' ILE . 5.7 mmp_? -91.07 177.59 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 110.142 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 38.6 m-85 -112.63 145.43 40.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.92 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 13.9 p90 -145.04 156.7 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 57.4 t80 -85.08 106.2 16.38 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' ALA . 39.5 t-20 -81.3 87.94 6.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.105 -0.997 . . . . 0.0 109.452 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.497 ' HB1' ' CD2' ' A' ' 6' ' ' LEU . . . -44.87 -27.4 0.52 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.05 -1.031 . . . . 0.0 109.787 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.39 -24.5 57.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -95.97 -17.47 20.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 0.87 89.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.437 ' HB2' ' HE1' ' A' ' 52' ' ' MET . 0.6 OUTLIER -143.9 -146.28 0.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.275 -1.132 . . . . 0.0 109.543 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 81.2 m -120.77 147.59 45.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 15.7 mt-30 -135.22 159.46 41.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.496 -0.752 . . . . 0.0 109.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -80.43 143.88 33.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.038 -1.038 . . . . 0.0 110.328 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 19.8 p90 -138.32 161.84 35.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.414 -0.804 . . . . 0.0 109.733 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 11' ' ' THR . 12.2 t -74.82 110.36 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 110.692 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.636 ' CE1' ' ND2' ' A' ' 44' ' ' ASN . 11.6 t80 -91.39 150.56 21.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 11' ' ' THR . . . -85.36 -4.59 85.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.59 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 70.4 7.04 6.06 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.144 -1.209 . . . . 0.0 110.242 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.3 p -144.58 163.27 34.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 47.81 35.06 4.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.51 ' CB ' ' OH ' ' A' ' 35' ' ' TYR . . . -48.76 151.78 1.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 9.1 mttm -131.38 -161.54 1.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.325 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.643 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.9 ptt180 -75.71 -32.52 60.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -89.15 67.71 8.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.928 -1.108 . . . . 0.0 109.252 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.636 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.0 t-20 -169.1 74.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m-85 -84.84 139.69 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.279 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -75.22 -21.33 58.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -134.15 156.31 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.173 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.479 ' HB3' ' CE2' ' A' ' 21' ' ' TYR . . . -67.54 -24.77 65.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.83 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.33 -32.57 62.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.504 -0.748 . . . . 0.0 109.968 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.75 -37.16 73.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.898 . . . . 0.0 109.201 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.553 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 52.6 t -73.21 -44.35 59.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -61.86 -51.74 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -52.55 -23.98 7.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.464 HG22 ' SG ' ' A' ' 5' ' ' CYS . 6.4 m -89.18 -48.96 7.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.437 -0.789 . . . . 0.0 109.82 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.565 ' O ' ' CE1' ' A' ' 23' ' ' TYR . 72.2 m . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CD1' ' CB ' ' A' ' 42' ' ' ARG . 9.1 p90 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.368 0.604 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 5.0 t -82.34 -24.59 34.49 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.82 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.4 mt -90.83 -14.61 31.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.89 . . . . 0.0 109.587 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -78.01 156.63 79.5 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.419 -0.801 . . . . 0.0 109.624 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.21 163.68 35.22 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.77 1.405 . . . . 0.0 110.071 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.503 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.8 Cg_endo -67.65 -176.45 0.94 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.876 1.461 . . . . 0.0 110.158 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -146.34 93.76 2.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 110.848 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.497 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -60.31 -22.67 63.46 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.14 170.62 1.05 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' CYS . 49.5 Cg_endo -75.13 -95.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.511 . . . . 0.0 109.956 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 39.39 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.525 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.77 48.68 1.61 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.14 -0.975 . . . . 0.0 110.247 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.454 ' HB1' ' HB1' ' A' ' 37' ' ' ALA . . . -137.02 179.65 6.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.29 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -153.4 70.05 0.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.447 HD11 ' CB ' ' A' ' 37' ' ' ALA . 76.9 mt -80.34 157.93 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.581 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 19' ' ' ILE . 41.0 mm -91.55 79.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.298 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.567 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 10.0 mmt85 -84.97 173.24 10.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.96 . . . . 0.0 110.05 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.508 ' CE1' HG21 ' A' ' 32' ' ' THR . 6.8 m-85 -112.83 144.87 41.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.938 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 7.0 p90 -144.05 163.61 33.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.737 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 77.5 t80 -96.59 120.22 36.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 111.033 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 27' ' ' ALA . 45.8 t-20 -89.95 91.99 8.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 109.727 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.17 -27.33 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -24.77 56.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.675 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -94.23 -36.01 12.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.739 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.0 65.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.566 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 1.1 mp -125.84 -146.67 0.35 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.039 -1.271 . . . . 0.0 109.638 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.38 149.02 44.38 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.528 -0.733 . . . . 0.0 110.118 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -139.34 178.27 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.901 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.508 HG21 ' CE1' ' A' ' 21' ' ' TYR . 44.2 p -105.07 147.75 27.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.784 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.503 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 21.0 p90 -142.43 163.79 31.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.574 -0.703 . . . . 0.0 110.004 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 11' ' ' THR . 83.0 t -75.16 110.46 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 4.7 t80 -94.07 144.56 25.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 110.322 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -76.95 4.98 51.68 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.104 -0.997 . . . . 0.0 110.901 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.5 -1.98 2.78 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.201 -1.176 . . . . 0.0 111.294 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.448 ' N ' ' CZ ' ' A' ' 35' ' ' TYR . 21.7 p -150.47 174.37 12.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.952 -1.093 . . . . 0.0 110.199 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' CYS . 1.3 mtt-85 42.92 52.82 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 109.799 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . . . -91.08 140.67 29.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 111.096 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.65 -165.63 1.28 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 108.923 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -70.04 -36.6 75.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.07 . . . . 0.0 110.13 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 7.8 t-20 -76.06 54.49 0.86 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.158 -0.964 . . . . 0.0 109.905 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.527 ' OD1' ' CG ' ' A' ' 20' ' ' ARG . 41.8 t-20 -155.79 69.13 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.592 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 12.4 m-85 -89.83 166.07 13.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.741 . . . . 0.0 110.238 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -92.1 -9.33 42.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.216 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -148.51 155.22 40.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.622 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.45 -26.75 68.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.647 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 5.1 mt-10 -72.33 -32.87 66.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.6 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 39.8 t0 -70.65 -36.55 73.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.98 -44.49 65.87 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.436 ' O ' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -63.52 -59.63 4.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.591 -0.693 . . . . 0.0 109.997 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -43.23 -26.37 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 0.0 109.695 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.5 m -97.89 -36.36 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.48 -179.788 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.571 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 6.3 p90 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.14 0.495 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 2.1 m -80.88 -26.97 36.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 0.0 109.265 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.58 -18.18 42.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.466 -0.771 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 159.52 83.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.962 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.38 171.96 16.62 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.01 1.532 . . . . 0.0 110.434 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.59 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.3 Cg_endo -71.74 166.26 30.01 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.932 1.491 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 5.3 t80 -123.0 94.03 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -0.973 . . . . 0.0 111.048 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.492 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.48 -22.25 66.91 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 56.6 166.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 14' ' ' CYS . 50.7 Cg_endo -72.86 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.961 1.506 . . . . 0.0 109.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' PRO . 3.1 m 38.62 -160.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 42.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.021 . . . . 0.0 110.116 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.27 150.83 35.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -0.859 . . . . 0.0 110.215 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.92 83.27 2.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.122 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mt -106.54 158.83 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.054 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.84 89.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.194 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' NH2' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -91.28 173.93 7.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.351 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.518 ' CE1' ' CG2' ' A' ' 32' ' ' THR . 30.7 m-85 -115.6 150.45 36.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 111.176 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.33 154.66 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.533 -0.73 . . . . 0.0 109.487 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 66.5 t80 -85.34 116.47 23.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.458 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 63.8 t-20 -89.28 93.96 9.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.013 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -21.7 1.42 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.753 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -81.05 -22.87 38.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.861 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -97.57 -28.06 14.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.237 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.51 -10.13 69.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.25 -146.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -1.167 . . . . 0.0 109.523 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 60.8 m -116.04 154.62 29.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.779 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -142.0 154.91 45.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.484 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.518 ' CG2' ' CE1' ' A' ' 21' ' ' TYR . 18.9 p -83.49 144.86 29.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.2 p90 -140.97 164.2 30.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.351 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 11' ' ' THR . 22.9 t -74.37 125.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.402 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.5 t80 -106.13 147.65 28.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 0.0 110.413 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -90.77 -4.1 70.17 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.72 5.46 5.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.161 -1.2 . . . . 0.0 110.845 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.8 p -157.49 164.32 37.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.883 -1.136 . . . . 0.0 110.855 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER 50.63 34.72 10.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.328 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -84.63 164.69 18.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.74 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -121.5 -159.69 0.82 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 2.7 mtm180 -77.51 -8.86 58.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.098 . . . . 0.0 109.766 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -94.11 59.39 2.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.694 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.581 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 14.8 t-20 -165.23 84.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.572 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.9 m-85 -93.97 150.71 20.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.708 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 16.4 mtpt -81.51 -12.24 58.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -142.45 156.52 45.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.296 -0.878 . . . . 0.0 110.186 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.12 -22.56 59.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.852 . . . . 0.0 109.953 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 5.1 tp10 -70.68 -35.95 73.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 110.482 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 54' ' ' THR . 0.4 OUTLIER -78.76 -35.44 44.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.668 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.572 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.3 t -67.97 -44.19 77.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 39.1 tpp -64.35 -61.05 2.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.573 -0.705 . . . . 0.0 110.514 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.49 -18.97 21.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.426 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 2.7 m -88.12 -45.62 9.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.1 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.498 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.535 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 19.1 p90 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.137 0.494 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.485 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -80.85 -19.0 45.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.38 -24.68 59.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 7.2 mt-10 -79.04 161.61 67.71 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 41.7 Cg_endo -69.76 168.28 22.02 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.108 1.583 . . . . 0.0 110.359 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.8 Cg_endo -71.08 156.98 58.87 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.963 1.507 . . . . 0.0 110.517 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 40.9 t80 -121.39 94.26 4.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.261 -0.9 . . . . 0.0 110.883 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -56.05 -23.5 33.9 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.579 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 63.27 -178.12 6.64 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 45.7 Cg_endo -72.24 -155.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.175 1.618 . . . . 0.0 110.685 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 11.9 m 64.24 154.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 6.34 46.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.22 169.21 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 110.102 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.94 102.37 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' N ' ' A' ' 19' ' ' ILE . 28.6 mt -134.23 145.99 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.844 . . . . 0.0 110.059 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.452 ' N ' HG21 ' A' ' 18' ' ' ILE . 41.2 mm -90.37 85.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 32' ' ' THR . 9.1 mmt-85 -91.02 176.91 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.927 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 71.6 m-85 -114.0 154.18 28.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 111.528 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.443 ' CE2' ' HD3' ' A' ' 9' ' ' PRO . 11.8 p90 -153.0 154.43 34.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.405 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.485 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 89.1 t80 -83.99 106.88 15.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.269 -0.894 . . . . 0.0 111.013 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.402 ' OD1' ' CB ' ' A' ' 26' ' ' LYS . 55.3 t-20 -80.24 98.54 7.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.86 -23.35 2.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.976 -1.077 . . . . 0.0 109.559 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.402 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -77.81 -23.71 49.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.448 -0.782 . . . . 0.0 110.209 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.79 -14.52 18.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.69 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.02 1.75 85.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 30' ' ' CYS . 1.8 pp -144.27 -147.35 0.21 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.383 -1.069 . . . . 0.0 109.102 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.476 ' O ' HD11 ' A' ' 29' ' ' LEU . 79.4 m -121.96 162.2 21.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 110.607 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 95.7 mt-30 -144.87 -175.36 4.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.607 -0.683 . . . . 0.0 109.395 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 25.2 p -103.13 144.15 31.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.994 -1.066 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.8 p90 -141.8 160.53 40.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.929 . . . . 0.0 110.056 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.7 t -74.05 122.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.035 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.602 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.7 t80 -101.26 141.33 34.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -89.57 -0.53 79.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.563 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 36' ' ' GLY . . . 72.4 -1.37 2.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.191 -1.182 . . . . 0.0 111.074 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 39' ' ' ARG . 15.8 p -140.68 163.09 33.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.822 -1.174 . . . . 0.0 111.03 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 41.77 45.5 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 110.911 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -73.78 146.66 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.751 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -95.06 -159.91 0.75 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 8.3 mtt-85 -85.55 -22.73 27.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.146 -0.971 . . . . 0.0 109.869 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.449 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 21.0 t-20 -89.07 53.86 2.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 0.0 110.14 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 3.9 t-20 -143.93 84.55 1.78 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 23.8 m-85 -99.6 153.34 19.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 110.552 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -76.24 -20.93 56.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.579 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.9 p -137.67 156.65 47.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 110.614 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.01 68.53 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.582 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.97 -38.52 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.414 -0.804 . . . . 0.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -62.04 -34.41 76.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.084 -1.01 . . . . 0.0 108.557 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.9 t -71.17 -43.18 67.99 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.465 ' HE2' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -71.13 -50.45 33.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.36 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -22.96 25.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.019 -1.051 . . . . 0.0 109.629 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.402 HG21 ' SG ' ' A' ' 55' ' ' CYS . 16.4 m -94.37 -45.85 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.532 -0.73 . . . . 0.0 109.914 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.402 ' SG ' HG21 ' A' ' 54' ' ' THR . 56.7 m . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 110.501 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.74 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 14.9 p90 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.321 0.581 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.522 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.5 -8.3 58.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.022 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 27.5 mt -76.59 -23.28 53.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 109.953 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -81.8 174.38 6.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.349 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.78 165.85 30.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.872 1.459 . . . . 0.0 110.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.3 Cg_endo -71.62 -175.99 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.967 1.509 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 67.6 t80 -127.63 93.88 3.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.699 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.453 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -65.83 -22.62 66.56 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 60.32 151.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.16 82.54 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.97 1.51 . . . . 0.0 110.513 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.46 175.88 10.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 110.155 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -108.9 -1.03 19.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.31 160.67 28.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.14 68.47 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.72 153.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 110.075 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.472 HG22 ' HB ' ' A' ' 32' ' ' THR . 28.9 mm -98.01 86.39 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 110.37 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 mmt180 -86.59 173.15 9.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 45' ' ' PHE . 64.5 m-85 -112.69 151.12 30.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.09 -1.006 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.3 p90 -150.56 163.63 38.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.66 -0.65 . . . . 0.0 109.403 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 70.7 t80 -87.2 132.14 33.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 27' ' ' ALA . 34.8 t-20 -102.89 87.9 3.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.815 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -45.13 -32.34 1.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.005 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 1.9 mptp? -72.84 -24.51 60.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.865 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.506 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -98.2 -33.69 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.88 . . . . 0.0 110.16 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.01 -12.37 58.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -127.91 -144.23 0.29 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.8 m -121.69 157.24 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 6.6 mt-30 -140.23 -177.51 5.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.472 ' HB ' HG22 ' A' ' 19' ' ' ILE . 19.8 p -102.37 144.4 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.046 -1.034 . . . . 0.0 110.546 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.6 p90 -141.57 160.28 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.79 108.34 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.249 -0.907 . . . . 0.0 110.832 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.3 t80 -87.44 146.22 25.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -85.65 -4.44 85.34 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 70.68 12.45 7.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.147 -1.207 . . . . 0.0 110.314 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 39' ' ' ARG . 27.0 p -150.11 162.88 39.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.1 mtt-85 40.65 44.42 1.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.434 ' CB ' ' OH ' ' A' ' 35' ' ' TYR . . . -62.64 155.11 27.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 2.4 mtpp -121.03 -157.8 0.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.368 -0.832 . . . . 0.0 109.578 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.74 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -83.23 -22.5 33.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 0.0 109.978 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 1.7 t-20 -90.13 54.29 2.75 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.768 0.794 . . . . 0.0 109.04 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.586 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 19.4 t-20 -157.5 76.5 0.82 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 22.9 m-85 -87.74 134.78 33.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.433 -0.792 . . . . 0.0 109.849 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -65.71 -16.61 63.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.287 -0.883 . . . . 0.0 111.34 -178.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 99.2 p -143.43 158.02 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 110.434 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -64.8 -29.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.066 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.66 -25.37 56.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.646 -0.659 . . . . 0.0 109.812 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.458 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 39.2 t0 -78.64 -30.59 46.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 109.514 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 39.9 t -78.65 -43.96 24.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.225 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 48' ' ' ALA . 72.9 mmm -66.28 -49.39 67.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.484 -0.76 . . . . 0.0 110.309 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -14.52 39.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 109.849 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.451 HG22 ' SG ' ' A' ' 55' ' ' CYS . 47.6 m -92.14 -53.56 4.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.575 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 57.6 m . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 110.687 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.512 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 37.7 p90 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 1.7 m -85.54 -19.47 31.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 mt -82.77 -19.03 38.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 110.837 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -86.1 169.86 14.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.93 -1.106 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.94 163.71 36.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.889 1.468 . . . . 0.0 110.183 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.6 Cg_endo -71.41 163.51 38.83 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.947 1.498 . . . . 0.0 110.516 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.412 ' CB ' ' HG3' ' A' ' 41' ' ' LYS . 17.5 t80 -120.77 93.88 4.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.32 -0.863 . . . . 0.0 110.269 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.2 m -50.62 -23.44 2.6 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.92 -176.17 21.99 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.515 ' CG ' ' HG3' ' A' ' 39' ' ' ARG . 48.8 Cg_endo -79.21 -153.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.075 1.566 . . . . 0.0 109.992 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 32.1 m 63.05 170.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.114 -0.991 . . . . 0.0 110.535 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -116.23 10.12 14.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 110.344 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 159.1 7.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.679 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -130.64 78.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.31 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 37' ' ' ALA . 6.0 mt -104.31 156.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.883 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.454 ' CG2' HG21 ' A' ' 32' ' ' THR . 44.3 mm -99.77 80.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 109.984 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 9.0 mmt180 -85.95 174.61 9.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -114.27 143.69 44.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 110.864 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 20.5 p90 -138.19 152.14 48.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.521 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 62.8 t80 -79.19 106.11 10.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.342 -0.849 . . . . 0.0 111.253 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' ALA . 53.0 t-20 -79.14 84.84 5.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.476 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.56 -26.03 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.925 -1.109 . . . . 0.0 109.439 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.67 64.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 109.579 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.5 -24.11 16.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.463 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.34 1.26 60.9 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -149.44 -142.2 0.12 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.319 -1.106 . . . . 0.0 109.227 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 m -117.55 164.2 15.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.129 0.966 . . . . 0.0 112.209 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.506 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 24.7 mt-30 -147.67 160.86 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.2 p -79.7 144.15 33.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 111.13 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 13.5 p90 -144.08 160.73 40.38 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 11' ' ' THR . 9.1 t -74.01 129.25 36.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 110.19 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.592 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.5 t80 -113.84 146.58 39.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 0.0 109.359 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -89.34 4.41 84.22 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.592 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 68.96 4.59 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.94 -1.329 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.464 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 7.9 p -145.01 159.27 43.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.415 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.515 ' HG3' ' CG ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER 51.47 33.12 9.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.215 -0.928 . . . . 0.0 110.794 179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -59.77 142.13 53.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 110.46 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HG3' ' CB ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -102.79 -170.29 1.78 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.063 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.565 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 2.6 mtt-85 -71.73 -25.33 62.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.083 -1.01 . . . . 0.0 109.782 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 11.3 t-20 -92.91 54.38 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 109.982 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.472 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 22.6 t-20 -153.43 70.39 0.85 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.565 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 13.1 m-85 -88.2 146.25 25.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 ttmt -76.89 -18.95 58.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 110.59 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.9 p -136.24 152.34 50.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 110.398 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.38 67.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.5 -0.75 . . . . 0.0 109.907 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.506 ' N ' ' OE1' ' A' ' 49' ' ' GLU . 3.4 mp0 -73.4 -19.87 60.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.675 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.5 t0 -83.32 -29.64 28.13 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 108.722 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.66 -45.97 56.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.41 0.624 . . . . 0.0 109.5 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -54.55 41.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.349 -0.845 . . . . 0.0 110.865 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -53.09 -19.1 2.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.9 m -97.28 -59.61 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.12 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.475 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 57.1 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.651 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 42.5 p90 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.816 0.341 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.598 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 94.8 m -82.84 -25.15 32.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.9 -1.125 . . . . 0.0 109.248 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mt -80.25 -22.93 41.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 109.485 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 5.9 mm-40 -73.07 154.85 90.63 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.19 167.04 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.927 1.488 . . . . 0.0 110.401 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.586 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.7 Cg_endo -69.22 159.05 55.33 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.027 1.541 . . . . 0.0 110.062 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 30.1 t80 -122.78 94.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 62.76 172.31 1.68 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 14' ' ' CYS . 45.9 Cg_endo -72.74 -93.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.983 1.517 . . . . 0.0 110.277 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.7 m 39.99 -162.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.208 -0.932 . . . . 0.0 110.61 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -141.61 8.98 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' O ' ' CD ' ' A' ' 17' ' ' ARG . . . -93.16 173.54 7.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.024 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' CD ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -150.08 81.97 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.53 164.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.983 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.3 mm -100.87 89.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HG3' ' CB ' ' A' ' 35' ' ' TYR . 3.6 mmt85 -95.42 177.27 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.948 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 51.1 m-85 -116.09 151.03 36.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 0.0 111.156 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 11.9 p90 -147.72 158.92 44.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.523 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 68.8 t80 -88.89 107.7 19.14 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.281 -0.887 . . . . 0.0 110.895 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 27' ' ' ALA . 62.4 t-20 -83.77 89.59 7.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 110.014 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.38 -24.99 0.57 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.001 -1.062 . . . . 0.0 109.535 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -25.97 57.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.835 . . . . 0.0 109.714 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.5 ' CB ' ' NE2' ' A' ' 31' ' ' GLN . . . -94.61 -28.9 15.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.57 -10.31 59.22 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' N ' HD21 ' A' ' 29' ' ' LEU . 1.3 pt? -140.52 -147.05 0.21 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.25 -1.147 . . . . 0.0 109.841 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 99.4 m -115.69 156.92 25.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 110.551 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.5 ' NE2' ' CB ' ' A' ' 27' ' ' ALA . 45.3 mt-30 -144.02 178.69 7.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.566 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 3.3 p -95.93 144.6 26.11 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.418 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.4 p90 -143.53 165.06 28.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.488 -0.757 . . . . 0.0 109.83 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 11' ' ' THR . 63.2 t -75.16 132.08 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.984 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.3 t80 -112.71 146.81 38.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 109.864 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -99.72 1.96 57.0 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.7 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 70.59 1.73 3.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.007 -1.29 . . . . 0.0 110.971 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 39' ' ' ARG . 22.3 p -149.53 172.43 15.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 0.0 110.482 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 1.5 mpt_? 40.63 30.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.514 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -73.49 156.97 37.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 111.031 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HD2' ' HB2' ' A' ' 10' ' ' TYR . 7.5 mtpt -110.33 -169.8 1.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.443 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.601 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 2.7 mtt-85 -76.7 -15.65 59.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.26 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 15.1 t-20 -90.39 53.79 2.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 109.473 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.0 t-20 -147.74 77.64 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 51' ' ' CYS . 17.9 m-85 -94.32 143.84 26.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.793 . . . . 0.0 110.24 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 110.294 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -136.53 157.65 46.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 110.414 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -24.88 66.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.956 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.15 -23.71 63.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.026 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 46.9 t0 -90.18 -24.7 20.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.561 ' HB2' ' CD1' ' A' ' 45' ' ' PHE . 29.7 t -82.15 -43.96 17.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 109.808 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.2 mtp -66.81 -50.25 63.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 0.0 110.547 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -17.59 2.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -110.76 -42.14 4.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.6 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.3 m . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.599 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 14.5 p90 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.195 0.521 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.6 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 6.4 m -85.3 -22.45 28.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 110.646 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.71 -2.78 47.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.74 -1.225 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.47 170.61 7.91 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 110.603 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.01 166.79 28.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.152 1.606 . . . . 0.0 110.35 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.56 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 43.3 Cg_endo -70.78 -173.13 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.883 1.465 . . . . 0.0 109.595 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.564 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 65.5 t80 -154.65 93.92 1.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.912 -1.117 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -58.68 -23.18 58.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 66.19 155.68 0.34 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.07 66.38 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.05 1.553 . . . . 0.0 110.31 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.456 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 23.0 m -121.7 -174.91 2.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.729 . . . . 0.0 109.825 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -120.68 12.33 11.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.114 -0.991 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.461 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . . . -96.96 166.69 11.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -144.0 68.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.005 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 35' ' ' TYR . 61.4 mt -87.46 155.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.432 -0.792 . . . . 0.0 110.123 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 19' ' ' ILE . 30.1 mm -93.5 89.0 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.537 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.8 mmt85 -99.52 -179.19 4.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 110.383 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.527 ' CZ ' HG23 ' A' ' 32' ' ' THR . 10.7 m-85 -116.81 153.46 32.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 111.328 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 15.5 p90 -149.06 176.77 10.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.519 -0.738 . . . . 0.0 109.361 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.615 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.8 OUTLIER -95.03 100.57 12.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' ALA . 48.8 t-20 -86.11 69.46 10.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.656 -1.278 . . . . 0.0 108.337 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.78 -26.04 0.87 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.435 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -62.08 -37.28 84.44 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -83.58 -31.86 26.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.587 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.09 -10.71 10.05 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.625 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -153.32 -141.89 0.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.754 -1.439 . . . . 0.0 109.889 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 96.2 m -107.2 151.93 24.77 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.48 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 5.7 mt-30 -141.59 179.38 6.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 110.467 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.527 HG23 ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -91.54 148.14 22.5 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.394 -0.817 . . . . 0.0 109.877 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.579 ' HB3' ' CD1' ' A' ' 22' ' ' PHE . 13.4 p90 -148.14 166.08 28.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 110.483 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.472 ' O ' ' OG1' ' A' ' 11' ' ' THR . 13.2 t -74.64 122.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.37 -0.831 . . . . 0.0 110.275 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.587 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -103.66 142.7 33.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.412 -0.805 . . . . 0.0 109.658 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -89.42 -0.98 78.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.545 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.587 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.6 0.81 3.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -1.194 . . . . 0.0 110.176 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -153.9 173.55 15.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 44.72 26.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.485 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -63.52 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.9 mtpp -95.83 -162.99 1.0 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.381 -0.825 . . . . 0.0 109.243 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.599 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.3 mtm180 -84.65 -9.33 58.36 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.002 -1.061 . . . . 0.0 109.979 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -96.97 53.99 1.24 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.561 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 13.6 t-20 -144.26 84.2 1.75 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 27.8 m-85 -101.21 164.51 11.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -91.99 -16.23 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.277 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 97.8 p -141.5 154.81 45.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.87 66.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.588 -0.695 . . . . 0.0 110.001 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -15.04 60.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.726 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 21.3 t70 -94.58 -25.39 16.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.599 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 7.3 t -73.84 -49.12 26.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.833 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.417 ' O ' ' C ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.67 -49.02 70.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.52 -0.738 . . . . 0.0 110.442 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -45.26 -29.32 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.892 -1.13 . . . . 0.0 109.472 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.475 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 1.2 m -104.56 -31.55 9.38 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.699 0.761 . . . . 0.0 109.083 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.615 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 92.9 m . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.612 -0.68 . . . . 0.0 110.92 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.568 ' CD2' ' HD2' ' A' ' 42' ' ' ARG . 5.1 p90 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 121.786 0.803 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 2.2 t -77.91 -29.27 50.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.691 -0.631 . . . . 0.0 109.793 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 mt -87.7 -10.09 52.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 109.51 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.27 153.32 84.16 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.647 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 43.2 Cg_endo -70.56 174.45 10.19 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.979 1.516 . . . . 0.0 110.071 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.7 Cg_endo -73.05 155.42 52.58 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.841 1.443 . . . . 0.0 109.813 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 24.3 t80 -118.72 93.95 4.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 111.102 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -59.88 -23.43 63.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 64.05 164.83 0.78 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -80.96 89.85 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 124.231 1.648 . . . . 0.0 110.027 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.35 171.25 18.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.056 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -14.02 17.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.19 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 37' ' ' ALA . . . -51.76 169.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.481 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -152.0 69.3 0.9 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.02 155.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 110.365 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.529 ' CG2' HG22 ' A' ' 32' ' ' THR . 18.3 mm -94.18 87.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.329 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 mmt85 -90.79 175.09 7.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 110.508 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 45' ' ' PHE . 57.5 m-85 -117.13 148.6 41.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -0.776 . . . . 0.0 111.389 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 17.8 p90 -148.41 161.16 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 69.1 t80 -90.05 108.85 19.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.965 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 26' ' ' LYS . 25.8 t-20 -80.87 87.18 5.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.252 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.26 -26.49 0.51 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.99 -1.069 . . . . 0.0 109.556 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 6.0 tttt -70.95 -29.13 65.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.667 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -91.57 -35.71 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.13 56.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -140.0 -144.74 0.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -1.165 . . . . 0.0 109.036 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.451 ' O ' HD11 ' A' ' 29' ' ' LEU . 84.7 m -116.71 150.98 37.33 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 110.572 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.468 ' OE1' ' ND2' ' A' ' 24' ' ' ASN . 87.1 mt-30 -139.52 167.2 22.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.529 HG22 ' CG2' ' A' ' 19' ' ' ILE . 0.6 OUTLIER -96.78 146.94 24.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.114 -0.991 . . . . 0.0 110.881 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -142.74 161.61 37.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.581 -0.699 . . . . 0.0 110.118 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' THR . 70.4 t -75.28 107.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.313 -0.867 . . . . 0.0 110.395 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.1 t80 -85.0 146.01 27.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.402 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 37' ' ' ALA . . . -89.56 2.85 83.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 67.55 13.36 9.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.108 -1.231 . . . . 0.0 110.613 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ARG . 31.3 p -156.36 170.59 21.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.94 . . . . 0.0 110.399 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.85 37.96 0.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.449 ' HB1' ' ND2' ' A' ' 44' ' ' ASN . . . -74.89 147.96 40.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.417 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -116.75 -165.3 1.05 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.581 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 6.2 mtt-85 -68.75 -20.12 64.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.268 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 1.7 t-20 -91.48 54.21 2.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.056 -1.028 . . . . 0.0 110.178 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.544 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -156.29 76.05 0.89 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 108.945 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.0 m-85 -91.13 147.59 22.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 110.677 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 0.0 OUTLIER -78.25 -21.36 50.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 110.349 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.467 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 91.8 p -135.8 156.57 48.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 0.0 110.492 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.12 -25.46 68.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.527 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 1.7 tp10 -73.79 -26.22 60.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 25.9 t0 -77.38 -31.77 54.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.265 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.592 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.3 t -82.48 -47.87 11.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.592 -0.692 . . . . 0.0 109.193 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.8 ttm -65.74 -44.44 85.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 109.993 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -58.12 -25.33 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.674 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -90.17 -42.32 11.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.448 -0.783 . . . . 0.0 109.767 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 110.815 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.576 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 4.4 p90 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.302 0.573 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -82.13 -28.88 31.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.6 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -82.02 -19.31 40.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 109.724 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.94 158.37 85.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.823 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.452 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 44.1 Cg_endo -71.84 174.83 10.57 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.853 1.449 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -71.55 169.74 20.24 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.902 1.475 . . . . 0.0 110.48 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.574 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 63.5 t80 -129.1 94.25 3.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.835 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.4 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -56.29 -23.39 36.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.574 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 58.44 -172.8 3.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.492 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.0 Cg_endo -73.63 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.17 1.616 . . . . 0.0 110.466 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 28.6 m 63.12 173.33 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -133.52 27.19 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.01 -168.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.102 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 38.8 ttm180 -150.69 73.81 1.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.162 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 82.1 mt -109.99 146.61 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.4 HG22 ' HB ' ' A' ' 32' ' ' THR . 43.9 mm -92.43 82.45 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.569 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -81.67 169.24 17.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.919 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 47.2 m-85 -112.44 149.87 31.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 111.492 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 13.0 p90 -150.12 156.81 42.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 47.7 t80 -83.6 116.3 22.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.125 -0.984 . . . . 0.0 110.486 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 27' ' ' ALA . 26.9 t-20 -91.24 88.48 6.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.874 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.58 -37.72 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.735 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 10.2 tptp -64.91 -27.99 69.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.527 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -92.66 -23.58 18.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.22 -11.29 72.6 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.45 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 1.7 mp -132.76 -142.53 0.21 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -1.138 . . . . 0.0 109.521 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 66.3 m -119.57 154.67 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.567 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 3.3 mt-30 -138.61 172.3 13.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.499 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 8.5 p -98.59 144.45 27.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 110.506 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -137.82 157.08 47.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.042 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.37 101.33 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.207 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 10.7 t80 -80.58 149.24 29.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.491 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -84.56 -1.68 89.11 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.597 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 73.26 6.69 5.22 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.45 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 20.2 p -149.77 171.91 15.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 110.456 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 39.34 47.17 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.486 -0.759 . . . . 0.0 110.645 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.28 156.07 39.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -120.47 -162.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.301 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.509 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.6 mtm-85 -80.11 -6.13 57.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 109.978 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.8 t-20 -110.25 54.59 0.66 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.86 . . . . 0.0 109.64 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.584 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 30.1 t-20 -155.41 82.49 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -94.49 142.65 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 111.099 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 11.2 tmtt? -71.92 -23.46 61.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.492 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 97.0 p -134.26 159.02 42.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 110.502 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.23 64.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.78 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -74.23 -28.68 61.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 110.236 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 54' ' ' THR . 56.4 t0 -78.86 -32.56 46.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.573 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.3 t -74.78 -43.98 51.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.45 ' HE1' ' HA ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -67.63 -48.92 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.253 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -64.69 -11.93 41.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 109.717 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.474 HG21 ' CE1' ' A' ' 45' ' ' PHE . 1.8 m -106.43 -38.79 6.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.885 . . . . 0.0 110.16 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.577 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.648 ' CB ' ' CD ' ' A' ' 42' ' ' ARG . 9.0 p90 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.984 0.421 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -72.96 -29.66 63.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.072 -1.018 . . . . 0.0 109.658 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.408 ' HA ' ' HB1' ' A' ' 25' ' ' ALA . 39.5 mt -78.31 -20.36 51.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.743 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 45.0 mt-10 -81.55 165.37 44.46 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 47.7 Cg_endo -72.87 163.0 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.937 1.493 . . . . 0.0 110.564 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 43.6 Cg_endo -71.79 -159.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.968 1.509 . . . . 0.0 110.456 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 45.5 t80 -146.43 93.68 2.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 109.946 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -58.67 -22.82 58.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 61.12 174.87 1.39 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.5 Cg_endo -81.55 -96.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.903 1.475 . . . . 0.0 110.658 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' PRO . 2.0 m 38.91 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.235 -0.915 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -142.54 17.2 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.832 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.01 -179.76 4.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 110.027 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.06 71.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.84 156.58 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.681 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 32' ' ' THR . 22.1 mm -93.74 80.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.113 -0.992 . . . . 0.0 110.602 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.545 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 7.8 mmt180 -81.35 175.04 10.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.702 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 47' ' ' SER . 89.8 m-85 -116.23 151.8 35.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.037 -1.039 . . . . 0.0 111.285 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.514 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 15.7 p90 -150.35 161.87 41.64 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 72.6 t80 -86.33 107.81 18.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.968 -1.082 . . . . 0.0 110.963 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' ALA . 37.5 t-20 -84.99 90.84 7.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.997 . . . . 0.0 109.86 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.53 -28.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.525 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.485 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -71.09 -27.14 63.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.333 -0.855 . . . . 0.0 109.762 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.41 -18.5 19.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.002 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 -3.04 87.54 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 30' ' ' CYS . 1.1 pp -144.1 -145.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.16 -1.2 . . . . 0.0 109.36 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 84.3 m -114.76 151.12 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 111.031 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -137.61 176.95 8.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.359 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.522 ' HB ' ' CG2' ' A' ' 19' ' ' ILE . 25.4 p -93.46 144.29 25.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 34' ' ' VAL . 7.8 p90 -144.48 161.52 38.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 55.5 t -74.72 135.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 0.0 110.231 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.3 t80 -122.27 141.63 51.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.787 . . . . 0.0 109.775 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' THR . . . -75.39 -1.76 65.9 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 71.2 1.89 4.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -1.127 . . . . 0.0 110.485 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 6.0 p -142.5 157.02 45.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.008 -1.058 . . . . 0.0 110.058 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 4.9 mtp85 56.72 35.6 26.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.46 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -55.03 149.9 11.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.493 ' CE ' ' HB2' ' A' ' 10' ' ' TYR . 2.1 mtmp? -124.86 -170.57 2.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.648 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 6.7 ptp180 -65.05 -32.93 74.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 111.278 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.9 t-20 -88.46 54.66 3.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.822 -1.174 . . . . 0.0 109.449 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.482 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 54.1 t-20 -158.55 76.34 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.593 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 23.1 m-85 -85.86 136.72 33.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 110.589 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -61.34 -26.96 68.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.848 . . . . 0.0 110.076 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.501 ' HA ' ' CD1' ' A' ' 21' ' ' TYR . 89.3 p -145.29 162.03 38.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 -20.43 66.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.906 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 2.7 tp10 -70.68 -34.47 72.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.3 t0 -79.28 -32.95 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.375 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.593 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 44.4 t -69.87 -44.43 69.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.765 . . . . 0.0 109.208 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.37 -55.39 18.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.499 -0.751 . . . . 0.0 109.522 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 2.2 ttp180 -46.08 -31.82 2.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.3 m -79.27 -59.44 2.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -0.786 . . . . 0.0 109.445 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.388 179.632 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.546 ' CB ' ' HD3' ' A' ' 42' ' ' ARG . 3.5 p90 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.525 0.679 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 3.7 t -84.55 -25.17 28.91 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.873 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.3 mt -86.96 -15.28 39.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.43 163.88 56.92 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 168.44 24.5 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.111 1.585 . . . . 0.0 110.187 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.59 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.9 Cg_endo -70.73 169.76 19.38 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.017 1.535 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 38.8 t80 -126.25 94.27 4.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 111.131 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.478 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -67.39 -22.64 65.54 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.83 171.8 0.56 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.6 Cg_endo -80.51 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.877 1.462 . . . . 0.0 110.333 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 41.52 -164.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 110.569 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -134.41 26.41 3.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 110.201 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.55 5.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.17 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 2.2 ptp180 -153.82 73.64 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.125 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mt -90.26 165.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.275 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.4 mm -102.79 92.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.549 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.537 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 4.2 mmt180 -94.48 -179.39 4.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.846 . . . . 0.0 110.038 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.507 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 72.6 m-85 -117.03 146.2 43.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.084 . . . . 0.0 111.06 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 7.7 p90 -145.69 163.38 35.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.482 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 86.9 t80 -92.26 124.33 36.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.452 ' OD1' ' HB3' ' A' ' 26' ' ' LYS . 59.8 t-20 -96.69 96.54 8.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -0.956 . . . . 0.0 109.929 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.6 -36.31 10.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -68.57 -25.5 64.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.776 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' O ' HD11 ' A' ' 29' ' ' LEU . . . -96.36 -24.91 15.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 86.43 -8.72 73.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.47 HD11 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -129.68 -146.3 0.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.247 -1.149 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 63.1 m -123.48 150.02 44.42 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.729 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.416 ' NE2' ' CB ' ' A' ' 27' ' ' ALA . 36.3 mt-30 -137.31 160.96 37.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.558 -0.714 . . . . 0.0 109.21 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.507 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 40.5 p -82.97 144.23 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.3 p90 -140.62 166.22 25.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.442 -0.787 . . . . 0.0 109.865 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.448 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 3.6 t -74.88 133.84 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.083 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.594 ' CE1' ' ND2' ' A' ' 44' ' ' ASN . 7.6 t80 -112.88 147.09 37.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 0.0 110.324 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -87.34 -4.16 81.06 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 74.37 -4.54 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.445 -1.032 . . . . 0.0 111.113 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 39' ' ' ARG . 29.3 p -146.7 170.35 17.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 110.441 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.536 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.2 ttt180 42.78 51.76 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.577 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -95.23 157.82 15.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 0.0 110.905 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.502 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 4.6 mttp -118.59 -161.48 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.348 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.546 ' HD3' ' CB ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -74.55 -23.98 58.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.1 t-20 -80.19 54.26 1.93 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.919 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.594 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 25.2 t-20 -162.41 74.31 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 20.3 m-85 -85.46 143.7 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.446 -0.783 . . . . 0.0 110.788 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -68.91 -25.11 64.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 0.0 110.096 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -136.39 157.11 47.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 0.0 110.543 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.51 -22.87 66.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.071 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 4.1 mt-10 -75.28 -27.86 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.599 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 14.6 t0 -72.85 -35.85 67.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.541 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.2 t -71.43 -44.52 64.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.7 mmt -67.69 -53.8 24.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.475 -0.766 . . . . 0.0 109.395 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -53.38 -22.43 7.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -96.22 -39.38 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 109.728 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.343 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.748 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 6.6 p90 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.158 0.504 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 53.4 m -84.19 -20.94 31.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 178.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.75 -22.82 59.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.52 160.37 81.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 110.141 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.7 170.28 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.017 1.535 . . . . 0.0 110.208 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.39 178.47 6.1 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.833 1.439 . . . . 0.0 110.153 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.504 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 11.0 t80 -139.56 93.86 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.91 . . . . 0.0 110.428 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -59.54 -22.74 62.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.39 144.94 0.03 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.54 65.47 4.65 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.958 1.504 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.457 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 18.5 m -117.56 170.83 8.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 4.49 53.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.357 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.53 175.55 5.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 109.998 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 13.5 ptp180 -155.08 71.97 0.81 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.575 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.496 HD11 ' CB ' ' A' ' 37' ' ' ALA . 32.1 mt -81.17 157.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.809 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 19' ' ' ILE . 4.3 mm -94.18 88.49 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.018 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.2 mmt180 -92.42 -175.65 4.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.338 -0.851 . . . . 0.0 110.034 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -119.37 144.82 46.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 111.434 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 14.4 p90 -142.14 166.52 24.47 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.568 ' CD1' ' HB3' ' A' ' 55' ' ' CYS . 73.0 t80 -95.95 111.59 23.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 110.835 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 27' ' ' ALA . 28.3 t-20 -84.32 91.83 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.07 -24.27 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -79.25 -22.93 44.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.407 -0.808 . . . . 0.0 109.823 179.421 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -93.56 -28.47 16.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 -0.6 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 30' ' ' CYS . 0.4 OUTLIER -151.26 -151.62 0.4 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -1.163 . . . . 0.0 109.851 179.677 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.558 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 95.4 m -109.99 153.75 24.13 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.871 0.843 . . . . 0.0 111.43 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -143.51 174.25 10.92 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.54 144.29 26.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.712 -1.243 . . . . 0.0 110.669 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -138.79 162.38 34.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.765 . . . . 0.0 109.583 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.99 99.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 111.283 -178.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.7 t80 -81.49 144.78 31.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.509 -0.745 . . . . 0.0 109.505 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.572 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -87.06 3.59 86.83 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.392 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 78.55 -24.5 0.21 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.467 -1.019 . . . . 0.0 111.169 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.44 168.35 19.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.898 -1.126 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.77 43.73 27.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 109.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -85.76 164.48 17.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.353 -0.842 . . . . 0.0 111.198 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.504 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.4 mttt -116.23 -166.3 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.748 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -76.88 -19.78 57.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.865 -1.147 . . . . 0.0 110.183 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' H ' ' HD2' ' A' ' 42' ' ' ARG . 3.8 t-20 -92.07 53.67 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.908 0.861 . . . . 0.0 109.341 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.466 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 17.8 t-20 -149.49 71.06 1.09 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.6 m-85 -84.89 141.21 30.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.531 -178.077 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 4.7 tttt -66.02 -23.12 66.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.477 -0.764 . . . . 0.0 110.911 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -143.38 153.85 43.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 110.418 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -56.86 -29.86 63.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.705 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.6 tt0 -64.68 -34.02 77.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.82 . . . . 0.0 110.363 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.412 ' O ' ' HB ' ' A' ' 54' ' ' THR . 22.5 t0 -79.25 -29.18 42.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.622 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 37.6 t -82.9 -44.2 15.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.429 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -67.98 -49.95 58.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.956 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -59.97 -23.7 63.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 0.0 109.42 179.295 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 50' ' ' ASP . 2.5 m -94.32 -44.3 8.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.559 -0.713 . . . . 0.0 109.824 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 55.8 m . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.585 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 28.6 p90 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.258 0.551 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 20.0 m -83.64 -26.43 29.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.075 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' HA ' ' HB1' ' A' ' 25' ' ' ALA . 5.3 mt -81.43 -18.24 46.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.721 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.27 162.25 57.14 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.934 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.04 168.97 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.932 1.491 . . . . 0.0 110.108 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.574 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -70.59 175.2 9.12 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.998 1.526 . . . . 0.0 110.667 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -133.91 93.9 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 0.0 110.389 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.72 -22.69 66.63 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.94 171.8 0.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.3 Cg_endo -74.68 -97.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.913 1.481 . . . . 0.0 110.453 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 42.96 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.044 -1.035 . . . . 0.0 110.739 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -133.23 15.75 4.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 110.08 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.11 172.43 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 71.13 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 110.284 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 18' ' ' ILE . 58.1 mt -98.35 153.78 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.42 HG23 ' HB ' ' A' ' 32' ' ' THR . 14.5 mm -96.64 87.67 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 32' ' ' THR . 8.2 mmt85 -88.67 177.31 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.579 ' CE1' HG23 ' A' ' 32' ' ' THR . 49.2 m-85 -113.39 152.89 29.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 111.082 -179.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -150.58 158.49 44.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.623 -0.673 . . . . 0.0 109.337 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.584 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 44.9 t80 -87.33 113.64 23.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.319 -0.863 . . . . 0.0 110.774 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' ALA . 45.3 t-20 -86.27 83.31 7.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 6' ' ' LEU . . . -45.47 -29.09 1.03 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.027 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -27.3 62.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.427 -0.795 . . . . 0.0 109.706 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -94.98 -26.33 16.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.239 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.48 -10.53 65.0 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -134.45 -144.11 0.21 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.188 -1.183 . . . . 0.0 109.571 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 95.1 m -121.83 153.97 37.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.703 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 20.0 mt-30 -140.38 160.45 39.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.484 -0.76 . . . . 0.0 109.383 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.579 HG23 ' CE1' ' A' ' 21' ' ' TYR . 2.0 p -84.6 144.56 28.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.009 -1.057 . . . . 0.0 110.723 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.9 p90 -139.15 162.3 35.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.92 179.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 11' ' ' THR . 11.8 t -74.67 122.6 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.596 ' CE1' ' ND2' ' A' ' 44' ' ' ASN . 7.5 t80 -99.79 147.09 25.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -0.88 . . . . 0.0 110.223 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -91.84 -4.38 67.41 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.595 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.95 -2.09 2.83 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.265 -1.138 . . . . 0.0 110.902 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 39' ' ' ARG . 28.3 p -146.3 172.24 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.991 -1.068 . . . . 0.0 110.182 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 38' ' ' CYS . 16.4 mtt-85 42.33 28.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.974 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.519 ' HB1' ' CE1' ' A' ' 35' ' ' TYR . . . -63.92 163.5 11.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -127.3 -171.04 2.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.539 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -69.56 -19.62 63.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.953 -1.092 . . . . 0.0 109.834 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 3.3 t-20 -88.25 67.03 8.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 109.695 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 39.0 t-20 -168.43 82.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 109.271 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 18.0 m-85 -96.42 148.8 22.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.585 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -69.22 -28.34 66.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.871 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -136.56 158.56 44.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -68.14 -20.45 64.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.067 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.74 -42.0 91.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.01 -40.24 71.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.57 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 34.7 t -64.91 -43.99 91.04 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.656 0.741 . . . . 0.0 109.41 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.439 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -67.39 -61.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.726 . . . . 0.0 110.685 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -55.41 -19.25 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.036 -1.04 . . . . 0.0 110.617 -179.441 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.506 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 45.9 m -95.61 -56.0 2.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.07 -1.019 . . . . 0.0 110.172 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.584 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 44.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.929 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.577 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 10.9 p90 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.221 0.534 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -83.68 -22.04 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.388 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.3 mt -82.36 -16.97 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.467 -0.771 . . . . 0.0 109.842 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.451 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -84.78 160.89 54.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.088 179.838 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 7' ' ' GLU . 44.1 Cg_endo -72.53 165.05 33.82 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.931 1.49 . . . . 0.0 110.071 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.583 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.6 Cg_endo -70.67 159.32 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.906 1.477 . . . . 0.0 110.712 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -116.33 94.33 4.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -0.836 . . . . 0.0 110.655 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.48 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -62.66 -22.87 66.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.5 170.25 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' CYS . 48.0 Cg_endo -73.58 -92.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.917 1.482 . . . . 0.0 110.941 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 44.26 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.052 -1.03 . . . . 0.0 110.313 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.09 8.27 3.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 -177.15 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 109.707 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -152.27 82.97 1.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.016 -1.052 . . . . 0.0 110.68 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 18' ' ' ILE . 56.1 mt -96.87 157.92 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 32' ' ' THR . 7.9 mm -104.54 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.153 -0.967 . . . . 0.0 110.242 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.8 mmt85 -88.51 179.97 6.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 62.1 m-85 -110.87 153.83 24.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 110.712 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.7 p90 -152.78 161.94 41.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.43 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.521 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 76.5 t80 -92.91 115.31 28.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 110.951 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.487 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 40.3 t-20 -90.5 98.55 11.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 0.0 110.01 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.24 -20.2 2.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.89 -19.09 29.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.982 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 24' ' ' ASN . . . -96.53 -29.77 13.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.908 . . . . 0.0 110.231 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.72 72.45 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -142.64 -145.2 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.106 -1.232 . . . . 0.0 109.641 179.508 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.486 ' O ' HD12 ' A' ' 29' ' ' LEU . 76.4 m -121.45 150.46 41.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.895 . . . . 0.0 110.97 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.48 179.65 6.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -99.45 144.47 28.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.893 -1.129 . . . . 0.0 111.156 -179.213 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.9 p90 -136.83 158.75 43.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.584 -0.697 . . . . 0.0 109.17 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.48 ' O ' ' OG1' ' A' ' 11' ' ' THR . 60.6 t -75.28 99.66 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.291 -0.881 . . . . 0.0 111.055 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.588 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.1 t80 -78.75 141.5 37.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.23 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -84.7 5.52 81.52 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.588 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 73.94 0.58 3.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -1.07 . . . . 0.0 111.0 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 39' ' ' ARG . 12.6 p -148.86 176.0 10.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.855 -1.153 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 41.56 44.55 2.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -83.35 137.27 34.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.94 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -103.0 -164.38 1.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.772 . . . . 0.0 109.433 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.577 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -69.55 -14.23 62.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.041 -1.037 . . . . 0.0 109.611 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.2 t-20 -94.39 55.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.471 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 16.8 t-20 -160.71 80.27 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 0.0 108.99 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.585 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -92.06 153.19 19.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.858 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -78.67 -23.18 45.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.446 -0.784 . . . . 0.0 110.16 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.1 p -142.68 161.44 38.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.27 -0.894 . . . . 0.0 110.296 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.87 -21.29 65.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -27.19 60.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.405 -0.809 . . . . 0.0 110.173 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.85 -30.81 31.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.348 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.585 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 43.6 t -78.64 -44.61 23.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.602 -0.686 . . . . 0.0 109.622 179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -46.8 75.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 110.293 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -63.72 -29.43 70.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.05 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 m -73.85 -50.17 21.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.125 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 77.3 m . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 -179.774 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.496 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.63 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 38.2 Cg_endo -66.07 165.92 22.54 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.761 1.401 . . . . 0.0 111.123 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.476 ' HA ' ' CD1' ' A' ' 6' ' ' LEU . 6.5 t70 -99.39 -18.55 17.44 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.491 -0.756 . . . . 0.0 110.1 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.63 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 21.1 p90 -66.07 -21.18 66.36 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.976 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.548 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 1.4 m -85.3 -21.98 28.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' CD2' ' HD2' ' A' ' 1' ' ' ARG . 48.1 mt -74.06 -24.37 59.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.356 -0.84 . . . . 0.0 108.807 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.513 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -79.74 164.02 55.5 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.606 -0.684 . . . . 0.0 109.466 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.513 ' HD2' ' CG ' ' A' ' 7' ' ' GLU . 46.5 Cg_endo -74.03 167.36 27.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.736 1.387 . . . . 0.0 109.965 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.5 Cg_endo -70.17 172.34 13.23 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.785 1.413 . . . . 0.0 110.127 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.548 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 36.1 t80 -140.76 93.59 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.406 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.451 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -52.67 -23.12 6.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.548 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 65.53 -170.23 27.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -72.71 -155.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.092 1.575 . . . . 0.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 23.0 m 62.29 -168.69 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.243 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.42 20.78 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.232 -0.918 . . . . 0.0 109.985 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.24 167.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -142.36 69.2 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.841 . . . . 0.0 109.811 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -107.32 148.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.445 HG23 ' HB ' ' A' ' 32' ' ' THR . 17.9 mm -94.33 78.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 109.865 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HG3' ' CB ' ' A' ' 35' ' ' TYR . 4.1 mmt180 -83.53 -176.55 6.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 109.886 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -118.55 144.45 46.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.976 -1.077 . . . . 0.0 111.276 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.538 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -139.43 163.36 32.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.548 ' CG ' ' HB3' ' A' ' 5' ' ' CYS . 57.2 t80 -93.44 117.2 29.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.003 -1.061 . . . . 0.0 111.837 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' O ' ' N ' ' A' ' 27' ' ' ALA . 42.9 t-20 -91.07 92.17 8.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.856 . . . . 0.0 108.86 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.464 ' HB2' HD23 ' A' ' 6' ' ' LEU . . . -44.58 -29.5 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.891 -1.131 . . . . 0.0 110.183 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -75.2 -23.93 57.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.811 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -92.96 -16.83 24.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 110.507 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.13 -5.72 75.15 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -145.84 -143.43 0.14 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -1.162 . . . . 0.0 109.286 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.3 m -117.44 163.33 16.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 111.687 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 5.9 mt-30 -143.8 166.56 24.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.445 ' HB ' HG23 ' A' ' 19' ' ' ILE . 82.5 p -82.97 144.29 30.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 110.555 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.538 ' HB3' ' CD1' ' A' ' 22' ' ' PHE . 7.6 p90 -145.45 171.73 14.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 109.659 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.4 t -85.71 122.54 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.7 t80 -99.77 148.88 23.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.523 -0.736 . . . . 0.0 109.911 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.532 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -96.89 -3.9 59.06 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.641 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.604 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.41 -2.81 2.49 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.184 -1.186 . . . . 0.0 111.066 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.432 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 26.0 p -139.81 152.49 46.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.886 -1.134 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 49.04 42.99 21.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.379 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -70.81 149.87 46.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -101.1 -164.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.538 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 12.2 mtt-85 -82.79 -12.81 57.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.047 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 6.7 t-20 -95.48 54.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.585 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 15.7 t-20 -152.73 84.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.819 . . . . 0.0 109.303 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 14.7 m-85 -98.5 154.67 17.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.813 . . . . 0.0 110.156 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -81.69 -18.64 43.72 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 110.611 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.402 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 95.3 p -142.18 155.67 45.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.53 70.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.93 -23.83 55.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 44.6 t0 -74.29 -33.98 63.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -71.69 -48.51 46.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' GLY . 1.3 mmt -56.01 -57.55 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.141 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -24.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.986 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.8 m -99.54 -63.72 1.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.487 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 56.7 m -103.68 34.09 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.584 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -87.2 44.89 3.34 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -110.08 50.36 0.78 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.246 -1.149 . . . . 0.0 110.187 -179.944 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.494 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.646 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 39.8 Cg_endo -70.64 158.82 54.72 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.045 1.55 . . . . 0.0 111.338 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -98.61 -25.44 14.72 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.681 -0.637 . . . . 0.0 109.412 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 53.5 p90 -67.48 -21.16 65.53 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.141 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.577 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 97.9 m -77.07 -24.2 51.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HA ' HD22 ' A' ' 6' ' ' LEU . 22.8 mt -83.63 -19.46 35.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.536 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.04 163.97 50.64 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.79 . . . . 0.0 109.938 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.75 160.25 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.856 1.45 . . . . 0.0 110.294 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.567 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.1 Cg_endo -71.4 -178.39 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.939 1.494 . . . . 0.0 110.546 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 86.1 t80 -132.15 93.35 3.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 110.128 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.27 -23.03 66.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.9 176.5 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.8 Cg_endo -79.9 -93.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.927 1.488 . . . . 0.0 110.357 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.5 m 42.77 -168.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.632 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -138.72 13.09 2.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.067 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.58 164.35 11.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 109.959 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -128.85 71.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.504 HD13 ' CB ' ' A' ' 37' ' ' ALA . 68.0 mt -77.88 151.9 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.772 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.4 ' HA ' HD12 ' A' ' 19' ' ' ILE . 26.2 mm -96.38 89.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.671 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -90.06 172.98 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.833 . . . . 0.0 110.327 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.512 ' CE1' HG22 ' A' ' 32' ' ' THR . 7.6 m-85 -114.41 144.73 42.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -144.7 154.2 42.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.649 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 67.3 t80 -83.0 112.87 20.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.382 -0.824 . . . . 0.0 110.876 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' A' ' 27' ' ' ALA . 61.1 t-20 -84.81 86.07 7.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.059 -1.025 . . . . 0.0 109.98 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.29 -25.39 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.06 -1.025 . . . . 0.0 109.741 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.416 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -76.07 -26.01 56.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.55 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.528 ' CB ' HD23 ' A' ' 29' ' ' LEU . . . -94.12 -25.49 17.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.161 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.77 78.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.528 HD23 ' CB ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -137.99 -145.16 0.19 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.138 -1.213 . . . . 0.0 109.588 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 95.5 m -119.16 150.6 39.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 111.048 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.408 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 24.7 mt-30 -140.48 160.4 40.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.512 HG22 ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -89.2 146.87 24.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.069 -1.019 . . . . 0.0 110.588 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.567 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.8 p90 -138.08 162.27 34.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.045 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 11' ' ' THR . 97.5 t -74.26 106.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 10.4 t80 -88.17 148.86 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.368 -0.833 . . . . 0.0 109.992 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -86.84 -1.35 85.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.577 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 75.42 -6.23 2.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.463 -1.022 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 p -136.07 165.76 24.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.893 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 4.7 mtt180 45.75 52.81 9.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.013 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -72.79 156.73 38.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.269 -0.895 . . . . 0.0 110.55 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -119.53 -162.62 0.93 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.872 . . . . 0.0 110.292 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.579 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 17.7 mtm180 -81.03 -26.07 36.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.002 -1.061 . . . . 0.0 109.964 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -93.0 53.92 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.7 t-20 -146.56 74.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.518 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 8.6 m-85 -92.95 163.6 13.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 0.0 110.586 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -91.45 -14.69 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -0.995 . . . . 0.0 110.086 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.4 p -145.95 160.46 41.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 110.212 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.63 -22.45 64.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.72 -26.4 59.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.102 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.415 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 65.1 m-20 -83.01 -30.69 27.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 109.37 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.5 t -74.2 -44.04 54.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.699 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -66.29 -57.04 8.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.18 -21.36 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.1 -1.0 . . . . 0.0 110.231 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.505 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 2.1 m -101.39 -39.71 7.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 110.048 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 65.4 m -96.19 -45.98 6.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.126 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -55.17 106.11 0.5 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.78 64.5 0.02 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.33 -1.1 . . . . 0.0 110.143 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.501 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.587 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 37.6 Cg_endo -65.01 160.24 42.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.878 1.462 . . . . 0.0 111.062 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.71 -20.85 28.74 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.53 -0.731 . . . . 0.0 110.331 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.636 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 3.5 p90 -66.23 -19.71 65.91 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.203 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.578 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 4.6 m -71.23 -31.14 67.2 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.33 -16.07 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -79.87 162.01 64.04 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.13 170.53 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.414 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.59 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 41.0 Cg_endo -72.01 172.03 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.002 1.527 . . . . 0.0 110.598 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.461 ' CD2' ' HD2' ' A' ' 41' ' ' LYS . 17.7 t80 -130.84 94.31 3.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 110.683 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -51.74 -23.11 4.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 72.69 151.3 1.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.98 93.3 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.073 1.565 . . . . 0.0 110.222 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -154.76 -163.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -127.32 -6.95 5.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.324 -0.86 . . . . 0.0 110.189 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.11 -176.8 6.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 109.776 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -155.01 76.26 0.98 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.02 -1.05 . . . . 0.0 110.674 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.486 HG21 HD13 ' A' ' 18' ' ' ILE . 19.6 mt -90.44 164.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.627 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 32.2 mm -105.31 92.7 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.993 . . . . 0.0 110.785 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.585 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.74 177.87 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.58 ' CE2' HG23 ' A' ' 32' ' ' THR . 67.1 m-85 -114.88 151.9 33.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.935 -1.103 . . . . 0.0 111.124 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -144.62 153.77 42.11 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.52 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 30.3 t80 -76.11 100.25 4.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.171 -0.956 . . . . 0.0 111.15 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.7 t-20 -75.28 71.67 2.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.804 -1.185 . . . . 0.0 109.081 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.428 ' HB1' ' CE2' ' A' ' 23' ' ' TYR . . . -47.74 -24.53 0.97 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.042 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -70.55 -31.31 68.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -92.15 -21.7 20.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.466 -0.771 . . . . 0.0 109.583 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.2 5.18 60.81 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -150.72 -142.5 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.058 -1.26 . . . . 0.0 109.713 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.458 ' O ' HD12 ' A' ' 29' ' ' LEU . 92.1 m -125.14 147.79 48.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 110.346 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -135.83 178.06 7.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.491 -0.756 . . . . 0.0 109.256 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.58 HG23 ' CE2' ' A' ' 21' ' ' TYR . 1.5 p -101.78 144.21 30.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.096 . . . . 0.0 110.633 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.59 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 24.2 p90 -133.04 162.89 30.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.454 ' O ' ' OG1' ' A' ' 11' ' ' THR . 94.0 t -75.4 97.21 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 0.0 111.146 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CD2' ' HG3' ' A' ' 20' ' ' ARG . 11.4 t80 -80.06 145.63 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.606 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -83.48 1.29 88.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.581 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 79.74 -27.33 0.15 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.622 -0.928 . . . . 0.0 110.852 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -127.23 169.63 13.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.96 -1.087 . . . . 0.0 109.672 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 17.1 mmt180 57.27 33.76 23.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.414 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . . . -69.87 161.31 30.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HD2' ' CD2' ' A' ' 10' ' ' TYR . 17.0 mtpt -137.04 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.004 . . . . 0.0 110.419 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.636 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.1 ptp180 -66.99 -32.04 73.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.835 . . . . 0.0 111.452 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.4 t-20 -90.63 61.72 4.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.731 -1.23 . . . . 0.0 109.748 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.563 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 33.1 t-20 -161.92 76.19 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 24.6 m-85 -85.69 134.56 33.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.388 -0.82 . . . . 0.0 110.155 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 20' ' ' ARG . 39.3 mttt -65.23 -16.49 63.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.6 p -149.6 159.34 44.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.34 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -20.36 66.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.007 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -31.9 64.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.226 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.66 -33.98 53.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.88 . . . . 0.0 109.625 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.584 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 18.6 t -72.85 -44.61 61.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 109.066 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLY . 48.1 tpp -69.61 -44.49 70.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.547 -0.721 . . . . 0.0 109.389 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -60.26 -24.03 64.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.873 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.418 HG23 ' SG ' ' A' ' 5' ' ' CYS . 4.5 m -85.38 -51.6 6.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 109.945 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.459 ' SG ' ' HD2' ' A' ' 2' ' ' PRO . 73.1 m -133.35 46.91 2.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.221 -0.924 . . . . 0.0 110.545 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -102.67 -164.95 26.17 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.95 30.29 1.99 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.175 -1.191 . . . . 0.0 110.228 179.931 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.501 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 7.0 ptt-85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.792 0.33 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.611 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 39.6 Cg_endo -68.45 161.52 44.6 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.077 1.567 . . . . 0.0 111.159 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -89.68 -21.28 22.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.561 -0.712 . . . . 0.0 110.232 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.611 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 6.0 p90 -65.7 -14.05 60.48 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.916 -1.114 . . . . 0.0 109.783 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 23' ' ' TYR . 1.7 m -78.63 -22.64 46.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 110.354 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.06 -10.29 39.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.677 -1.264 . . . . 0.0 109.592 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.76 156.57 82.68 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 0.0 110.074 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 47.2 Cg_endo -73.85 174.4 12.39 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.93 1.489 . . . . 0.0 110.221 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.594 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 45.4 Cg_endo -72.97 -178.36 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.02 1.537 . . . . 0.0 110.357 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.422 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 14.4 t80 -155.25 94.18 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -53.5 -23.2 9.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.8 152.4 2.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 60.88 4.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.951 1.5 . . . . 0.0 110.08 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.415 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 15.5 m -123.03 -164.53 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -122.5 0.24 9.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.69 171.49 15.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.436 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.9 ttt-85 -149.21 69.22 1.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.447 HD12 HG22 ' A' ' 18' ' ' ILE . 12.8 mt -95.52 163.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.875 . . . . 0.0 109.988 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.458 ' CG2' ' HB ' ' A' ' 32' ' ' THR . 15.4 mm -104.98 86.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.254 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.486 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -88.93 179.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.845 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.576 ' CE1' HG21 ' A' ' 32' ' ' THR . 36.6 m-85 -115.3 149.3 38.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 110.942 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 14.2 p90 -144.11 -179.03 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.57 -0.706 . . . . 0.0 109.771 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.66 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.7 OUTLIER -95.8 98.53 10.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.927 -1.108 . . . . 0.0 110.92 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.5 t-20 -81.46 63.92 5.97 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.149 177.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -47.25 -26.98 1.35 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.324 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -35.42 80.9 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -88.09 -17.89 30.06 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.23 10.73 60.62 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.479 ' CD2' ' N ' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -163.19 -179.13 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -1.217 . . . . 0.0 108.951 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 85.3 m -82.5 150.45 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.566 -0.709 . . . . 0.0 110.019 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -140.78 169.11 18.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.576 HG21 ' CE1' ' A' ' 21' ' ' TYR . 19.6 p -88.64 144.38 26.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 110.098 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.594 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.1 p90 -140.02 165.28 27.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 11' ' ' THR . 24.4 t -74.68 124.96 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 110.221 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.3 t80 -109.46 147.43 32.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -0.848 . . . . 0.0 109.985 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -93.77 -2.08 65.22 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.964 -1.085 . . . . 0.0 110.406 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.79 -0.83 3.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.123 -1.222 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 152.29 28.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 0.0 109.923 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.69 29.97 16.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -75.27 175.06 8.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.526 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.422 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 22.2 mtpt -121.46 -174.38 2.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 109.548 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.578 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.5 mtt-85 -70.26 -16.76 63.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.077 . . . . 0.0 109.3 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 2.1 t-20 -93.45 62.96 3.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.512 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 8.7 t-20 -154.84 80.22 1.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 17.1 m-85 -95.5 155.64 16.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.97 -22.8 48.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.332 -0.855 . . . . 0.0 110.33 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 98.9 p -134.17 157.97 44.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 110.591 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.04 -24.38 59.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -74.97 -17.57 60.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.482 -0.761 . . . . 0.0 110.032 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.459 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.2 t0 -93.5 -30.2 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.207 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 1.7 t -66.89 -52.57 41.68 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' GLY . 3.4 tpt -66.04 -49.43 67.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.641 -0.662 . . . . 0.0 109.846 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -41.47 -41.25 2.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 m -91.83 -45.22 8.51 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.835 0.826 . . . . 0.0 109.131 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.66 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 72.8 m -86.21 28.78 0.8 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.742 -0.598 . . . . 0.0 111.396 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -123.92 131.1 7.87 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.72 42.38 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.16 -1.2 . . . . 0.0 110.142 179.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.474 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 1.6 ptt-85 . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 38.0 Cg_endo -66.27 160.15 46.53 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.833 1.439 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.453 ' HA ' HD13 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -100.98 -16.27 17.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.55 -0.719 . . . . 0.0 110.355 -179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.735 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 4.1 p90 -65.79 -17.65 64.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.916 -1.115 . . . . 0.0 110.681 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.566 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.33 -14.31 46.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.927 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.453 HD13 ' HA ' ' A' ' 3' ' ' ASP . 54.6 mt -75.51 -27.93 58.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.965 -1.084 . . . . 0.0 110.182 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.445 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -64.68 166.57 11.35 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 110.283 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD2' ' CG ' ' A' ' 7' ' ' GLU . 46.2 Cg_endo -74.7 168.68 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.121 1.59 . . . . 0.0 110.448 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.7 Cg_endo -71.54 -170.41 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.02 1.537 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CD1' ' HE3' ' A' ' 41' ' ' LYS . 43.0 t80 -145.62 93.39 2.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 110.611 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.462 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.4 m -64.73 -22.89 67.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.23 158.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.14 81.1 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.036 1.545 . . . . 0.0 110.582 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -147.45 167.37 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 0.0 110.235 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -107.53 14.53 25.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.26 152.66 23.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.37 77.89 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 20' ' ' ARG . 70.0 mt -103.13 138.13 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.479 HG22 ' HB ' ' A' ' 32' ' ' THR . 42.8 mm -86.57 81.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.082 -1.011 . . . . 0.0 110.264 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HG3' ' CB ' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -86.54 173.25 9.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.563 ' CE2' ' HB1' ' A' ' 48' ' ' ALA . 61.9 m-85 -114.24 154.29 28.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.145 -0.972 . . . . 0.0 111.373 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 9.1 p90 -150.56 156.97 42.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.566 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 49.5 t80 -83.14 115.69 22.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.135 -0.978 . . . . 0.0 111.266 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.498 ' ND2' ' HB1' ' A' ' 27' ' ' ALA . 60.5 t-20 -91.91 87.78 6.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.438 ' HB3' HD22 ' A' ' 6' ' ' LEU . . . -45.37 -25.42 0.4 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.052 -1.03 . . . . 0.0 109.721 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -24.02 52.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' HB1' ' ND2' ' A' ' 24' ' ' ASN . . . -95.52 -33.54 12.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 110.492 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.428 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 102.12 -10.69 56.96 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HG ' ' C ' ' A' ' 28' ' ' GLY . 1.1 mt -134.45 -143.99 0.21 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.387 -1.066 . . . . 0.0 109.092 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.2 m -120.24 145.68 46.8 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 109.76 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -129.24 161.05 31.07 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 6.3 p -86.98 144.48 26.9 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.504 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.4 p90 -140.44 161.89 36.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.589 -0.694 . . . . 0.0 109.933 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 11' ' ' THR . 63.5 t -74.47 111.08 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.499 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.602 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.2 t80 -91.94 147.65 22.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -85.8 -4.12 85.25 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.602 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 68.59 12.48 8.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 110.089 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.2 p -147.3 147.31 30.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 110.454 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 51.89 44.77 29.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -67.78 146.13 54.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.579 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' HE3' ' CD1' ' A' ' 10' ' ' TYR . 26.5 mttm -109.55 -160.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.653 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.735 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -80.87 -22.21 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.042 -1.036 . . . . 0.0 110.351 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.476 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 9.6 t-20 -91.31 53.32 2.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.906 0.86 . . . . 0.0 109.048 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.5 t-20 -159.82 75.41 0.62 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 23.4 m-85 -85.18 134.23 34.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.524 -0.735 . . . . 0.0 110.414 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.1 tptm -60.42 -20.85 61.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.77 . . . . 0.0 111.325 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.4 p -142.52 162.22 36.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.976 -1.077 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.563 ' HB1' ' CE2' ' A' ' 21' ' ' TYR . . . -66.32 -27.04 67.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 82.1 mt-10 -75.26 -28.04 59.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.21 -31.27 58.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.493 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 54.0 t -80.58 -44.01 19.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.99 -45.89 59.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 110.246 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -60.81 -15.15 26.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.976 -1.078 . . . . 0.0 109.141 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.9 m -94.99 -54.79 3.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 0.0 110.144 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 58.1 m -114.71 25.75 10.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.688 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -75.33 -172.33 31.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.54 -10.43 10.58 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.351 -1.087 . . . . 0.0 110.305 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.482 ' HD3' ' CD2' ' A' ' 6' ' ' LEU . 12.6 ttm105 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.964 0.411 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.584 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 38.5 Cg_endo -67.04 155.3 71.45 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 124.478 1.778 . . . . 0.0 111.421 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 4' ' ' PHE . 19.1 p30 -76.16 -29.67 57.83 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.919 -0.713 . . . . 0.0 109.775 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.584 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 4.1 p90 -67.64 -16.52 64.2 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.689 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 4.5 t -78.68 -29.76 45.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.595 -0.691 . . . . 0.0 109.734 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.482 ' CD2' ' HD3' ' A' ' 1' ' ' ARG . 27.7 mt -95.47 -9.02 33.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 109.631 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.443 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 3.9 mm-40 -75.1 160.85 79.46 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.913 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.89 162.13 39.93 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.916 1.482 . . . . 0.0 110.266 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.548 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.5 Cg_endo -70.15 171.76 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.034 1.544 . . . . 0.0 110.342 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.577 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 37.4 t80 -133.24 94.45 3.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.133 -0.979 . . . . 0.0 111.019 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -59.55 -22.91 62.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.577 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 70.85 143.97 0.27 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.92 60.95 5.51 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.049 1.552 . . . . 0.0 110.348 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.13 -169.75 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -105.71 -31.7 8.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.16 154.77 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.402 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 12.7 ptt85 -143.05 77.6 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 mt -92.14 160.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.455 HD13 HG22 ' A' ' 19' ' ' ILE . 46.7 mm -91.93 83.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.834 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.581 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -80.82 175.49 10.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.054 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.559 ' CE1' HG22 ' A' ' 32' ' ' THR . 51.3 m-85 -115.25 147.72 40.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 110.95 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 15.3 p90 -147.39 156.26 42.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 72.8 t80 -81.42 114.57 20.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.294 -0.878 . . . . 0.0 110.808 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 27' ' ' ALA . 30.6 t-20 -82.06 82.11 7.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.794 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.67 -26.61 0.65 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.993 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.462 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 36.8 mmtm -78.05 -23.04 48.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.861 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -98.28 -26.83 14.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.227 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -3.1 57.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -141.58 -142.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 99.2 m -121.74 159.45 26.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.496 -0.753 . . . . 0.0 110.731 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 4.7 mt-30 -143.2 169.08 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.509 -0.745 . . . . 0.0 109.32 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.559 HG22 ' CE1' ' A' ' 21' ' ' TYR . 1.5 p -91.54 144.27 25.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.386 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 14.1 p90 -143.39 166.57 24.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 11' ' ' THR . 65.1 t -74.41 128.3 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.452 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.609 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -112.27 145.83 39.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.064 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.49 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -96.93 7.98 65.17 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.046 -1.073 . . . . 0.0 110.742 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.609 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 58.99 12.47 2.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.283 . . . . 0.0 110.899 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 39' ' ' ARG . 17.9 p -152.34 164.58 37.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.043 -1.036 . . . . 0.0 110.494 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 98.7 mtt180 42.56 38.43 1.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.922 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.447 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -79.88 157.58 26.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -122.02 -168.15 1.66 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.369 -0.832 . . . . 0.0 109.63 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.519 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.6 mtm-85 -71.56 -19.16 62.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.022 -1.049 . . . . 0.0 110.152 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 5.1 t-20 -86.23 54.7 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.536 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -163.03 80.87 0.48 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.837 . . . . 0.0 109.227 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 19.8 m-85 -87.8 146.34 25.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.79 -25.45 62.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.758 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 97.5 p -140.47 160.4 40.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.563 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.57 67.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 0.0 109.666 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.57 -28.69 61.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.988 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 1.1 m-20 -80.83 -30.62 35.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.616 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 42.7 t -79.37 -44.64 21.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 109.333 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.7 ttm -67.45 -50.28 59.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 109.48 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -58.32 -19.06 31.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.889 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -90.72 -47.48 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.4 t -126.98 45.93 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -101.98 13.96 57.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.27 63.09 4.48 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.221 -1.164 . . . . 0.0 110.179 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.473 ' NH2' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.85 0.357 . . . . 0.0 110.221 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.626 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 40.1 Cg_endo -71.37 159.79 50.59 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.008 1.531 . . . . 0.0 110.631 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -95.32 -26.28 15.98 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.355 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.626 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 52.1 p90 -67.99 -27.32 66.47 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.627 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.552 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 53.4 m -68.15 -29.47 68.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 109.31 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.3 mt -77.09 -13.64 59.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.69 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.428 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -79.48 165.01 51.02 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.405 -0.81 . . . . 0.0 110.286 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD2' ' OE1' ' A' ' 7' ' ' GLU . 44.4 Cg_endo -71.97 160.19 48.29 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.995 1.524 . . . . 0.0 110.15 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.6 Cg_endo -70.2 166.56 27.75 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.975 1.513 . . . . 0.0 110.612 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -117.49 94.1 4.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -0.911 . . . . 0.0 110.692 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -63.3 -22.75 67.07 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 63.54 169.34 1.35 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -75.01 -93.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.961 1.506 . . . . 0.0 110.453 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 40.37 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HD3' ' C ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -143.13 18.24 1.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.68 172.3 6.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.449 ' HG2' HG13 ' A' ' 34' ' ' VAL . 8.4 ttp180 -134.74 73.06 1.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.845 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.524 HD11 ' CB ' ' A' ' 37' ' ' ALA . 97.1 mt -88.56 155.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.383 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.456 HG21 ' HB ' ' A' ' 32' ' ' THR . 15.4 mm -102.01 92.15 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.582 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.6 mmp_? -92.48 -179.92 5.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.696 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 45' ' ' PHE . 47.6 m-85 -112.26 150.25 31.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -151.74 157.75 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.552 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 47.0 t80 -83.8 110.99 18.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 110.951 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 27' ' ' ALA . 41.7 t-20 -88.52 87.52 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.844 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.16 -33.82 2.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 109.411 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -28.95 69.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 109.549 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -94.87 -17.57 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.38 -9.5 70.22 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.519 ' HB2' ' CE ' ' A' ' 52' ' ' MET . 0.6 OUTLIER -135.19 -143.11 0.19 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.228 -1.16 . . . . 0.0 109.426 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.4 m -116.95 145.39 43.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 110.621 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 mt-30 -128.86 162.79 26.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.795 . . . . 0.0 109.595 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.456 ' HB ' HG21 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -86.38 148.9 25.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 0.0 110.88 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.6 p90 -143.59 161.74 37.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.994 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 11' ' ' THR . 70.1 t -74.92 97.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.327 -0.858 . . . . 0.0 110.857 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.582 ' CD2' ' HG3' ' A' ' 20' ' ' ARG . 7.9 t80 -79.26 146.45 33.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.367 -0.833 . . . . 0.0 110.356 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -80.0 0.58 82.68 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 36' ' ' GLY . . . 73.95 -1.39 3.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.441 -1.035 . . . . 0.0 110.995 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 p -143.6 168.94 18.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.917 -1.115 . . . . 0.0 110.708 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 48.97 37.87 11.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.64 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.429 ' HB1' ' CZ ' ' A' ' 35' ' ' TYR . . . -65.31 144.55 57.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 109.672 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -127.68 -155.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.953 . . . . 0.0 110.704 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.616 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 14.7 ptp180 -70.69 -30.6 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.858 . . . . 0.0 111.829 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.7 t-20 -93.92 54.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.64 -1.288 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.4 t-20 -164.12 79.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.603 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 40.1 m-85 -85.46 148.78 25.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 110.041 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 15.3 mttt -97.02 7.03 47.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.037 -1.04 . . . . 0.0 110.665 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.539 ' OG ' ' CB ' ' A' ' 50' ' ' ASP . 51.7 p -134.97 161.44 35.26 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.2 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.77 27.44 0.63 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.583 0.706 . . . . 0.0 111.069 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -160.6 -16.66 0.05 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.602 -0.686 . . . . 0.0 111.616 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.539 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 12.1 t0 -70.76 -25.11 62.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.711 -1.243 . . . . 0.0 108.055 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.603 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.8 t -71.49 -43.91 65.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.519 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 7.7 mtt -67.9 -50.82 54.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.65 -0.656 . . . . 0.0 109.764 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.83 -19.35 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -104.5 -43.51 5.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.474 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 56.7 m -85.0 -61.27 1.81 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 110.514 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 52' ' ' MET . . . -144.46 -118.31 1.23 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.4 ' HA2' ' HB3' ' A' ' 52' ' ' MET . . . 168.84 123.59 0.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.062 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.47 ' HD2' HD21 ' A' ' 6' ' ' LEU . 2.1 ttp-105 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.943 0.401 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.646 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 38.3 Cg_endo -68.09 159.29 53.7 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.244 1.654 . . . . 0.0 111.082 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.11 -28.15 17.3 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.209 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 49.0 p90 -67.97 -26.56 65.99 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.655 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 26.5 m -70.29 -30.35 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.47 HD21 ' HD2' ' A' ' 1' ' ' ARG . 16.6 mt -75.77 -23.08 55.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.703 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -75.31 160.93 78.82 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 109.715 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.46 169.36 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.832 1.438 . . . . 0.0 109.958 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.582 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.4 Cg_endo -71.13 173.86 11.54 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.898 1.472 . . . . 0.0 110.461 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 36.6 t80 -135.07 94.08 3.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.62 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -62.52 -23.29 66.88 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.51 -163.44 3.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 48.8 Cg_endo -74.92 -156.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.152 1.606 . . . . 0.0 110.493 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 20.2 m 63.09 147.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 10.79 39.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.472 ' CB ' ' HB3' ' A' ' 37' ' ' ALA . . . -51.91 165.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.942 . . . . 0.0 110.558 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -146.61 65.98 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.909 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.427 HD12 HG22 ' A' ' 18' ' ' ILE . 29.1 mt -97.53 152.18 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.745 . . . . 0.0 110.04 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 19' ' ' ILE . 39.2 mm -89.25 84.62 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 110.462 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -85.0 168.14 15.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.801 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.491 ' CE2' HG22 ' A' ' 32' ' ' THR . 37.1 m-85 -110.04 149.8 29.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.952 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -152.67 160.57 43.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.581 -0.7 . . . . 0.0 109.501 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 5' ' ' CYS . 72.6 t80 -90.09 127.82 36.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.285 -0.884 . . . . 0.0 110.654 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.468 ' HB3' ' HB1' ' A' ' 27' ' ' ALA . 43.7 t-20 -101.78 87.55 3.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.68 -24.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 109.665 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.06 -26.41 59.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.779 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.468 ' HB1' ' HB3' ' A' ' 24' ' ' ASN . . . -96.56 -37.05 10.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.86 -11.31 38.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.0 mp -133.97 -144.17 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -1.202 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 65.9 m -116.36 156.43 26.73 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.438 -0.789 . . . . 0.0 110.903 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.476 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 18.2 mt-30 -144.62 167.59 22.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.505 -0.747 . . . . 0.0 109.575 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.4 p -96.41 144.9 26.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.784 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 24.0 p90 -139.37 165.42 27.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.441 -0.787 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' ' OG1' ' A' ' 11' ' ' THR . 30.1 t -75.72 113.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.475 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 8.6 t80 -93.42 148.0 22.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.328 -0.857 . . . . 0.0 109.855 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -89.95 -2.24 75.23 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.43 8.34 5.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.063 -1.257 . . . . 0.0 110.541 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.447 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 25.4 p -153.16 174.08 14.69 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.294 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.7 32.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 0.0 110.36 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' CB ' ' OH ' ' A' ' 35' ' ' TYR . . . -64.01 157.52 24.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.5 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 79.7 mttt -126.71 -159.45 0.93 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 109.683 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.56 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -77.54 -19.24 56.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.689 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.2 t-20 -92.94 64.48 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 0.0 109.711 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 31.1 t-20 -169.18 80.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.568 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.8 m-85 -91.71 157.59 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.076 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -85.82 -15.17 42.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 0.0 110.536 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.2 p -144.5 158.4 43.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.9 -24.14 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.784 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 32.6 mm-40 -75.2 -29.83 60.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.394 -0.816 . . . . 0.0 110.184 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -76.58 -32.58 58.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.525 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.568 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 35.9 t -75.02 -43.73 52.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 109.238 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -37.28 77.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.63 -0.669 . . . . 0.0 110.529 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 12.6 mtp85 -70.83 -20.95 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -102.25 -42.45 6.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.271 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.464 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.2 m -87.7 -40.55 14.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.254 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -45.19 165.57 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.71 46.0 0.36 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.181 -1.188 . . . . 0.0 110.19 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.476 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 4.0 ttp-105 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.924 0.393 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.511 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 41.8 Cg_endo -69.67 157.3 61.06 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.192 1.628 . . . . 0.0 110.727 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -85.58 -22.71 27.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.419 -0.801 . . . . 0.0 110.059 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.643 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 4.0 p90 -67.13 -21.3 65.84 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.634 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.57 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 3.9 m -68.25 -32.88 73.37 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.465 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.497 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 7.5 mt -84.56 -12.08 54.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.44 168.1 28.06 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.818 . . . . 0.0 110.206 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.14 159.18 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.926 1.488 . . . . 0.0 110.371 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.4 Cg_endo -70.78 174.1 10.89 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.006 1.529 . . . . 0.0 110.335 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.569 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 89.7 t80 -121.85 93.81 4.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 0.0 110.696 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.519 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.05 -23.12 67.21 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.569 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 64.09 147.56 0.03 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -76.9 81.95 2.46 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.141 1.6 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.92 168.56 19.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.066 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.45 3.76 54.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.91 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . -89.7 163.24 15.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 16' ' ' ALA . 27.1 mtp180 -142.75 73.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.507 HG23 ' CZ ' ' A' ' 20' ' ' ARG . 51.5 mt -86.95 155.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 32' ' ' THR . 27.4 mm -97.71 87.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 109.993 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' CZ ' HG23 ' A' ' 18' ' ' ILE . 5.7 mmp_? -91.07 177.59 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 110.142 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 38.6 m-85 -112.63 145.43 40.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.92 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 13.9 p90 -145.04 156.7 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.57 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 57.4 t80 -85.08 106.2 16.38 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' ALA . 39.5 t-20 -81.3 87.94 6.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.105 -0.997 . . . . 0.0 109.452 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.497 ' HB1' ' CD2' ' A' ' 6' ' ' LEU . . . -44.87 -27.4 0.52 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.05 -1.031 . . . . 0.0 109.787 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.39 -24.5 57.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -95.97 -17.47 20.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 0.87 89.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.437 ' HB2' ' HE1' ' A' ' 52' ' ' MET . 0.6 OUTLIER -143.9 -146.28 0.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.275 -1.132 . . . . 0.0 109.543 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 81.2 m -120.77 147.59 45.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 15.7 mt-30 -135.22 159.46 41.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.496 -0.752 . . . . 0.0 109.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -80.43 143.88 33.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.038 -1.038 . . . . 0.0 110.328 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 19.8 p90 -138.32 161.84 35.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.414 -0.804 . . . . 0.0 109.733 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 11' ' ' THR . 12.2 t -74.82 110.36 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 110.692 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.636 ' CE1' ' ND2' ' A' ' 44' ' ' ASN . 11.6 t80 -91.39 150.56 21.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 11' ' ' THR . . . -85.36 -4.59 85.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.59 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 70.4 7.04 6.06 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.144 -1.209 . . . . 0.0 110.242 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.3 p -144.58 163.27 34.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 47.81 35.06 4.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.51 ' CB ' ' OH ' ' A' ' 35' ' ' TYR . . . -48.76 151.78 1.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 9.1 mttm -131.38 -161.54 1.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.325 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.643 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.9 ptt180 -75.71 -32.52 60.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -89.15 67.71 8.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.928 -1.108 . . . . 0.0 109.252 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.636 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.0 t-20 -169.1 74.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m-85 -84.84 139.69 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.279 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -75.22 -21.33 58.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -134.15 156.31 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.173 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.479 ' HB3' ' CE2' ' A' ' 21' ' ' TYR . . . -67.54 -24.77 65.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.83 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.33 -32.57 62.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.504 -0.748 . . . . 0.0 109.968 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.75 -37.16 73.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.898 . . . . 0.0 109.201 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.553 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 52.6 t -73.21 -44.35 59.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.503 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -61.86 -51.74 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -52.55 -23.98 7.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.464 HG22 ' SG ' ' A' ' 5' ' ' CYS . 6.4 m -89.18 -48.96 7.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.437 -0.789 . . . . 0.0 109.82 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.565 ' O ' ' CE1' ' A' ' 23' ' ' TYR . 72.2 m -141.81 51.4 1.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -102.48 -179.52 27.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.03 105.67 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.195 -1.179 . . . . 0.0 110.284 -179.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.469 ' HG2' ' SG ' ' A' ' 55' ' ' CYS . 12.9 mtt85 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.584 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 37.8 Cg_endo -69.56 149.49 68.25 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.94 1.494 . . . . 0.0 110.726 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.97 -31.39 71.93 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.147 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CD1' ' CB ' ' A' ' 42' ' ' ARG . 9.1 p90 -68.39 -22.16 64.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.895 -1.128 . . . . 0.0 110.487 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 5.0 t -82.34 -24.59 34.49 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.82 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 2' ' ' PRO . 20.4 mt -90.83 -14.61 31.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.89 . . . . 0.0 109.587 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -78.01 156.63 79.5 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.419 -0.801 . . . . 0.0 109.624 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.21 163.68 35.22 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.77 1.405 . . . . 0.0 110.071 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.503 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.8 Cg_endo -67.65 -176.45 0.94 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.876 1.461 . . . . 0.0 110.158 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -146.34 93.76 2.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 110.848 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.497 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -60.31 -22.67 63.46 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.14 170.62 1.05 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' CYS . 49.5 Cg_endo -75.13 -95.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.511 . . . . 0.0 109.956 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 39.39 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.525 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.77 48.68 1.61 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.14 -0.975 . . . . 0.0 110.247 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.454 ' HB1' ' HB1' ' A' ' 37' ' ' ALA . . . -137.02 179.65 6.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.29 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -153.4 70.05 0.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.447 HD11 ' CB ' ' A' ' 37' ' ' ALA . 76.9 mt -80.34 157.93 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.581 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 19' ' ' ILE . 41.0 mm -91.55 79.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.298 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.567 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 10.0 mmt85 -84.97 173.24 10.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.96 . . . . 0.0 110.05 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.508 ' CE1' HG21 ' A' ' 32' ' ' THR . 6.8 m-85 -112.83 144.87 41.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.938 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 7.0 p90 -144.05 163.61 33.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.737 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 77.5 t80 -96.59 120.22 36.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 111.033 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.504 ' O ' ' N ' ' A' ' 27' ' ' ALA . 45.8 t-20 -89.95 91.99 8.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 109.727 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.17 -27.33 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.62 -24.77 56.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.675 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -94.23 -36.01 12.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.739 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.0 65.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.566 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 1.1 mp -125.84 -146.67 0.35 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.039 -1.271 . . . . 0.0 109.638 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.38 149.02 44.38 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.528 -0.733 . . . . 0.0 110.118 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -139.34 178.27 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.901 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.508 HG21 ' CE1' ' A' ' 21' ' ' TYR . 44.2 p -105.07 147.75 27.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.784 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.503 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 21.0 p90 -142.43 163.79 31.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.574 -0.703 . . . . 0.0 110.004 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 11' ' ' THR . 83.0 t -75.16 110.46 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 4.7 t80 -94.07 144.56 25.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 110.322 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -76.95 4.98 51.68 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.104 -0.997 . . . . 0.0 110.901 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.5 -1.98 2.78 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.201 -1.176 . . . . 0.0 111.294 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.448 ' N ' ' CZ ' ' A' ' 35' ' ' TYR . 21.7 p -150.47 174.37 12.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.952 -1.093 . . . . 0.0 110.199 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' CYS . 1.3 mtt-85 42.92 52.82 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 109.799 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 35' ' ' TYR . . . -91.08 140.67 29.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 111.096 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.65 -165.63 1.28 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 108.923 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -70.04 -36.6 75.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.07 . . . . 0.0 110.13 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 7.8 t-20 -76.06 54.49 0.86 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.158 -0.964 . . . . 0.0 109.905 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.527 ' OD1' ' CG ' ' A' ' 20' ' ' ARG . 41.8 t-20 -155.79 69.13 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.592 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 12.4 m-85 -89.83 166.07 13.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.741 . . . . 0.0 110.238 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -92.1 -9.33 42.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.216 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -148.51 155.22 40.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.622 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.45 -26.75 68.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.647 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 5.1 mt-10 -72.33 -32.87 66.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.6 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 39.8 t0 -70.65 -36.55 73.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.98 -44.49 65.87 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.545 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -63.52 -59.63 4.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.591 -0.693 . . . . 0.0 109.997 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -43.23 -26.37 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 0.0 109.695 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.5 m -97.89 -36.36 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.469 ' SG ' ' HG2' ' A' ' 1' ' ' ARG . 2.3 t -136.58 47.74 2.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.48 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -92.01 132.9 11.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 157.04 -140.92 7.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.379 -1.071 . . . . 0.0 110.34 -179.964 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.6 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.4 Cg_endo -70.0 156.68 62.13 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.065 1.56 . . . . 0.0 110.405 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -79.26 -26.95 42.31 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.772 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 6.3 p90 -67.74 -19.46 65.13 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.279 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 2.1 m -80.88 -26.97 36.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 0.0 109.265 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.58 -18.18 42.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.466 -0.771 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 159.52 83.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.962 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.38 171.96 16.62 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.01 1.532 . . . . 0.0 110.434 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.59 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.3 Cg_endo -71.74 166.26 30.01 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.932 1.491 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 5.3 t80 -123.0 94.03 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -0.973 . . . . 0.0 111.048 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.492 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.48 -22.25 66.91 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 56.6 166.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 14' ' ' CYS . 50.7 Cg_endo -72.86 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.961 1.506 . . . . 0.0 109.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' PRO . 3.1 m 38.62 -160.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 42.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.021 . . . . 0.0 110.116 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.27 150.83 35.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -0.859 . . . . 0.0 110.215 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.92 83.27 2.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.122 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mt -106.54 158.83 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.054 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.84 89.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.194 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' NH2' ' HB3' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -91.28 173.93 7.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.351 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.518 ' CE1' ' CG2' ' A' ' 32' ' ' THR . 30.7 m-85 -115.6 150.45 36.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 111.176 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.33 154.66 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.533 -0.73 . . . . 0.0 109.487 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 66.5 t80 -85.34 116.47 23.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.458 ' OD1' ' HB2' ' A' ' 26' ' ' LYS . 63.8 t-20 -89.28 93.96 9.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.013 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -21.7 1.42 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.753 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -81.05 -22.87 38.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.861 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -97.57 -28.06 14.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.237 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.51 -10.13 69.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.25 -146.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -1.167 . . . . 0.0 109.523 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 60.8 m -116.04 154.62 29.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.779 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -142.0 154.91 45.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.484 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.518 ' CG2' ' CE1' ' A' ' 21' ' ' TYR . 18.9 p -83.49 144.86 29.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.2 p90 -140.97 164.2 30.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.351 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 11' ' ' THR . 22.9 t -74.37 125.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.402 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.591 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.5 t80 -106.13 147.65 28.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 0.0 110.413 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -90.77 -4.1 70.17 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.72 5.46 5.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.161 -1.2 . . . . 0.0 110.845 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.8 p -157.49 164.32 37.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.883 -1.136 . . . . 0.0 110.855 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER 50.63 34.72 10.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.328 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -84.63 164.69 18.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.74 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -121.5 -159.69 0.82 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.547 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 2.7 mtm180 -77.51 -8.86 58.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.098 . . . . 0.0 109.766 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -94.11 59.39 2.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.694 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.581 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 14.8 t-20 -165.23 84.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.572 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.9 m-85 -93.97 150.71 20.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.708 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 16.4 mtpt -81.51 -12.24 58.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -142.45 156.52 45.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.296 -0.878 . . . . 0.0 110.186 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -74.12 -22.56 59.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.852 . . . . 0.0 109.953 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 5.1 tp10 -70.68 -35.95 73.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 110.482 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 54' ' ' THR . 0.4 OUTLIER -78.76 -35.44 44.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.668 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.572 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.3 t -67.97 -44.19 77.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.44 ' SD ' ' HA2' ' A' ' 56' ' ' GLY . 39.1 tpp -64.35 -61.05 2.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.573 -0.705 . . . . 0.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.49 -18.97 21.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.426 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 2.7 m -88.12 -45.62 9.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.1 m -99.6 -50.4 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.498 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 46.89 -160.83 0.27 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.48 62.93 0.83 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.308 -1.113 . . . . 0.0 110.237 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.848 0.356 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 43.7 Cg_endo -72.74 169.81 21.09 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.145 1.603 . . . . 0.0 110.95 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -91.93 -23.42 19.6 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.509 -0.744 . . . . 0.0 109.574 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.633 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 19.1 p90 -68.05 -21.79 64.98 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.557 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.485 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -80.85 -19.0 45.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.38 -24.68 59.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 7.2 mt-10 -79.04 161.61 67.71 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 41.7 Cg_endo -69.76 168.28 22.02 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.108 1.583 . . . . 0.0 110.359 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.591 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.8 Cg_endo -71.08 156.98 58.87 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.963 1.507 . . . . 0.0 110.517 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.579 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 40.9 t80 -121.39 94.26 4.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.261 -0.9 . . . . 0.0 110.883 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -56.05 -23.5 33.9 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.579 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 63.27 -178.12 6.64 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 45.7 Cg_endo -72.24 -155.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.175 1.618 . . . . 0.0 110.685 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 11.9 m 64.24 154.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 6.34 46.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.22 169.21 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 110.102 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.94 102.37 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' N ' ' A' ' 19' ' ' ILE . 28.6 mt -134.23 145.99 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.844 . . . . 0.0 110.059 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.452 ' N ' HG21 ' A' ' 18' ' ' ILE . 41.2 mm -90.37 85.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 32' ' ' THR . 9.1 mmt-85 -91.02 176.91 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.927 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 71.6 m-85 -114.0 154.18 28.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 111.528 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.443 ' CE2' ' HD3' ' A' ' 9' ' ' PRO . 11.8 p90 -153.0 154.43 34.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.405 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.485 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 89.1 t80 -83.99 106.88 15.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.269 -0.894 . . . . 0.0 111.013 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.402 ' OD1' ' CB ' ' A' ' 26' ' ' LYS . 55.3 t-20 -80.24 98.54 7.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.86 -23.35 2.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.976 -1.077 . . . . 0.0 109.559 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.402 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -77.81 -23.71 49.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.448 -0.782 . . . . 0.0 110.209 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.79 -14.52 18.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.69 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.02 1.75 85.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 30' ' ' CYS . 1.8 pp -144.27 -147.35 0.21 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.383 -1.069 . . . . 0.0 109.102 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.476 ' O ' HD11 ' A' ' 29' ' ' LEU . 79.4 m -121.96 162.2 21.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 110.607 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 95.7 mt-30 -144.87 -175.36 4.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.607 -0.683 . . . . 0.0 109.395 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 25.2 p -103.13 144.15 31.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.994 -1.066 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.8 p90 -141.8 160.53 40.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.929 . . . . 0.0 110.056 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.7 t -74.05 122.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.035 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.602 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.7 t80 -101.26 141.33 34.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.537 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -89.57 -0.53 79.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.563 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 36' ' ' GLY . . . 72.4 -1.37 2.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.191 -1.182 . . . . 0.0 111.074 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 39' ' ' ARG . 15.8 p -140.68 163.09 33.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.822 -1.174 . . . . 0.0 111.03 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 41.77 45.5 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 110.911 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -73.78 146.66 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.751 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 42.5 mtpt -95.06 -159.91 0.75 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 8.3 mtt-85 -85.55 -22.73 27.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.146 -0.971 . . . . 0.0 109.869 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.449 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 21.0 t-20 -89.07 53.86 2.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 0.0 110.14 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 3.9 t-20 -143.93 84.55 1.78 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 23.8 m-85 -99.6 153.34 19.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 110.552 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -76.24 -20.93 56.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.579 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.9 p -137.67 156.65 47.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 110.614 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.01 68.53 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.582 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.97 -38.52 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.414 -0.804 . . . . 0.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -62.04 -34.41 76.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.084 -1.01 . . . . 0.0 108.557 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.9 t -71.17 -43.18 67.99 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.535 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.13 -50.45 33.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.36 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -22.96 25.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.019 -1.051 . . . . 0.0 109.629 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.402 HG21 ' SG ' ' A' ' 55' ' ' CYS . 16.4 m -94.37 -45.85 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.532 -0.73 . . . . 0.0 109.914 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.453 ' SG ' ' CG ' ' A' ' 2' ' ' PRO . 56.7 m -116.75 38.06 3.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 110.501 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -91.92 25.3 17.26 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.06 -68.0 1.29 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.346 -1.091 . . . . 0.0 110.458 -179.647 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.499 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.584 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 39.2 Cg_endo -68.08 163.17 36.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.003 1.528 . . . . 0.0 110.456 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.3 -15.2 15.11 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.939 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.74 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 14.9 p90 -66.27 -17.03 64.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.048 -1.033 . . . . 0.0 110.23 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.522 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.5 -8.3 58.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.022 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 25' ' ' ALA . 27.5 mt -76.59 -23.28 53.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 109.953 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -81.8 174.38 6.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.349 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.78 165.85 30.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.872 1.459 . . . . 0.0 110.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.3 Cg_endo -71.62 -175.99 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.967 1.509 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 67.6 t80 -127.63 93.88 3.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.699 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.453 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -65.83 -22.62 66.56 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 60.32 151.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.16 82.54 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.97 1.51 . . . . 0.0 110.513 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.46 175.88 10.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 110.155 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -108.9 -1.03 19.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.31 160.67 28.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.14 68.47 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.72 153.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 110.075 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.472 HG22 ' HB ' ' A' ' 32' ' ' THR . 28.9 mm -98.01 86.39 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 110.37 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 mmt180 -86.59 173.15 9.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 45' ' ' PHE . 64.5 m-85 -112.69 151.12 30.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.09 -1.006 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.3 p90 -150.56 163.63 38.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.66 -0.65 . . . . 0.0 109.403 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.522 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 70.7 t80 -87.2 132.14 33.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 27' ' ' ALA . 34.8 t-20 -102.89 87.9 3.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.815 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 6' ' ' LEU . . . -45.13 -32.34 1.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.005 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.446 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 1.9 mptp? -72.84 -24.51 60.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.865 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.506 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -98.2 -33.69 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.88 . . . . 0.0 110.16 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.01 -12.37 58.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 27' ' ' ALA . 0.7 OUTLIER -127.91 -144.23 0.29 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.8 m -121.69 157.24 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 6.6 mt-30 -140.23 -177.51 5.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.472 ' HB ' HG22 ' A' ' 19' ' ' ILE . 19.8 p -102.37 144.4 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.046 -1.034 . . . . 0.0 110.546 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.6 p90 -141.57 160.28 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.79 108.34 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.249 -0.907 . . . . 0.0 110.832 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.3 t80 -87.44 146.22 25.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -85.65 -4.44 85.34 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 70.68 12.45 7.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.147 -1.207 . . . . 0.0 110.314 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 39' ' ' ARG . 27.0 p -150.11 162.88 39.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.1 mtt-85 40.65 44.42 1.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.434 ' CB ' ' OH ' ' A' ' 35' ' ' TYR . . . -62.64 155.11 27.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 2.4 mtpp -121.03 -157.8 0.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.368 -0.832 . . . . 0.0 109.578 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.74 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -83.23 -22.5 33.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 0.0 109.978 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 1.7 t-20 -90.13 54.29 2.75 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.768 0.794 . . . . 0.0 109.04 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.586 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 19.4 t-20 -157.5 76.5 0.82 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 22.9 m-85 -87.74 134.78 33.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.433 -0.792 . . . . 0.0 109.849 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -65.71 -16.61 63.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.287 -0.883 . . . . 0.0 111.34 -178.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.458 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 99.2 p -143.43 158.02 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 110.434 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 52' ' ' MET . . . -64.8 -29.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.066 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.66 -25.37 56.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.646 -0.659 . . . . 0.0 109.812 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.458 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 39.2 t0 -78.64 -30.59 46.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 109.514 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 39.9 t -78.65 -43.96 24.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.225 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLY . 72.9 mmm -66.28 -49.39 67.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.484 -0.76 . . . . 0.0 110.309 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -14.52 39.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 109.849 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.451 HG22 ' SG ' ' A' ' 55' ' ' CYS . 47.6 m -92.14 -53.56 4.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.575 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 57.6 m -110.89 20.41 17.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 110.687 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -66.27 -177.54 7.95 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.426 ' O ' ' HB1' ' A' ' 58' ' ' ALA . . . 117.75 -126.88 7.1 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 57' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.235 . . . . 0.0 110.154 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.477 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 2.1 ttp-105 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.637 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 38.5 Cg_endo -67.87 169.1 16.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.039 1.547 . . . . 0.0 111.115 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.45 -18.01 13.63 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.55 -0.719 . . . . 0.0 109.942 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.637 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 37.7 p90 -66.35 -24.09 66.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.877 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 1.7 m -85.54 -19.47 31.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.418 HD11 ' O ' ' A' ' 2' ' ' PRO . 15.1 mt -82.77 -19.03 38.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 110.837 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -86.1 169.86 14.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.93 -1.106 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.94 163.71 36.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.889 1.468 . . . . 0.0 110.183 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.6 Cg_endo -71.41 163.51 38.83 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.947 1.498 . . . . 0.0 110.516 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.412 ' CB ' ' HG3' ' A' ' 41' ' ' LYS . 17.5 t80 -120.77 93.88 4.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.32 -0.863 . . . . 0.0 110.269 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.2 m -50.62 -23.44 2.6 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.92 -176.17 21.99 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.515 ' CG ' ' HG3' ' A' ' 39' ' ' ARG . 48.8 Cg_endo -79.21 -153.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.075 1.566 . . . . 0.0 109.992 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 32.1 m 63.05 170.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.114 -0.991 . . . . 0.0 110.535 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -116.23 10.12 14.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 110.344 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 159.1 7.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.679 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -130.64 78.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.31 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 37' ' ' ALA . 6.0 mt -104.31 156.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.883 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.454 ' CG2' HG21 ' A' ' 32' ' ' THR . 44.3 mm -99.77 80.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 109.984 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 9.0 mmt180 -85.95 174.61 9.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -114.27 143.69 44.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 110.864 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.531 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 20.5 p90 -138.19 152.14 48.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.521 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 62.8 t80 -79.19 106.11 10.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.342 -0.849 . . . . 0.0 111.253 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' ALA . 53.0 t-20 -79.14 84.84 5.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.476 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.56 -26.03 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.925 -1.109 . . . . 0.0 109.439 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.67 64.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 109.579 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.5 -24.11 16.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.463 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.454 ' O ' ' HA2' ' A' ' 57' ' ' GLY . . . 96.34 1.26 60.9 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -149.44 -142.2 0.12 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.319 -1.106 . . . . 0.0 109.227 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.531 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 m -117.55 164.2 15.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.129 0.966 . . . . 0.0 112.209 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.506 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 24.7 mt-30 -147.67 160.86 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.2 p -79.7 144.15 33.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 111.13 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 13.5 p90 -144.08 160.73 40.38 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 11' ' ' THR . 9.1 t -74.01 129.25 36.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 110.19 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.592 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.5 t80 -113.84 146.58 39.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 0.0 109.359 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -89.34 4.41 84.22 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.592 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 68.96 4.59 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.94 -1.329 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.464 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 7.9 p -145.01 159.27 43.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.415 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.515 ' HG3' ' CG ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER 51.47 33.12 9.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.215 -0.928 . . . . 0.0 110.794 179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -59.77 142.13 53.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 110.46 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.412 ' HG3' ' CB ' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -102.79 -170.29 1.78 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.063 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.565 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 2.6 mtt-85 -71.73 -25.33 62.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.083 -1.01 . . . . 0.0 109.782 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 11.3 t-20 -92.91 54.38 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 109.982 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.472 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 22.6 t-20 -153.43 70.39 0.85 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.565 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 13.1 m-85 -88.2 146.25 25.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 ttmt -76.89 -18.95 58.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 110.59 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.9 p -136.24 152.34 50.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 110.398 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.38 67.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.5 -0.75 . . . . 0.0 109.907 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.506 ' N ' ' OE1' ' A' ' 49' ' ' GLU . 3.4 mp0 -73.4 -19.87 60.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.675 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.479 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.5 t0 -83.32 -29.64 28.13 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 108.722 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.66 -45.97 56.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.41 0.624 . . . . 0.0 109.5 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.53 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -61.64 -54.55 41.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.349 -0.845 . . . . 0.0 110.865 -178.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -53.09 -19.1 2.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.9 m -97.28 -59.61 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.12 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.475 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 57.1 m -112.16 -56.63 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.651 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.53 ' CA ' ' HA ' ' A' ' 52' ' ' MET . . . 54.52 167.24 0.03 OUTLIER Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 28' ' ' GLY . . . -48.33 -95.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 57' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.142 -1.211 . . . . 0.0 110.205 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.3 mtm-85 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.86 0.362 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.587 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 40.2 Cg_endo -68.61 162.89 39.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.965 1.508 . . . . 0.0 110.624 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.62 -25.47 21.27 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.723 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.601 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 42.5 p90 -68.01 -19.05 64.88 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.871 -1.131 . . . . 0.0 111.248 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.598 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 94.8 m -82.84 -25.15 32.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.9 -1.125 . . . . 0.0 109.248 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 mt -80.25 -22.93 41.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 109.485 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 5.9 mm-40 -73.07 154.85 90.63 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.19 167.04 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.927 1.488 . . . . 0.0 110.401 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.586 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.7 Cg_endo -69.22 159.05 55.33 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.027 1.541 . . . . 0.0 110.062 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 30.1 t80 -122.78 94.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 62.76 172.31 1.68 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 14' ' ' CYS . 45.9 Cg_endo -72.74 -93.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.983 1.517 . . . . 0.0 110.277 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.7 m 39.99 -162.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.208 -0.932 . . . . 0.0 110.61 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -141.61 8.98 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' O ' ' CD ' ' A' ' 17' ' ' ARG . . . -93.16 173.54 7.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.024 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' CD ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -150.08 81.97 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.2 mp -95.53 164.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.983 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.3 mm -100.87 89.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HG3' ' CB ' ' A' ' 35' ' ' TYR . 3.6 mmt85 -95.42 177.27 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.948 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 51.1 m-85 -116.09 151.03 36.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 0.0 111.156 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 11.9 p90 -147.72 158.92 44.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.523 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 68.8 t80 -88.89 107.7 19.14 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.281 -0.887 . . . . 0.0 110.895 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 27' ' ' ALA . 62.4 t-20 -83.77 89.59 7.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 110.014 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.38 -24.99 0.57 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.001 -1.062 . . . . 0.0 109.535 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -25.97 57.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.835 . . . . 0.0 109.714 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.5 ' CB ' ' NE2' ' A' ' 31' ' ' GLN . . . -94.61 -28.9 15.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.57 -10.31 59.22 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' N ' HD21 ' A' ' 29' ' ' LEU . 1.3 pt? -140.52 -147.05 0.21 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.25 -1.147 . . . . 0.0 109.841 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 99.4 m -115.69 156.92 25.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 110.551 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.5 ' NE2' ' CB ' ' A' ' 27' ' ' ALA . 45.3 mt-30 -144.02 178.69 7.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.566 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 3.3 p -95.93 144.6 26.11 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.418 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.4 p90 -143.53 165.06 28.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.488 -0.757 . . . . 0.0 109.83 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 11' ' ' THR . 63.2 t -75.16 132.08 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.984 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.3 t80 -112.71 146.81 38.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 109.864 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -99.72 1.96 57.0 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.7 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 70.59 1.73 3.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.007 -1.29 . . . . 0.0 110.971 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 39' ' ' ARG . 22.3 p -149.53 172.43 15.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 0.0 110.482 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 1.5 mpt_? 40.63 30.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.514 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -73.49 156.97 37.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 111.031 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' HD2' ' HB2' ' A' ' 10' ' ' TYR . 7.5 mtpt -110.33 -169.8 1.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.443 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.601 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 2.7 mtt-85 -76.7 -15.65 59.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.26 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 15.1 t-20 -90.39 53.79 2.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 109.473 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.0 t-20 -147.74 77.64 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 51' ' ' CYS . 17.9 m-85 -94.32 143.84 26.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.793 . . . . 0.0 110.24 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 110.294 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -136.53 157.65 46.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 110.414 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -24.88 66.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.956 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.15 -23.71 63.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.026 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 46.9 t0 -90.18 -24.7 20.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.561 ' HB2' ' CD1' ' A' ' 45' ' ' PHE . 29.7 t -82.15 -43.96 17.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 109.808 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.2 mtp -66.81 -50.25 63.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 0.0 110.547 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -17.59 2.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -110.76 -42.14 4.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.6 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.3 m -99.09 -40.16 8.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 55' ' ' CYS . . . -41.14 98.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 55' ' ' CYS . . . -100.65 -125.88 5.66 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.198 -1.178 . . . . 0.0 110.247 179.902 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.109 0.481 . . . . 0.0 110.011 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.628 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.7 Cg_endo -69.68 162.01 43.71 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.312 1.69 . . . . 0.0 111.193 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -87.35 -24.54 24.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.568 -0.707 . . . . 0.0 109.78 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.628 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 14.5 p90 -66.36 -13.94 61.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.02 -1.05 . . . . 0.0 110.142 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.6 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 6.4 m -85.3 -22.45 28.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 110.646 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.71 -2.78 47.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.74 -1.225 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.47 170.61 7.91 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 110.603 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.01 166.79 28.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.152 1.606 . . . . 0.0 110.35 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.56 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 43.3 Cg_endo -70.78 -173.13 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.883 1.465 . . . . 0.0 109.595 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.564 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 65.5 t80 -154.65 93.92 1.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.912 -1.117 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -58.68 -23.18 58.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 66.19 155.68 0.34 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.07 66.38 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.05 1.553 . . . . 0.0 110.31 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.456 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 23.0 m -121.7 -174.91 2.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.729 . . . . 0.0 109.825 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -120.68 12.33 11.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.114 -0.991 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.461 ' CB ' ' HB2' ' A' ' 37' ' ' ALA . . . -96.96 166.69 11.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 110.268 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -144.0 68.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.005 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 35' ' ' TYR . 61.4 mt -87.46 155.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.432 -0.792 . . . . 0.0 110.123 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.422 ' HA ' HD13 ' A' ' 19' ' ' ILE . 30.1 mm -93.5 89.0 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.537 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.8 mmt85 -99.52 -179.19 4.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 110.383 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.527 ' CZ ' HG23 ' A' ' 32' ' ' THR . 10.7 m-85 -116.81 153.46 32.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 111.328 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 15.5 p90 -149.06 176.77 10.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.519 -0.738 . . . . 0.0 109.361 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.615 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.8 OUTLIER -95.03 100.57 12.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' ALA . 48.8 t-20 -86.11 69.46 10.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.656 -1.278 . . . . 0.0 108.337 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.78 -26.04 0.87 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.435 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -62.08 -37.28 84.44 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -83.58 -31.86 26.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.587 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.09 -10.71 10.05 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.625 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -153.32 -141.89 0.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.754 -1.439 . . . . 0.0 109.889 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 96.2 m -107.2 151.93 24.77 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.48 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 5.7 mt-30 -141.59 179.38 6.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 110.467 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.527 HG23 ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -91.54 148.14 22.5 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.394 -0.817 . . . . 0.0 109.877 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.579 ' HB3' ' CD1' ' A' ' 22' ' ' PHE . 13.4 p90 -148.14 166.08 28.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 110.483 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.472 ' O ' ' OG1' ' A' ' 11' ' ' THR . 13.2 t -74.64 122.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.37 -0.831 . . . . 0.0 110.275 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.587 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -103.66 142.7 33.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.412 -0.805 . . . . 0.0 109.658 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -89.42 -0.98 78.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.545 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.587 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.6 0.81 3.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -1.194 . . . . 0.0 110.176 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -153.9 173.55 15.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 44.72 26.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.485 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -63.52 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.523 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.9 mtpp -95.83 -162.99 1.0 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.381 -0.825 . . . . 0.0 109.243 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.599 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.3 mtm180 -84.65 -9.33 58.36 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.002 -1.061 . . . . 0.0 109.979 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -96.97 53.99 1.24 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.561 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 13.6 t-20 -144.26 84.2 1.75 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 27.8 m-85 -101.21 164.51 11.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -91.99 -16.23 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.277 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 97.8 p -141.5 154.81 45.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.87 66.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.588 -0.695 . . . . 0.0 110.001 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -15.04 60.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.726 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.487 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 21.3 t70 -94.58 -25.39 16.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.599 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 7.3 t -73.84 -49.12 26.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.833 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.542 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -65.67 -49.02 70.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.52 -0.738 . . . . 0.0 110.442 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -45.26 -29.32 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.892 -1.13 . . . . 0.0 109.472 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.475 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 1.2 m -104.56 -31.55 9.38 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.699 0.761 . . . . 0.0 109.083 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.615 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 92.9 m -100.6 20.0 15.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.612 -0.68 . . . . 0.0 110.92 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -129.1 170.76 20.1 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.73 31.3 3.22 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.187 -1.184 . . . . 0.0 110.182 179.969 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.922 0.392 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.591 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.2 Cg_endo -70.94 154.8 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.118 1.588 . . . . 0.0 111.267 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.63 -30.68 64.52 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.506 -0.746 . . . . 0.0 110.061 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 5.1 p90 -67.97 -20.13 65.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.892 -1.13 . . . . 0.0 109.565 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 2.2 t -77.91 -29.27 50.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.691 -0.631 . . . . 0.0 109.793 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 mt -87.7 -10.09 52.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 109.51 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.27 153.32 84.16 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.647 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 43.2 Cg_endo -70.56 174.45 10.19 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.979 1.516 . . . . 0.0 110.071 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.7 Cg_endo -73.05 155.42 52.58 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.841 1.443 . . . . 0.0 109.813 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.405 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 24.3 t80 -118.72 93.95 4.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 111.102 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -59.88 -23.43 63.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.405 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 64.05 164.83 0.78 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -80.96 89.85 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 124.231 1.648 . . . . 0.0 110.027 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.35 171.25 18.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.056 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -14.02 17.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.19 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 37' ' ' ALA . . . -51.76 169.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.481 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -152.0 69.3 0.9 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.02 155.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 110.365 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.529 ' CG2' HG22 ' A' ' 32' ' ' THR . 18.3 mm -94.18 87.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.329 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 mmt85 -90.79 175.09 7.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 110.508 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.484 ' N ' ' O ' ' A' ' 45' ' ' PHE . 57.5 m-85 -117.13 148.6 41.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -0.776 . . . . 0.0 111.389 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 17.8 p90 -148.41 161.16 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 69.1 t80 -90.05 108.85 19.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.965 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 26' ' ' LYS . 25.8 t-20 -80.87 87.18 5.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.252 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.26 -26.49 0.51 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.99 -1.069 . . . . 0.0 109.556 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 6.0 tttt -70.95 -29.13 65.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.667 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -91.57 -35.71 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.13 56.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.451 HD11 ' O ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -140.0 -144.74 0.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -1.165 . . . . 0.0 109.036 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.451 ' O ' HD11 ' A' ' 29' ' ' LEU . 84.7 m -116.71 150.98 37.33 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 110.572 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.468 ' OE1' ' ND2' ' A' ' 24' ' ' ASN . 87.1 mt-30 -139.52 167.2 22.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.529 HG22 ' CG2' ' A' ' 19' ' ' ILE . 0.6 OUTLIER -96.78 146.94 24.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.114 -0.991 . . . . 0.0 110.881 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -142.74 161.61 37.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.581 -0.699 . . . . 0.0 110.118 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' THR . 70.4 t -75.28 107.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.313 -0.867 . . . . 0.0 110.395 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.1 t80 -85.0 146.01 27.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.402 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 37' ' ' ALA . . . -89.56 2.85 83.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 67.55 13.36 9.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.108 -1.231 . . . . 0.0 110.613 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ARG . 31.3 p -156.36 170.59 21.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.94 . . . . 0.0 110.399 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.85 37.96 0.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' HB1' ' ND2' ' A' ' 44' ' ' ASN . . . -74.89 147.96 40.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.417 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -116.75 -165.3 1.05 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.581 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 6.2 mtt-85 -68.75 -20.12 64.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.268 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 1.7 t-20 -91.48 54.21 2.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.056 -1.028 . . . . 0.0 110.178 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.544 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -156.29 76.05 0.89 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 108.945 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.592 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.0 m-85 -91.13 147.59 22.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 110.677 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 0.0 OUTLIER -78.25 -21.36 50.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 110.349 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.467 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 91.8 p -135.8 156.57 48.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 0.0 110.492 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.12 -25.46 68.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.527 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 1.7 tp10 -73.79 -26.22 60.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 25.9 t0 -77.38 -31.77 54.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.265 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.592 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.3 t -82.48 -47.87 11.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.592 -0.692 . . . . 0.0 109.193 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.543 ' O ' ' N ' ' A' ' 56' ' ' GLY . 5.8 ttm -65.74 -44.44 85.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 109.993 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -58.12 -25.33 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.674 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -90.17 -42.32 11.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.448 -0.783 . . . . 0.0 109.767 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -127.32 44.03 3.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 110.815 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -105.69 -130.91 6.8 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.17 35.32 88.35 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.197 -1.178 . . . . 0.0 110.296 179.931 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.542 ' CG ' ' HD2' ' A' ' 2' ' ' PRO . 15.7 ttm105 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.913 0.387 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.589 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 38.1 Cg_endo -67.16 157.38 61.99 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.182 1.622 . . . . 0.0 110.73 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.484 ' HA ' HD11 ' A' ' 6' ' ' LEU . 9.3 p-10 -82.29 -25.71 33.74 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.502 -0.749 . . . . 0.0 109.936 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.589 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 4.4 p90 -67.26 -15.04 63.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.11 -0.994 . . . . 0.0 110.44 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -82.13 -28.88 31.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.6 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.484 HD11 ' HA ' ' A' ' 3' ' ' ASP . 13.9 mt -82.02 -19.31 40.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 109.724 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.94 158.37 85.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.823 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.452 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 44.1 Cg_endo -71.84 174.83 10.57 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.853 1.449 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -71.55 169.74 20.24 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.902 1.475 . . . . 0.0 110.48 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.574 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 63.5 t80 -129.1 94.25 3.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.835 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.4 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -56.29 -23.39 36.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.574 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 58.44 -172.8 3.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.492 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.0 Cg_endo -73.63 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.17 1.616 . . . . 0.0 110.466 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 28.6 m 63.12 173.33 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -133.52 27.19 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.01 -168.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.102 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 38.8 ttm180 -150.69 73.81 1.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.162 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 82.1 mt -109.99 146.61 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.4 HG22 ' HB ' ' A' ' 32' ' ' THR . 43.9 mm -92.43 82.45 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.569 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -81.67 169.24 17.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.919 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 47.2 m-85 -112.44 149.87 31.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 111.492 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 13.0 p90 -150.12 156.81 42.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 47.7 t80 -83.6 116.3 22.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.125 -0.984 . . . . 0.0 110.486 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 27' ' ' ALA . 26.9 t-20 -91.24 88.48 6.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.874 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.58 -37.72 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.735 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 10.2 tptp -64.91 -27.99 69.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.527 ' N ' ' OD1' ' A' ' 24' ' ' ASN . . . -92.66 -23.58 18.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.22 -11.29 72.6 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.45 ' HA ' ' HE1' ' A' ' 52' ' ' MET . 1.7 mp -132.76 -142.53 0.21 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -1.138 . . . . 0.0 109.521 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 66.3 m -119.57 154.67 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.567 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 3.3 mt-30 -138.61 172.3 13.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.499 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 8.5 p -98.59 144.45 27.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 110.506 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -137.82 157.08 47.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.042 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.37 101.33 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.207 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 10.7 t80 -80.58 149.24 29.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.491 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -84.56 -1.68 89.11 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.597 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 73.26 6.69 5.22 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.45 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 20.2 p -149.77 171.91 15.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 110.456 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 39.34 47.17 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.486 -0.759 . . . . 0.0 110.645 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.28 156.07 39.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -120.47 -162.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.301 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.509 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.6 mtm-85 -80.11 -6.13 57.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 109.978 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.8 t-20 -110.25 54.59 0.66 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.86 . . . . 0.0 109.64 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.584 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 30.1 t-20 -155.41 82.49 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -94.49 142.65 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 111.099 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 11.2 tmtt? -71.92 -23.46 61.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.492 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 97.0 p -134.26 159.02 42.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 110.502 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.23 64.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.78 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -74.23 -28.68 61.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 110.236 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 54' ' ' THR . 56.4 t0 -78.86 -32.56 46.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.573 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.3 t -74.78 -43.98 51.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -67.63 -48.92 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.253 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -64.69 -11.93 41.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 109.717 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.474 HG21 ' CE1' ' A' ' 45' ' ' PHE . 1.8 m -106.43 -38.79 6.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.885 . . . . 0.0 110.16 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.577 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.6 m -108.26 -0.94 20.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -49.15 111.41 0.98 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.11 20.44 0.75 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.316 -1.108 . . . . 0.0 110.165 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 2' ' ' PRO . 9.0 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.1 0.476 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.628 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 44.0 Cg_endo -71.7 162.04 43.33 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 124.292 1.68 . . . . 0.0 110.097 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -86.51 -23.16 26.02 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 109.772 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.648 ' CB ' ' CD ' ' A' ' 42' ' ' ARG . 9.0 p90 -67.53 -19.16 65.26 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.623 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -72.96 -29.66 63.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.072 -1.018 . . . . 0.0 109.658 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.408 ' HA ' ' HB1' ' A' ' 25' ' ' ALA . 39.5 mt -78.31 -20.36 51.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.743 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 45.0 mt-10 -81.55 165.37 44.46 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 47.7 Cg_endo -72.87 163.0 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.937 1.493 . . . . 0.0 110.564 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 43.6 Cg_endo -71.79 -159.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.968 1.509 . . . . 0.0 110.456 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.573 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 45.5 t80 -146.43 93.68 2.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 109.946 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -58.67 -22.82 58.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.573 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 61.12 174.87 1.39 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.5 Cg_endo -81.55 -96.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.903 1.475 . . . . 0.0 110.658 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' PRO . 2.0 m 38.91 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.235 -0.915 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -142.54 17.2 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.832 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.01 -179.76 4.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 110.027 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.06 71.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.84 156.58 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.681 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 32' ' ' THR . 22.1 mm -93.74 80.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.113 -0.992 . . . . 0.0 110.602 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.545 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 7.8 mmt180 -81.35 175.04 10.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.702 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 47' ' ' SER . 89.8 m-85 -116.23 151.8 35.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.037 -1.039 . . . . 0.0 111.285 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.514 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 15.7 p90 -150.35 161.87 41.64 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 72.6 t80 -86.33 107.81 18.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.968 -1.082 . . . . 0.0 110.963 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' ALA . 37.5 t-20 -84.99 90.84 7.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.997 . . . . 0.0 109.86 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.53 -28.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.525 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.485 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -71.09 -27.14 63.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.333 -0.855 . . . . 0.0 109.762 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.41 -18.5 19.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.002 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 -3.04 87.54 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.434 HD12 ' O ' ' A' ' 30' ' ' CYS . 1.1 pp -144.1 -145.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.16 -1.2 . . . . 0.0 109.36 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 84.3 m -114.76 151.12 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 111.031 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -137.61 176.95 8.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.359 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.522 ' HB ' ' CG2' ' A' ' 19' ' ' ILE . 25.4 p -93.46 144.29 25.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.48 ' CD1' ' O ' ' A' ' 34' ' ' VAL . 7.8 p90 -144.48 161.52 38.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 55.5 t -74.72 135.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 0.0 110.231 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.585 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.3 t80 -122.27 141.63 51.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.787 . . . . 0.0 109.775 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' THR . . . -75.39 -1.76 65.9 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 71.2 1.89 4.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -1.127 . . . . 0.0 110.485 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 6.0 p -142.5 157.02 45.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.008 -1.058 . . . . 0.0 110.058 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 4.9 mtp85 56.72 35.6 26.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.46 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -55.03 149.9 11.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.493 ' CE ' ' HB2' ' A' ' 10' ' ' TYR . 2.1 mtmp? -124.86 -170.57 2.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.648 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 6.7 ptp180 -65.05 -32.93 74.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 111.278 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.9 t-20 -88.46 54.66 3.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.822 -1.174 . . . . 0.0 109.449 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.482 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 54.1 t-20 -158.55 76.34 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.593 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 23.1 m-85 -85.86 136.72 33.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 110.589 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -61.34 -26.96 68.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.848 . . . . 0.0 110.076 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.501 ' HA ' ' CD1' ' A' ' 21' ' ' TYR . 89.3 p -145.29 162.03 38.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 -20.43 66.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.906 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 2.7 tp10 -70.68 -34.47 72.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.3 t0 -79.28 -32.95 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.375 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.593 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 44.4 t -69.87 -44.43 69.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.765 . . . . 0.0 109.208 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.507 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -65.37 -55.39 18.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.499 -0.751 . . . . 0.0 109.522 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 2.2 ttp180 -46.08 -31.82 2.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.3 m -79.27 -59.44 2.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -0.786 . . . . 0.0 109.445 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.525 ' SG ' ' CG ' ' A' ' 2' ' ' PRO . 59.2 m -114.1 -47.12 2.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.388 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.507 ' CA ' ' HA ' ' A' ' 52' ' ' MET . . . 43.13 -128.7 5.51 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.07 5.57 68.59 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.179 -1.189 . . . . 0.0 110.227 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.76 0.314 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.573 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.2 Cg_endo -69.31 154.29 69.75 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.972 1.512 . . . . 0.0 110.867 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -70.12 -31.38 68.89 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.455 -0.778 . . . . 0.0 109.673 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.573 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 3.5 p90 -67.85 -17.23 64.43 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.224 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 3.7 t -84.55 -25.17 28.91 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.873 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 2' ' ' PRO . 7.3 mt -86.96 -15.28 39.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.904 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.43 163.88 56.92 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 168.44 24.5 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.111 1.585 . . . . 0.0 110.187 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.59 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.9 Cg_endo -70.73 169.76 19.38 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.017 1.535 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 38.8 t80 -126.25 94.27 4.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 111.131 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.478 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -67.39 -22.64 65.54 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.83 171.8 0.56 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.6 Cg_endo -80.51 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.877 1.462 . . . . 0.0 110.333 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 41.52 -164.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 110.569 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -134.41 26.41 3.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 110.201 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.55 5.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.17 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 2.2 ptp180 -153.82 73.64 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.125 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mt -90.26 165.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.275 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.4 mm -102.79 92.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.549 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.537 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 4.2 mmt180 -94.48 -179.39 4.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.846 . . . . 0.0 110.038 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.507 ' CE2' ' CG2' ' A' ' 32' ' ' THR . 72.6 m-85 -117.03 146.2 43.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.084 . . . . 0.0 111.06 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 7.7 p90 -145.69 163.38 35.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.482 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 86.9 t80 -92.26 124.33 36.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.452 ' OD1' ' HB3' ' A' ' 26' ' ' LYS . 59.8 t-20 -96.69 96.54 8.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -0.956 . . . . 0.0 109.929 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.6 -36.31 10.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -68.57 -25.5 64.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.776 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' O ' HD11 ' A' ' 29' ' ' LEU . . . -96.36 -24.91 15.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 86.43 -8.72 73.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.47 HD11 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -129.68 -146.3 0.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.247 -1.149 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 63.1 m -123.48 150.02 44.42 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.729 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.416 ' NE2' ' CB ' ' A' ' 27' ' ' ALA . 36.3 mt-30 -137.31 160.96 37.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.558 -0.714 . . . . 0.0 109.21 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.507 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 40.5 p -82.97 144.23 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.3 p90 -140.62 166.22 25.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.442 -0.787 . . . . 0.0 109.865 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.448 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 3.6 t -74.88 133.84 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.083 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.594 ' CE1' ' ND2' ' A' ' 44' ' ' ASN . 7.6 t80 -112.88 147.09 37.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 0.0 110.324 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -87.34 -4.16 81.06 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.585 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 74.37 -4.54 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.445 -1.032 . . . . 0.0 111.113 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 39' ' ' ARG . 29.3 p -146.7 170.35 17.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 110.441 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.536 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.2 ttt180 42.78 51.76 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.577 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -95.23 157.82 15.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 0.0 110.905 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.502 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 4.6 mttp -118.59 -161.48 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.348 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.546 ' HD3' ' CB ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -74.55 -23.98 58.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.1 t-20 -80.19 54.26 1.93 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.919 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.594 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 25.2 t-20 -162.41 74.31 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 20.3 m-85 -85.46 143.7 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.446 -0.783 . . . . 0.0 110.788 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -68.91 -25.11 64.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 0.0 110.096 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -136.39 157.11 47.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 0.0 110.543 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.51 -22.87 66.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.071 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 4.1 mt-10 -75.28 -27.86 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.599 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 14.6 t0 -72.85 -35.85 67.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.541 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.2 t -71.43 -44.52 64.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' GLY . 2.7 mmt -67.69 -53.8 24.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.475 -0.766 . . . . 0.0 109.395 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -53.38 -22.43 7.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -96.22 -39.38 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 109.728 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.8 t -132.6 46.63 2.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -106.96 158.33 15.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.67 109.55 2.76 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.242 -1.152 . . . . 0.0 110.238 -179.854 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.518 ' NE ' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.736 0.303 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.559 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 41.7 Cg_endo -70.97 141.91 41.38 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.939 1.494 . . . . 0.0 110.081 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -75.92 -21.83 56.68 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 110.264 -179.919 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.748 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 6.6 p90 -67.01 -16.68 64.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.892 -1.123 . . . . 0.0 110.47 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 53.4 m -84.19 -20.94 31.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 178.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -73.75 -22.82 59.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -70.52 160.37 81.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 110.141 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.7 170.28 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.017 1.535 . . . . 0.0 110.208 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.39 178.47 6.1 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.833 1.439 . . . . 0.0 110.153 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.504 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 11.0 t80 -139.56 93.86 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.91 . . . . 0.0 110.428 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -59.54 -22.74 62.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.39 144.94 0.03 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.54 65.47 4.65 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.958 1.504 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.457 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 18.5 m -117.56 170.83 8.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 4.49 53.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.357 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.53 175.55 5.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 109.998 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 13.5 ptp180 -155.08 71.97 0.81 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.575 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.496 HD11 ' CB ' ' A' ' 37' ' ' ALA . 32.1 mt -81.17 157.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.809 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 19' ' ' ILE . 4.3 mm -94.18 88.49 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.018 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.2 mmt180 -92.42 -175.65 4.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.338 -0.851 . . . . 0.0 110.034 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -119.37 144.82 46.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 111.434 -179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 14.4 p90 -142.14 166.52 24.47 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.568 ' CD1' ' HB3' ' A' ' 55' ' ' CYS . 73.0 t80 -95.95 111.59 23.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 110.835 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 27' ' ' ALA . 28.3 t-20 -84.32 91.83 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.07 -24.27 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -79.25 -22.93 44.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.407 -0.808 . . . . 0.0 109.823 179.421 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -93.56 -28.47 16.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 -0.6 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 30' ' ' CYS . 0.4 OUTLIER -151.26 -151.62 0.4 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -1.163 . . . . 0.0 109.851 179.677 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.558 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 95.4 m -109.99 153.75 24.13 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.871 0.843 . . . . 0.0 111.43 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -143.51 174.25 10.92 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.54 144.29 26.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.712 -1.243 . . . . 0.0 110.669 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -138.79 162.38 34.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.765 . . . . 0.0 109.583 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.3 t -75.99 99.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 111.283 -178.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.7 t80 -81.49 144.78 31.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.509 -0.745 . . . . 0.0 109.505 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.572 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -87.06 3.59 86.83 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.392 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.599 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 78.55 -24.5 0.21 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.467 -1.019 . . . . 0.0 111.169 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.44 168.35 19.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.898 -1.126 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.77 43.73 27.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 109.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -85.76 164.48 17.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.353 -0.842 . . . . 0.0 111.198 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.504 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.4 mttt -116.23 -166.3 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.748 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -76.88 -19.78 57.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.865 -1.147 . . . . 0.0 110.183 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' H ' ' HD2' ' A' ' 42' ' ' ARG . 3.8 t-20 -92.07 53.67 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.908 0.861 . . . . 0.0 109.341 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.466 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 17.8 t-20 -149.49 71.06 1.09 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.6 m-85 -84.89 141.21 30.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.531 -178.077 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 4.7 tttt -66.02 -23.12 66.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.477 -0.764 . . . . 0.0 110.911 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -143.38 153.85 43.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 110.418 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -56.86 -29.86 63.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.705 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.6 tt0 -64.68 -34.02 77.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.82 . . . . 0.0 110.363 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' O ' ' HB ' ' A' ' 54' ' ' THR . 22.5 t0 -79.25 -29.18 42.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.622 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 37.6 t -82.9 -44.2 15.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.429 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.511 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -67.98 -49.95 58.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.956 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -59.97 -23.7 63.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 0.0 109.42 179.295 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 50' ' ' ASP . 2.5 m -94.32 -44.3 8.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.559 -0.713 . . . . 0.0 109.824 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 55.8 m -101.13 21.92 13.16 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -67.13 129.77 29.39 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.518 ' HA3' ' NE ' ' A' ' 1' ' ' ARG . . . -140.74 -60.92 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.2 -1.177 . . . . 0.0 110.156 -179.953 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' A' ' 55' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.781 0.324 . . . . 0.0 110.172 . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.605 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 41.3 Cg_endo -70.44 161.01 47.57 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.057 1.556 . . . . 0.0 110.584 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -91.38 -25.84 19.18 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.41 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.605 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 28.6 p90 -67.33 -16.65 64.38 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.359 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 20.0 m -83.64 -26.43 29.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.075 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' HA ' ' HB1' ' A' ' 25' ' ' ALA . 5.3 mt -81.43 -18.24 46.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.721 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.27 162.25 57.14 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.934 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.04 168.97 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.932 1.491 . . . . 0.0 110.108 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.574 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -70.59 175.2 9.12 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.998 1.526 . . . . 0.0 110.667 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -133.91 93.9 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 0.0 110.389 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.72 -22.69 66.63 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.94 171.8 0.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.3 Cg_endo -74.68 -97.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.913 1.481 . . . . 0.0 110.453 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 42.96 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.044 -1.035 . . . . 0.0 110.739 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -133.23 15.75 4.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 110.08 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.11 172.43 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 71.13 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 110.284 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.428 HG22 HD13 ' A' ' 18' ' ' ILE . 58.1 mt -98.35 153.78 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.42 HG23 ' HB ' ' A' ' 32' ' ' THR . 14.5 mm -96.64 87.67 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 32' ' ' THR . 8.2 mmt85 -88.67 177.31 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.579 ' CE1' HG23 ' A' ' 32' ' ' THR . 49.2 m-85 -113.39 152.89 29.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 111.082 -179.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -150.58 158.49 44.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.623 -0.673 . . . . 0.0 109.337 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.584 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 44.9 t80 -87.33 113.64 23.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.319 -0.863 . . . . 0.0 110.774 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' ALA . 45.3 t-20 -86.27 83.31 7.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.481 ' HB1' ' HA ' ' A' ' 6' ' ' LEU . . . -45.47 -29.09 1.03 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.027 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -27.3 62.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.427 -0.795 . . . . 0.0 109.706 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -94.98 -26.33 16.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.239 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.48 -10.53 65.0 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -134.45 -144.11 0.21 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.188 -1.183 . . . . 0.0 109.571 179.864 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 95.1 m -121.83 153.97 37.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.703 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 20.0 mt-30 -140.38 160.45 39.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.484 -0.76 . . . . 0.0 109.383 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.579 HG23 ' CE1' ' A' ' 21' ' ' TYR . 2.0 p -84.6 144.56 28.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.009 -1.057 . . . . 0.0 110.723 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.9 p90 -139.15 162.3 35.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.92 179.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 11' ' ' THR . 11.8 t -74.67 122.6 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.596 ' CE1' ' ND2' ' A' ' 44' ' ' ASN . 7.5 t80 -99.79 147.09 25.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -0.88 . . . . 0.0 110.223 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -91.84 -4.38 67.41 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.595 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 72.95 -2.09 2.83 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.265 -1.138 . . . . 0.0 110.902 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 39' ' ' ARG . 28.3 p -146.3 172.24 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.991 -1.068 . . . . 0.0 110.182 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 38' ' ' CYS . 16.4 mtt-85 42.33 28.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.974 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.519 ' HB1' ' CE1' ' A' ' 35' ' ' TYR . . . -63.92 163.5 11.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -127.3 -171.04 2.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.539 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -69.56 -19.62 63.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.953 -1.092 . . . . 0.0 109.834 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.466 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 3.3 t-20 -88.25 67.03 8.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 109.695 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 39.0 t-20 -168.43 82.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 109.271 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.57 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 18.0 m-85 -96.42 148.8 22.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.585 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -69.22 -28.34 66.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.871 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -136.56 158.56 44.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -68.14 -20.45 64.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.067 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.74 -42.0 91.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.01 -40.24 71.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.57 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 34.7 t -64.91 -43.99 91.04 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.656 0.741 . . . . 0.0 109.41 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -67.39 -61.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.726 . . . . 0.0 110.685 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -55.41 -19.25 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.036 -1.04 . . . . 0.0 110.617 -179.441 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.506 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 45.9 m -95.61 -56.0 2.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.07 -1.019 . . . . 0.0 110.172 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.584 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 44.6 m -85.56 0.57 52.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.929 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -60.94 -173.57 1.05 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.09 -6.27 25.35 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.261 -1.14 . . . . 0.0 110.146 179.916 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.885 0.374 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.644 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 43.6 Cg_endo -73.47 166.29 30.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.131 1.595 . . . . 0.0 111.001 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -94.03 -22.21 18.68 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.433 -0.792 . . . . 0.0 109.626 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.644 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 10.9 p90 -66.67 -20.87 66.08 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.907 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -83.68 -22.04 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.388 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.3 mt -82.36 -16.97 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.467 -0.771 . . . . 0.0 109.842 179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.451 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -84.78 160.89 54.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.088 179.838 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD2' ' HG3' ' A' ' 7' ' ' GLU . 44.1 Cg_endo -72.53 165.05 33.82 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.931 1.49 . . . . 0.0 110.071 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.583 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.6 Cg_endo -70.67 159.32 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.906 1.477 . . . . 0.0 110.712 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -116.33 94.33 4.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -0.836 . . . . 0.0 110.655 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.48 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -62.66 -22.87 66.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.709 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.5 170.25 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' CYS . 48.0 Cg_endo -73.58 -92.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.917 1.482 . . . . 0.0 110.941 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 44.26 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.052 -1.03 . . . . 0.0 110.313 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.09 8.27 3.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 -177.15 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 109.707 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -152.27 82.97 1.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.016 -1.052 . . . . 0.0 110.68 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 18' ' ' ILE . 56.1 mt -96.87 157.92 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 179.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.409 HG23 ' HB ' ' A' ' 32' ' ' THR . 7.9 mm -104.54 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.153 -0.967 . . . . 0.0 110.242 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.8 mmt85 -88.51 179.97 6.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.4 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 62.1 m-85 -110.87 153.83 24.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 110.712 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.7 p90 -152.78 161.94 41.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.43 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.521 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 76.5 t80 -92.91 115.31 28.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 110.951 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.487 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . 40.3 t-20 -90.5 98.55 11.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 0.0 110.01 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.24 -20.2 2.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.89 -19.09 29.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.982 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.487 ' CB ' ' HB3' ' A' ' 24' ' ' ASN . . . -96.53 -29.77 13.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.908 . . . . 0.0 110.231 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.72 72.45 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -142.64 -145.2 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.106 -1.232 . . . . 0.0 109.641 179.508 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.486 ' O ' HD12 ' A' ' 29' ' ' LEU . 76.4 m -121.45 150.46 41.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.895 . . . . 0.0 110.97 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.48 179.65 6.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 1.0 OUTLIER -99.45 144.47 28.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.893 -1.129 . . . . 0.0 111.156 -179.213 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.583 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.9 p90 -136.83 158.75 43.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.584 -0.697 . . . . 0.0 109.17 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.48 ' O ' ' OG1' ' A' ' 11' ' ' THR . 60.6 t -75.28 99.66 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.291 -0.881 . . . . 0.0 111.055 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.588 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.1 t80 -78.75 141.5 37.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.23 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 37' ' ' ALA . . . -84.7 5.52 81.52 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.588 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 73.94 0.58 3.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -1.07 . . . . 0.0 111.0 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 39' ' ' ARG . 12.6 p -148.86 176.0 10.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.855 -1.153 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 41.56 44.55 2.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -83.35 137.27 34.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.94 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -103.0 -164.38 1.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.772 . . . . 0.0 109.433 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.577 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -69.55 -14.23 62.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.041 -1.037 . . . . 0.0 109.611 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.2 t-20 -94.39 55.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.471 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 16.8 t-20 -160.71 80.27 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 0.0 108.99 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.585 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -92.06 153.19 19.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.858 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -78.67 -23.18 45.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.446 -0.784 . . . . 0.0 110.16 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.1 p -142.68 161.44 38.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.27 -0.894 . . . . 0.0 110.296 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.87 -21.29 65.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -27.19 60.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.405 -0.809 . . . . 0.0 110.173 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.85 -30.81 31.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.348 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.585 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 43.6 t -78.64 -44.61 23.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.602 -0.686 . . . . 0.0 109.622 179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -66.35 -46.8 75.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 110.293 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -63.72 -29.43 70.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.05 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.4 m -73.85 -50.17 21.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.125 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.42 ' SG ' ' CG ' ' A' ' 2' ' ' PRO . 77.3 m -119.15 -42.43 2.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 76.39 -75.63 1.58 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.512 ' CA ' ' OH ' ' A' ' 23' ' ' TYR . . . 97.61 -160.35 21.1 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 57' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.282 -1.128 . . . . 0.0 110.261 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.559 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 21.1 p90 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.199 0.523 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 1.4 m -85.3 -21.98 28.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.655 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 48.1 mt -74.06 -24.37 59.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.356 -0.84 . . . . 0.0 108.807 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -79.74 164.02 55.5 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.606 -0.684 . . . . 0.0 109.466 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 7' ' ' GLU . 46.5 Cg_endo -74.03 167.36 27.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.736 1.387 . . . . 0.0 109.965 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.5 Cg_endo -70.17 172.34 13.23 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.785 1.413 . . . . 0.0 110.127 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 36.1 t80 -140.76 93.59 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.406 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.452 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -52.67 -23.12 6.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 65.53 -170.23 27.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -72.71 -155.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.092 1.575 . . . . 0.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 23.0 m 62.29 -168.69 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.243 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.42 20.78 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.232 -0.918 . . . . 0.0 109.985 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.24 167.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -142.36 69.2 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.841 . . . . 0.0 109.811 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.519 HG22 ' HG2' ' A' ' 20' ' ' ARG . 3.5 mt -107.32 148.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.468 HG23 ' HB ' ' A' ' 32' ' ' THR . 17.9 mm -94.33 78.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 109.865 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 18' ' ' ILE . 4.1 mmt180 -83.53 -176.55 6.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 109.886 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 57.6 m-85 -118.55 144.45 46.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.976 -1.077 . . . . 0.0 111.276 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -139.43 163.36 32.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.55 ' CG ' ' HB3' ' A' ' 5' ' ' CYS . 57.2 t80 -93.44 117.2 29.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.003 -1.061 . . . . 0.0 111.837 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 42.9 t-20 -91.07 92.17 8.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.856 . . . . 0.0 108.86 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -44.58 -29.5 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.891 -1.131 . . . . 0.0 110.183 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -75.2 -23.93 57.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.811 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.77 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -92.96 -16.83 24.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 110.507 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.13 -5.72 75.15 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -145.84 -143.43 0.14 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -1.162 . . . . 0.0 109.286 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.3 m -117.44 163.33 16.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 111.687 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 5.9 mt-30 -143.8 166.56 24.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.468 ' HB ' HG23 ' A' ' 19' ' ' ILE . 82.5 p -82.97 144.29 30.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 110.555 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 7.6 p90 -145.45 171.73 14.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 109.659 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.4 t -85.71 122.54 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.7 t80 -99.77 148.88 23.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.523 -0.736 . . . . 0.0 109.911 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.742 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -96.89 -3.9 59.06 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.641 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.41 -2.81 2.49 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.184 -1.186 . . . . 0.0 111.066 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.423 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 26.0 p -139.81 152.49 46.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.886 -1.134 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HD3' ' HG3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 49.04 42.99 21.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.379 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -70.81 149.87 46.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -101.1 -164.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.559 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 12.2 mtt-85 -82.79 -12.81 57.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.047 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 6.7 t-20 -95.48 54.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.585 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 15.7 t-20 -152.73 84.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.819 . . . . 0.0 109.303 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.588 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 14.7 m-85 -98.5 154.67 17.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.813 . . . . 0.0 110.156 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -81.69 -18.64 43.72 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 110.611 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 95.3 p -142.18 155.67 45.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.53 70.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.93 -23.83 55.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 44.6 t0 -74.29 -33.98 63.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.588 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -71.69 -48.51 46.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.3 mmt -56.01 -57.55 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.141 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -24.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.986 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.8 m -99.54 -63.72 1.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.487 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 56.7 m . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.584 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.598 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 53.5 p90 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.139 0.495 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.577 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 97.9 m -77.07 -24.2 51.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.731 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 22.8 mt -83.63 -19.46 35.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.536 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.04 163.97 50.64 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.79 . . . . 0.0 109.938 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.75 160.25 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.856 1.45 . . . . 0.0 110.294 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.593 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.1 Cg_endo -71.4 -178.39 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.939 1.494 . . . . 0.0 110.546 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 86.1 t80 -132.15 93.35 3.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 110.128 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.27 -23.03 66.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 11' ' ' THR . . . 59.9 176.5 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.8 Cg_endo -79.9 -93.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.927 1.488 . . . . 0.0 110.357 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.5 m 42.77 -168.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.632 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -138.72 13.09 2.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.067 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.58 164.35 11.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 109.959 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -128.85 71.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 68.0 mt -77.88 151.9 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.772 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.2 mm -96.38 89.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.671 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -90.06 172.98 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.833 . . . . 0.0 110.327 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.731 ' CE1' HG23 ' A' ' 32' ' ' THR . 7.6 m-85 -114.41 144.73 42.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -144.7 154.2 42.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.649 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 67.3 t80 -83.0 112.87 20.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.382 -0.824 . . . . 0.0 110.876 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.664 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 61.1 t-20 -84.81 86.07 7.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.059 -1.025 . . . . 0.0 109.98 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -46.29 -25.39 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.06 -1.025 . . . . 0.0 109.741 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -76.07 -26.01 56.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.55 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.12 -25.49 17.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.161 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.77 78.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -137.99 -145.16 0.19 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.138 -1.213 . . . . 0.0 109.588 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 95.5 m -119.16 150.6 39.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 111.048 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' ' 31' ' ' GLN . 4.0 mt-30 -140.48 160.4 40.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.731 HG23 ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -89.2 146.87 24.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.069 -1.019 . . . . 0.0 110.588 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.8 p90 -138.08 162.27 34.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.045 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' THR . 97.5 t -74.26 106.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.894 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 10.4 t80 -88.17 148.86 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.368 -0.833 . . . . 0.0 109.992 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.754 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -86.84 -1.35 85.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 75.42 -6.23 2.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.463 -1.022 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 p -136.07 165.76 24.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.893 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 4.7 mtt180 45.75 52.81 9.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.013 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.894 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -72.79 156.73 38.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.269 -0.895 . . . . 0.0 110.55 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -119.53 -162.62 0.93 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.872 . . . . 0.0 110.292 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.598 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 17.7 mtm180 -81.03 -26.07 36.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.002 -1.061 . . . . 0.0 109.964 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -93.0 53.92 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.7 t-20 -146.56 74.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.506 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 8.6 m-85 -92.95 163.6 13.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 0.0 110.586 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -91.45 -14.69 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -0.995 . . . . 0.0 110.086 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.4 p -145.95 160.46 41.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 110.212 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.63 -22.45 64.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.72 -26.4 59.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.102 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 65.1 m-20 -83.01 -30.69 27.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 109.37 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.506 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.5 t -74.2 -44.04 54.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.699 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -57.04 8.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.18 -21.36 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.1 -1.0 . . . . 0.0 110.231 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.496 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 2.1 m -101.39 -39.71 7.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 110.048 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 65.4 m . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.126 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.639 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 3.5 p90 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.274 0.559 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.578 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 4.6 m -71.23 -31.14 67.2 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 25' ' ' ALA . 28.0 mt -80.33 -16.07 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -79.87 162.01 64.04 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.13 170.53 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.414 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.62 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 41.0 Cg_endo -72.01 172.03 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.002 1.527 . . . . 0.0 110.598 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.485 ' CD2' ' HD2' ' A' ' 41' ' ' LYS . 17.7 t80 -130.84 94.31 3.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 110.683 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -51.74 -23.11 4.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 72.69 151.3 1.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 39' ' ' ARG . 46.3 Cg_endo -73.98 93.3 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.073 1.565 . . . . 0.0 110.222 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -154.76 -163.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -127.32 -6.95 5.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.324 -0.86 . . . . 0.0 110.189 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . -83.11 -176.8 6.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 109.776 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -155.01 76.26 0.98 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.02 -1.05 . . . . 0.0 110.674 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 19' ' ' ILE . 19.6 mt -90.44 164.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.627 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.45 ' N ' HG22 ' A' ' 18' ' ' ILE . 32.2 mm -105.31 92.7 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.993 . . . . 0.0 110.785 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.74 177.87 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.728 ' CE2' HG23 ' A' ' 32' ' ' THR . 67.1 m-85 -114.88 151.9 33.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.935 -1.103 . . . . 0.0 111.124 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.401 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 23.7 p90 -144.62 153.77 42.11 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 30.3 t80 -76.11 100.25 4.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.171 -0.956 . . . . 0.0 111.15 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.7 t-20 -75.28 71.67 2.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.804 -1.185 . . . . 0.0 109.081 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB2' HD23 ' A' ' 6' ' ' LEU . . . -47.74 -24.53 0.97 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.042 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -70.55 -31.31 68.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -92.15 -21.7 20.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.466 -0.771 . . . . 0.0 109.583 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.2 5.18 60.81 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -150.72 -142.5 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.058 -1.26 . . . . 0.0 109.713 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.502 ' O ' HD12 ' A' ' 29' ' ' LEU . 92.1 m -125.14 147.79 48.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 110.346 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -135.83 178.06 7.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.491 -0.756 . . . . 0.0 109.256 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.728 HG23 ' CE2' ' A' ' 21' ' ' TYR . 1.5 p -101.78 144.21 30.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.096 . . . . 0.0 110.633 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.62 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 24.2 p90 -133.04 162.89 30.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.4 97.21 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 0.0 111.146 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 1.009 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 11.4 t80 -80.06 145.63 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.606 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.777 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -83.48 1.29 88.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 79.74 -27.33 0.15 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.622 -0.928 . . . . 0.0 110.852 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -127.23 169.63 13.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.96 -1.087 . . . . 0.0 109.672 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 17.1 mmt180 57.27 33.76 23.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.414 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 1.009 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -69.87 161.31 30.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HD2' ' CD2' ' A' ' 10' ' ' TYR . 17.0 mtpt -137.04 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.004 . . . . 0.0 110.419 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.639 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.1 ptp180 -66.99 -32.04 73.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.835 . . . . 0.0 111.452 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.4 t-20 -90.63 61.72 4.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.731 -1.23 . . . . 0.0 109.748 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.563 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 33.1 t-20 -161.92 76.19 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 24.6 m-85 -85.69 134.56 33.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.388 -0.82 . . . . 0.0 110.155 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 20' ' ' ARG . 39.3 mttt -65.23 -16.49 63.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.6 p -149.6 159.34 44.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.34 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -20.36 66.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.007 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -31.9 64.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.226 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.66 -33.98 53.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.88 . . . . 0.0 109.625 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 18.6 t -72.85 -44.61 61.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 109.066 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.1 tpp -69.61 -44.49 70.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.547 -0.721 . . . . 0.0 109.389 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -60.26 -24.03 64.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.873 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.765 HG22 ' SG ' ' A' ' 55' ' ' CYS . 4.5 m -85.38 -51.6 6.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 109.945 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.765 ' SG ' HG22 ' A' ' 54' ' ' THR . 73.1 m . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.221 -0.924 . . . . 0.0 110.545 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 6.0 p90 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.423 0.63 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 23' ' ' TYR . 1.7 m -78.63 -22.64 46.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 110.354 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.06 -10.29 39.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.677 -1.264 . . . . 0.0 109.592 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.76 156.57 82.68 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 0.0 110.074 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 47.2 Cg_endo -73.85 174.4 12.39 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.93 1.489 . . . . 0.0 110.221 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.627 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 45.4 Cg_endo -72.97 -178.36 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.02 1.537 . . . . 0.0 110.357 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 14.4 t80 -155.25 94.18 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -53.5 -23.2 9.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.8 152.4 2.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 60.88 4.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.951 1.5 . . . . 0.0 110.08 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.441 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 15.5 m -123.03 -164.53 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -122.5 0.24 9.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . -78.69 171.49 15.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.436 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.419 ' NH2' HD11 ' A' ' 19' ' ' ILE . 6.9 ttt-85 -149.21 69.22 1.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 35' ' ' TYR . 12.8 mt -95.52 163.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.875 . . . . 0.0 109.988 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.579 HG23 ' HB ' ' A' ' 32' ' ' THR . 15.4 mm -104.98 86.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.254 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -88.93 179.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.845 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 36.6 m-85 -115.3 149.3 38.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 110.942 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 14.2 p90 -144.11 -179.03 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.57 -0.706 . . . . 0.0 109.771 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.683 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.7 OUTLIER -95.8 98.53 10.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.927 -1.108 . . . . 0.0 110.92 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.5 t-20 -81.46 63.92 5.97 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.149 177.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -47.25 -26.98 1.35 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.324 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -35.42 80.9 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -88.09 -17.89 30.06 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.23 10.73 60.62 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -163.19 -179.13 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -1.217 . . . . 0.0 108.951 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 85.3 m -82.5 150.45 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.566 -0.709 . . . . 0.0 110.019 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -140.78 169.11 18.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.579 ' HB ' HG23 ' A' ' 19' ' ' ILE . 19.6 p -88.64 144.38 26.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 110.098 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.627 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.1 p90 -140.02 165.28 27.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 11' ' ' THR . 24.4 t -74.68 124.96 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 110.221 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.881 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -109.46 147.43 32.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -0.848 . . . . 0.0 109.985 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -93.77 -2.08 65.22 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.964 -1.085 . . . . 0.0 110.406 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.79 -0.83 3.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.123 -1.222 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 152.29 28.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 0.0 109.923 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.69 29.97 16.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.881 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -75.27 175.06 8.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.526 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 22.2 mtpt -121.46 -174.38 2.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 109.548 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.5 mtt-85 -70.26 -16.76 63.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.077 . . . . 0.0 109.3 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 2.1 t-20 -93.45 62.96 3.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.512 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 8.7 t-20 -154.84 80.22 1.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 17.1 m-85 -95.5 155.64 16.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG2' ' NH1' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -77.97 -22.8 48.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.332 -0.855 . . . . 0.0 110.33 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 98.9 p -134.17 157.97 44.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 110.591 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . . . -74.04 -24.38 59.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -74.97 -17.57 60.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.482 -0.761 . . . . 0.0 110.032 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.482 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.2 t0 -93.5 -30.2 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.207 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 1.7 t -66.89 -52.57 41.68 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.458 ' O ' ' C ' ' A' ' 53' ' ' ARG . 3.4 tpt -66.04 -49.43 67.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.641 -0.662 . . . . 0.0 109.846 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -41.47 -41.25 2.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 m -91.83 -45.22 8.51 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.835 0.826 . . . . 0.0 109.131 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.683 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 72.8 m . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.742 -0.598 . . . . 0.0 111.396 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.735 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 4.1 p90 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.152 0.501 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.33 -14.31 46.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.927 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 54.6 mt -75.51 -27.93 58.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.965 -1.084 . . . . 0.0 110.182 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.477 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -64.68 166.57 11.35 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 110.283 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 7' ' ' GLU . 46.2 Cg_endo -74.7 168.68 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.121 1.59 . . . . 0.0 110.448 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.7 Cg_endo -71.54 -170.41 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.02 1.537 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CE1' ' HE3' ' A' ' 41' ' ' LYS . 43.0 t80 -145.62 93.39 2.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 110.611 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.466 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.4 m -64.73 -22.89 67.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.23 158.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.14 81.1 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.036 1.545 . . . . 0.0 110.582 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.457 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -147.45 167.37 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 0.0 110.235 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -107.53 14.53 25.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.26 152.66 23.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.37 77.89 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.51 HG22 ' HG2' ' A' ' 20' ' ' ARG . 70.0 mt -103.13 138.13 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.57 81.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.082 -1.011 . . . . 0.0 110.264 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -86.54 173.25 9.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 61.9 m-85 -114.24 154.29 28.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.145 -0.972 . . . . 0.0 111.373 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 9.1 p90 -150.56 156.97 42.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 49.5 t80 -83.14 115.69 22.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.135 -0.978 . . . . 0.0 111.266 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.588 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 60.5 t-20 -91.91 87.78 6.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.37 -25.42 0.4 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.052 -1.03 . . . . 0.0 109.721 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -24.02 52.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -95.52 -33.54 12.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 110.492 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 102.12 -10.69 56.96 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.435 ' HG ' ' C ' ' A' ' 28' ' ' GLY . 1.1 mt -134.45 -143.99 0.21 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.387 -1.066 . . . . 0.0 109.092 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.2 m -120.24 145.68 46.8 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 109.76 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -129.24 161.05 31.07 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 6.3 p -86.98 144.48 26.9 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.4 p90 -140.44 161.89 36.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.589 -0.694 . . . . 0.0 109.933 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 11' ' ' THR . 63.5 t -74.47 111.08 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.499 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 1.071 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.2 t80 -91.94 147.65 22.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.8 -4.12 85.25 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 68.59 12.48 8.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 110.089 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.2 p -147.3 147.31 30.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 110.454 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 51.89 44.77 29.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 1.071 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -67.78 146.13 54.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.579 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 10' ' ' TYR . 26.5 mttm -109.55 -160.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.653 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.735 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -80.87 -22.21 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.042 -1.036 . . . . 0.0 110.351 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.487 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 9.6 t-20 -91.31 53.32 2.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.906 0.86 . . . . 0.0 109.048 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.5 t-20 -159.82 75.41 0.62 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 23.4 m-85 -85.18 134.23 34.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.524 -0.735 . . . . 0.0 110.414 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.1 tptm -60.42 -20.85 61.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.77 . . . . 0.0 111.325 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.4 p -142.52 162.22 36.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.976 -1.077 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -66.32 -27.04 67.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 82.1 mt-10 -75.26 -28.04 59.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.21 -31.27 58.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.493 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 54.0 t -80.58 -44.01 19.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -45.89 59.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 110.246 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -60.81 -15.15 26.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.976 -1.078 . . . . 0.0 109.141 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.449 HG22 ' SG ' ' A' ' 55' ' ' CYS . 61.9 m -94.99 -54.79 3.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 0.0 110.144 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.449 ' SG ' HG22 ' A' ' 54' ' ' THR . 58.1 m . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.688 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 4.1 p90 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.61 0.719 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 4.5 t -78.68 -29.76 45.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.595 -0.691 . . . . 0.0 109.734 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.7 mt -95.47 -9.02 33.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 109.631 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 3.9 mm-40 -75.1 160.85 79.46 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.913 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.89 162.13 39.93 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.916 1.482 . . . . 0.0 110.266 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.575 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.5 Cg_endo -70.15 171.76 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.034 1.544 . . . . 0.0 110.342 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.597 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 37.4 t80 -133.24 94.45 3.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.133 -0.979 . . . . 0.0 111.019 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -59.55 -22.91 62.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 70.85 143.97 0.27 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.92 60.95 5.51 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.049 1.552 . . . . 0.0 110.348 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.13 -169.75 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -105.71 -31.7 8.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.16 154.77 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -143.05 77.6 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 mt -92.14 160.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 32' ' ' THR . 46.7 mm -91.93 83.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.834 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.607 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -80.82 175.49 10.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.054 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 45' ' ' PHE . 51.3 m-85 -115.25 147.72 40.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 110.95 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 15.3 p90 -147.39 156.26 42.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 72.8 t80 -81.42 114.57 20.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.294 -0.878 . . . . 0.0 110.808 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 30.6 t-20 -82.06 82.11 7.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.794 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.67 -26.61 0.65 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.993 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 36.8 mmtm -78.05 -23.04 48.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.861 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -98.28 -26.83 14.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.227 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -3.1 57.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -141.58 -142.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 99.2 m -121.74 159.45 26.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.496 -0.753 . . . . 0.0 110.731 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 4.7 mt-30 -143.2 169.08 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.509 -0.745 . . . . 0.0 109.32 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.528 ' HB ' HG23 ' A' ' 19' ' ' ILE . 1.5 p -91.54 144.27 25.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.386 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 14.1 p90 -143.39 166.57 24.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' THR . 65.1 t -74.41 128.3 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.452 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -112.27 145.83 39.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.064 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -96.93 7.98 65.17 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.046 -1.073 . . . . 0.0 110.742 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.61 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 58.99 12.47 2.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.283 . . . . 0.0 110.899 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 39' ' ' ARG . 17.9 p -152.34 164.58 37.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.043 -1.036 . . . . 0.0 110.494 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 98.7 mtt180 42.56 38.43 1.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.922 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.572 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -79.88 157.58 26.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -122.02 -168.15 1.66 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.369 -0.832 . . . . 0.0 109.63 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.54 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.6 mtm-85 -71.56 -19.16 62.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.022 -1.049 . . . . 0.0 110.152 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 5.1 t-20 -86.23 54.7 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.536 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -163.03 80.87 0.48 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.837 . . . . 0.0 109.227 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 19.8 m-85 -87.8 146.34 25.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.79 -25.45 62.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.758 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 97.5 p -140.47 160.4 40.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.563 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.57 67.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 0.0 109.666 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.57 -28.69 61.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.988 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 1.1 m-20 -80.83 -30.62 35.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.616 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 42.7 t -79.37 -44.64 21.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 109.333 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 6.7 ttm -67.45 -50.28 59.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 109.48 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -58.32 -19.06 31.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.889 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -90.72 -47.48 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -179.71 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.616 ' CB ' ' CD ' ' A' ' 42' ' ' ARG . 52.1 p90 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.155 0.502 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 53.4 m -68.15 -29.47 68.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 109.31 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' N ' HD23 ' A' ' 6' ' ' LEU . 8.3 mt -77.09 -13.64 59.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.69 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -79.48 165.01 51.02 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.405 -0.81 . . . . 0.0 110.286 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD2' ' OE1' ' A' ' 7' ' ' GLU . 44.4 Cg_endo -71.97 160.19 48.29 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.995 1.524 . . . . 0.0 110.15 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.619 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.6 Cg_endo -70.2 166.56 27.75 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.975 1.513 . . . . 0.0 110.612 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.414 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 67.2 t80 -117.49 94.1 4.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -0.911 . . . . 0.0 110.692 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -63.3 -22.75 67.07 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 63.54 169.34 1.35 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -75.01 -93.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.961 1.506 . . . . 0.0 110.453 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 40.37 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HD3' ' C ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -143.13 18.24 1.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.68 172.3 6.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.703 ' HG2' HG13 ' A' ' 34' ' ' VAL . 8.4 ttp180 -134.74 73.06 1.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.845 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.7 HD12 ' HB2' ' A' ' 37' ' ' ALA . 97.1 mt -88.56 155.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.383 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 19' ' ' ILE . 15.4 mm -102.01 92.15 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.609 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.6 mmp_? -92.48 -179.92 5.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.696 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.584 ' CE1' HG23 ' A' ' 32' ' ' THR . 47.6 m-85 -112.26 150.25 31.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -151.74 157.75 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.568 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 47.0 t80 -83.8 110.99 18.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 110.951 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 41.7 t-20 -88.52 87.52 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.844 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.16 -33.82 2.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 109.411 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -28.95 69.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 109.549 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.671 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -94.87 -17.57 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.38 -9.5 70.22 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -135.19 -143.11 0.19 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.228 -1.16 . . . . 0.0 109.426 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.4 m -116.95 145.39 43.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 110.621 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 mt-30 -128.86 162.79 26.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.795 . . . . 0.0 109.595 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.584 HG23 ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -86.38 148.9 25.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 0.0 110.88 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.6 p90 -143.59 161.74 37.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.994 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.703 HG13 ' HG2' ' A' ' 17' ' ' ARG . 70.1 t -74.92 97.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.327 -0.858 . . . . 0.0 110.857 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.821 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.9 t80 -79.26 146.45 33.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.367 -0.833 . . . . 0.0 110.356 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -80.0 0.58 82.68 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.95 -1.39 3.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.441 -1.035 . . . . 0.0 110.995 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 p -143.6 168.94 18.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.917 -1.115 . . . . 0.0 110.708 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 48.97 37.87 11.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.64 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.821 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -65.31 144.55 57.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 109.672 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -127.68 -155.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.953 . . . . 0.0 110.704 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.616 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 14.7 ptp180 -70.69 -30.6 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.858 . . . . 0.0 111.829 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.7 t-20 -93.92 54.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.64 -1.288 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.4 t-20 -164.12 79.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 40.1 m-85 -85.46 148.78 25.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 110.041 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 15.3 mttt -97.02 7.03 47.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.037 -1.04 . . . . 0.0 110.665 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.539 ' OG ' ' CB ' ' A' ' 50' ' ' ASP . 51.7 p -134.97 161.44 35.26 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.2 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.77 27.44 0.63 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.583 0.706 . . . . 0.0 111.069 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -160.6 -16.66 0.05 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.602 -0.686 . . . . 0.0 111.616 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.539 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 12.1 t0 -70.76 -25.11 62.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.711 -1.243 . . . . 0.0 108.055 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.8 t -71.49 -43.91 65.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.538 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 7.7 mtt -67.9 -50.82 54.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.65 -0.656 . . . . 0.0 109.764 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.83 -19.35 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -104.5 -43.51 5.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 56.7 m . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 110.514 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 49.0 p90 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.046 0.451 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 26.5 m -70.29 -30.35 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 16.6 mt -75.77 -23.08 55.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.703 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 3.7 mt-10 -75.31 160.93 78.82 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 109.715 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 7' ' ' GLU . 44.0 Cg_endo -71.46 169.36 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.832 1.438 . . . . 0.0 109.958 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.4 Cg_endo -71.13 173.86 11.54 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.898 1.472 . . . . 0.0 110.461 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.492 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 36.6 t80 -135.07 94.08 3.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.62 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -62.52 -23.29 66.88 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.51 -163.44 3.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 48.8 Cg_endo -74.92 -156.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.152 1.606 . . . . 0.0 110.493 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 20.2 m 63.09 147.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 10.79 39.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.91 165.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.942 . . . . 0.0 110.558 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -146.61 65.98 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.909 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mt -97.53 152.18 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.745 . . . . 0.0 110.04 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.472 HG23 ' HB ' ' A' ' 32' ' ' THR . 39.2 mm -89.25 84.62 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 110.462 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -85.0 168.14 15.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.801 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 37.1 m-85 -110.04 149.8 29.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.952 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -152.67 160.57 43.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.581 -0.7 . . . . 0.0 109.501 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 72.6 t80 -90.09 127.82 36.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.285 -0.884 . . . . 0.0 110.654 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 27' ' ' ALA . 43.7 t-20 -101.78 87.55 3.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.68 -24.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 109.665 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.06 -26.41 59.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.779 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.56 -37.05 10.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.86 -11.31 38.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.0 mp -133.97 -144.17 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -1.202 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 65.9 m -116.36 156.43 26.73 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.438 -0.789 . . . . 0.0 110.903 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 18.2 mt-30 -144.62 167.59 22.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.505 -0.747 . . . . 0.0 109.575 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.4 p -96.41 144.9 26.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.784 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 24.0 p90 -139.37 165.42 27.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.441 -0.787 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -75.72 113.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.475 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.986 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 8.6 t80 -93.42 148.0 22.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.328 -0.857 . . . . 0.0 109.855 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.736 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.95 -2.24 75.23 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.43 8.34 5.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.063 -1.257 . . . . 0.0 110.541 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 39' ' ' ARG . 25.4 p -153.16 174.08 14.69 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.294 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.7 32.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 0.0 110.36 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.986 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -64.01 157.52 24.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 79.7 mttt -126.71 -159.45 0.93 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 109.683 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.58 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -77.54 -19.24 56.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.689 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.2 t-20 -92.94 64.48 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 0.0 109.711 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 31.1 t-20 -169.18 80.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.549 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.8 m-85 -91.71 157.59 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.076 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -85.82 -15.17 42.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 0.0 110.536 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.2 p -144.5 158.4 43.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -65.9 -24.14 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.784 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 32.6 mm-40 -75.2 -29.83 60.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.394 -0.816 . . . . 0.0 110.184 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -76.58 -32.58 58.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.525 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.549 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 35.9 t -75.02 -43.73 52.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 109.238 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -37.28 77.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.63 -0.669 . . . . 0.0 110.529 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 12.6 mtp85 -70.83 -20.95 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -102.25 -42.45 6.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.271 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.2 m . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.254 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.647 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 4.0 p90 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.046 0.45 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 3.9 m -68.25 -32.88 73.37 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.465 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.795 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 7.5 mt -84.56 -12.08 54.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.44 168.1 28.06 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.818 . . . . 0.0 110.206 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.14 159.18 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.926 1.488 . . . . 0.0 110.371 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.602 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.4 Cg_endo -70.78 174.1 10.89 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.006 1.529 . . . . 0.0 110.335 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.592 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 89.7 t80 -121.85 93.81 4.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 0.0 110.696 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.519 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.05 -23.12 67.21 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.592 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 64.09 147.56 0.03 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -76.9 81.95 2.46 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.141 1.6 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.92 168.56 19.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.066 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.45 3.76 54.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.91 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . -89.7 163.24 15.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 16' ' ' ALA . 27.1 mtp180 -142.75 73.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG21 ' CZ ' ' A' ' 20' ' ' ARG . 51.5 mt -86.95 155.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 32' ' ' THR . 27.4 mm -97.71 87.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 109.993 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.546 ' CZ ' HG21 ' A' ' 18' ' ' ILE . 5.7 mmp_? -91.07 177.59 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 110.142 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 38.6 m-85 -112.63 145.43 40.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.92 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 13.9 p90 -145.04 156.7 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.572 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 57.4 t80 -85.08 106.2 16.38 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 39.5 t-20 -81.3 87.94 6.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.105 -0.997 . . . . 0.0 109.452 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.795 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -44.87 -27.4 0.52 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.05 -1.031 . . . . 0.0 109.787 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.39 -24.5 57.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -95.97 -17.47 20.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 0.87 89.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -143.9 -146.28 0.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.275 -1.132 . . . . 0.0 109.543 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.54 ' O ' HD12 ' A' ' 29' ' ' LEU . 81.2 m -120.77 147.59 45.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 15.7 mt-30 -135.22 159.46 41.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.496 -0.752 . . . . 0.0 109.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -80.43 143.88 33.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.038 -1.038 . . . . 0.0 110.328 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 19.8 p90 -138.32 161.84 35.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.414 -0.804 . . . . 0.0 109.733 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' THR . 12.2 t -74.82 110.36 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 110.692 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.879 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 11.6 t80 -91.39 150.56 21.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.725 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.36 -4.59 85.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.4 7.04 6.06 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.144 -1.209 . . . . 0.0 110.242 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.3 p -144.58 163.27 34.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 47.81 35.06 4.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.879 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -48.76 151.78 1.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 9.1 mttm -131.38 -161.54 1.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.325 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.647 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.9 ptt180 -75.71 -32.52 60.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -89.15 67.71 8.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.928 -1.108 . . . . 0.0 109.252 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.636 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.0 t-20 -169.1 74.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.537 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m-85 -84.84 139.69 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.279 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -21.33 58.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -134.15 156.31 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.173 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -67.54 -24.77 65.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.83 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.33 -32.57 62.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.504 -0.748 . . . . 0.0 109.968 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.75 -37.16 73.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.898 . . . . 0.0 109.201 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.537 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 52.6 t -73.21 -44.35 59.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -61.86 -51.74 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -52.55 -23.98 7.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.874 HG22 ' SG ' ' A' ' 55' ' ' CYS . 6.4 m -89.18 -48.96 7.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.437 -0.789 . . . . 0.0 109.82 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.874 ' SG ' HG22 ' A' ' 54' ' ' THR . 72.2 m . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CD1' ' CB ' ' A' ' 42' ' ' ARG . 9.1 p90 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.368 0.604 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 5.0 t -82.34 -24.59 34.49 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.82 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.4 mt -90.83 -14.61 31.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.89 . . . . 0.0 109.587 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -78.01 156.63 79.5 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.419 -0.801 . . . . 0.0 109.624 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.21 163.68 35.22 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.77 1.405 . . . . 0.0 110.071 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.8 Cg_endo -67.65 -176.45 0.94 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.876 1.461 . . . . 0.0 110.158 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -146.34 93.76 2.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 110.848 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.503 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -60.31 -22.67 63.46 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.14 170.62 1.05 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' CYS . 49.5 Cg_endo -75.13 -95.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.511 . . . . 0.0 109.956 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 39.39 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.525 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.77 48.68 1.61 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.14 -0.975 . . . . 0.0 110.247 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.02 179.65 6.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.29 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -153.4 70.05 0.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 37' ' ' ALA . 76.9 mt -80.34 157.93 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.581 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.55 79.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.298 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.589 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 10.0 mmt85 -84.97 173.24 10.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.96 . . . . 0.0 110.05 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.509 ' CE1' HG22 ' A' ' 32' ' ' THR . 6.8 m-85 -112.83 144.87 41.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.938 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 7.0 p90 -144.05 163.61 33.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.737 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 77.5 t80 -96.59 120.22 36.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 111.033 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 45.8 t-20 -89.95 91.99 8.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 109.727 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.17 -27.33 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.415 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -75.62 -24.77 56.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.675 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.23 -36.01 12.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.739 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.0 65.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.566 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 1.1 mp -125.84 -146.67 0.35 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.039 -1.271 . . . . 0.0 109.638 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.38 149.02 44.38 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.528 -0.733 . . . . 0.0 110.118 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 97.4 mt-30 -139.34 178.27 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.901 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.509 HG22 ' CE1' ' A' ' 21' ' ' TYR . 44.2 p -105.07 147.75 27.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.784 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 21.0 p90 -142.43 163.79 31.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.574 -0.703 . . . . 0.0 110.004 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' THR . 83.0 t -75.16 110.46 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 4.7 t80 -94.07 144.56 25.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 110.322 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.76 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -76.95 4.98 51.68 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.104 -0.997 . . . . 0.0 110.901 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.5 -1.98 2.78 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.201 -1.176 . . . . 0.0 111.294 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.448 ' N ' ' CZ ' ' A' ' 35' ' ' TYR . 21.7 p -150.47 174.37 12.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.952 -1.093 . . . . 0.0 110.199 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' CYS . 1.3 mtt-85 42.92 52.82 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 109.799 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -91.08 140.67 29.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 111.096 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.65 -165.63 1.28 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 108.923 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -70.04 -36.6 75.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.07 . . . . 0.0 110.13 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 7.8 t-20 -76.06 54.49 0.86 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.158 -0.964 . . . . 0.0 109.905 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.544 ' ND2' ' HB1' ' A' ' 40' ' ' ALA . 41.8 t-20 -155.79 69.13 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.592 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 12.4 m-85 -89.83 166.07 13.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.741 . . . . 0.0 110.238 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -92.1 -9.33 42.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.216 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -148.51 155.22 40.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.622 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.45 -26.75 68.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.647 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 5.1 mt-10 -72.33 -32.87 66.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.6 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 39.8 t0 -70.65 -36.55 73.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.98 -44.49 65.87 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.436 ' O ' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -63.52 -59.63 4.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.591 -0.693 . . . . 0.0 109.997 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -43.23 -26.37 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 0.0 109.695 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.5 m -97.89 -36.36 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.48 -179.788 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.571 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 6.3 p90 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.14 0.495 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 2.1 m -80.88 -26.97 36.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 0.0 109.265 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.58 -18.18 42.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.466 -0.771 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 159.52 83.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.962 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.38 171.96 16.62 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.01 1.532 . . . . 0.0 110.434 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.3 Cg_endo -71.74 166.26 30.01 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.932 1.491 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 5.3 t80 -123.0 94.03 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -0.973 . . . . 0.0 111.048 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.492 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.48 -22.25 66.91 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 56.6 166.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 14' ' ' CYS . 50.7 Cg_endo -72.86 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.961 1.506 . . . . 0.0 109.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' PRO . 3.1 m 38.62 -160.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 42.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.021 . . . . 0.0 110.116 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.27 150.83 35.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -0.859 . . . . 0.0 110.215 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.92 83.27 2.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.122 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mt -106.54 158.83 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.054 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.84 89.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.194 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -91.28 173.93 7.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.351 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.518 ' CE1' ' CG2' ' A' ' 32' ' ' THR . 30.7 m-85 -115.6 150.45 36.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 111.176 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.33 154.66 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.533 -0.73 . . . . 0.0 109.487 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.505 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 66.5 t80 -85.34 116.47 23.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.593 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 63.8 t-20 -89.28 93.96 9.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.013 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -21.7 1.42 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.753 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -81.05 -22.87 38.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.861 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -97.57 -28.06 14.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.237 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.51 -10.13 69.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -134.25 -146.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -1.167 . . . . 0.0 109.523 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.67 ' O ' HD12 ' A' ' 29' ' ' LEU . 60.8 m -116.04 154.62 29.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.779 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -142.0 154.91 45.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.484 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 18.9 p -83.49 144.86 29.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.626 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.2 p90 -140.97 164.2 30.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.351 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' THR . 22.9 t -74.37 125.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.402 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.695 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -106.13 147.65 28.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 0.0 110.413 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -90.77 -4.1 70.17 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.72 5.46 5.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.161 -1.2 . . . . 0.0 110.845 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.8 p -157.49 164.32 37.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.883 -1.136 . . . . 0.0 110.855 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER 50.63 34.72 10.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.328 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -84.63 164.69 18.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.74 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -121.5 -159.69 0.82 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.569 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 2.7 mtm180 -77.51 -8.86 58.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.098 . . . . 0.0 109.766 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -94.11 59.39 2.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.694 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.581 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 14.8 t-20 -165.23 84.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.9 m-85 -93.97 150.71 20.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.708 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 16.4 mtpt -81.51 -12.24 58.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -142.45 156.52 45.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.296 -0.878 . . . . 0.0 110.186 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . . . -74.12 -22.56 59.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.852 . . . . 0.0 109.953 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 5.1 tp10 -70.68 -35.95 73.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 110.482 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 54' ' ' THR . 0.4 OUTLIER -78.76 -35.44 44.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.668 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.557 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.3 t -67.97 -44.19 77.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 39.1 tpp -64.35 -61.05 2.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.573 -0.705 . . . . 0.0 110.514 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.49 -18.97 21.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.54 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.7 m -88.12 -45.62 9.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.1 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.498 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 19.1 p90 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.137 0.494 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -80.85 -19.0 45.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.735 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 18.4 mt -74.38 -24.68 59.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 7.2 mt-10 -79.04 161.61 67.71 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 41.7 Cg_endo -69.76 168.28 22.02 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.108 1.583 . . . . 0.0 110.359 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.621 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.8 Cg_endo -71.08 156.98 58.87 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.963 1.507 . . . . 0.0 110.517 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.6 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 40.9 t80 -121.39 94.26 4.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.261 -0.9 . . . . 0.0 110.883 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -56.05 -23.5 33.9 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.6 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 63.27 -178.12 6.64 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 45.7 Cg_endo -72.24 -155.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.175 1.618 . . . . 0.0 110.685 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 11.9 m 64.24 154.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 6.34 46.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.22 169.21 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 110.102 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.94 102.37 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.641 HG21 ' NH2' ' A' ' 20' ' ' ARG . 28.6 mt -134.23 145.99 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.844 . . . . 0.0 110.059 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.401 HG23 ' HB ' ' A' ' 32' ' ' THR . 41.2 mm -90.37 85.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.641 ' NH2' HG21 ' A' ' 18' ' ' ILE . 9.1 mmt-85 -91.02 176.91 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.927 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 71.6 m-85 -114.0 154.18 28.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 111.528 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 11.8 p90 -153.0 154.43 34.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.405 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 89.1 t80 -83.99 106.88 15.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.269 -0.894 . . . . 0.0 111.013 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 55.3 t-20 -80.24 98.54 7.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -50.86 -23.35 2.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.976 -1.077 . . . . 0.0 109.559 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.402 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -77.81 -23.71 49.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.448 -0.782 . . . . 0.0 110.209 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -99.79 -14.52 18.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.69 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.02 1.75 85.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 30' ' ' CYS . 1.8 pp -144.27 -147.35 0.21 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.383 -1.069 . . . . 0.0 109.102 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.671 ' N ' HD12 ' A' ' 29' ' ' LEU . 79.4 m -121.96 162.2 21.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 110.607 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 95.7 mt-30 -144.87 -175.36 4.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.607 -0.683 . . . . 0.0 109.395 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 25.2 p -103.13 144.15 31.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.994 -1.066 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.8 p90 -141.8 160.53 40.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.929 . . . . 0.0 110.056 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.7 t -74.05 122.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.035 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.669 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.7 t80 -101.26 141.33 34.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.753 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.57 -0.53 79.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.563 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.4 -1.37 2.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.191 -1.182 . . . . 0.0 111.074 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 39' ' ' ARG . 15.8 p -140.68 163.09 33.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.822 -1.174 . . . . 0.0 111.03 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.442 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER 41.77 45.5 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 110.911 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -73.78 146.66 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.751 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' HB2' ' A' ' 10' ' ' TYR . 42.5 mtpt -95.06 -159.91 0.75 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 8.3 mtt-85 -85.55 -22.73 27.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.146 -0.971 . . . . 0.0 109.869 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.488 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 21.0 t-20 -89.07 53.86 2.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 0.0 110.14 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 3.9 t-20 -143.93 84.55 1.78 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 43' ' ' ASN . 23.8 m-85 -99.6 153.34 19.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 110.552 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -76.24 -20.93 56.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.579 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.9 p -137.67 156.65 47.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 110.614 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.01 68.53 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.582 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.97 -38.52 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.414 -0.804 . . . . 0.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -62.04 -34.41 76.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.084 -1.01 . . . . 0.0 108.557 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.9 t -71.17 -43.18 67.99 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -50.45 33.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.36 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -22.96 25.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.019 -1.051 . . . . 0.0 109.629 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.566 HG22 ' SG ' ' A' ' 55' ' ' CYS . 16.4 m -94.37 -45.85 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.532 -0.73 . . . . 0.0 109.914 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 54' ' ' THR . 56.7 m . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 110.501 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.74 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 14.9 p90 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.321 0.581 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.5 -8.3 58.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.022 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.664 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 27.5 mt -76.59 -23.28 53.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 109.953 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -81.8 174.38 6.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.349 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.78 165.85 30.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.872 1.459 . . . . 0.0 110.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.599 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.3 Cg_endo -71.62 -175.99 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.967 1.509 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 67.6 t80 -127.63 93.88 3.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.699 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.46 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -65.83 -22.62 66.56 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 60.32 151.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.16 82.54 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.97 1.51 . . . . 0.0 110.513 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.46 175.88 10.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 110.155 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -108.9 -1.03 19.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.31 160.67 28.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.14 68.47 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.72 153.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 110.075 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -98.01 86.39 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 110.37 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.56 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 mmt180 -86.59 173.15 9.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 64.5 m-85 -112.69 151.12 30.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.09 -1.006 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 8.3 p90 -150.56 163.63 38.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.66 -0.65 . . . . 0.0 109.403 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 70.7 t80 -87.2 132.14 33.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 34.8 t-20 -102.89 87.9 3.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.815 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.13 -32.34 1.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.005 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 1.9 mptp? -72.84 -24.51 60.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.865 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -98.2 -33.69 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.88 . . . . 0.0 110.16 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.01 -12.37 58.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -127.91 -144.23 0.29 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.8 m -121.69 157.24 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 6.6 mt-30 -140.23 -177.51 5.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 19.8 p -102.37 144.4 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.046 -1.034 . . . . 0.0 110.546 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.6 p90 -141.57 160.28 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.79 108.34 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.249 -0.907 . . . . 0.0 110.832 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.984 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -87.44 146.22 25.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.72 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.65 -4.44 85.34 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.68 12.45 7.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.147 -1.207 . . . . 0.0 110.314 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 39' ' ' ARG . 27.0 p -150.11 162.88 39.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.1 mtt-85 40.65 44.42 1.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.984 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -62.64 155.11 27.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.551 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 2.4 mtpp -121.03 -157.8 0.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.368 -0.832 . . . . 0.0 109.578 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.74 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -83.23 -22.5 33.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 0.0 109.978 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 1.7 t-20 -90.13 54.29 2.75 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.768 0.794 . . . . 0.0 109.04 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.586 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 19.4 t-20 -157.5 76.5 0.82 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 22.9 m-85 -87.74 134.78 33.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.433 -0.792 . . . . 0.0 109.849 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -65.71 -16.61 63.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.287 -0.883 . . . . 0.0 111.34 -178.701 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 99.2 p -143.43 158.02 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 110.434 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -64.8 -29.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.066 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.66 -25.37 56.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.646 -0.659 . . . . 0.0 109.812 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.485 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 39.2 t0 -78.64 -30.59 46.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 109.514 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.547 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 39.9 t -78.65 -43.96 24.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.225 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 48' ' ' ALA . 72.9 mmm -66.28 -49.39 67.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.484 -0.76 . . . . 0.0 110.309 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -62.23 -14.52 39.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 109.849 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.505 HG22 ' HZ ' ' A' ' 4' ' ' PHE . 47.6 m -92.14 -53.56 4.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.575 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 57.6 m . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 110.687 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.513 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 37.7 p90 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.536 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 1.7 m -85.54 -19.47 31.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.714 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 15.1 mt -82.77 -19.03 38.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 110.837 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -86.1 169.86 14.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.93 -1.106 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.94 163.71 36.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.889 1.468 . . . . 0.0 110.183 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.604 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.6 Cg_endo -71.41 163.51 38.83 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.947 1.498 . . . . 0.0 110.516 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.437 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 17.5 t80 -120.77 93.88 4.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.32 -0.863 . . . . 0.0 110.269 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.2 m -50.62 -23.44 2.6 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.92 -176.17 21.99 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.512 ' CG ' ' HG3' ' A' ' 39' ' ' ARG . 48.8 Cg_endo -79.21 -153.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.075 1.566 . . . . 0.0 109.992 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 32.1 m 63.05 170.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.114 -0.991 . . . . 0.0 110.535 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -116.23 10.12 14.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 110.344 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 159.1 7.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.679 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -130.64 78.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.31 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.757 HD11 ' HB2' ' A' ' 37' ' ' ALA . 6.0 mt -104.31 156.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.883 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.439 HG23 ' HB ' ' A' ' 32' ' ' THR . 44.3 mm -99.77 80.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 109.984 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.572 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 9.0 mmt180 -85.95 174.61 9.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -114.27 143.69 44.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 110.864 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 20.5 p90 -138.19 152.14 48.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 62.8 t80 -79.19 106.11 10.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.342 -0.849 . . . . 0.0 111.253 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' ALA . 53.0 t-20 -79.14 84.84 5.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.476 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.714 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.56 -26.03 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.925 -1.109 . . . . 0.0 109.439 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.67 64.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 109.579 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.5 -24.11 16.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.463 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.34 1.26 60.9 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -149.44 -142.2 0.12 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.319 -1.106 . . . . 0.0 109.227 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 m -117.55 164.2 15.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.129 0.966 . . . . 0.0 112.209 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 24.7 mt-30 -147.67 160.86 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.2 p -79.7 144.15 33.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 111.13 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 13.5 p90 -144.08 160.73 40.38 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 11' ' ' THR . 9.1 t -74.01 129.25 36.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 110.19 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.893 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -113.84 146.58 39.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 0.0 109.359 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.713 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.34 4.41 84.22 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.757 ' HB2' HD11 ' A' ' 18' ' ' ILE . . . 68.96 4.59 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.94 -1.329 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 7.9 p -145.01 159.27 43.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.415 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.512 ' HG3' ' CG ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER 51.47 33.12 9.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.215 -0.928 . . . . 0.0 110.794 179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.893 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -59.77 142.13 53.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 110.46 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -102.79 -170.29 1.78 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.063 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.565 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 2.6 mtt-85 -71.73 -25.33 62.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.083 -1.01 . . . . 0.0 109.782 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 11.3 t-20 -92.91 54.38 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 109.982 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.472 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 22.6 t-20 -153.43 70.39 0.85 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.565 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 13.1 m-85 -88.2 146.25 25.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 ttmt -76.89 -18.95 58.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 110.59 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.9 p -136.24 152.34 50.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 110.398 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.38 67.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.5 -0.75 . . . . 0.0 109.907 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.506 ' N ' ' OE1' ' A' ' 49' ' ' GLU . 3.4 mp0 -73.4 -19.87 60.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.675 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.5 t0 -83.32 -29.64 28.13 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 108.722 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.66 -45.97 56.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.41 0.624 . . . . 0.0 109.5 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -54.55 41.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.349 -0.845 . . . . 0.0 110.865 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -53.09 -19.1 2.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.608 HG22 ' SG ' ' A' ' 55' ' ' CYS . 40.9 m -97.28 -59.61 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.12 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.608 ' SG ' HG22 ' A' ' 54' ' ' THR . 57.1 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.651 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.628 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 42.5 p90 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.816 0.341 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.598 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 94.8 m -82.84 -25.15 32.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.9 -1.125 . . . . 0.0 109.248 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.401 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.7 mt -80.25 -22.93 41.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 109.485 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 5.9 mm-40 -73.07 154.85 90.63 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.19 167.04 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.927 1.488 . . . . 0.0 110.401 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.615 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.7 Cg_endo -69.22 159.05 55.33 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.027 1.541 . . . . 0.0 110.062 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 30.1 t80 -122.78 94.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.479 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 62.76 172.31 1.68 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 14' ' ' CYS . 45.9 Cg_endo -72.74 -93.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.983 1.517 . . . . 0.0 110.277 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.7 m 39.99 -162.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.208 -0.932 . . . . 0.0 110.61 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -141.61 8.98 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' O ' ' CD ' ' A' ' 17' ' ' ARG . . . -93.16 173.54 7.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.024 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' CD ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -150.08 81.97 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.2 mp -95.53 164.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.983 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.3 mm -100.87 89.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.519 HH21 HG21 ' A' ' 18' ' ' ILE . 3.6 mmt85 -95.42 177.27 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.948 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.526 ' CE1' HG23 ' A' ' 32' ' ' THR . 51.1 m-85 -116.09 151.03 36.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 0.0 111.156 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 11.9 p90 -147.72 158.92 44.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.523 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.627 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 68.8 t80 -88.89 107.7 19.14 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.281 -0.887 . . . . 0.0 110.895 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 62.4 t-20 -83.77 89.59 7.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 110.014 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.38 -24.99 0.57 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.001 -1.062 . . . . 0.0 109.535 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -75.53 -25.97 57.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.835 . . . . 0.0 109.714 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.61 -28.9 15.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.57 -10.31 59.22 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 29' ' ' LEU . 1.3 pt? -140.52 -147.05 0.21 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.25 -1.147 . . . . 0.0 109.841 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 99.4 m -115.69 156.92 25.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 110.551 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.521 HE22 ' HB2' ' A' ' 27' ' ' ALA . 45.3 mt-30 -144.02 178.69 7.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.566 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.526 HG23 ' CE1' ' A' ' 21' ' ' TYR . 3.3 p -95.93 144.6 26.11 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.418 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.4 p90 -143.53 165.06 28.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.488 -0.757 . . . . 0.0 109.83 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.457 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 63.2 t -75.16 132.08 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.984 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.671 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -112.71 146.81 38.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 109.864 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -99.72 1.96 57.0 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.7 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.59 1.73 3.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.007 -1.29 . . . . 0.0 110.971 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 39' ' ' ARG . 22.3 p -149.53 172.43 15.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 0.0 110.482 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 1.5 mpt_? 40.63 30.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -73.49 156.97 37.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 111.031 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HD2' ' HB2' ' A' ' 10' ' ' TYR . 7.5 mtpt -110.33 -169.8 1.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.443 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.628 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 2.7 mtt-85 -76.7 -15.65 59.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.26 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 15.1 t-20 -90.39 53.79 2.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 109.473 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.0 t-20 -147.74 77.64 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 51' ' ' CYS . 17.9 m-85 -94.32 143.84 26.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.793 . . . . 0.0 110.24 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 110.294 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -136.53 157.65 46.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 110.414 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -24.88 66.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.956 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.15 -23.71 63.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.026 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 46.9 t0 -90.18 -24.7 20.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.542 ' HB2' ' CD1' ' A' ' 45' ' ' PHE . 29.7 t -82.15 -43.96 17.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 109.808 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.2 mtp -66.81 -50.25 63.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 0.0 110.547 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -17.59 2.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -110.76 -42.14 4.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.627 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.3 m . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.624 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 14.5 p90 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.195 0.521 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.6 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 6.4 m -85.3 -22.45 28.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 110.646 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.71 -2.78 47.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.74 -1.225 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.47 170.61 7.91 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 110.603 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.01 166.79 28.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.152 1.606 . . . . 0.0 110.35 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.588 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 43.3 Cg_endo -70.78 -173.13 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.883 1.465 . . . . 0.0 109.595 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.59 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 65.5 t80 -154.65 93.92 1.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.912 -1.117 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.402 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -58.68 -23.18 58.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.59 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 66.19 155.68 0.34 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.07 66.38 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.05 1.553 . . . . 0.0 110.31 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.491 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 23.0 m -121.7 -174.91 2.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.729 . . . . 0.0 109.825 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -120.68 12.33 11.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.114 -0.991 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.96 166.69 11.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 110.268 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -144.0 68.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.005 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 35' ' ' TYR . 61.4 mt -87.46 155.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.432 -0.792 . . . . 0.0 110.123 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.1 mm -93.5 89.0 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.557 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.8 mmt85 -99.52 -179.19 4.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 110.383 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.536 ' CZ ' HG23 ' A' ' 32' ' ' THR . 10.7 m-85 -116.81 153.46 32.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 111.328 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 15.5 p90 -149.06 176.77 10.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.519 -0.738 . . . . 0.0 109.361 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.8 OUTLIER -95.03 100.57 12.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' ALA . 48.8 t-20 -86.11 69.46 10.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.656 -1.278 . . . . 0.0 108.337 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.78 -26.04 0.87 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.435 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -62.08 -37.28 84.44 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -83.58 -31.86 26.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.587 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.09 -10.71 10.05 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.625 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.32 -141.89 0.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.754 -1.439 . . . . 0.0 109.889 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 96.2 m -107.2 151.93 24.77 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.499 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 5.7 mt-30 -141.59 179.38 6.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 110.467 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.536 HG23 ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -91.54 148.14 22.5 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.394 -0.817 . . . . 0.0 109.877 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.592 ' HB3' ' CD1' ' A' ' 22' ' ' PHE . 13.4 p90 -148.14 166.08 28.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 110.483 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.452 ' CG1' ' HG3' ' A' ' 17' ' ' ARG . 13.2 t -74.64 122.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.37 -0.831 . . . . 0.0 110.275 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -103.66 142.7 33.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.412 -0.805 . . . . 0.0 109.658 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.754 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.42 -0.98 78.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.545 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.6 0.81 3.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -1.194 . . . . 0.0 110.176 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -153.9 173.55 15.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 44.72 26.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -63.52 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.538 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.9 mtpp -95.83 -162.99 1.0 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.381 -0.825 . . . . 0.0 109.243 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.624 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.3 mtm180 -84.65 -9.33 58.36 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.002 -1.061 . . . . 0.0 109.979 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -96.97 53.99 1.24 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.561 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 13.6 t-20 -144.26 84.2 1.75 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 27.8 m-85 -101.21 164.51 11.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -91.99 -16.23 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.277 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.507 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 97.8 p -141.5 154.81 45.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.87 66.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.588 -0.695 . . . . 0.0 110.001 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -15.04 60.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.726 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.557 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 21.3 t70 -94.58 -25.39 16.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.599 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 7.3 t -73.84 -49.12 26.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.833 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.417 ' O ' ' C ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.67 -49.02 70.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.52 -0.738 . . . . 0.0 110.442 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -45.26 -29.32 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.892 -1.13 . . . . 0.0 109.472 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.462 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 1.2 m -104.56 -31.55 9.38 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.699 0.761 . . . . 0.0 109.083 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.639 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 92.9 m . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.612 -0.68 . . . . 0.0 110.92 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.573 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 5.1 p90 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 121.786 0.803 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 2.2 t -77.91 -29.27 50.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.691 -0.631 . . . . 0.0 109.793 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 13.1 mt -87.7 -10.09 52.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 109.51 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.27 153.32 84.16 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.647 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 43.2 Cg_endo -70.56 174.45 10.19 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.979 1.516 . . . . 0.0 110.071 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.7 Cg_endo -73.05 155.42 52.58 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.841 1.443 . . . . 0.0 109.813 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 24.3 t80 -118.72 93.95 4.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 111.102 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.469 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -59.88 -23.43 63.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.43 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 64.05 164.83 0.78 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -80.96 89.85 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 124.231 1.648 . . . . 0.0 110.027 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.35 171.25 18.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.056 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -14.02 17.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.19 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.76 169.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.481 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -152.0 69.3 0.9 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.02 155.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 110.365 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.3 mm -94.18 87.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.329 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 mmt85 -90.79 175.09 7.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 110.508 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.593 ' CE2' HG23 ' A' ' 32' ' ' THR . 57.5 m-85 -117.13 148.6 41.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -0.776 . . . . 0.0 111.389 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 17.8 p90 -148.41 161.16 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 69.1 t80 -90.05 108.85 19.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.965 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 26' ' ' LYS . 25.8 t-20 -80.87 87.18 5.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.252 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.26 -26.49 0.51 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.99 -1.069 . . . . 0.0 109.556 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 6.0 tttt -70.95 -29.13 65.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.667 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -91.57 -35.71 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.13 56.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -140.0 -144.74 0.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -1.165 . . . . 0.0 109.036 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.7 m -116.71 150.98 37.33 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 110.572 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 87.1 mt-30 -139.52 167.2 22.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.593 HG23 ' CE2' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -96.78 146.94 24.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.114 -0.991 . . . . 0.0 110.881 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -142.74 161.61 37.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.581 -0.699 . . . . 0.0 110.118 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' THR . 70.4 t -75.28 107.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.313 -0.867 . . . . 0.0 110.395 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.813 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.1 t80 -85.0 146.01 27.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.402 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.686 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.56 2.85 83.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 67.55 13.36 9.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.108 -1.231 . . . . 0.0 110.613 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ARG . 31.3 p -156.36 170.59 21.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.94 . . . . 0.0 110.399 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.85 37.96 0.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -74.89 147.96 40.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.417 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -116.75 -165.3 1.05 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.581 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 6.2 mtt-85 -68.75 -20.12 64.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.268 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 1.7 t-20 -91.48 54.21 2.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.056 -1.028 . . . . 0.0 110.178 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.544 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -156.29 76.05 0.89 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 108.945 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.0 m-85 -91.13 147.59 22.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 110.677 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 0.0 OUTLIER -78.25 -21.36 50.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 110.349 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.491 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 91.8 p -135.8 156.57 48.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 0.0 110.492 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.12 -25.46 68.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.527 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 1.7 tp10 -73.79 -26.22 60.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 25.9 t0 -77.38 -31.77 54.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.265 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.587 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.3 t -82.48 -47.87 11.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.592 -0.692 . . . . 0.0 109.193 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.8 ttm -65.74 -44.44 85.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 109.993 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -58.12 -25.33 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.674 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -90.17 -42.32 11.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.448 -0.783 . . . . 0.0 109.767 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 110.815 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.576 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 4.4 p90 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.302 0.573 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -82.13 -28.88 31.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.6 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -82.02 -19.31 40.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 109.724 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.94 158.37 85.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.823 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 44.1 Cg_endo -71.84 174.83 10.57 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.853 1.449 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.606 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -71.55 169.74 20.24 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.902 1.475 . . . . 0.0 110.48 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.597 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 63.5 t80 -129.1 94.25 3.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.835 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.401 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -56.29 -23.39 36.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 58.44 -172.8 3.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.0 Cg_endo -73.63 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.17 1.616 . . . . 0.0 110.466 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 28.6 m 63.12 173.33 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -133.52 27.19 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.01 -168.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.102 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 38.8 ttm180 -150.69 73.81 1.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.162 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 82.1 mt -109.99 146.61 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.518 HG23 ' HB ' ' A' ' 32' ' ' THR . 43.9 mm -92.43 82.45 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -81.67 169.24 17.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.919 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 47.2 m-85 -112.44 149.87 31.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 111.492 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 13.0 p90 -150.12 156.81 42.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 47.7 t80 -83.6 116.3 22.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.125 -0.984 . . . . 0.0 110.486 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 26.9 t-20 -91.24 88.48 6.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.874 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.58 -37.72 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.735 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 10.2 tptp -64.91 -27.99 69.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.586 ' O ' HD12 ' A' ' 29' ' ' LEU . . . -92.66 -23.58 18.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.4 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 91.22 -11.29 72.6 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 27' ' ' ALA . 1.7 mp -132.76 -142.53 0.21 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -1.138 . . . . 0.0 109.521 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 66.3 m -119.57 154.67 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.579 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 3.3 mt-30 -138.61 172.3 13.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.499 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.518 ' HB ' HG23 ' A' ' 19' ' ' ILE . 8.5 p -98.59 144.45 27.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 110.506 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -137.82 157.08 47.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.042 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.37 101.33 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.207 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.817 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 10.7 t80 -80.58 149.24 29.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.491 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.741 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -84.56 -1.68 89.11 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.26 6.69 5.22 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 20.2 p -149.77 171.91 15.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 110.456 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 39.34 47.17 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.486 -0.759 . . . . 0.0 110.645 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.817 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -69.28 156.07 39.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -120.47 -162.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.301 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.528 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.6 mtm-85 -80.11 -6.13 57.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 109.978 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.8 t-20 -110.25 54.59 0.66 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.86 . . . . 0.0 109.64 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.584 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 30.1 t-20 -155.41 82.49 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -94.49 142.65 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 111.099 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 11.2 tmtt? -71.92 -23.46 61.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.496 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 97.0 p -134.26 159.02 42.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 110.502 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.23 64.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.78 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -74.23 -28.68 61.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 110.236 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.491 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 56.4 t0 -78.86 -32.56 46.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.559 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.3 t -74.78 -43.98 51.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -48.92 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.253 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -64.69 -11.93 41.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 109.717 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.465 HG22 ' SG ' ' A' ' 5' ' ' CYS . 1.8 m -106.43 -38.79 6.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.885 . . . . 0.0 110.16 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.6 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.648 ' CB ' ' CD ' ' A' ' 42' ' ' ARG . 9.0 p90 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.984 0.421 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.577 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -72.96 -29.66 63.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.072 -1.018 . . . . 0.0 109.658 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.731 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 39.5 mt -78.31 -20.36 51.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.743 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 45.0 mt-10 -81.55 165.37 44.46 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 47.7 Cg_endo -72.87 163.0 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.937 1.493 . . . . 0.0 110.564 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.489 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 43.6 Cg_endo -71.79 -159.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.968 1.509 . . . . 0.0 110.456 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 45.5 t80 -146.43 93.68 2.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 109.946 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -58.67 -22.82 58.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.593 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 61.12 174.87 1.39 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.5 Cg_endo -81.55 -96.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.903 1.475 . . . . 0.0 110.658 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' PRO . 2.0 m 38.91 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.235 -0.915 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -142.54 17.2 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.832 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.01 -179.76 4.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 110.027 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.06 71.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.612 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 3.7 mp -85.84 156.58 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.681 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 32' ' ' THR . 22.1 mm -93.74 80.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.113 -0.992 . . . . 0.0 110.602 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 7.8 mmt180 -81.35 175.04 10.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.702 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.538 ' CD1' ' HA ' ' A' ' 47' ' ' SER . 89.8 m-85 -116.23 151.8 35.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.037 -1.039 . . . . 0.0 111.285 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.511 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 15.7 p90 -150.35 161.87 41.64 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 72.6 t80 -86.33 107.81 18.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.968 -1.082 . . . . 0.0 110.963 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' ALA . 37.5 t-20 -84.99 90.84 7.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.997 . . . . 0.0 109.86 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.53 -28.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.525 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.485 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -71.09 -27.14 63.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.333 -0.855 . . . . 0.0 109.762 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.41 -18.5 19.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.002 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 -3.04 87.54 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.665 HD12 ' O ' ' A' ' 30' ' ' CYS . 1.1 pp -144.1 -145.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.16 -1.2 . . . . 0.0 109.36 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.665 ' O ' HD12 ' A' ' 29' ' ' LEU . 84.3 m -114.76 151.12 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 111.031 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -137.61 176.95 8.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.359 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.532 ' HB ' ' CG2' ' A' ' 19' ' ' ILE . 25.4 p -93.46 144.29 25.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 7.8 p90 -144.48 161.52 38.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 55.5 t -74.72 135.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 0.0 110.231 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.827 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -122.27 141.63 51.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.787 . . . . 0.0 109.775 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -75.39 -1.76 65.9 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 71.2 1.89 4.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -1.127 . . . . 0.0 110.485 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 6.0 p -142.5 157.02 45.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.008 -1.058 . . . . 0.0 110.058 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 4.9 mtp85 56.72 35.6 26.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.827 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -55.03 149.9 11.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.505 ' CE ' ' HB2' ' A' ' 10' ' ' TYR . 2.1 mtmp? -124.86 -170.57 2.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.648 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 6.7 ptp180 -65.05 -32.93 74.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 111.278 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.9 t-20 -88.46 54.66 3.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.822 -1.174 . . . . 0.0 109.449 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.482 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 54.1 t-20 -158.55 76.34 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 23.1 m-85 -85.86 136.72 33.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 110.589 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -61.34 -26.96 68.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.848 . . . . 0.0 110.076 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.538 ' HA ' ' CD1' ' A' ' 21' ' ' TYR . 89.3 p -145.29 162.03 38.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 -20.43 66.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.906 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 2.7 tp10 -70.68 -34.47 72.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.3 t0 -79.28 -32.95 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.375 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.579 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 44.4 t -69.87 -44.43 69.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.765 . . . . 0.0 109.208 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.37 -55.39 18.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.499 -0.751 . . . . 0.0 109.522 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 2.2 ttp180 -46.08 -31.82 2.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' SG ' ' A' ' 55' ' ' CYS . 85.3 m -79.27 -59.44 2.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -0.786 . . . . 0.0 109.445 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.441 ' SG ' HG22 ' A' ' 54' ' ' THR . 59.2 m . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.388 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.552 ' CB ' ' HD3' ' A' ' 42' ' ' ARG . 3.5 p90 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.525 0.679 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 3.7 t -84.55 -25.17 28.91 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.873 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 6' ' ' LEU . 7.3 mt -86.96 -15.28 39.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.904 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.43 163.88 56.92 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 168.44 24.5 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.111 1.585 . . . . 0.0 110.187 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.619 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.9 Cg_endo -70.73 169.76 19.38 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.017 1.535 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 38.8 t80 -126.25 94.27 4.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 111.131 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.478 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -67.39 -22.64 65.54 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.83 171.8 0.56 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.6 Cg_endo -80.51 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.877 1.462 . . . . 0.0 110.333 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 41.52 -164.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 110.569 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -134.41 26.41 3.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 110.201 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.55 5.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.17 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 2.2 ptp180 -153.82 73.64 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.125 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 19' ' ' ILE . 4.1 mt -90.26 165.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.275 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' N ' HG22 ' A' ' 18' ' ' ILE . 29.4 mm -102.79 92.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.549 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.555 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 4.2 mmt180 -94.48 -179.39 4.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.846 . . . . 0.0 110.038 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.557 ' CE2' HG22 ' A' ' 32' ' ' THR . 72.6 m-85 -117.03 146.2 43.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.084 . . . . 0.0 111.06 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.7 p90 -145.69 163.38 35.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.482 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 86.9 t80 -92.26 124.33 36.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.742 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 59.8 t-20 -96.69 96.54 8.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -0.956 . . . . 0.0 109.929 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.6 -36.31 10.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -68.57 -25.5 64.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.776 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -96.36 -24.91 15.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 86.43 -8.72 73.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -129.68 -146.3 0.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.247 -1.149 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 63.1 m -123.48 150.02 44.42 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.729 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.589 HE22 ' HB2' ' A' ' 27' ' ' ALA . 36.3 mt-30 -137.31 160.96 37.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.558 -0.714 . . . . 0.0 109.21 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.557 HG22 ' CE2' ' A' ' 21' ' ' TYR . 40.5 p -82.97 144.23 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.3 p90 -140.62 166.22 25.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.442 -0.787 . . . . 0.0 109.865 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.448 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 3.6 t -74.88 133.84 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.083 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.723 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.6 t80 -112.88 147.09 37.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 0.0 110.324 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.749 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -87.34 -4.16 81.06 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 74.37 -4.54 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.445 -1.032 . . . . 0.0 111.113 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 39' ' ' ARG . 29.3 p -146.7 170.35 17.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 110.441 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.536 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.2 ttt180 42.78 51.76 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.723 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -95.23 157.82 15.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 0.0 110.905 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 4.6 mttp -118.59 -161.48 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.348 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.552 ' HD3' ' CB ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -74.55 -23.98 58.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.1 t-20 -80.19 54.26 1.93 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.919 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.594 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 25.2 t-20 -162.41 74.31 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 20.3 m-85 -85.46 143.7 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.446 -0.783 . . . . 0.0 110.788 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -68.91 -25.11 64.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 0.0 110.096 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -136.39 157.11 47.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 0.0 110.543 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.51 -22.87 66.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.071 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 4.1 mt-10 -75.28 -27.86 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.599 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 14.6 t0 -72.85 -35.85 67.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.526 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.2 t -71.43 -44.52 64.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.7 mmt -67.69 -53.8 24.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.475 -0.766 . . . . 0.0 109.395 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -53.38 -22.43 7.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -96.22 -39.38 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 109.728 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.343 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.748 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 6.6 p90 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.158 0.504 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 53.4 m -84.19 -20.94 31.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 178.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.692 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 15.7 mt -73.75 -22.82 59.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.52 160.37 81.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 110.141 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.7 170.28 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.017 1.535 . . . . 0.0 110.208 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.39 178.47 6.1 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.833 1.439 . . . . 0.0 110.153 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 11.0 t80 -139.56 93.86 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.91 . . . . 0.0 110.428 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -59.54 -22.74 62.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.39 144.94 0.03 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.54 65.47 4.65 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.958 1.504 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.488 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 18.5 m -117.56 170.83 8.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 4.49 53.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.357 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.53 175.55 5.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 109.998 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 13.5 ptp180 -155.08 71.97 0.81 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.575 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 mt -81.17 157.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.809 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 19' ' ' ILE . 4.3 mm -94.18 88.49 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.018 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.611 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.2 mmt180 -92.42 -175.65 4.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.338 -0.851 . . . . 0.0 110.034 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.623 ' CE2' HG23 ' A' ' 32' ' ' THR . 69.0 m-85 -119.37 144.82 46.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 111.434 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 14.4 p90 -142.14 166.52 24.47 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 55' ' ' CYS . 73.0 t80 -95.95 111.59 23.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 110.835 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 28.3 t-20 -84.32 91.83 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -47.07 -24.27 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -79.25 -22.93 44.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.407 -0.808 . . . . 0.0 109.823 179.421 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -93.56 -28.47 16.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 -0.6 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -151.26 -151.62 0.4 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -1.163 . . . . 0.0 109.851 179.677 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.58 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 95.4 m -109.99 153.75 24.13 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.871 0.843 . . . . 0.0 111.43 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -143.51 174.25 10.92 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.623 HG23 ' CE2' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -96.54 144.29 26.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.712 -1.243 . . . . 0.0 110.669 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -138.79 162.38 34.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.765 . . . . 0.0 109.583 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 17' ' ' ARG . 53.3 t -75.99 99.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 111.283 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.7 t80 -81.49 144.78 31.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.509 -0.745 . . . . 0.0 109.505 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.778 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -87.06 3.59 86.83 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.392 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 78.55 -24.5 0.21 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.467 -1.019 . . . . 0.0 111.169 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.44 168.35 19.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.898 -1.126 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.77 43.73 27.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 109.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.594 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -85.76 164.48 17.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.353 -0.842 . . . . 0.0 111.198 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.4 mttt -116.23 -166.3 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.748 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -76.88 -19.78 57.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.865 -1.147 . . . . 0.0 110.183 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.434 ' H ' ' HD2' ' A' ' 42' ' ' ARG . 3.8 t-20 -92.07 53.67 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.908 0.861 . . . . 0.0 109.341 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.466 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 17.8 t-20 -149.49 71.06 1.09 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.6 m-85 -84.89 141.21 30.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.531 -178.077 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 4.7 tttt -66.02 -23.12 66.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.477 -0.764 . . . . 0.0 110.911 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -143.38 153.85 43.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 110.418 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -56.86 -29.86 63.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.705 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.6 tt0 -64.68 -34.02 77.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.82 . . . . 0.0 110.363 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' ' HB ' ' A' ' 54' ' ' THR . 22.5 t0 -79.25 -29.18 42.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.622 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 37.6 t -82.9 -44.2 15.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.429 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -67.98 -49.95 58.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.956 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -59.97 -23.7 63.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 0.0 109.42 179.295 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.509 HG23 ' HZ ' ' A' ' 4' ' ' PHE . 2.5 m -94.32 -44.3 8.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.559 -0.713 . . . . 0.0 109.824 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 55.8 m . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.585 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 28.6 p90 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.258 0.551 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 20.0 m -83.64 -26.43 29.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.075 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 6' ' ' LEU . 5.3 mt -81.43 -18.24 46.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.721 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.27 162.25 57.14 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.934 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.04 168.97 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.932 1.491 . . . . 0.0 110.108 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.602 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -70.59 175.2 9.12 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.998 1.526 . . . . 0.0 110.667 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -133.91 93.9 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 0.0 110.389 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.72 -22.69 66.63 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 11' ' ' THR . . . 57.94 171.8 0.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.3 Cg_endo -74.68 -97.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.913 1.481 . . . . 0.0 110.453 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 42.96 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.044 -1.035 . . . . 0.0 110.739 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -133.23 15.75 4.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 110.08 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.11 172.43 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 71.13 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 110.284 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -98.35 153.78 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 32' ' ' THR . 14.5 mm -96.64 87.67 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 32' ' ' THR . 8.2 mmt85 -88.67 177.31 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.535 ' CE1' HG23 ' A' ' 32' ' ' THR . 49.2 m-85 -113.39 152.89 29.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 111.082 -179.472 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -150.58 158.49 44.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.623 -0.673 . . . . 0.0 109.337 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.61 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 44.9 t80 -87.33 113.64 23.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.319 -0.863 . . . . 0.0 110.774 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.621 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 45.3 t-20 -86.27 83.31 7.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.47 -29.09 1.03 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.027 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -27.3 62.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.427 -0.795 . . . . 0.0 109.706 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.98 -26.33 16.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.239 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.48 -10.53 65.0 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.45 -144.11 0.21 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.188 -1.183 . . . . 0.0 109.571 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 95.1 m -121.83 153.97 37.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.703 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 20.0 mt-30 -140.38 160.45 39.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.484 -0.76 . . . . 0.0 109.383 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.535 HG23 ' CE1' ' A' ' 21' ' ' TYR . 2.0 p -84.6 144.56 28.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.009 -1.057 . . . . 0.0 110.723 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.9 p90 -139.15 162.3 35.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.92 179.383 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' THR . 11.8 t -74.67 122.6 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.797 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -99.79 147.09 25.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -0.88 . . . . 0.0 110.223 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -91.84 -4.38 67.41 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.95 -2.09 2.83 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.265 -1.138 . . . . 0.0 110.902 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 39' ' ' ARG . 28.3 p -146.3 172.24 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.991 -1.068 . . . . 0.0 110.182 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 38' ' ' CYS . 16.4 mtt-85 42.33 28.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.974 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.797 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -63.92 163.5 11.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -127.3 -171.04 2.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.557 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -69.56 -19.62 63.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.953 -1.092 . . . . 0.0 109.834 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 3.3 t-20 -88.25 67.03 8.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 109.695 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 39.0 t-20 -168.43 82.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 109.271 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.561 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 18.0 m-85 -96.42 148.8 22.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.585 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -69.22 -28.34 66.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.871 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -136.56 158.56 44.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -68.14 -20.45 64.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.067 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 5.3 tt0 -65.74 -42.0 91.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.01 -40.24 71.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 34.7 t -64.91 -43.99 91.04 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.656 0.741 . . . . 0.0 109.41 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -67.39 -61.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.726 . . . . 0.0 110.685 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -55.41 -19.25 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.036 -1.04 . . . . 0.0 110.617 -179.441 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.508 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 45.9 m -95.61 -56.0 2.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.07 -1.019 . . . . 0.0 110.172 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.61 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 44.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.929 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 10.9 p90 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.221 0.534 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.516 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -83.68 -22.04 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.388 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 19.3 mt -82.36 -16.97 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.467 -0.771 . . . . 0.0 109.842 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.493 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -84.78 160.89 54.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.088 179.838 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD2' ' HG3' ' A' ' 7' ' ' GLU . 44.1 Cg_endo -72.53 165.05 33.82 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.931 1.49 . . . . 0.0 110.071 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.6 Cg_endo -70.67 159.32 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.906 1.477 . . . . 0.0 110.712 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -116.33 94.33 4.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -0.836 . . . . 0.0 110.655 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.485 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -62.66 -22.87 66.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.5 170.25 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' CYS . 48.0 Cg_endo -73.58 -92.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.917 1.482 . . . . 0.0 110.941 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 44.26 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.052 -1.03 . . . . 0.0 110.313 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.09 8.27 3.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 -177.15 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 109.707 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -152.27 82.97 1.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.016 -1.052 . . . . 0.0 110.68 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.1 mt -96.87 157.92 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.752 HG23 ' HB ' ' A' ' 32' ' ' THR . 7.9 mm -104.54 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.153 -0.967 . . . . 0.0 110.242 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.8 mmt85 -88.51 179.97 6.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 62.1 m-85 -110.87 153.83 24.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 110.712 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.7 p90 -152.78 161.94 41.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.43 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 76.5 t80 -92.91 115.31 28.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 110.951 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 40.3 t-20 -90.5 98.55 11.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 0.0 110.01 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -52.24 -20.2 2.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.89 -19.09 29.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.982 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -96.53 -29.77 13.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.908 . . . . 0.0 110.231 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.72 72.45 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.64 -145.2 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.106 -1.232 . . . . 0.0 109.641 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.4 m -121.45 150.46 41.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.895 . . . . 0.0 110.97 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.48 179.65 6.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.752 ' HB ' HG23 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -99.45 144.47 28.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.893 -1.129 . . . . 0.0 111.156 -179.213 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.9 p90 -136.83 158.75 43.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.584 -0.697 . . . . 0.0 109.17 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 11' ' ' THR . 60.6 t -75.28 99.66 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.291 -0.881 . . . . 0.0 111.055 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.636 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 6.1 t80 -78.75 141.5 37.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.23 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.757 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -84.7 5.52 81.52 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.94 0.58 3.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -1.07 . . . . 0.0 111.0 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 39' ' ' ARG . 12.6 p -148.86 176.0 10.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.855 -1.153 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 41.56 44.55 2.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -83.35 137.27 34.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.94 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -103.0 -164.38 1.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.772 . . . . 0.0 109.433 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -69.55 -14.23 62.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.041 -1.037 . . . . 0.0 109.611 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.2 t-20 -94.39 55.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.471 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 16.8 t-20 -160.71 80.27 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 0.0 108.99 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.574 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -92.06 153.19 19.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.858 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -78.67 -23.18 45.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.446 -0.784 . . . . 0.0 110.16 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.1 p -142.68 161.44 38.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.27 -0.894 . . . . 0.0 110.296 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.87 -21.29 65.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -27.19 60.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.405 -0.809 . . . . 0.0 110.173 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.85 -30.81 31.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.348 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.574 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 43.6 t -78.64 -44.61 23.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.602 -0.686 . . . . 0.0 109.622 179.491 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -46.8 75.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 110.293 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -63.72 -29.43 70.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.05 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.616 HG22 ' SG ' ' A' ' 55' ' ' CYS . 5.4 m -73.85 -50.17 21.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.125 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.616 ' SG ' HG22 ' A' ' 54' ' ' THR . 77.3 m . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 1.0 ' HD2' HD21 ' A' ' 6' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.642 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 38.2 Cg_endo -66.07 165.92 22.54 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.761 1.401 . . . . 0.0 111.123 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.496 ' HA ' HD12 ' A' ' 6' ' ' LEU . 6.5 t70 -99.39 -18.55 17.44 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.491 -0.756 . . . . 0.0 110.1 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.642 ' CE2' ' HB2' ' A' ' 2' ' ' PRO . 21.1 p90 -66.07 -21.18 66.36 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.976 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 1.4 m -85.3 -21.98 28.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.0 HD21 ' HD2' ' A' ' 1' ' ' ARG . 48.1 mt -74.06 -24.37 59.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.356 -0.84 . . . . 0.0 108.807 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -79.74 164.02 55.5 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.606 -0.684 . . . . 0.0 109.466 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 7' ' ' GLU . 46.5 Cg_endo -74.03 167.36 27.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.736 1.387 . . . . 0.0 109.965 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.5 Cg_endo -70.17 172.34 13.23 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.785 1.413 . . . . 0.0 110.127 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 36.1 t80 -140.76 93.59 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.406 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.452 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -52.67 -23.12 6.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 65.53 -170.23 27.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -72.71 -155.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.092 1.575 . . . . 0.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 23.0 m 62.29 -168.69 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.243 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.42 20.78 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.232 -0.918 . . . . 0.0 109.985 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.24 167.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -142.36 69.2 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.841 . . . . 0.0 109.811 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.519 HG22 ' HG2' ' A' ' 20' ' ' ARG . 3.5 mt -107.32 148.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.468 HG23 ' HB ' ' A' ' 32' ' ' THR . 17.9 mm -94.33 78.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 109.865 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 18' ' ' ILE . 4.1 mmt180 -83.53 -176.55 6.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 109.886 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 57.6 m-85 -118.55 144.45 46.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.976 -1.077 . . . . 0.0 111.276 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -139.43 163.36 32.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.55 ' CG ' ' HB3' ' A' ' 5' ' ' CYS . 57.2 t80 -93.44 117.2 29.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.003 -1.061 . . . . 0.0 111.837 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 42.9 t-20 -91.07 92.17 8.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.856 . . . . 0.0 108.86 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -44.58 -29.5 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.891 -1.131 . . . . 0.0 110.183 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -75.2 -23.93 57.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.811 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.77 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -92.96 -16.83 24.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 110.507 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.13 -5.72 75.15 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -145.84 -143.43 0.14 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -1.162 . . . . 0.0 109.286 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.3 m -117.44 163.33 16.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 111.687 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 5.9 mt-30 -143.8 166.56 24.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.468 ' HB ' HG23 ' A' ' 19' ' ' ILE . 82.5 p -82.97 144.29 30.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 110.555 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 7.6 p90 -145.45 171.73 14.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 109.659 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.4 t -85.71 122.54 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.7 t80 -99.77 148.88 23.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.523 -0.736 . . . . 0.0 109.911 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.742 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -96.89 -3.9 59.06 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.641 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.41 -2.81 2.49 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.184 -1.186 . . . . 0.0 111.066 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.423 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 26.0 p -139.81 152.49 46.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.886 -1.134 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HD3' ' HG3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 49.04 42.99 21.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.379 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -70.81 149.87 46.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -101.1 -164.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.559 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 12.2 mtt-85 -82.79 -12.81 57.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.047 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 6.7 t-20 -95.48 54.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.585 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 15.7 t-20 -152.73 84.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.819 . . . . 0.0 109.303 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.588 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 14.7 m-85 -98.5 154.67 17.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.813 . . . . 0.0 110.156 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -81.69 -18.64 43.72 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 110.611 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 95.3 p -142.18 155.67 45.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.53 70.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.93 -23.83 55.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 44.6 t0 -74.29 -33.98 63.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.588 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -71.69 -48.51 46.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' GLY . 1.3 mmt -56.01 -57.55 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.141 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -24.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.986 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.8 m -99.54 -63.72 1.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.49 ' SG ' ' HG2' ' A' ' 2' ' ' PRO . 56.7 m -103.68 34.09 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.584 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -87.2 44.89 3.34 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -110.08 50.36 0.78 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.246 -1.149 . . . . 0.0 110.187 -179.944 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 2' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.646 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 39.8 Cg_endo -70.64 158.82 54.72 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.045 1.55 . . . . 0.0 111.338 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -98.61 -25.44 14.72 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.681 -0.637 . . . . 0.0 109.412 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 53.5 p90 -67.48 -21.16 65.53 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.141 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.577 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 97.9 m -77.07 -24.2 51.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.731 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 22.8 mt -83.63 -19.46 35.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.536 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.04 163.97 50.64 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.79 . . . . 0.0 109.938 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.75 160.25 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.856 1.45 . . . . 0.0 110.294 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.593 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.1 Cg_endo -71.4 -178.39 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.939 1.494 . . . . 0.0 110.546 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 86.1 t80 -132.15 93.35 3.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 110.128 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.27 -23.03 66.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 11' ' ' THR . . . 59.9 176.5 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.8 Cg_endo -79.9 -93.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.927 1.488 . . . . 0.0 110.357 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.5 m 42.77 -168.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.632 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -138.72 13.09 2.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.067 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.58 164.35 11.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 109.959 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -128.85 71.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 68.0 mt -77.88 151.9 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.772 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.2 mm -96.38 89.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.671 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -90.06 172.98 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.833 . . . . 0.0 110.327 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.731 ' CE1' HG23 ' A' ' 32' ' ' THR . 7.6 m-85 -114.41 144.73 42.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -144.7 154.2 42.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.649 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 67.3 t80 -83.0 112.87 20.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.382 -0.824 . . . . 0.0 110.876 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.664 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 61.1 t-20 -84.81 86.07 7.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.059 -1.025 . . . . 0.0 109.98 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -46.29 -25.39 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.06 -1.025 . . . . 0.0 109.741 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -76.07 -26.01 56.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.55 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.12 -25.49 17.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.161 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.77 78.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -137.99 -145.16 0.19 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.138 -1.213 . . . . 0.0 109.588 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 95.5 m -119.16 150.6 39.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 111.048 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' ' 31' ' ' GLN . 4.0 mt-30 -140.48 160.4 40.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.731 HG23 ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -89.2 146.87 24.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.069 -1.019 . . . . 0.0 110.588 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.8 p90 -138.08 162.27 34.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.045 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' THR . 97.5 t -74.26 106.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.894 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 10.4 t80 -88.17 148.86 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.368 -0.833 . . . . 0.0 109.992 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.754 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -86.84 -1.35 85.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 75.42 -6.23 2.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.463 -1.022 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 p -136.07 165.76 24.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.893 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 4.7 mtt180 45.75 52.81 9.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.013 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.894 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -72.79 156.73 38.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.269 -0.895 . . . . 0.0 110.55 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -119.53 -162.62 0.93 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.872 . . . . 0.0 110.292 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.598 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 17.7 mtm180 -81.03 -26.07 36.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.002 -1.061 . . . . 0.0 109.964 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -93.0 53.92 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.7 t-20 -146.56 74.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.506 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 8.6 m-85 -92.95 163.6 13.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 0.0 110.586 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -91.45 -14.69 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -0.995 . . . . 0.0 110.086 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.4 p -145.95 160.46 41.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 110.212 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.63 -22.45 64.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.72 -26.4 59.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.102 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 65.1 m-20 -83.01 -30.69 27.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 109.37 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.506 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.5 t -74.2 -44.04 54.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.699 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -66.29 -57.04 8.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.18 -21.36 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.1 -1.0 . . . . 0.0 110.231 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.496 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 2.1 m -101.39 -39.71 7.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 110.048 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 65.4 m -96.19 -45.98 6.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.126 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -55.17 106.11 0.5 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.78 64.5 0.02 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.33 -1.1 . . . . 0.0 110.143 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.498 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.614 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 37.6 Cg_endo -65.01 160.24 42.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.878 1.462 . . . . 0.0 111.062 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.71 -20.85 28.74 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.53 -0.731 . . . . 0.0 110.331 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.639 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 3.5 p90 -66.23 -19.71 65.91 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.203 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.578 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 4.6 m -71.23 -31.14 67.2 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 25' ' ' ALA . 28.0 mt -80.33 -16.07 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -79.87 162.01 64.04 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.13 170.53 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.414 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.62 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 41.0 Cg_endo -72.01 172.03 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.002 1.527 . . . . 0.0 110.598 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.485 ' CD2' ' HD2' ' A' ' 41' ' ' LYS . 17.7 t80 -130.84 94.31 3.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 110.683 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -51.74 -23.11 4.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 72.69 151.3 1.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 39' ' ' ARG . 46.3 Cg_endo -73.98 93.3 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.073 1.565 . . . . 0.0 110.222 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -154.76 -163.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -127.32 -6.95 5.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.324 -0.86 . . . . 0.0 110.189 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . -83.11 -176.8 6.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 109.776 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -155.01 76.26 0.98 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.02 -1.05 . . . . 0.0 110.674 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 19' ' ' ILE . 19.6 mt -90.44 164.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.627 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.45 ' N ' HG22 ' A' ' 18' ' ' ILE . 32.2 mm -105.31 92.7 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.993 . . . . 0.0 110.785 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.74 177.87 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.728 ' CE2' HG23 ' A' ' 32' ' ' THR . 67.1 m-85 -114.88 151.9 33.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.935 -1.103 . . . . 0.0 111.124 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.401 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 23.7 p90 -144.62 153.77 42.11 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 30.3 t80 -76.11 100.25 4.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.171 -0.956 . . . . 0.0 111.15 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.7 t-20 -75.28 71.67 2.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.804 -1.185 . . . . 0.0 109.081 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB2' HD23 ' A' ' 6' ' ' LEU . . . -47.74 -24.53 0.97 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.042 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -70.55 -31.31 68.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -92.15 -21.7 20.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.466 -0.771 . . . . 0.0 109.583 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.2 5.18 60.81 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -150.72 -142.5 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.058 -1.26 . . . . 0.0 109.713 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.502 ' O ' HD12 ' A' ' 29' ' ' LEU . 92.1 m -125.14 147.79 48.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 110.346 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -135.83 178.06 7.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.491 -0.756 . . . . 0.0 109.256 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.728 HG23 ' CE2' ' A' ' 21' ' ' TYR . 1.5 p -101.78 144.21 30.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.096 . . . . 0.0 110.633 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.62 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 24.2 p90 -133.04 162.89 30.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.4 97.21 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 0.0 111.146 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 1.009 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 11.4 t80 -80.06 145.63 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.606 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.777 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -83.48 1.29 88.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 79.74 -27.33 0.15 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.622 -0.928 . . . . 0.0 110.852 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -127.23 169.63 13.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.96 -1.087 . . . . 0.0 109.672 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 17.1 mmt180 57.27 33.76 23.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.414 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 1.009 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -69.87 161.31 30.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HD2' ' CD2' ' A' ' 10' ' ' TYR . 17.0 mtpt -137.04 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.004 . . . . 0.0 110.419 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.639 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.1 ptp180 -66.99 -32.04 73.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.835 . . . . 0.0 111.452 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.4 t-20 -90.63 61.72 4.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.731 -1.23 . . . . 0.0 109.748 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.563 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 33.1 t-20 -161.92 76.19 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 24.6 m-85 -85.69 134.56 33.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.388 -0.82 . . . . 0.0 110.155 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 20' ' ' ARG . 39.3 mttt -65.23 -16.49 63.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.6 p -149.6 159.34 44.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.34 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -20.36 66.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.007 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -31.9 64.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.226 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.66 -33.98 53.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.88 . . . . 0.0 109.625 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 18.6 t -72.85 -44.61 61.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 109.066 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLY . 48.1 tpp -69.61 -44.49 70.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.547 -0.721 . . . . 0.0 109.389 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -60.26 -24.03 64.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.873 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.765 HG22 ' SG ' ' A' ' 55' ' ' CYS . 4.5 m -85.38 -51.6 6.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 109.945 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.765 ' SG ' HG22 ' A' ' 54' ' ' THR . 73.1 m -133.35 46.91 2.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.221 -0.924 . . . . 0.0 110.545 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -102.67 -164.95 26.17 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.95 30.29 1.99 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.175 -1.191 . . . . 0.0 110.228 179.931 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.664 ' NH2' ' HB2' ' A' ' 58' ' ' ALA . 7.0 ptt-85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.792 0.33 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.643 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 39.6 Cg_endo -68.45 161.52 44.6 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.077 1.567 . . . . 0.0 111.159 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -89.68 -21.28 22.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.561 -0.712 . . . . 0.0 110.232 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.643 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 6.0 p90 -65.7 -14.05 60.48 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.916 -1.114 . . . . 0.0 109.783 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 23' ' ' TYR . 1.7 m -78.63 -22.64 46.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 110.354 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.629 HD21 ' HE ' ' A' ' 1' ' ' ARG . 19.8 mt -92.06 -10.29 39.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.677 -1.264 . . . . 0.0 109.592 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.76 156.57 82.68 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 0.0 110.074 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 47.2 Cg_endo -73.85 174.4 12.39 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.93 1.489 . . . . 0.0 110.221 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.627 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 45.4 Cg_endo -72.97 -178.36 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.02 1.537 . . . . 0.0 110.357 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 14.4 t80 -155.25 94.18 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -53.5 -23.2 9.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.8 152.4 2.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 60.88 4.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.951 1.5 . . . . 0.0 110.08 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.441 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 15.5 m -123.03 -164.53 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -122.5 0.24 9.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . -78.69 171.49 15.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.436 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.419 ' NH2' HD11 ' A' ' 19' ' ' ILE . 6.9 ttt-85 -149.21 69.22 1.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 35' ' ' TYR . 12.8 mt -95.52 163.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.875 . . . . 0.0 109.988 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.579 HG23 ' HB ' ' A' ' 32' ' ' THR . 15.4 mm -104.98 86.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.254 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -88.93 179.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.845 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 36.6 m-85 -115.3 149.3 38.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 110.942 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 14.2 p90 -144.11 -179.03 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.57 -0.706 . . . . 0.0 109.771 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.683 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.7 OUTLIER -95.8 98.53 10.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.927 -1.108 . . . . 0.0 110.92 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.5 t-20 -81.46 63.92 5.97 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.149 177.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -47.25 -26.98 1.35 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.324 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -35.42 80.9 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -88.09 -17.89 30.06 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.23 10.73 60.62 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -163.19 -179.13 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -1.217 . . . . 0.0 108.951 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 85.3 m -82.5 150.45 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.566 -0.709 . . . . 0.0 110.019 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -140.78 169.11 18.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.579 ' HB ' HG23 ' A' ' 19' ' ' ILE . 19.6 p -88.64 144.38 26.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 110.098 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.627 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.1 p90 -140.02 165.28 27.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 11' ' ' THR . 24.4 t -74.68 124.96 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 110.221 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.881 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -109.46 147.43 32.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -0.848 . . . . 0.0 109.985 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -93.77 -2.08 65.22 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.964 -1.085 . . . . 0.0 110.406 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.79 -0.83 3.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.123 -1.222 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 152.29 28.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 0.0 109.923 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.69 29.97 16.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.881 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -75.27 175.06 8.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.526 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 22.2 mtpt -121.46 -174.38 2.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 109.548 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.5 mtt-85 -70.26 -16.76 63.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.077 . . . . 0.0 109.3 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 2.1 t-20 -93.45 62.96 3.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.512 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 8.7 t-20 -154.84 80.22 1.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 17.1 m-85 -95.5 155.64 16.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG2' ' NH1' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -77.97 -22.8 48.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.332 -0.855 . . . . 0.0 110.33 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 98.9 p -134.17 157.97 44.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 110.591 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . . . -74.04 -24.38 59.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -74.97 -17.57 60.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.482 -0.761 . . . . 0.0 110.032 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.482 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.2 t0 -93.5 -30.2 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.207 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 1.7 t -66.89 -52.57 41.68 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' GLY . 3.4 tpt -66.04 -49.43 67.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.641 -0.662 . . . . 0.0 109.846 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -41.47 -41.25 2.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 m -91.83 -45.22 8.51 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.835 0.826 . . . . 0.0 109.131 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.683 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 72.8 m -86.21 28.78 0.8 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.742 -0.598 . . . . 0.0 111.396 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -123.92 131.1 7.87 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.72 42.38 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.664 ' HB2' ' NH2' ' A' ' 1' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.16 -1.2 . . . . 0.0 110.142 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.47 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 1.6 ptt-85 . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 38.0 Cg_endo -66.27 160.15 46.53 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.833 1.439 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -16.27 17.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.55 -0.719 . . . . 0.0 110.355 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.735 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 4.1 p90 -65.79 -17.65 64.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.916 -1.115 . . . . 0.0 110.681 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.33 -14.31 46.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.927 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 54.6 mt -75.51 -27.93 58.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.965 -1.084 . . . . 0.0 110.182 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.477 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -64.68 166.57 11.35 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 110.283 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 7' ' ' GLU . 46.2 Cg_endo -74.7 168.68 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.121 1.59 . . . . 0.0 110.448 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.7 Cg_endo -71.54 -170.41 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.02 1.537 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CE1' ' HE3' ' A' ' 41' ' ' LYS . 43.0 t80 -145.62 93.39 2.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 110.611 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.466 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.4 m -64.73 -22.89 67.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.23 158.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.14 81.1 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.036 1.545 . . . . 0.0 110.582 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.457 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -147.45 167.37 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 0.0 110.235 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -107.53 14.53 25.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.26 152.66 23.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.37 77.89 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.51 HG22 ' HG2' ' A' ' 20' ' ' ARG . 70.0 mt -103.13 138.13 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.57 81.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.082 -1.011 . . . . 0.0 110.264 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -86.54 173.25 9.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 61.9 m-85 -114.24 154.29 28.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.145 -0.972 . . . . 0.0 111.373 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 9.1 p90 -150.56 156.97 42.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 49.5 t80 -83.14 115.69 22.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.135 -0.978 . . . . 0.0 111.266 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.588 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 60.5 t-20 -91.91 87.78 6.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.37 -25.42 0.4 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.052 -1.03 . . . . 0.0 109.721 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -24.02 52.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -95.52 -33.54 12.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 110.492 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 102.12 -10.69 56.96 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.435 ' HG ' ' C ' ' A' ' 28' ' ' GLY . 1.1 mt -134.45 -143.99 0.21 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.387 -1.066 . . . . 0.0 109.092 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.2 m -120.24 145.68 46.8 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 109.76 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -129.24 161.05 31.07 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 6.3 p -86.98 144.48 26.9 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.4 p90 -140.44 161.89 36.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.589 -0.694 . . . . 0.0 109.933 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 11' ' ' THR . 63.5 t -74.47 111.08 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.499 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 1.071 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.2 t80 -91.94 147.65 22.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.8 -4.12 85.25 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 68.59 12.48 8.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 110.089 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.2 p -147.3 147.31 30.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 110.454 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 51.89 44.77 29.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 1.071 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -67.78 146.13 54.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.579 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 10' ' ' TYR . 26.5 mttm -109.55 -160.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.653 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.735 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -80.87 -22.21 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.042 -1.036 . . . . 0.0 110.351 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.487 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 9.6 t-20 -91.31 53.32 2.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.906 0.86 . . . . 0.0 109.048 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.5 t-20 -159.82 75.41 0.62 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 23.4 m-85 -85.18 134.23 34.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.524 -0.735 . . . . 0.0 110.414 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.1 tptm -60.42 -20.85 61.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.77 . . . . 0.0 111.325 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.4 p -142.52 162.22 36.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.976 -1.077 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -66.32 -27.04 67.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 82.1 mt-10 -75.26 -28.04 59.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.21 -31.27 58.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.493 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 54.0 t -80.58 -44.01 19.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.99 -45.89 59.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 110.246 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -60.81 -15.15 26.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.976 -1.078 . . . . 0.0 109.141 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.449 HG22 ' SG ' ' A' ' 55' ' ' CYS . 61.9 m -94.99 -54.79 3.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 0.0 110.144 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.449 ' SG ' HG22 ' A' ' 54' ' ' THR . 58.1 m -114.71 25.75 10.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.688 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -75.33 -172.33 31.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.54 -10.43 10.58 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.351 -1.087 . . . . 0.0 110.305 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.898 ' CD ' HD21 ' A' ' 6' ' ' LEU . 12.6 ttm105 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.964 0.411 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.61 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 38.5 Cg_endo -67.04 155.3 71.45 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 124.478 1.778 . . . . 0.0 111.421 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 4' ' ' PHE . 19.1 p30 -76.16 -29.67 57.83 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.919 -0.713 . . . . 0.0 109.775 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.61 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 4.1 p90 -67.64 -16.52 64.2 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.689 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 4.5 t -78.68 -29.76 45.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.595 -0.691 . . . . 0.0 109.734 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.898 HD21 ' CD ' ' A' ' 1' ' ' ARG . 27.7 mt -95.47 -9.02 33.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 109.631 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 3.9 mm-40 -75.1 160.85 79.46 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.913 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.89 162.13 39.93 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.916 1.482 . . . . 0.0 110.266 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.575 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.5 Cg_endo -70.15 171.76 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.034 1.544 . . . . 0.0 110.342 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.597 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 37.4 t80 -133.24 94.45 3.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.133 -0.979 . . . . 0.0 111.019 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -59.55 -22.91 62.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 70.85 143.97 0.27 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.92 60.95 5.51 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.049 1.552 . . . . 0.0 110.348 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.13 -169.75 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -105.71 -31.7 8.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.16 154.77 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -143.05 77.6 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 mt -92.14 160.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 32' ' ' THR . 46.7 mm -91.93 83.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.834 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.607 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -80.82 175.49 10.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.054 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 45' ' ' PHE . 51.3 m-85 -115.25 147.72 40.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 110.95 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 15.3 p90 -147.39 156.26 42.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 72.8 t80 -81.42 114.57 20.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.294 -0.878 . . . . 0.0 110.808 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 30.6 t-20 -82.06 82.11 7.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.794 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.67 -26.61 0.65 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.993 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 36.8 mmtm -78.05 -23.04 48.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.861 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -98.28 -26.83 14.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.227 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -3.1 57.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -141.58 -142.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 99.2 m -121.74 159.45 26.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.496 -0.753 . . . . 0.0 110.731 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 4.7 mt-30 -143.2 169.08 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.509 -0.745 . . . . 0.0 109.32 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.528 ' HB ' HG23 ' A' ' 19' ' ' ILE . 1.5 p -91.54 144.27 25.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.386 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 14.1 p90 -143.39 166.57 24.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' THR . 65.1 t -74.41 128.3 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.452 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -112.27 145.83 39.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.064 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -96.93 7.98 65.17 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.046 -1.073 . . . . 0.0 110.742 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.61 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 58.99 12.47 2.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.283 . . . . 0.0 110.899 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 39' ' ' ARG . 17.9 p -152.34 164.58 37.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.043 -1.036 . . . . 0.0 110.494 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 98.7 mtt180 42.56 38.43 1.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.922 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.572 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -79.88 157.58 26.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -122.02 -168.15 1.66 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.369 -0.832 . . . . 0.0 109.63 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.54 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.6 mtm-85 -71.56 -19.16 62.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.022 -1.049 . . . . 0.0 110.152 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 5.1 t-20 -86.23 54.7 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.536 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -163.03 80.87 0.48 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.837 . . . . 0.0 109.227 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 19.8 m-85 -87.8 146.34 25.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.79 -25.45 62.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.758 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 97.5 p -140.47 160.4 40.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.563 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.57 67.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 0.0 109.666 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.57 -28.69 61.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.988 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 1.1 m-20 -80.83 -30.62 35.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.616 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 42.7 t -79.37 -44.64 21.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 109.333 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.7 ttm -67.45 -50.28 59.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 109.48 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -58.32 -19.06 31.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.889 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -90.72 -47.48 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.4 t -126.98 45.93 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -101.98 13.96 57.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.27 63.09 4.48 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.221 -1.164 . . . . 0.0 110.179 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.473 ' NH2' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.85 0.357 . . . . 0.0 110.221 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.637 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 40.1 Cg_endo -71.37 159.79 50.59 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.008 1.531 . . . . 0.0 110.631 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -95.32 -26.28 15.98 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.355 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.637 ' CE2' ' HB2' ' A' ' 2' ' ' PRO . 52.1 p90 -67.99 -27.32 66.47 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.627 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 53.4 m -68.15 -29.47 68.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 109.31 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' N ' HD23 ' A' ' 6' ' ' LEU . 8.3 mt -77.09 -13.64 59.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.69 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -79.48 165.01 51.02 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.405 -0.81 . . . . 0.0 110.286 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD2' ' OE1' ' A' ' 7' ' ' GLU . 44.4 Cg_endo -71.97 160.19 48.29 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.995 1.524 . . . . 0.0 110.15 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.619 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.6 Cg_endo -70.2 166.56 27.75 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.975 1.513 . . . . 0.0 110.612 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.414 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 67.2 t80 -117.49 94.1 4.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -0.911 . . . . 0.0 110.692 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -63.3 -22.75 67.07 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 63.54 169.34 1.35 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -75.01 -93.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.961 1.506 . . . . 0.0 110.453 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 40.37 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HD3' ' C ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -143.13 18.24 1.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.68 172.3 6.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.703 ' HG2' HG13 ' A' ' 34' ' ' VAL . 8.4 ttp180 -134.74 73.06 1.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.845 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.7 HD12 ' HB2' ' A' ' 37' ' ' ALA . 97.1 mt -88.56 155.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.383 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 19' ' ' ILE . 15.4 mm -102.01 92.15 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.609 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.6 mmp_? -92.48 -179.92 5.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.696 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.584 ' CE1' HG23 ' A' ' 32' ' ' THR . 47.6 m-85 -112.26 150.25 31.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -151.74 157.75 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.568 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 47.0 t80 -83.8 110.99 18.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 110.951 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 41.7 t-20 -88.52 87.52 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.844 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.16 -33.82 2.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 109.411 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -28.95 69.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 109.549 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.671 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -94.87 -17.57 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.38 -9.5 70.22 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -135.19 -143.11 0.19 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.228 -1.16 . . . . 0.0 109.426 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.4 m -116.95 145.39 43.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 110.621 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 mt-30 -128.86 162.79 26.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.795 . . . . 0.0 109.595 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.584 HG23 ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -86.38 148.9 25.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 0.0 110.88 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.6 p90 -143.59 161.74 37.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.994 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.703 HG13 ' HG2' ' A' ' 17' ' ' ARG . 70.1 t -74.92 97.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.327 -0.858 . . . . 0.0 110.857 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.821 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.9 t80 -79.26 146.45 33.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.367 -0.833 . . . . 0.0 110.356 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -80.0 0.58 82.68 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.95 -1.39 3.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.441 -1.035 . . . . 0.0 110.995 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 p -143.6 168.94 18.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.917 -1.115 . . . . 0.0 110.708 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 48.97 37.87 11.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.64 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.821 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -65.31 144.55 57.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 109.672 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -127.68 -155.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.953 . . . . 0.0 110.704 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.616 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 14.7 ptp180 -70.69 -30.6 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.858 . . . . 0.0 111.829 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.7 t-20 -93.92 54.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.64 -1.288 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.4 t-20 -164.12 79.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 40.1 m-85 -85.46 148.78 25.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 110.041 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 15.3 mttt -97.02 7.03 47.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.037 -1.04 . . . . 0.0 110.665 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.539 ' OG ' ' CB ' ' A' ' 50' ' ' ASP . 51.7 p -134.97 161.44 35.26 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.2 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.77 27.44 0.63 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.583 0.706 . . . . 0.0 111.069 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -160.6 -16.66 0.05 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.602 -0.686 . . . . 0.0 111.616 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.539 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 12.1 t0 -70.76 -25.11 62.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.711 -1.243 . . . . 0.0 108.055 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.8 t -71.49 -43.91 65.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.538 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 7.7 mtt -67.9 -50.82 54.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.65 -0.656 . . . . 0.0 109.764 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.83 -19.35 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -104.5 -43.51 5.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 56.7 m -85.0 -61.27 1.81 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 110.514 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 52' ' ' MET . . . -144.46 -118.31 1.23 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 52' ' ' MET . . . 168.84 123.59 0.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.062 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.462 ' CD ' HD21 ' A' ' 6' ' ' LEU . 2.1 ttp-105 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.943 0.401 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.646 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 38.3 Cg_endo -68.09 159.29 53.7 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.244 1.654 . . . . 0.0 111.082 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.11 -28.15 17.3 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.209 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 49.0 p90 -67.97 -26.56 65.99 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.655 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 26.5 m -70.29 -30.35 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 16.6 mt -75.77 -23.08 55.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.703 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 3.7 mt-10 -75.31 160.93 78.82 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 109.715 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 7' ' ' GLU . 44.0 Cg_endo -71.46 169.36 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.832 1.438 . . . . 0.0 109.958 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.4 Cg_endo -71.13 173.86 11.54 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.898 1.472 . . . . 0.0 110.461 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.492 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 36.6 t80 -135.07 94.08 3.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.62 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -62.52 -23.29 66.88 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.51 -163.44 3.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 48.8 Cg_endo -74.92 -156.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.152 1.606 . . . . 0.0 110.493 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 20.2 m 63.09 147.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 10.79 39.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.91 165.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.942 . . . . 0.0 110.558 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -146.61 65.98 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.909 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mt -97.53 152.18 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.745 . . . . 0.0 110.04 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.472 HG23 ' HB ' ' A' ' 32' ' ' THR . 39.2 mm -89.25 84.62 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 110.462 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -85.0 168.14 15.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.801 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 37.1 m-85 -110.04 149.8 29.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.952 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -152.67 160.57 43.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.581 -0.7 . . . . 0.0 109.501 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 72.6 t80 -90.09 127.82 36.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.285 -0.884 . . . . 0.0 110.654 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 27' ' ' ALA . 43.7 t-20 -101.78 87.55 3.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.68 -24.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 109.665 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.06 -26.41 59.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.779 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.56 -37.05 10.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.86 -11.31 38.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.0 mp -133.97 -144.17 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -1.202 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 65.9 m -116.36 156.43 26.73 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.438 -0.789 . . . . 0.0 110.903 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 18.2 mt-30 -144.62 167.59 22.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.505 -0.747 . . . . 0.0 109.575 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.4 p -96.41 144.9 26.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.784 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 24.0 p90 -139.37 165.42 27.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.441 -0.787 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -75.72 113.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.475 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.986 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 8.6 t80 -93.42 148.0 22.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.328 -0.857 . . . . 0.0 109.855 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.736 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.95 -2.24 75.23 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.43 8.34 5.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.063 -1.257 . . . . 0.0 110.541 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 39' ' ' ARG . 25.4 p -153.16 174.08 14.69 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.294 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.7 32.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 0.0 110.36 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.986 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -64.01 157.52 24.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 79.7 mttt -126.71 -159.45 0.93 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 109.683 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.58 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -77.54 -19.24 56.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.689 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.2 t-20 -92.94 64.48 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 0.0 109.711 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 31.1 t-20 -169.18 80.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.549 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.8 m-85 -91.71 157.59 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.076 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -85.82 -15.17 42.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 0.0 110.536 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.2 p -144.5 158.4 43.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -65.9 -24.14 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.784 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 32.6 mm-40 -75.2 -29.83 60.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.394 -0.816 . . . . 0.0 110.184 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -76.58 -32.58 58.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.525 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.549 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 35.9 t -75.02 -43.73 52.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 109.238 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -37.28 77.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.63 -0.669 . . . . 0.0 110.529 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 12.6 mtp85 -70.83 -20.95 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -102.25 -42.45 6.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.271 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.2 m -87.7 -40.55 14.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.254 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -45.19 165.57 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.71 46.0 0.36 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.181 -1.188 . . . . 0.0 110.19 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.448 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 4.0 ttp-105 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.924 0.393 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.534 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 41.8 Cg_endo -69.67 157.3 61.06 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.192 1.628 . . . . 0.0 110.727 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -85.58 -22.71 27.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.419 -0.801 . . . . 0.0 110.059 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.647 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 4.0 p90 -67.13 -21.3 65.84 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.634 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 3.9 m -68.25 -32.88 73.37 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.465 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.795 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 7.5 mt -84.56 -12.08 54.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.44 168.1 28.06 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.818 . . . . 0.0 110.206 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.14 159.18 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.926 1.488 . . . . 0.0 110.371 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.602 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.4 Cg_endo -70.78 174.1 10.89 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.006 1.529 . . . . 0.0 110.335 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.592 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 89.7 t80 -121.85 93.81 4.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 0.0 110.696 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.519 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.05 -23.12 67.21 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.592 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 64.09 147.56 0.03 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -76.9 81.95 2.46 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.141 1.6 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.92 168.56 19.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.066 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.45 3.76 54.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.91 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . -89.7 163.24 15.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 16' ' ' ALA . 27.1 mtp180 -142.75 73.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG21 ' CZ ' ' A' ' 20' ' ' ARG . 51.5 mt -86.95 155.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 32' ' ' THR . 27.4 mm -97.71 87.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 109.993 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.546 ' CZ ' HG21 ' A' ' 18' ' ' ILE . 5.7 mmp_? -91.07 177.59 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 110.142 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 38.6 m-85 -112.63 145.43 40.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.92 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 13.9 p90 -145.04 156.7 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.572 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 57.4 t80 -85.08 106.2 16.38 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 39.5 t-20 -81.3 87.94 6.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.105 -0.997 . . . . 0.0 109.452 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.795 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -44.87 -27.4 0.52 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.05 -1.031 . . . . 0.0 109.787 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.39 -24.5 57.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -95.97 -17.47 20.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 0.87 89.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -143.9 -146.28 0.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.275 -1.132 . . . . 0.0 109.543 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.54 ' O ' HD12 ' A' ' 29' ' ' LEU . 81.2 m -120.77 147.59 45.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 15.7 mt-30 -135.22 159.46 41.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.496 -0.752 . . . . 0.0 109.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -80.43 143.88 33.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.038 -1.038 . . . . 0.0 110.328 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 19.8 p90 -138.32 161.84 35.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.414 -0.804 . . . . 0.0 109.733 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' THR . 12.2 t -74.82 110.36 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 110.692 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.879 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 11.6 t80 -91.39 150.56 21.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.725 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.36 -4.59 85.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.4 7.04 6.06 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.144 -1.209 . . . . 0.0 110.242 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.3 p -144.58 163.27 34.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 47.81 35.06 4.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.879 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -48.76 151.78 1.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 9.1 mttm -131.38 -161.54 1.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.325 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.647 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.9 ptt180 -75.71 -32.52 60.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -89.15 67.71 8.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.928 -1.108 . . . . 0.0 109.252 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.636 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.0 t-20 -169.1 74.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.537 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m-85 -84.84 139.69 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.279 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -21.33 58.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -134.15 156.31 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.173 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -67.54 -24.77 65.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.83 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.33 -32.57 62.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.504 -0.748 . . . . 0.0 109.968 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.75 -37.16 73.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.898 . . . . 0.0 109.201 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.537 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 52.6 t -73.21 -44.35 59.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.503 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -61.86 -51.74 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -52.55 -23.98 7.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.874 HG22 ' SG ' ' A' ' 55' ' ' CYS . 6.4 m -89.18 -48.96 7.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.437 -0.789 . . . . 0.0 109.82 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.874 ' SG ' HG22 ' A' ' 54' ' ' THR . 72.2 m -141.81 51.4 1.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -102.48 -179.52 27.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.03 105.67 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.195 -1.179 . . . . 0.0 110.284 -179.998 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.465 ' HG2' ' SG ' ' A' ' 55' ' ' CYS . 12.9 mtt85 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.615 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 37.8 Cg_endo -69.56 149.49 68.25 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.94 1.494 . . . . 0.0 110.726 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.97 -31.39 71.93 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.147 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 9.1 p90 -68.39 -22.16 64.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.895 -1.128 . . . . 0.0 110.487 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 5.0 t -82.34 -24.59 34.49 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.82 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 2' ' ' PRO . 20.4 mt -90.83 -14.61 31.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.89 . . . . 0.0 109.587 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -78.01 156.63 79.5 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.419 -0.801 . . . . 0.0 109.624 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.21 163.68 35.22 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.77 1.405 . . . . 0.0 110.071 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.8 Cg_endo -67.65 -176.45 0.94 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.876 1.461 . . . . 0.0 110.158 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -146.34 93.76 2.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 110.848 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.503 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -60.31 -22.67 63.46 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.14 170.62 1.05 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' CYS . 49.5 Cg_endo -75.13 -95.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.511 . . . . 0.0 109.956 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 39.39 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.525 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.77 48.68 1.61 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.14 -0.975 . . . . 0.0 110.247 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.02 179.65 6.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.29 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -153.4 70.05 0.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 37' ' ' ALA . 76.9 mt -80.34 157.93 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.581 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.55 79.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.298 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.589 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 10.0 mmt85 -84.97 173.24 10.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.96 . . . . 0.0 110.05 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.509 ' CE1' HG22 ' A' ' 32' ' ' THR . 6.8 m-85 -112.83 144.87 41.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.938 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 7.0 p90 -144.05 163.61 33.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.737 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 77.5 t80 -96.59 120.22 36.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 111.033 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 45.8 t-20 -89.95 91.99 8.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 109.727 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.17 -27.33 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.415 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -75.62 -24.77 56.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.675 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.23 -36.01 12.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.739 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.0 65.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.566 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 1.1 mp -125.84 -146.67 0.35 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.039 -1.271 . . . . 0.0 109.638 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.38 149.02 44.38 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.528 -0.733 . . . . 0.0 110.118 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 97.4 mt-30 -139.34 178.27 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.901 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.509 HG22 ' CE1' ' A' ' 21' ' ' TYR . 44.2 p -105.07 147.75 27.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.784 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 21.0 p90 -142.43 163.79 31.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.574 -0.703 . . . . 0.0 110.004 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' THR . 83.0 t -75.16 110.46 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 4.7 t80 -94.07 144.56 25.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 110.322 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.76 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -76.95 4.98 51.68 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.104 -0.997 . . . . 0.0 110.901 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.5 -1.98 2.78 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.201 -1.176 . . . . 0.0 111.294 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.448 ' N ' ' CZ ' ' A' ' 35' ' ' TYR . 21.7 p -150.47 174.37 12.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.952 -1.093 . . . . 0.0 110.199 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' CYS . 1.3 mtt-85 42.92 52.82 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 109.799 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -91.08 140.67 29.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 111.096 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.65 -165.63 1.28 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 108.923 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -70.04 -36.6 75.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.07 . . . . 0.0 110.13 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 7.8 t-20 -76.06 54.49 0.86 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.158 -0.964 . . . . 0.0 109.905 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.544 ' ND2' ' HB1' ' A' ' 40' ' ' ALA . 41.8 t-20 -155.79 69.13 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.592 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 12.4 m-85 -89.83 166.07 13.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.741 . . . . 0.0 110.238 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -92.1 -9.33 42.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.216 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -148.51 155.22 40.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.622 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.45 -26.75 68.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.647 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 5.1 mt-10 -72.33 -32.87 66.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.6 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 39.8 t0 -70.65 -36.55 73.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.98 -44.49 65.87 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.545 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -63.52 -59.63 4.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.591 -0.693 . . . . 0.0 109.997 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -43.23 -26.37 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 0.0 109.695 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.5 m -97.89 -36.36 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.465 ' SG ' ' HG2' ' A' ' 1' ' ' ARG . 2.3 t -136.58 47.74 2.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.48 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -92.01 132.9 11.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 58' ' ' ALA . . . 157.04 -140.92 7.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 57' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.379 -1.071 . . . . 0.0 110.34 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.4 Cg_endo -70.0 156.68 62.13 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.065 1.56 . . . . 0.0 110.405 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -79.26 -26.95 42.31 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.772 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.626 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 6.3 p90 -67.74 -19.46 65.13 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.279 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 2.1 m -80.88 -26.97 36.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 0.0 109.265 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.58 -18.18 42.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.466 -0.771 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 159.52 83.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.962 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.38 171.96 16.62 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.01 1.532 . . . . 0.0 110.434 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.3 Cg_endo -71.74 166.26 30.01 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.932 1.491 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 5.3 t80 -123.0 94.03 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -0.973 . . . . 0.0 111.048 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.492 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.48 -22.25 66.91 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 56.6 166.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 14' ' ' CYS . 50.7 Cg_endo -72.86 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.961 1.506 . . . . 0.0 109.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' PRO . 3.1 m 38.62 -160.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 42.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.021 . . . . 0.0 110.116 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.27 150.83 35.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -0.859 . . . . 0.0 110.215 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.92 83.27 2.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.122 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mt -106.54 158.83 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.054 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.84 89.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.194 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -91.28 173.93 7.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.351 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.518 ' CE1' ' CG2' ' A' ' 32' ' ' THR . 30.7 m-85 -115.6 150.45 36.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 111.176 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.33 154.66 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.533 -0.73 . . . . 0.0 109.487 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.505 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 66.5 t80 -85.34 116.47 23.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.593 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 63.8 t-20 -89.28 93.96 9.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.013 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -21.7 1.42 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.753 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -81.05 -22.87 38.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.861 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -97.57 -28.06 14.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.237 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.51 -10.13 69.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -134.25 -146.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -1.167 . . . . 0.0 109.523 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.67 ' O ' HD12 ' A' ' 29' ' ' LEU . 60.8 m -116.04 154.62 29.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.779 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -142.0 154.91 45.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.484 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 18.9 p -83.49 144.86 29.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.626 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.2 p90 -140.97 164.2 30.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.351 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' THR . 22.9 t -74.37 125.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.402 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.695 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -106.13 147.65 28.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 0.0 110.413 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -90.77 -4.1 70.17 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.72 5.46 5.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.161 -1.2 . . . . 0.0 110.845 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.8 p -157.49 164.32 37.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.883 -1.136 . . . . 0.0 110.855 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER 50.63 34.72 10.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.328 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -84.63 164.69 18.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.74 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -121.5 -159.69 0.82 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.569 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 2.7 mtm180 -77.51 -8.86 58.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.098 . . . . 0.0 109.766 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -94.11 59.39 2.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.694 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.581 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 14.8 t-20 -165.23 84.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.9 m-85 -93.97 150.71 20.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.708 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 16.4 mtpt -81.51 -12.24 58.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -142.45 156.52 45.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.296 -0.878 . . . . 0.0 110.186 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . . . -74.12 -22.56 59.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.852 . . . . 0.0 109.953 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 5.1 tp10 -70.68 -35.95 73.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 110.482 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 54' ' ' THR . 0.4 OUTLIER -78.76 -35.44 44.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.668 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.557 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.3 t -67.97 -44.19 77.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.451 ' SD ' ' HA2' ' A' ' 56' ' ' GLY . 39.1 tpp -64.35 -61.05 2.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.573 -0.705 . . . . 0.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.49 -18.97 21.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.54 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.7 m -88.12 -45.62 9.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.1 m -99.6 -50.4 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.498 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.451 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 46.89 -160.83 0.27 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.48 62.93 0.83 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.308 -1.113 . . . . 0.0 110.237 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.848 0.356 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 43.7 Cg_endo -72.74 169.81 21.09 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.145 1.603 . . . . 0.0 110.95 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -91.93 -23.42 19.6 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.509 -0.744 . . . . 0.0 109.574 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.633 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 19.1 p90 -68.05 -21.79 64.98 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.557 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -80.85 -19.0 45.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.735 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 18.4 mt -74.38 -24.68 59.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 7.2 mt-10 -79.04 161.61 67.71 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 41.7 Cg_endo -69.76 168.28 22.02 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.108 1.583 . . . . 0.0 110.359 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.621 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.8 Cg_endo -71.08 156.98 58.87 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.963 1.507 . . . . 0.0 110.517 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.6 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 40.9 t80 -121.39 94.26 4.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.261 -0.9 . . . . 0.0 110.883 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -56.05 -23.5 33.9 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.6 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 63.27 -178.12 6.64 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 45.7 Cg_endo -72.24 -155.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.175 1.618 . . . . 0.0 110.685 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 11.9 m 64.24 154.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 6.34 46.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.22 169.21 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 110.102 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.94 102.37 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.641 HG21 ' NH2' ' A' ' 20' ' ' ARG . 28.6 mt -134.23 145.99 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.844 . . . . 0.0 110.059 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.401 HG23 ' HB ' ' A' ' 32' ' ' THR . 41.2 mm -90.37 85.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.641 ' NH2' HG21 ' A' ' 18' ' ' ILE . 9.1 mmt-85 -91.02 176.91 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.927 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 71.6 m-85 -114.0 154.18 28.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 111.528 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 11.8 p90 -153.0 154.43 34.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.405 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 89.1 t80 -83.99 106.88 15.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.269 -0.894 . . . . 0.0 111.013 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 55.3 t-20 -80.24 98.54 7.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -50.86 -23.35 2.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.976 -1.077 . . . . 0.0 109.559 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.402 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -77.81 -23.71 49.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.448 -0.782 . . . . 0.0 110.209 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -99.79 -14.52 18.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.69 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.02 1.75 85.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 30' ' ' CYS . 1.8 pp -144.27 -147.35 0.21 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.383 -1.069 . . . . 0.0 109.102 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.671 ' N ' HD12 ' A' ' 29' ' ' LEU . 79.4 m -121.96 162.2 21.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 110.607 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 95.7 mt-30 -144.87 -175.36 4.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.607 -0.683 . . . . 0.0 109.395 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 25.2 p -103.13 144.15 31.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.994 -1.066 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.8 p90 -141.8 160.53 40.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.929 . . . . 0.0 110.056 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.7 t -74.05 122.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.035 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.669 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.7 t80 -101.26 141.33 34.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.753 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.57 -0.53 79.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.563 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.4 -1.37 2.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.191 -1.182 . . . . 0.0 111.074 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 39' ' ' ARG . 15.8 p -140.68 163.09 33.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.822 -1.174 . . . . 0.0 111.03 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.442 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER 41.77 45.5 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 110.911 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -73.78 146.66 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.751 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' HB2' ' A' ' 10' ' ' TYR . 42.5 mtpt -95.06 -159.91 0.75 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 8.3 mtt-85 -85.55 -22.73 27.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.146 -0.971 . . . . 0.0 109.869 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.488 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 21.0 t-20 -89.07 53.86 2.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 0.0 110.14 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 3.9 t-20 -143.93 84.55 1.78 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 43' ' ' ASN . 23.8 m-85 -99.6 153.34 19.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 110.552 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -76.24 -20.93 56.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.579 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.9 p -137.67 156.65 47.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 110.614 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.01 68.53 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.582 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.97 -38.52 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.414 -0.804 . . . . 0.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -62.04 -34.41 76.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.084 -1.01 . . . . 0.0 108.557 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.9 t -71.17 -43.18 67.99 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.535 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.13 -50.45 33.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.36 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -22.96 25.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.019 -1.051 . . . . 0.0 109.629 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.566 HG22 ' SG ' ' A' ' 55' ' ' CYS . 16.4 m -94.37 -45.85 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.532 -0.73 . . . . 0.0 109.914 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 54' ' ' THR . 56.7 m -116.75 38.06 3.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 110.501 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -91.92 25.3 17.26 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.06 -68.0 1.29 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.346 -1.091 . . . . 0.0 110.458 -179.647 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.481 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.613 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 39.2 Cg_endo -68.08 163.17 36.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.003 1.528 . . . . 0.0 110.456 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.411 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -105.3 -15.2 15.11 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.939 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.74 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 14.9 p90 -66.27 -17.03 64.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.048 -1.033 . . . . 0.0 110.23 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.5 -8.3 58.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.022 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.664 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 27.5 mt -76.59 -23.28 53.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 109.953 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -81.8 174.38 6.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.349 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.78 165.85 30.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.872 1.459 . . . . 0.0 110.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.599 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.3 Cg_endo -71.62 -175.99 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.967 1.509 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 67.6 t80 -127.63 93.88 3.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.699 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.46 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -65.83 -22.62 66.56 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 60.32 151.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.16 82.54 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.97 1.51 . . . . 0.0 110.513 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.46 175.88 10.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 110.155 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -108.9 -1.03 19.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.31 160.67 28.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.14 68.47 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.72 153.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 110.075 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -98.01 86.39 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 110.37 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.56 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 mmt180 -86.59 173.15 9.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 64.5 m-85 -112.69 151.12 30.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.09 -1.006 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 8.3 p90 -150.56 163.63 38.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.66 -0.65 . . . . 0.0 109.403 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 70.7 t80 -87.2 132.14 33.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 34.8 t-20 -102.89 87.9 3.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.815 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.13 -32.34 1.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.005 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 1.9 mptp? -72.84 -24.51 60.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.865 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -98.2 -33.69 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.88 . . . . 0.0 110.16 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.01 -12.37 58.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -127.91 -144.23 0.29 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.8 m -121.69 157.24 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 6.6 mt-30 -140.23 -177.51 5.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 19.8 p -102.37 144.4 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.046 -1.034 . . . . 0.0 110.546 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.6 p90 -141.57 160.28 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.79 108.34 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.249 -0.907 . . . . 0.0 110.832 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.984 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -87.44 146.22 25.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.72 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.65 -4.44 85.34 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.68 12.45 7.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.147 -1.207 . . . . 0.0 110.314 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 39' ' ' ARG . 27.0 p -150.11 162.88 39.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.1 mtt-85 40.65 44.42 1.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.984 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -62.64 155.11 27.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.551 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 2.4 mtpp -121.03 -157.8 0.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.368 -0.832 . . . . 0.0 109.578 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.74 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -83.23 -22.5 33.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 0.0 109.978 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 1.7 t-20 -90.13 54.29 2.75 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.768 0.794 . . . . 0.0 109.04 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.586 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 19.4 t-20 -157.5 76.5 0.82 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 22.9 m-85 -87.74 134.78 33.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.433 -0.792 . . . . 0.0 109.849 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -65.71 -16.61 63.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.287 -0.883 . . . . 0.0 111.34 -178.701 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 99.2 p -143.43 158.02 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 110.434 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -64.8 -29.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.066 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.66 -25.37 56.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.646 -0.659 . . . . 0.0 109.812 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.485 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 39.2 t0 -78.64 -30.59 46.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 109.514 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.547 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 39.9 t -78.65 -43.96 24.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.225 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.504 ' O ' ' N ' ' A' ' 56' ' ' GLY . 72.9 mmm -66.28 -49.39 67.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.484 -0.76 . . . . 0.0 110.309 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -62.23 -14.52 39.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 109.849 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.505 HG22 ' HZ ' ' A' ' 4' ' ' PHE . 47.6 m -92.14 -53.56 4.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.575 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 57.6 m -110.89 20.41 17.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 110.687 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -66.27 -177.54 7.95 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 58' ' ' ALA . . . 117.75 -126.88 7.1 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 57' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.235 . . . . 0.0 110.154 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.475 ' HD2' HD21 ' A' ' 6' ' ' LEU . 2.1 ttp-105 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.655 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 38.5 Cg_endo -67.87 169.1 16.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.039 1.547 . . . . 0.0 111.115 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.45 -18.01 13.63 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.55 -0.719 . . . . 0.0 109.942 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.655 ' CE2' ' HB2' ' A' ' 2' ' ' PRO . 37.7 p90 -66.35 -24.09 66.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.877 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.536 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 1.7 m -85.54 -19.47 31.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.714 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 15.1 mt -82.77 -19.03 38.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 110.837 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -86.1 169.86 14.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.93 -1.106 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.94 163.71 36.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.889 1.468 . . . . 0.0 110.183 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.604 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.6 Cg_endo -71.41 163.51 38.83 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.947 1.498 . . . . 0.0 110.516 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.437 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 17.5 t80 -120.77 93.88 4.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.32 -0.863 . . . . 0.0 110.269 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.2 m -50.62 -23.44 2.6 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.92 -176.17 21.99 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.512 ' CG ' ' HG3' ' A' ' 39' ' ' ARG . 48.8 Cg_endo -79.21 -153.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.075 1.566 . . . . 0.0 109.992 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 32.1 m 63.05 170.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.114 -0.991 . . . . 0.0 110.535 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -116.23 10.12 14.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 110.344 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 159.1 7.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.679 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -130.64 78.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.31 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.757 HD11 ' HB2' ' A' ' 37' ' ' ALA . 6.0 mt -104.31 156.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.883 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.439 HG23 ' HB ' ' A' ' 32' ' ' THR . 44.3 mm -99.77 80.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 109.984 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.572 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 9.0 mmt180 -85.95 174.61 9.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -114.27 143.69 44.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 110.864 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 20.5 p90 -138.19 152.14 48.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 62.8 t80 -79.19 106.11 10.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.342 -0.849 . . . . 0.0 111.253 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' ALA . 53.0 t-20 -79.14 84.84 5.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.476 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.714 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.56 -26.03 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.925 -1.109 . . . . 0.0 109.439 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.67 64.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 109.579 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.5 -24.11 16.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.463 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' O ' ' HA2' ' A' ' 57' ' ' GLY . . . 96.34 1.26 60.9 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -149.44 -142.2 0.12 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.319 -1.106 . . . . 0.0 109.227 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 m -117.55 164.2 15.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.129 0.966 . . . . 0.0 112.209 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 24.7 mt-30 -147.67 160.86 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.2 p -79.7 144.15 33.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 111.13 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 13.5 p90 -144.08 160.73 40.38 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 11' ' ' THR . 9.1 t -74.01 129.25 36.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 110.19 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.893 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -113.84 146.58 39.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 0.0 109.359 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.713 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.34 4.41 84.22 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.757 ' HB2' HD11 ' A' ' 18' ' ' ILE . . . 68.96 4.59 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.94 -1.329 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 7.9 p -145.01 159.27 43.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.415 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.512 ' HG3' ' CG ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER 51.47 33.12 9.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.215 -0.928 . . . . 0.0 110.794 179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.893 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -59.77 142.13 53.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 110.46 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -102.79 -170.29 1.78 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.063 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.565 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 2.6 mtt-85 -71.73 -25.33 62.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.083 -1.01 . . . . 0.0 109.782 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 11.3 t-20 -92.91 54.38 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 109.982 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.472 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 22.6 t-20 -153.43 70.39 0.85 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.565 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 13.1 m-85 -88.2 146.25 25.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 ttmt -76.89 -18.95 58.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 110.59 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.9 p -136.24 152.34 50.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 110.398 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.38 67.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.5 -0.75 . . . . 0.0 109.907 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.506 ' N ' ' OE1' ' A' ' 49' ' ' GLU . 3.4 mp0 -73.4 -19.87 60.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.675 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.5 t0 -83.32 -29.64 28.13 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 108.722 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.66 -45.97 56.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.41 0.624 . . . . 0.0 109.5 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.555 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -61.64 -54.55 41.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.349 -0.845 . . . . 0.0 110.865 -178.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -53.09 -19.1 2.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.608 HG22 ' SG ' ' A' ' 55' ' ' CYS . 40.9 m -97.28 -59.61 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.12 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.608 ' SG ' HG22 ' A' ' 54' ' ' THR . 57.1 m -112.16 -56.63 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.651 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.555 ' CA ' ' HA ' ' A' ' 52' ' ' MET . . . 54.52 167.24 0.03 OUTLIER Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.666 ' O ' ' HB2' ' A' ' 58' ' ' ALA . . . -48.33 -95.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 57' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.142 -1.211 . . . . 0.0 110.205 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.3 mtm-85 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.86 0.362 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.622 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.2 Cg_endo -68.61 162.89 39.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.965 1.508 . . . . 0.0 110.624 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.62 -25.47 21.27 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.723 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.628 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 42.5 p90 -68.01 -19.05 64.88 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.871 -1.131 . . . . 0.0 111.248 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.598 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 94.8 m -82.84 -25.15 32.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.9 -1.125 . . . . 0.0 109.248 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.401 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.7 mt -80.25 -22.93 41.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 109.485 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 5.9 mm-40 -73.07 154.85 90.63 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.19 167.04 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.927 1.488 . . . . 0.0 110.401 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.615 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.7 Cg_endo -69.22 159.05 55.33 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.027 1.541 . . . . 0.0 110.062 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 30.1 t80 -122.78 94.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.479 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 62.76 172.31 1.68 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 14' ' ' CYS . 45.9 Cg_endo -72.74 -93.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.983 1.517 . . . . 0.0 110.277 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.7 m 39.99 -162.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.208 -0.932 . . . . 0.0 110.61 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -141.61 8.98 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' O ' ' CD ' ' A' ' 17' ' ' ARG . . . -93.16 173.54 7.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.024 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' CD ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -150.08 81.97 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.2 mp -95.53 164.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.983 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.3 mm -100.87 89.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.519 HH21 HG21 ' A' ' 18' ' ' ILE . 3.6 mmt85 -95.42 177.27 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.948 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.526 ' CE1' HG23 ' A' ' 32' ' ' THR . 51.1 m-85 -116.09 151.03 36.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 0.0 111.156 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 11.9 p90 -147.72 158.92 44.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.523 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.627 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 68.8 t80 -88.89 107.7 19.14 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.281 -0.887 . . . . 0.0 110.895 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 62.4 t-20 -83.77 89.59 7.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 110.014 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.38 -24.99 0.57 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.001 -1.062 . . . . 0.0 109.535 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -75.53 -25.97 57.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.835 . . . . 0.0 109.714 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.61 -28.9 15.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.57 -10.31 59.22 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 29' ' ' LEU . 1.3 pt? -140.52 -147.05 0.21 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.25 -1.147 . . . . 0.0 109.841 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 99.4 m -115.69 156.92 25.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 110.551 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.521 HE22 ' HB2' ' A' ' 27' ' ' ALA . 45.3 mt-30 -144.02 178.69 7.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.566 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.526 HG23 ' CE1' ' A' ' 21' ' ' TYR . 3.3 p -95.93 144.6 26.11 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.418 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.4 p90 -143.53 165.06 28.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.488 -0.757 . . . . 0.0 109.83 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.457 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 63.2 t -75.16 132.08 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.984 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.671 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -112.71 146.81 38.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 109.864 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -99.72 1.96 57.0 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.7 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.59 1.73 3.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.007 -1.29 . . . . 0.0 110.971 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 39' ' ' ARG . 22.3 p -149.53 172.43 15.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 0.0 110.482 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 1.5 mpt_? 40.63 30.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -73.49 156.97 37.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 111.031 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HD2' ' HB2' ' A' ' 10' ' ' TYR . 7.5 mtpt -110.33 -169.8 1.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.443 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.628 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 2.7 mtt-85 -76.7 -15.65 59.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.26 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 15.1 t-20 -90.39 53.79 2.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 109.473 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.0 t-20 -147.74 77.64 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 51' ' ' CYS . 17.9 m-85 -94.32 143.84 26.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.793 . . . . 0.0 110.24 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 110.294 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -136.53 157.65 46.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 110.414 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -24.88 66.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.956 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.15 -23.71 63.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.026 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 46.9 t0 -90.18 -24.7 20.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.542 ' HB2' ' CD1' ' A' ' 45' ' ' PHE . 29.7 t -82.15 -43.96 17.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 109.808 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.43 ' HA ' ' H ' ' A' ' 56' ' ' GLY . 14.2 mtp -66.81 -50.25 63.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 0.0 110.547 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -17.59 2.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -110.76 -42.14 4.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.627 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.3 m -99.09 -40.16 8.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 55' ' ' CYS . . . -41.14 98.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 55' ' ' CYS . . . -100.65 -125.88 5.66 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.198 -1.178 . . . . 0.0 110.247 179.902 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.109 0.481 . . . . 0.0 110.011 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.66 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.7 Cg_endo -69.68 162.01 43.71 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.312 1.69 . . . . 0.0 111.193 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -87.35 -24.54 24.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.568 -0.707 . . . . 0.0 109.78 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.66 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 14.5 p90 -66.36 -13.94 61.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.02 -1.05 . . . . 0.0 110.142 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.6 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 6.4 m -85.3 -22.45 28.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 110.646 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.71 -2.78 47.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.74 -1.225 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.47 170.61 7.91 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 110.603 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.01 166.79 28.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.152 1.606 . . . . 0.0 110.35 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.588 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 43.3 Cg_endo -70.78 -173.13 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.883 1.465 . . . . 0.0 109.595 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.59 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 65.5 t80 -154.65 93.92 1.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.912 -1.117 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.402 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -58.68 -23.18 58.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.59 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 66.19 155.68 0.34 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.07 66.38 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.05 1.553 . . . . 0.0 110.31 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.491 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 23.0 m -121.7 -174.91 2.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.729 . . . . 0.0 109.825 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -120.68 12.33 11.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.114 -0.991 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.96 166.69 11.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 110.268 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -144.0 68.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.005 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 35' ' ' TYR . 61.4 mt -87.46 155.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.432 -0.792 . . . . 0.0 110.123 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.1 mm -93.5 89.0 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.557 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.8 mmt85 -99.52 -179.19 4.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 110.383 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.536 ' CZ ' HG23 ' A' ' 32' ' ' THR . 10.7 m-85 -116.81 153.46 32.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 111.328 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 15.5 p90 -149.06 176.77 10.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.519 -0.738 . . . . 0.0 109.361 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.8 OUTLIER -95.03 100.57 12.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' ALA . 48.8 t-20 -86.11 69.46 10.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.656 -1.278 . . . . 0.0 108.337 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.78 -26.04 0.87 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.435 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -62.08 -37.28 84.44 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -83.58 -31.86 26.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.587 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.09 -10.71 10.05 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.625 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.32 -141.89 0.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.754 -1.439 . . . . 0.0 109.889 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 96.2 m -107.2 151.93 24.77 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.499 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 5.7 mt-30 -141.59 179.38 6.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 110.467 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.536 HG23 ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -91.54 148.14 22.5 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.394 -0.817 . . . . 0.0 109.877 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.592 ' HB3' ' CD1' ' A' ' 22' ' ' PHE . 13.4 p90 -148.14 166.08 28.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 110.483 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.452 ' CG1' ' HG3' ' A' ' 17' ' ' ARG . 13.2 t -74.64 122.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.37 -0.831 . . . . 0.0 110.275 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -103.66 142.7 33.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.412 -0.805 . . . . 0.0 109.658 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.754 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.42 -0.98 78.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.545 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.6 0.81 3.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -1.194 . . . . 0.0 110.176 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -153.9 173.55 15.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 44.72 26.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -63.52 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.538 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.9 mtpp -95.83 -162.99 1.0 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.381 -0.825 . . . . 0.0 109.243 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.624 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.3 mtm180 -84.65 -9.33 58.36 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.002 -1.061 . . . . 0.0 109.979 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -96.97 53.99 1.24 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.561 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 13.6 t-20 -144.26 84.2 1.75 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 27.8 m-85 -101.21 164.51 11.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -91.99 -16.23 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.277 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.507 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 97.8 p -141.5 154.81 45.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.87 66.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.588 -0.695 . . . . 0.0 110.001 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -15.04 60.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.726 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.557 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 21.3 t70 -94.58 -25.39 16.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.599 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 7.3 t -73.84 -49.12 26.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.833 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.542 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -65.67 -49.02 70.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.52 -0.738 . . . . 0.0 110.442 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -45.26 -29.32 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.892 -1.13 . . . . 0.0 109.472 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.462 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 1.2 m -104.56 -31.55 9.38 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.699 0.761 . . . . 0.0 109.083 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.639 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 92.9 m -100.6 20.0 15.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.612 -0.68 . . . . 0.0 110.92 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -129.1 170.76 20.1 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.73 31.3 3.22 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.187 -1.184 . . . . 0.0 110.182 179.969 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.922 0.392 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.617 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.2 Cg_endo -70.94 154.8 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.118 1.588 . . . . 0.0 111.267 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.63 -30.68 64.52 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.506 -0.746 . . . . 0.0 110.061 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 5.1 p90 -67.97 -20.13 65.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.892 -1.13 . . . . 0.0 109.565 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 2.2 t -77.91 -29.27 50.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.691 -0.631 . . . . 0.0 109.793 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 13.1 mt -87.7 -10.09 52.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 109.51 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.27 153.32 84.16 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.647 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 43.2 Cg_endo -70.56 174.45 10.19 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.979 1.516 . . . . 0.0 110.071 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.7 Cg_endo -73.05 155.42 52.58 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.841 1.443 . . . . 0.0 109.813 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 24.3 t80 -118.72 93.95 4.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 111.102 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.469 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -59.88 -23.43 63.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 64.05 164.83 0.78 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -80.96 89.85 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 124.231 1.648 . . . . 0.0 110.027 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.35 171.25 18.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.056 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -14.02 17.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.19 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.76 169.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.481 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -152.0 69.3 0.9 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.02 155.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 110.365 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.3 mm -94.18 87.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.329 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 mmt85 -90.79 175.09 7.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 110.508 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.593 ' CE2' HG23 ' A' ' 32' ' ' THR . 57.5 m-85 -117.13 148.6 41.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -0.776 . . . . 0.0 111.389 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 17.8 p90 -148.41 161.16 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 69.1 t80 -90.05 108.85 19.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.965 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 26' ' ' LYS . 25.8 t-20 -80.87 87.18 5.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.252 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.26 -26.49 0.51 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.99 -1.069 . . . . 0.0 109.556 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 6.0 tttt -70.95 -29.13 65.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.667 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -91.57 -35.71 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.13 56.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -140.0 -144.74 0.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -1.165 . . . . 0.0 109.036 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.7 m -116.71 150.98 37.33 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 110.572 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 87.1 mt-30 -139.52 167.2 22.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.593 HG23 ' CE2' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -96.78 146.94 24.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.114 -0.991 . . . . 0.0 110.881 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -142.74 161.61 37.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.581 -0.699 . . . . 0.0 110.118 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' THR . 70.4 t -75.28 107.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.313 -0.867 . . . . 0.0 110.395 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.813 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.1 t80 -85.0 146.01 27.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.402 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.686 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.56 2.85 83.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 67.55 13.36 9.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.108 -1.231 . . . . 0.0 110.613 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ARG . 31.3 p -156.36 170.59 21.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.94 . . . . 0.0 110.399 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.85 37.96 0.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -74.89 147.96 40.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.417 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -116.75 -165.3 1.05 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.581 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 6.2 mtt-85 -68.75 -20.12 64.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.268 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 1.7 t-20 -91.48 54.21 2.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.056 -1.028 . . . . 0.0 110.178 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.544 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -156.29 76.05 0.89 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 108.945 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.0 m-85 -91.13 147.59 22.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 110.677 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 0.0 OUTLIER -78.25 -21.36 50.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 110.349 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.491 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 91.8 p -135.8 156.57 48.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 0.0 110.492 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.12 -25.46 68.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.527 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 1.7 tp10 -73.79 -26.22 60.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 25.9 t0 -77.38 -31.77 54.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.265 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.587 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.3 t -82.48 -47.87 11.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.592 -0.692 . . . . 0.0 109.193 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.543 ' O ' ' N ' ' A' ' 56' ' ' GLY . 5.8 ttm -65.74 -44.44 85.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 109.993 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -58.12 -25.33 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.674 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -90.17 -42.32 11.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.448 -0.783 . . . . 0.0 109.767 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -127.32 44.03 3.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 110.815 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -105.69 -130.91 6.8 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.17 35.32 88.35 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.197 -1.178 . . . . 0.0 110.296 179.931 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.579 ' HD2' HD21 ' A' ' 6' ' ' LEU . 15.7 ttm105 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.913 0.387 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.617 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 38.1 Cg_endo -67.16 157.38 61.99 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.182 1.622 . . . . 0.0 110.73 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 4' ' ' PHE . 9.3 p-10 -82.29 -25.71 33.74 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.502 -0.749 . . . . 0.0 109.936 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 4.4 p90 -67.26 -15.04 63.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.11 -0.994 . . . . 0.0 110.44 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -82.13 -28.88 31.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.6 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.579 HD21 ' HD2' ' A' ' 1' ' ' ARG . 13.9 mt -82.02 -19.31 40.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 109.724 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.94 158.37 85.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.823 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 44.1 Cg_endo -71.84 174.83 10.57 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.853 1.449 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.606 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -71.55 169.74 20.24 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.902 1.475 . . . . 0.0 110.48 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.597 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 63.5 t80 -129.1 94.25 3.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.835 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.401 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -56.29 -23.39 36.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 58.44 -172.8 3.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.0 Cg_endo -73.63 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.17 1.616 . . . . 0.0 110.466 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 28.6 m 63.12 173.33 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -133.52 27.19 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.01 -168.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.102 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 38.8 ttm180 -150.69 73.81 1.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.162 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 82.1 mt -109.99 146.61 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.518 HG23 ' HB ' ' A' ' 32' ' ' THR . 43.9 mm -92.43 82.45 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -81.67 169.24 17.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.919 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 47.2 m-85 -112.44 149.87 31.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 111.492 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 13.0 p90 -150.12 156.81 42.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 47.7 t80 -83.6 116.3 22.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.125 -0.984 . . . . 0.0 110.486 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 26.9 t-20 -91.24 88.48 6.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.874 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.58 -37.72 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.735 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 10.2 tptp -64.91 -27.99 69.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.586 ' O ' HD12 ' A' ' 29' ' ' LEU . . . -92.66 -23.58 18.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 91.22 -11.29 72.6 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 27' ' ' ALA . 1.7 mp -132.76 -142.53 0.21 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -1.138 . . . . 0.0 109.521 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 66.3 m -119.57 154.67 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.579 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 3.3 mt-30 -138.61 172.3 13.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.499 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.518 ' HB ' HG23 ' A' ' 19' ' ' ILE . 8.5 p -98.59 144.45 27.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 110.506 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -137.82 157.08 47.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.042 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.37 101.33 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.207 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.817 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 10.7 t80 -80.58 149.24 29.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.491 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.741 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -84.56 -1.68 89.11 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.26 6.69 5.22 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 20.2 p -149.77 171.91 15.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 110.456 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 39.34 47.17 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.486 -0.759 . . . . 0.0 110.645 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.817 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -69.28 156.07 39.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -120.47 -162.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.301 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.528 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.6 mtm-85 -80.11 -6.13 57.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 109.978 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.8 t-20 -110.25 54.59 0.66 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.86 . . . . 0.0 109.64 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.584 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 30.1 t-20 -155.41 82.49 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -94.49 142.65 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 111.099 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 11.2 tmtt? -71.92 -23.46 61.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.496 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 97.0 p -134.26 159.02 42.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 110.502 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.23 64.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.78 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -74.23 -28.68 61.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 110.236 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.491 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 56.4 t0 -78.86 -32.56 46.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.559 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.3 t -74.78 -43.98 51.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -67.63 -48.92 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.253 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -64.69 -11.93 41.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 109.717 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.465 HG22 ' SG ' ' A' ' 5' ' ' CYS . 1.8 m -106.43 -38.79 6.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.885 . . . . 0.0 110.16 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.6 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.6 m -108.26 -0.94 20.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -49.15 111.41 0.98 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.11 20.44 0.75 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.316 -1.108 . . . . 0.0 110.165 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 2' ' ' PRO . 9.0 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.1 0.476 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.628 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 44.0 Cg_endo -71.7 162.04 43.33 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 124.292 1.68 . . . . 0.0 110.097 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -86.51 -23.16 26.02 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 109.772 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.648 ' CB ' ' CD ' ' A' ' 42' ' ' ARG . 9.0 p90 -67.53 -19.16 65.26 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.623 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.577 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -72.96 -29.66 63.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.072 -1.018 . . . . 0.0 109.658 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.731 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 39.5 mt -78.31 -20.36 51.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.743 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 45.0 mt-10 -81.55 165.37 44.46 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 47.7 Cg_endo -72.87 163.0 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.937 1.493 . . . . 0.0 110.564 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.489 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 43.6 Cg_endo -71.79 -159.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.968 1.509 . . . . 0.0 110.456 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 45.5 t80 -146.43 93.68 2.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 109.946 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -58.67 -22.82 58.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.593 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 61.12 174.87 1.39 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.5 Cg_endo -81.55 -96.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.903 1.475 . . . . 0.0 110.658 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' PRO . 2.0 m 38.91 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.235 -0.915 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -142.54 17.2 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.832 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.01 -179.76 4.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 110.027 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.06 71.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.612 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 3.7 mp -85.84 156.58 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.681 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 32' ' ' THR . 22.1 mm -93.74 80.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.113 -0.992 . . . . 0.0 110.602 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 7.8 mmt180 -81.35 175.04 10.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.702 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.538 ' CD1' ' HA ' ' A' ' 47' ' ' SER . 89.8 m-85 -116.23 151.8 35.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.037 -1.039 . . . . 0.0 111.285 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.511 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 15.7 p90 -150.35 161.87 41.64 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 72.6 t80 -86.33 107.81 18.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.968 -1.082 . . . . 0.0 110.963 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' ALA . 37.5 t-20 -84.99 90.84 7.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.997 . . . . 0.0 109.86 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.53 -28.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.525 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.485 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -71.09 -27.14 63.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.333 -0.855 . . . . 0.0 109.762 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.41 -18.5 19.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.002 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 -3.04 87.54 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.665 HD12 ' O ' ' A' ' 30' ' ' CYS . 1.1 pp -144.1 -145.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.16 -1.2 . . . . 0.0 109.36 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.665 ' O ' HD12 ' A' ' 29' ' ' LEU . 84.3 m -114.76 151.12 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 111.031 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -137.61 176.95 8.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.359 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.532 ' HB ' ' CG2' ' A' ' 19' ' ' ILE . 25.4 p -93.46 144.29 25.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 7.8 p90 -144.48 161.52 38.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 55.5 t -74.72 135.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 0.0 110.231 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.827 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -122.27 141.63 51.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.787 . . . . 0.0 109.775 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -75.39 -1.76 65.9 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 71.2 1.89 4.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -1.127 . . . . 0.0 110.485 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 6.0 p -142.5 157.02 45.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.008 -1.058 . . . . 0.0 110.058 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 4.9 mtp85 56.72 35.6 26.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.827 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -55.03 149.9 11.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.505 ' CE ' ' HB2' ' A' ' 10' ' ' TYR . 2.1 mtmp? -124.86 -170.57 2.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.648 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 6.7 ptp180 -65.05 -32.93 74.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 111.278 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.9 t-20 -88.46 54.66 3.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.822 -1.174 . . . . 0.0 109.449 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.482 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 54.1 t-20 -158.55 76.34 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 23.1 m-85 -85.86 136.72 33.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 110.589 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -61.34 -26.96 68.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.848 . . . . 0.0 110.076 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.538 ' HA ' ' CD1' ' A' ' 21' ' ' TYR . 89.3 p -145.29 162.03 38.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 -20.43 66.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.906 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 2.7 tp10 -70.68 -34.47 72.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.3 t0 -79.28 -32.95 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.375 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.579 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 44.4 t -69.87 -44.43 69.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.765 . . . . 0.0 109.208 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.545 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -65.37 -55.39 18.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.499 -0.751 . . . . 0.0 109.522 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 2.2 ttp180 -46.08 -31.82 2.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' SG ' ' A' ' 55' ' ' CYS . 85.3 m -79.27 -59.44 2.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -0.786 . . . . 0.0 109.445 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.525 ' SG ' ' CG ' ' A' ' 2' ' ' PRO . 59.2 m -114.1 -47.12 2.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.388 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 52' ' ' MET . . . 43.13 -128.7 5.51 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.07 5.57 68.59 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.179 -1.189 . . . . 0.0 110.227 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.76 0.314 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.598 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.2 Cg_endo -69.31 154.29 69.75 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.972 1.512 . . . . 0.0 110.867 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -70.12 -31.38 68.89 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.455 -0.778 . . . . 0.0 109.673 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 3.5 p90 -67.85 -17.23 64.43 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.224 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 3.7 t -84.55 -25.17 28.91 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.873 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 6' ' ' LEU . 7.3 mt -86.96 -15.28 39.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.904 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.43 163.88 56.92 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 168.44 24.5 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.111 1.585 . . . . 0.0 110.187 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.619 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.9 Cg_endo -70.73 169.76 19.38 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.017 1.535 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 38.8 t80 -126.25 94.27 4.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 111.131 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.478 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -67.39 -22.64 65.54 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.83 171.8 0.56 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.6 Cg_endo -80.51 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.877 1.462 . . . . 0.0 110.333 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 41.52 -164.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 110.569 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -134.41 26.41 3.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 110.201 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.55 5.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.17 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 2.2 ptp180 -153.82 73.64 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.125 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 19' ' ' ILE . 4.1 mt -90.26 165.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.275 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' N ' HG22 ' A' ' 18' ' ' ILE . 29.4 mm -102.79 92.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.549 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.555 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 4.2 mmt180 -94.48 -179.39 4.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.846 . . . . 0.0 110.038 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.557 ' CE2' HG22 ' A' ' 32' ' ' THR . 72.6 m-85 -117.03 146.2 43.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.084 . . . . 0.0 111.06 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.7 p90 -145.69 163.38 35.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.482 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 86.9 t80 -92.26 124.33 36.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.742 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 59.8 t-20 -96.69 96.54 8.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -0.956 . . . . 0.0 109.929 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.6 -36.31 10.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -68.57 -25.5 64.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.776 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -96.36 -24.91 15.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 86.43 -8.72 73.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -129.68 -146.3 0.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.247 -1.149 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 63.1 m -123.48 150.02 44.42 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.729 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.589 HE22 ' HB2' ' A' ' 27' ' ' ALA . 36.3 mt-30 -137.31 160.96 37.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.558 -0.714 . . . . 0.0 109.21 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.557 HG22 ' CE2' ' A' ' 21' ' ' TYR . 40.5 p -82.97 144.23 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.3 p90 -140.62 166.22 25.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.442 -0.787 . . . . 0.0 109.865 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.448 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 3.6 t -74.88 133.84 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.083 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.723 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.6 t80 -112.88 147.09 37.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 0.0 110.324 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.749 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -87.34 -4.16 81.06 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 74.37 -4.54 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.445 -1.032 . . . . 0.0 111.113 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 39' ' ' ARG . 29.3 p -146.7 170.35 17.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 110.441 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.536 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.2 ttt180 42.78 51.76 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.723 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -95.23 157.82 15.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 0.0 110.905 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 4.6 mttp -118.59 -161.48 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.348 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.552 ' HD3' ' CB ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -74.55 -23.98 58.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.1 t-20 -80.19 54.26 1.93 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.919 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.594 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 25.2 t-20 -162.41 74.31 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 20.3 m-85 -85.46 143.7 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.446 -0.783 . . . . 0.0 110.788 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -68.91 -25.11 64.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 0.0 110.096 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -136.39 157.11 47.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 0.0 110.543 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.51 -22.87 66.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.071 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 4.1 mt-10 -75.28 -27.86 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.599 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 14.6 t0 -72.85 -35.85 67.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.526 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.2 t -71.43 -44.52 64.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' GLY . 2.7 mmt -67.69 -53.8 24.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.475 -0.766 . . . . 0.0 109.395 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -53.38 -22.43 7.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -96.22 -39.38 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 109.728 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.8 t -132.6 46.63 2.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -106.96 158.33 15.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.67 109.55 2.76 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.242 -1.152 . . . . 0.0 110.238 -179.854 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.528 ' NE ' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.736 0.303 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.589 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 41.7 Cg_endo -70.97 141.91 41.38 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.939 1.494 . . . . 0.0 110.081 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -75.92 -21.83 56.68 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 110.264 -179.919 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.748 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 6.6 p90 -67.01 -16.68 64.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.892 -1.123 . . . . 0.0 110.47 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 53.4 m -84.19 -20.94 31.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 178.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.692 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 15.7 mt -73.75 -22.82 59.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -70.52 160.37 81.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 110.141 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.7 170.28 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.017 1.535 . . . . 0.0 110.208 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.39 178.47 6.1 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.833 1.439 . . . . 0.0 110.153 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 11.0 t80 -139.56 93.86 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.91 . . . . 0.0 110.428 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -59.54 -22.74 62.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.39 144.94 0.03 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.54 65.47 4.65 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.958 1.504 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.488 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 18.5 m -117.56 170.83 8.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 4.49 53.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.357 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.53 175.55 5.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 109.998 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 13.5 ptp180 -155.08 71.97 0.81 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.575 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 mt -81.17 157.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.809 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 19' ' ' ILE . 4.3 mm -94.18 88.49 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.018 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.611 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.2 mmt180 -92.42 -175.65 4.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.338 -0.851 . . . . 0.0 110.034 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.623 ' CE2' HG23 ' A' ' 32' ' ' THR . 69.0 m-85 -119.37 144.82 46.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 111.434 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 14.4 p90 -142.14 166.52 24.47 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 55' ' ' CYS . 73.0 t80 -95.95 111.59 23.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 110.835 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 28.3 t-20 -84.32 91.83 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -47.07 -24.27 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -79.25 -22.93 44.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.407 -0.808 . . . . 0.0 109.823 179.421 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -93.56 -28.47 16.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 -0.6 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -151.26 -151.62 0.4 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -1.163 . . . . 0.0 109.851 179.677 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.58 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 95.4 m -109.99 153.75 24.13 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.871 0.843 . . . . 0.0 111.43 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -143.51 174.25 10.92 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.623 HG23 ' CE2' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -96.54 144.29 26.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.712 -1.243 . . . . 0.0 110.669 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -138.79 162.38 34.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.765 . . . . 0.0 109.583 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 17' ' ' ARG . 53.3 t -75.99 99.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 111.283 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.7 t80 -81.49 144.78 31.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.509 -0.745 . . . . 0.0 109.505 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.778 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -87.06 3.59 86.83 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.392 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 78.55 -24.5 0.21 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.467 -1.019 . . . . 0.0 111.169 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.44 168.35 19.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.898 -1.126 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.77 43.73 27.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 109.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.594 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -85.76 164.48 17.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.353 -0.842 . . . . 0.0 111.198 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.4 mttt -116.23 -166.3 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.748 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -76.88 -19.78 57.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.865 -1.147 . . . . 0.0 110.183 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' H ' ' HD2' ' A' ' 42' ' ' ARG . 3.8 t-20 -92.07 53.67 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.908 0.861 . . . . 0.0 109.341 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.466 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 17.8 t-20 -149.49 71.06 1.09 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.6 m-85 -84.89 141.21 30.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.531 -178.077 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 4.7 tttt -66.02 -23.12 66.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.477 -0.764 . . . . 0.0 110.911 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -143.38 153.85 43.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 110.418 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -56.86 -29.86 63.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.705 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.6 tt0 -64.68 -34.02 77.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.82 . . . . 0.0 110.363 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' ' HB ' ' A' ' 54' ' ' THR . 22.5 t0 -79.25 -29.18 42.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.622 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 37.6 t -82.9 -44.2 15.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.429 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.511 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -67.98 -49.95 58.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.956 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -59.97 -23.7 63.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 0.0 109.42 179.295 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.509 HG23 ' HZ ' ' A' ' 4' ' ' PHE . 2.5 m -94.32 -44.3 8.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.559 -0.713 . . . . 0.0 109.824 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 55.8 m -101.13 21.92 13.16 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -67.13 129.77 29.39 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.528 ' HA3' ' NE ' ' A' ' 1' ' ' ARG . . . -140.74 -60.92 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.2 -1.177 . . . . 0.0 110.156 -179.953 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.495 HH22 ' HB2' ' A' ' 58' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.781 0.324 . . . . 0.0 110.172 . . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.623 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 41.3 Cg_endo -70.44 161.01 47.57 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.057 1.556 . . . . 0.0 110.584 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -91.38 -25.84 19.18 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.41 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.623 ' CE2' ' HB2' ' A' ' 2' ' ' PRO . 28.6 p90 -67.33 -16.65 64.38 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.359 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 20.0 m -83.64 -26.43 29.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.075 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 6' ' ' LEU . 5.3 mt -81.43 -18.24 46.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.721 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.27 162.25 57.14 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.934 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.04 168.97 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.932 1.491 . . . . 0.0 110.108 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.602 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -70.59 175.2 9.12 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.998 1.526 . . . . 0.0 110.667 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -133.91 93.9 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 0.0 110.389 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.72 -22.69 66.63 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 11' ' ' THR . . . 57.94 171.8 0.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.3 Cg_endo -74.68 -97.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.913 1.481 . . . . 0.0 110.453 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 42.96 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.044 -1.035 . . . . 0.0 110.739 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -133.23 15.75 4.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 110.08 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.11 172.43 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 71.13 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 110.284 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -98.35 153.78 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 32' ' ' THR . 14.5 mm -96.64 87.67 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 32' ' ' THR . 8.2 mmt85 -88.67 177.31 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.535 ' CE1' HG23 ' A' ' 32' ' ' THR . 49.2 m-85 -113.39 152.89 29.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 111.082 -179.472 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -150.58 158.49 44.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.623 -0.673 . . . . 0.0 109.337 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.61 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 44.9 t80 -87.33 113.64 23.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.319 -0.863 . . . . 0.0 110.774 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.621 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 45.3 t-20 -86.27 83.31 7.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.47 -29.09 1.03 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.027 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -27.3 62.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.427 -0.795 . . . . 0.0 109.706 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.98 -26.33 16.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.239 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.48 -10.53 65.0 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.45 -144.11 0.21 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.188 -1.183 . . . . 0.0 109.571 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 95.1 m -121.83 153.97 37.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.703 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 20.0 mt-30 -140.38 160.45 39.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.484 -0.76 . . . . 0.0 109.383 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.535 HG23 ' CE1' ' A' ' 21' ' ' TYR . 2.0 p -84.6 144.56 28.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.009 -1.057 . . . . 0.0 110.723 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.9 p90 -139.15 162.3 35.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.92 179.383 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' THR . 11.8 t -74.67 122.6 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.797 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -99.79 147.09 25.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -0.88 . . . . 0.0 110.223 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -91.84 -4.38 67.41 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.95 -2.09 2.83 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.265 -1.138 . . . . 0.0 110.902 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 39' ' ' ARG . 28.3 p -146.3 172.24 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.991 -1.068 . . . . 0.0 110.182 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 38' ' ' CYS . 16.4 mtt-85 42.33 28.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.974 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.797 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -63.92 163.5 11.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -127.3 -171.04 2.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.557 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -69.56 -19.62 63.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.953 -1.092 . . . . 0.0 109.834 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 3.3 t-20 -88.25 67.03 8.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 109.695 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 39.0 t-20 -168.43 82.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 109.271 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.561 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 18.0 m-85 -96.42 148.8 22.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.585 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -69.22 -28.34 66.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.871 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -136.56 158.56 44.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -68.14 -20.45 64.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.067 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 5.3 tt0 -65.74 -42.0 91.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.01 -40.24 71.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 34.7 t -64.91 -43.99 91.04 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.656 0.741 . . . . 0.0 109.41 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -67.39 -61.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.726 . . . . 0.0 110.685 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -55.41 -19.25 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.036 -1.04 . . . . 0.0 110.617 -179.441 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.508 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 45.9 m -95.61 -56.0 2.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.07 -1.019 . . . . 0.0 110.172 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.61 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 44.6 m -85.56 0.57 52.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.929 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -60.94 -173.57 1.05 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.09 -6.27 25.35 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.495 ' HB2' HH22 ' A' ' 1' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.261 -1.14 . . . . 0.0 110.146 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.885 0.374 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.644 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 43.6 Cg_endo -73.47 166.29 30.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.131 1.595 . . . . 0.0 111.001 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' OD1' HD12 ' A' ' 6' ' ' LEU . 2.6 t0 -94.03 -22.21 18.68 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.433 -0.792 . . . . 0.0 109.626 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.644 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 10.9 p90 -66.67 -20.87 66.08 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.907 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.516 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -83.68 -22.04 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.388 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 19.3 mt -82.36 -16.97 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.467 -0.771 . . . . 0.0 109.842 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.493 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -84.78 160.89 54.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.088 179.838 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD2' ' HG3' ' A' ' 7' ' ' GLU . 44.1 Cg_endo -72.53 165.05 33.82 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.931 1.49 . . . . 0.0 110.071 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.6 Cg_endo -70.67 159.32 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.906 1.477 . . . . 0.0 110.712 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -116.33 94.33 4.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -0.836 . . . . 0.0 110.655 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.485 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -62.66 -22.87 66.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.5 170.25 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' CYS . 48.0 Cg_endo -73.58 -92.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.917 1.482 . . . . 0.0 110.941 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 44.26 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.052 -1.03 . . . . 0.0 110.313 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.09 8.27 3.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 -177.15 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 109.707 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -152.27 82.97 1.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.016 -1.052 . . . . 0.0 110.68 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.1 mt -96.87 157.92 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.752 HG23 ' HB ' ' A' ' 32' ' ' THR . 7.9 mm -104.54 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.153 -0.967 . . . . 0.0 110.242 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.8 mmt85 -88.51 179.97 6.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 62.1 m-85 -110.87 153.83 24.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 110.712 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.7 p90 -152.78 161.94 41.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.43 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 76.5 t80 -92.91 115.31 28.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 110.951 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 40.3 t-20 -90.5 98.55 11.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 0.0 110.01 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -52.24 -20.2 2.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.89 -19.09 29.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.982 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -96.53 -29.77 13.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.908 . . . . 0.0 110.231 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.72 72.45 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.64 -145.2 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.106 -1.232 . . . . 0.0 109.641 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.4 m -121.45 150.46 41.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.895 . . . . 0.0 110.97 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.48 179.65 6.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.752 ' HB ' HG23 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -99.45 144.47 28.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.893 -1.129 . . . . 0.0 111.156 -179.213 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.9 p90 -136.83 158.75 43.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.584 -0.697 . . . . 0.0 109.17 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 11' ' ' THR . 60.6 t -75.28 99.66 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.291 -0.881 . . . . 0.0 111.055 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.636 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 6.1 t80 -78.75 141.5 37.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.23 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.757 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -84.7 5.52 81.52 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.94 0.58 3.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -1.07 . . . . 0.0 111.0 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 39' ' ' ARG . 12.6 p -148.86 176.0 10.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.855 -1.153 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 41.56 44.55 2.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -83.35 137.27 34.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.94 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -103.0 -164.38 1.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.772 . . . . 0.0 109.433 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -69.55 -14.23 62.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.041 -1.037 . . . . 0.0 109.611 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.2 t-20 -94.39 55.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.471 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 16.8 t-20 -160.71 80.27 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 0.0 108.99 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.574 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -92.06 153.19 19.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.858 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -78.67 -23.18 45.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.446 -0.784 . . . . 0.0 110.16 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.1 p -142.68 161.44 38.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.27 -0.894 . . . . 0.0 110.296 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.87 -21.29 65.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -27.19 60.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.405 -0.809 . . . . 0.0 110.173 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.85 -30.81 31.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.348 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.574 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 43.6 t -78.64 -44.61 23.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.602 -0.686 . . . . 0.0 109.622 179.491 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -66.35 -46.8 75.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 110.293 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -63.72 -29.43 70.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.05 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.616 HG22 ' SG ' ' A' ' 55' ' ' CYS . 5.4 m -73.85 -50.17 21.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.125 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.616 ' SG ' HG22 ' A' ' 54' ' ' THR . 77.3 m -119.15 -42.43 2.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 76.39 -75.63 1.58 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 58' ' ' ALA . . . 97.61 -160.35 21.1 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 57' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.282 -1.128 . . . . 0.0 110.261 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.559 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 21.1 p90 . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.199 0.523 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 1.4 m -85.3 -21.98 28.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.655 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 48.1 mt -74.06 -24.37 59.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.356 -0.84 . . . . 0.0 108.807 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -79.74 164.02 55.5 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.606 -0.684 . . . . 0.0 109.466 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 7' ' ' GLU . 46.5 Cg_endo -74.03 167.36 27.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.736 1.387 . . . . 0.0 109.965 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.5 Cg_endo -70.17 172.34 13.23 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.785 1.413 . . . . 0.0 110.127 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 36.1 t80 -140.76 93.59 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.406 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.452 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -52.67 -23.12 6.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 65.53 -170.23 27.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -72.71 -155.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.092 1.575 . . . . 0.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 23.0 m 62.29 -168.69 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.243 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.42 20.78 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.232 -0.918 . . . . 0.0 109.985 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.24 167.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -142.36 69.2 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.841 . . . . 0.0 109.811 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.519 HG22 ' HG2' ' A' ' 20' ' ' ARG . 3.5 mt -107.32 148.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.468 HG23 ' HB ' ' A' ' 32' ' ' THR . 17.9 mm -94.33 78.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 109.865 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 18' ' ' ILE . 4.1 mmt180 -83.53 -176.55 6.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 109.886 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 57.6 m-85 -118.55 144.45 46.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.976 -1.077 . . . . 0.0 111.276 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -139.43 163.36 32.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.55 ' CG ' ' HB3' ' A' ' 5' ' ' CYS . 57.2 t80 -93.44 117.2 29.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.003 -1.061 . . . . 0.0 111.837 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 42.9 t-20 -91.07 92.17 8.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.856 . . . . 0.0 108.86 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -44.58 -29.5 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.891 -1.131 . . . . 0.0 110.183 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -75.2 -23.93 57.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.811 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.77 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -92.96 -16.83 24.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 110.507 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.13 -5.72 75.15 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -145.84 -143.43 0.14 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -1.162 . . . . 0.0 109.286 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.3 m -117.44 163.33 16.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 111.687 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 5.9 mt-30 -143.8 166.56 24.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.468 ' HB ' HG23 ' A' ' 19' ' ' ILE . 82.5 p -82.97 144.29 30.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 110.555 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 7.6 p90 -145.45 171.73 14.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 109.659 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.4 t -85.71 122.54 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.7 t80 -99.77 148.88 23.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.523 -0.736 . . . . 0.0 109.911 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.742 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -96.89 -3.9 59.06 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.641 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.41 -2.81 2.49 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.184 -1.186 . . . . 0.0 111.066 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.423 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 26.0 p -139.81 152.49 46.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.886 -1.134 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HD3' ' HG3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 49.04 42.99 21.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.379 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -70.81 149.87 46.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -101.1 -164.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.559 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 12.2 mtt-85 -82.79 -12.81 57.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.047 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 6.7 t-20 -95.48 54.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.585 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 15.7 t-20 -152.73 84.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.819 . . . . 0.0 109.303 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.588 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 14.7 m-85 -98.5 154.67 17.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.813 . . . . 0.0 110.156 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -81.69 -18.64 43.72 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 110.611 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 95.3 p -142.18 155.67 45.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.53 70.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.93 -23.83 55.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 44.6 t0 -74.29 -33.98 63.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.588 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -71.69 -48.51 46.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.3 mmt -56.01 -57.55 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.141 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -24.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.986 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.8 m -99.54 -63.72 1.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.487 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 56.7 m . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.584 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.598 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 53.5 p90 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.139 0.495 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.577 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 97.9 m -77.07 -24.2 51.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.731 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 22.8 mt -83.63 -19.46 35.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.536 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.04 163.97 50.64 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.79 . . . . 0.0 109.938 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.75 160.25 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.856 1.45 . . . . 0.0 110.294 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.593 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.1 Cg_endo -71.4 -178.39 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.939 1.494 . . . . 0.0 110.546 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 86.1 t80 -132.15 93.35 3.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 110.128 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.27 -23.03 66.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 11' ' ' THR . . . 59.9 176.5 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.8 Cg_endo -79.9 -93.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.927 1.488 . . . . 0.0 110.357 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.5 m 42.77 -168.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.632 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -138.72 13.09 2.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.067 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.58 164.35 11.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 109.959 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -128.85 71.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 68.0 mt -77.88 151.9 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.772 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.2 mm -96.38 89.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.671 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -90.06 172.98 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.833 . . . . 0.0 110.327 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.731 ' CE1' HG23 ' A' ' 32' ' ' THR . 7.6 m-85 -114.41 144.73 42.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -144.7 154.2 42.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.649 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 67.3 t80 -83.0 112.87 20.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.382 -0.824 . . . . 0.0 110.876 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.664 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 61.1 t-20 -84.81 86.07 7.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.059 -1.025 . . . . 0.0 109.98 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -46.29 -25.39 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.06 -1.025 . . . . 0.0 109.741 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -76.07 -26.01 56.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.55 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.12 -25.49 17.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.161 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.77 78.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -137.99 -145.16 0.19 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.138 -1.213 . . . . 0.0 109.588 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 95.5 m -119.16 150.6 39.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 111.048 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.408 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 24.7 mt-30 -140.48 160.4 40.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.731 HG23 ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -89.2 146.87 24.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.069 -1.019 . . . . 0.0 110.588 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.8 p90 -138.08 162.27 34.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.045 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' THR . 97.5 t -74.26 106.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.894 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 10.4 t80 -88.17 148.86 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.368 -0.833 . . . . 0.0 109.992 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.754 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -86.84 -1.35 85.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 75.42 -6.23 2.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.463 -1.022 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 p -136.07 165.76 24.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.893 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 4.7 mtt180 45.75 52.81 9.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.013 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.894 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -72.79 156.73 38.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.269 -0.895 . . . . 0.0 110.55 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -119.53 -162.62 0.93 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.872 . . . . 0.0 110.292 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.598 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 17.7 mtm180 -81.03 -26.07 36.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.002 -1.061 . . . . 0.0 109.964 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -93.0 53.92 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.7 t-20 -146.56 74.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.506 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 8.6 m-85 -92.95 163.6 13.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 0.0 110.586 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -91.45 -14.69 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -0.995 . . . . 0.0 110.086 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.4 p -145.95 160.46 41.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 110.212 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.63 -22.45 64.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.72 -26.4 59.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.102 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 65.1 m-20 -83.01 -30.69 27.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 109.37 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.506 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.5 t -74.2 -44.04 54.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.699 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -66.29 -57.04 8.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.18 -21.36 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.1 -1.0 . . . . 0.0 110.231 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.496 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 2.1 m -101.39 -39.71 7.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 110.048 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 65.4 m . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.126 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.639 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 3.5 p90 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.274 0.559 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.578 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 4.6 m -71.23 -31.14 67.2 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 25' ' ' ALA . 28.0 mt -80.33 -16.07 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -79.87 162.01 64.04 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.13 170.53 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.414 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.62 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 41.0 Cg_endo -72.01 172.03 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.002 1.527 . . . . 0.0 110.598 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.485 ' CD2' ' HD2' ' A' ' 41' ' ' LYS . 17.7 t80 -130.84 94.31 3.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 110.683 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -51.74 -23.11 4.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 72.69 151.3 1.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 39' ' ' ARG . 46.3 Cg_endo -73.98 93.3 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.073 1.565 . . . . 0.0 110.222 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -154.76 -163.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -127.32 -6.95 5.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.324 -0.86 . . . . 0.0 110.189 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . -83.11 -176.8 6.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 109.776 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -155.01 76.26 0.98 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.02 -1.05 . . . . 0.0 110.674 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 19' ' ' ILE . 19.6 mt -90.44 164.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.627 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.45 ' N ' HG22 ' A' ' 18' ' ' ILE . 32.2 mm -105.31 92.7 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.993 . . . . 0.0 110.785 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.74 177.87 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.728 ' CE2' HG23 ' A' ' 32' ' ' THR . 67.1 m-85 -114.88 151.9 33.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.935 -1.103 . . . . 0.0 111.124 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.401 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 23.7 p90 -144.62 153.77 42.11 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 30.3 t80 -76.11 100.25 4.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.171 -0.956 . . . . 0.0 111.15 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.7 t-20 -75.28 71.67 2.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.804 -1.185 . . . . 0.0 109.081 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB2' HD23 ' A' ' 6' ' ' LEU . . . -47.74 -24.53 0.97 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.042 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -70.55 -31.31 68.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -92.15 -21.7 20.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.466 -0.771 . . . . 0.0 109.583 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.2 5.18 60.81 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -150.72 -142.5 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.058 -1.26 . . . . 0.0 109.713 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.502 ' O ' HD12 ' A' ' 29' ' ' LEU . 92.1 m -125.14 147.79 48.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 110.346 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -135.83 178.06 7.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.491 -0.756 . . . . 0.0 109.256 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.728 HG23 ' CE2' ' A' ' 21' ' ' TYR . 1.5 p -101.78 144.21 30.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.096 . . . . 0.0 110.633 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.62 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 24.2 p90 -133.04 162.89 30.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.4 97.21 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 0.0 111.146 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 1.009 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 11.4 t80 -80.06 145.63 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.606 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.777 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -83.48 1.29 88.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 79.74 -27.33 0.15 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.622 -0.928 . . . . 0.0 110.852 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -127.23 169.63 13.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.96 -1.087 . . . . 0.0 109.672 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 17.1 mmt180 57.27 33.76 23.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.414 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 1.009 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -69.87 161.31 30.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HD2' ' CD2' ' A' ' 10' ' ' TYR . 17.0 mtpt -137.04 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.004 . . . . 0.0 110.419 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.639 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.1 ptp180 -66.99 -32.04 73.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.835 . . . . 0.0 111.452 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.4 t-20 -90.63 61.72 4.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.731 -1.23 . . . . 0.0 109.748 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.563 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 33.1 t-20 -161.92 76.19 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 24.6 m-85 -85.69 134.56 33.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.388 -0.82 . . . . 0.0 110.155 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 20' ' ' ARG . 39.3 mttt -65.23 -16.49 63.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.6 p -149.6 159.34 44.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.34 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -20.36 66.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.007 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -31.9 64.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.226 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.66 -33.98 53.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.88 . . . . 0.0 109.625 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 18.6 t -72.85 -44.61 61.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 109.066 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 48.1 tpp -69.61 -44.49 70.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.547 -0.721 . . . . 0.0 109.389 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -60.26 -24.03 64.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.873 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.765 HG22 ' SG ' ' A' ' 55' ' ' CYS . 4.5 m -85.38 -51.6 6.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 109.945 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.765 ' SG ' HG22 ' A' ' 54' ' ' THR . 73.1 m . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.221 -0.924 . . . . 0.0 110.545 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 6.0 p90 . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.423 0.63 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 23' ' ' TYR . 1.7 m -78.63 -22.64 46.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 110.354 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.8 mt -92.06 -10.29 39.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.677 -1.264 . . . . 0.0 109.592 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.76 156.57 82.68 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 0.0 110.074 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 47.2 Cg_endo -73.85 174.4 12.39 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.93 1.489 . . . . 0.0 110.221 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.627 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 45.4 Cg_endo -72.97 -178.36 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.02 1.537 . . . . 0.0 110.357 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 14.4 t80 -155.25 94.18 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -53.5 -23.2 9.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.8 152.4 2.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 60.88 4.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.951 1.5 . . . . 0.0 110.08 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.441 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 15.5 m -123.03 -164.53 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -122.5 0.24 9.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . -78.69 171.49 15.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.436 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.419 ' NH2' HD11 ' A' ' 19' ' ' ILE . 6.9 ttt-85 -149.21 69.22 1.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 35' ' ' TYR . 12.8 mt -95.52 163.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.875 . . . . 0.0 109.988 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.579 HG23 ' HB ' ' A' ' 32' ' ' THR . 15.4 mm -104.98 86.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.254 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -88.93 179.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.845 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 36.6 m-85 -115.3 149.3 38.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 110.942 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 14.2 p90 -144.11 -179.03 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.57 -0.706 . . . . 0.0 109.771 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.683 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.7 OUTLIER -95.8 98.53 10.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.927 -1.108 . . . . 0.0 110.92 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.5 t-20 -81.46 63.92 5.97 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.149 177.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -47.25 -26.98 1.35 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.324 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -35.42 80.9 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -88.09 -17.89 30.06 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.23 10.73 60.62 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -163.19 -179.13 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -1.217 . . . . 0.0 108.951 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 85.3 m -82.5 150.45 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.566 -0.709 . . . . 0.0 110.019 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -140.78 169.11 18.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.579 ' HB ' HG23 ' A' ' 19' ' ' ILE . 19.6 p -88.64 144.38 26.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 110.098 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.627 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.1 p90 -140.02 165.28 27.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 11' ' ' THR . 24.4 t -74.68 124.96 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 110.221 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.881 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -109.46 147.43 32.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -0.848 . . . . 0.0 109.985 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -93.77 -2.08 65.22 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.964 -1.085 . . . . 0.0 110.406 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.79 -0.83 3.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.123 -1.222 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 152.29 28.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 0.0 109.923 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.69 29.97 16.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.881 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -75.27 175.06 8.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.526 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 22.2 mtpt -121.46 -174.38 2.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 109.548 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.5 mtt-85 -70.26 -16.76 63.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.077 . . . . 0.0 109.3 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 2.1 t-20 -93.45 62.96 3.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.512 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 8.7 t-20 -154.84 80.22 1.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 17.1 m-85 -95.5 155.64 16.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG2' ' NH1' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -77.97 -22.8 48.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.332 -0.855 . . . . 0.0 110.33 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 98.9 p -134.17 157.97 44.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 110.591 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . . . -74.04 -24.38 59.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -74.97 -17.57 60.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.482 -0.761 . . . . 0.0 110.032 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.482 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.2 t0 -93.5 -30.2 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.207 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 1.7 t -66.89 -52.57 41.68 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.458 ' O ' ' C ' ' A' ' 53' ' ' ARG . 3.4 tpt -66.04 -49.43 67.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.641 -0.662 . . . . 0.0 109.846 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -41.47 -41.25 2.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 m -91.83 -45.22 8.51 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.835 0.826 . . . . 0.0 109.131 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.683 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 72.8 m . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.742 -0.598 . . . . 0.0 111.396 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.735 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 4.1 p90 . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.152 0.501 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.33 -14.31 46.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.927 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 54.6 mt -75.51 -27.93 58.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.965 -1.084 . . . . 0.0 110.182 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.477 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -64.68 166.57 11.35 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 110.283 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 7' ' ' GLU . 46.2 Cg_endo -74.7 168.68 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.121 1.59 . . . . 0.0 110.448 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.7 Cg_endo -71.54 -170.41 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.02 1.537 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CE1' ' HE3' ' A' ' 41' ' ' LYS . 43.0 t80 -145.62 93.39 2.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 110.611 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.466 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.4 m -64.73 -22.89 67.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.23 158.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.14 81.1 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.036 1.545 . . . . 0.0 110.582 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.457 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -147.45 167.37 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 0.0 110.235 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -107.53 14.53 25.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.26 152.66 23.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.37 77.89 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.51 HG22 ' HG2' ' A' ' 20' ' ' ARG . 70.0 mt -103.13 138.13 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.57 81.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.082 -1.011 . . . . 0.0 110.264 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -86.54 173.25 9.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 61.9 m-85 -114.24 154.29 28.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.145 -0.972 . . . . 0.0 111.373 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 9.1 p90 -150.56 156.97 42.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 49.5 t80 -83.14 115.69 22.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.135 -0.978 . . . . 0.0 111.266 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.588 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 60.5 t-20 -91.91 87.78 6.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.37 -25.42 0.4 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.052 -1.03 . . . . 0.0 109.721 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -24.02 52.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -95.52 -33.54 12.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 110.492 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 102.12 -10.69 56.96 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.435 ' HG ' ' C ' ' A' ' 28' ' ' GLY . 1.1 mt -134.45 -143.99 0.21 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.387 -1.066 . . . . 0.0 109.092 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.2 m -120.24 145.68 46.8 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 109.76 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -129.24 161.05 31.07 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 6.3 p -86.98 144.48 26.9 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.4 p90 -140.44 161.89 36.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.589 -0.694 . . . . 0.0 109.933 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 11' ' ' THR . 63.5 t -74.47 111.08 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.499 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 1.071 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.2 t80 -91.94 147.65 22.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.8 -4.12 85.25 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 68.59 12.48 8.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 110.089 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.2 p -147.3 147.31 30.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 110.454 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 51.89 44.77 29.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 1.071 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -67.78 146.13 54.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.579 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 10' ' ' TYR . 26.5 mttm -109.55 -160.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.653 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.735 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -80.87 -22.21 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.042 -1.036 . . . . 0.0 110.351 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.487 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 9.6 t-20 -91.31 53.32 2.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.906 0.86 . . . . 0.0 109.048 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.5 t-20 -159.82 75.41 0.62 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 23.4 m-85 -85.18 134.23 34.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.524 -0.735 . . . . 0.0 110.414 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.1 tptm -60.42 -20.85 61.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.77 . . . . 0.0 111.325 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.4 p -142.52 162.22 36.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.976 -1.077 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -66.32 -27.04 67.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 82.1 mt-10 -75.26 -28.04 59.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.21 -31.27 58.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.493 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 54.0 t -80.58 -44.01 19.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -45.89 59.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 110.246 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -60.81 -15.15 26.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.976 -1.078 . . . . 0.0 109.141 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.449 HG22 ' SG ' ' A' ' 55' ' ' CYS . 61.9 m -94.99 -54.79 3.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 0.0 110.144 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.449 ' SG ' HG22 ' A' ' 54' ' ' THR . 58.1 m . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.688 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.544 ' C ' ' CD1' ' A' ' 4' ' ' PHE . 4.1 p90 . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 121.61 0.719 . . . . 0.0 109.689 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 4.5 t -78.68 -29.76 45.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.595 -0.691 . . . . 0.0 109.734 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 27.7 mt -95.47 -9.02 33.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 109.631 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 3.9 mm-40 -75.1 160.85 79.46 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.913 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.89 162.13 39.93 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.916 1.482 . . . . 0.0 110.266 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.575 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.5 Cg_endo -70.15 171.76 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.034 1.544 . . . . 0.0 110.342 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.597 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 37.4 t80 -133.24 94.45 3.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.133 -0.979 . . . . 0.0 111.019 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -59.55 -22.91 62.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 70.85 143.97 0.27 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.92 60.95 5.51 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.049 1.552 . . . . 0.0 110.348 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.13 -169.75 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -105.71 -31.7 8.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.16 154.77 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -143.05 77.6 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 mt -92.14 160.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 32' ' ' THR . 46.7 mm -91.93 83.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.834 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.607 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -80.82 175.49 10.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.054 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 45' ' ' PHE . 51.3 m-85 -115.25 147.72 40.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 110.95 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 15.3 p90 -147.39 156.26 42.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 72.8 t80 -81.42 114.57 20.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.294 -0.878 . . . . 0.0 110.808 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 30.6 t-20 -82.06 82.11 7.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.794 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.67 -26.61 0.65 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.993 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 36.8 mmtm -78.05 -23.04 48.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.861 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -98.28 -26.83 14.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.227 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -3.1 57.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -141.58 -142.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 99.2 m -121.74 159.45 26.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.496 -0.753 . . . . 0.0 110.731 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 4.7 mt-30 -143.2 169.08 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.509 -0.745 . . . . 0.0 109.32 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.528 ' HB ' HG23 ' A' ' 19' ' ' ILE . 1.5 p -91.54 144.27 25.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.386 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 14.1 p90 -143.39 166.57 24.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' THR . 65.1 t -74.41 128.3 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.452 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -112.27 145.83 39.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.064 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -96.93 7.98 65.17 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.046 -1.073 . . . . 0.0 110.742 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.61 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 58.99 12.47 2.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.283 . . . . 0.0 110.899 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 39' ' ' ARG . 17.9 p -152.34 164.58 37.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.043 -1.036 . . . . 0.0 110.494 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 98.7 mtt180 42.56 38.43 1.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.922 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.572 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -79.88 157.58 26.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -122.02 -168.15 1.66 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.369 -0.832 . . . . 0.0 109.63 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.54 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.6 mtm-85 -71.56 -19.16 62.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.022 -1.049 . . . . 0.0 110.152 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 5.1 t-20 -86.23 54.7 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.536 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -163.03 80.87 0.48 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.837 . . . . 0.0 109.227 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 19.8 m-85 -87.8 146.34 25.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.79 -25.45 62.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.758 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 97.5 p -140.47 160.4 40.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.563 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.57 67.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 0.0 109.666 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.57 -28.69 61.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.988 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 1.1 m-20 -80.83 -30.62 35.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.616 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 42.7 t -79.37 -44.64 21.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 109.333 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 6.7 ttm -67.45 -50.28 59.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 109.48 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -58.32 -19.06 31.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.889 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -90.72 -47.48 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -179.71 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.616 ' CB ' ' CD ' ' A' ' 42' ' ' ARG . 52.1 p90 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.155 0.502 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 53.4 m -68.15 -29.47 68.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 109.31 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' N ' HD23 ' A' ' 6' ' ' LEU . 8.3 mt -77.09 -13.64 59.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.69 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -79.48 165.01 51.02 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.405 -0.81 . . . . 0.0 110.286 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD2' ' OE1' ' A' ' 7' ' ' GLU . 44.4 Cg_endo -71.97 160.19 48.29 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.995 1.524 . . . . 0.0 110.15 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.619 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.6 Cg_endo -70.2 166.56 27.75 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.975 1.513 . . . . 0.0 110.612 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.414 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 67.2 t80 -117.49 94.1 4.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -0.911 . . . . 0.0 110.692 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -63.3 -22.75 67.07 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 63.54 169.34 1.35 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -75.01 -93.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.961 1.506 . . . . 0.0 110.453 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 40.37 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HD3' ' C ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -143.13 18.24 1.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.68 172.3 6.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.703 ' HG2' HG13 ' A' ' 34' ' ' VAL . 8.4 ttp180 -134.74 73.06 1.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.845 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.7 HD12 ' HB2' ' A' ' 37' ' ' ALA . 97.1 mt -88.56 155.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.383 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 19' ' ' ILE . 15.4 mm -102.01 92.15 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.609 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.6 mmp_? -92.48 -179.92 5.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.696 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.584 ' CE1' HG23 ' A' ' 32' ' ' THR . 47.6 m-85 -112.26 150.25 31.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -151.74 157.75 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.568 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 47.0 t80 -83.8 110.99 18.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 110.951 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 41.7 t-20 -88.52 87.52 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.844 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.16 -33.82 2.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 109.411 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -28.95 69.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 109.549 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.671 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -94.87 -17.57 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.38 -9.5 70.22 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -135.19 -143.11 0.19 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.228 -1.16 . . . . 0.0 109.426 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.4 m -116.95 145.39 43.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 110.621 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 mt-30 -128.86 162.79 26.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.795 . . . . 0.0 109.595 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.584 HG23 ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -86.38 148.9 25.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 0.0 110.88 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.6 p90 -143.59 161.74 37.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.994 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.703 HG13 ' HG2' ' A' ' 17' ' ' ARG . 70.1 t -74.92 97.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.327 -0.858 . . . . 0.0 110.857 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.821 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.9 t80 -79.26 146.45 33.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.367 -0.833 . . . . 0.0 110.356 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -80.0 0.58 82.68 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.95 -1.39 3.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.441 -1.035 . . . . 0.0 110.995 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 p -143.6 168.94 18.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.917 -1.115 . . . . 0.0 110.708 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 48.97 37.87 11.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.64 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.821 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -65.31 144.55 57.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 109.672 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -127.68 -155.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.953 . . . . 0.0 110.704 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.616 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 14.7 ptp180 -70.69 -30.6 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.858 . . . . 0.0 111.829 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.7 t-20 -93.92 54.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.64 -1.288 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.4 t-20 -164.12 79.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 40.1 m-85 -85.46 148.78 25.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 110.041 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 15.3 mttt -97.02 7.03 47.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.037 -1.04 . . . . 0.0 110.665 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.539 ' OG ' ' CB ' ' A' ' 50' ' ' ASP . 51.7 p -134.97 161.44 35.26 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.2 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.77 27.44 0.63 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.583 0.706 . . . . 0.0 111.069 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -160.6 -16.66 0.05 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.602 -0.686 . . . . 0.0 111.616 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.539 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 12.1 t0 -70.76 -25.11 62.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.711 -1.243 . . . . 0.0 108.055 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.8 t -71.49 -43.91 65.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.538 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 7.7 mtt -67.9 -50.82 54.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.65 -0.656 . . . . 0.0 109.764 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.83 -19.35 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -104.5 -43.51 5.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 56.7 m . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 110.514 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 49.0 p90 . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.046 0.451 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 26.5 m -70.29 -30.35 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 16.6 mt -75.77 -23.08 55.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.703 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 3.7 mt-10 -75.31 160.93 78.82 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 109.715 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 7' ' ' GLU . 44.0 Cg_endo -71.46 169.36 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.832 1.438 . . . . 0.0 109.958 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.4 Cg_endo -71.13 173.86 11.54 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.898 1.472 . . . . 0.0 110.461 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.492 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 36.6 t80 -135.07 94.08 3.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.62 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -62.52 -23.29 66.88 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.51 -163.44 3.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 48.8 Cg_endo -74.92 -156.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.152 1.606 . . . . 0.0 110.493 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 20.2 m 63.09 147.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 10.79 39.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.91 165.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.942 . . . . 0.0 110.558 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -146.61 65.98 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.909 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mt -97.53 152.18 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.745 . . . . 0.0 110.04 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.472 HG23 ' HB ' ' A' ' 32' ' ' THR . 39.2 mm -89.25 84.62 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 110.462 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -85.0 168.14 15.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.801 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 37.1 m-85 -110.04 149.8 29.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.952 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -152.67 160.57 43.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.581 -0.7 . . . . 0.0 109.501 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 72.6 t80 -90.09 127.82 36.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.285 -0.884 . . . . 0.0 110.654 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 27' ' ' ALA . 43.7 t-20 -101.78 87.55 3.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.68 -24.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 109.665 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.06 -26.41 59.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.779 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.56 -37.05 10.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.86 -11.31 38.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.0 mp -133.97 -144.17 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -1.202 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 65.9 m -116.36 156.43 26.73 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.438 -0.789 . . . . 0.0 110.903 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 18.2 mt-30 -144.62 167.59 22.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.505 -0.747 . . . . 0.0 109.575 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.4 p -96.41 144.9 26.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.784 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 24.0 p90 -139.37 165.42 27.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.441 -0.787 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -75.72 113.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.475 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.986 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 8.6 t80 -93.42 148.0 22.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.328 -0.857 . . . . 0.0 109.855 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.736 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.95 -2.24 75.23 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.43 8.34 5.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.063 -1.257 . . . . 0.0 110.541 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 39' ' ' ARG . 25.4 p -153.16 174.08 14.69 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.294 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.7 32.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 0.0 110.36 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.986 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -64.01 157.52 24.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 79.7 mttt -126.71 -159.45 0.93 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 109.683 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.58 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -77.54 -19.24 56.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.689 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.2 t-20 -92.94 64.48 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 0.0 109.711 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 31.1 t-20 -169.18 80.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.549 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.8 m-85 -91.71 157.59 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.076 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -85.82 -15.17 42.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 0.0 110.536 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.2 p -144.5 158.4 43.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -65.9 -24.14 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.784 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 32.6 mm-40 -75.2 -29.83 60.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.394 -0.816 . . . . 0.0 110.184 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -76.58 -32.58 58.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.525 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.549 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 35.9 t -75.02 -43.73 52.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 109.238 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -37.28 77.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.63 -0.669 . . . . 0.0 110.529 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 12.6 mtp85 -70.83 -20.95 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -102.25 -42.45 6.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.271 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.2 m . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.254 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.647 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 4.0 p90 . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.046 0.45 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 3.9 m -68.25 -32.88 73.37 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.465 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.795 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 7.5 mt -84.56 -12.08 54.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.44 168.1 28.06 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.818 . . . . 0.0 110.206 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.14 159.18 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.926 1.488 . . . . 0.0 110.371 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.602 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.4 Cg_endo -70.78 174.1 10.89 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.006 1.529 . . . . 0.0 110.335 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.592 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 89.7 t80 -121.85 93.81 4.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 0.0 110.696 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.519 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.05 -23.12 67.21 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.592 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 64.09 147.56 0.03 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -76.9 81.95 2.46 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.141 1.6 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.92 168.56 19.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.066 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.45 3.76 54.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.91 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . -89.7 163.24 15.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 16' ' ' ALA . 27.1 mtp180 -142.75 73.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG21 ' CZ ' ' A' ' 20' ' ' ARG . 51.5 mt -86.95 155.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 32' ' ' THR . 27.4 mm -97.71 87.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 109.993 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.546 ' CZ ' HG21 ' A' ' 18' ' ' ILE . 5.7 mmp_? -91.07 177.59 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 110.142 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 38.6 m-85 -112.63 145.43 40.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.92 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 13.9 p90 -145.04 156.7 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.572 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 57.4 t80 -85.08 106.2 16.38 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 39.5 t-20 -81.3 87.94 6.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.105 -0.997 . . . . 0.0 109.452 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.795 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -44.87 -27.4 0.52 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.05 -1.031 . . . . 0.0 109.787 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.39 -24.5 57.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -95.97 -17.47 20.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 0.87 89.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -143.9 -146.28 0.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.275 -1.132 . . . . 0.0 109.543 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.54 ' O ' HD12 ' A' ' 29' ' ' LEU . 81.2 m -120.77 147.59 45.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 15.7 mt-30 -135.22 159.46 41.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.496 -0.752 . . . . 0.0 109.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -80.43 143.88 33.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.038 -1.038 . . . . 0.0 110.328 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 19.8 p90 -138.32 161.84 35.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.414 -0.804 . . . . 0.0 109.733 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' THR . 12.2 t -74.82 110.36 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 110.692 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.879 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 11.6 t80 -91.39 150.56 21.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.725 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.36 -4.59 85.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.4 7.04 6.06 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.144 -1.209 . . . . 0.0 110.242 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.3 p -144.58 163.27 34.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 47.81 35.06 4.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.879 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -48.76 151.78 1.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 9.1 mttm -131.38 -161.54 1.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.325 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.647 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.9 ptt180 -75.71 -32.52 60.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -89.15 67.71 8.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.928 -1.108 . . . . 0.0 109.252 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.636 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.0 t-20 -169.1 74.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.537 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m-85 -84.84 139.69 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.279 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -21.33 58.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -134.15 156.31 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.173 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -67.54 -24.77 65.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.83 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.33 -32.57 62.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.504 -0.748 . . . . 0.0 109.968 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.75 -37.16 73.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.898 . . . . 0.0 109.201 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.537 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 52.6 t -73.21 -44.35 59.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -61.86 -51.74 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -52.55 -23.98 7.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.874 HG22 ' SG ' ' A' ' 55' ' ' CYS . 6.4 m -89.18 -48.96 7.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.437 -0.789 . . . . 0.0 109.82 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.874 ' SG ' HG22 ' A' ' 54' ' ' THR . 72.2 m . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CD1' ' CB ' ' A' ' 42' ' ' ARG . 9.1 p90 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.368 0.604 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 5.0 t -82.34 -24.59 34.49 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.82 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.4 mt -90.83 -14.61 31.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.89 . . . . 0.0 109.587 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.533 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -78.01 156.63 79.5 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.419 -0.801 . . . . 0.0 109.624 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.21 163.68 35.22 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.77 1.405 . . . . 0.0 110.071 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.8 Cg_endo -67.65 -176.45 0.94 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.876 1.461 . . . . 0.0 110.158 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -146.34 93.76 2.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 110.848 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.503 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -60.31 -22.67 63.46 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.14 170.62 1.05 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' CYS . 49.5 Cg_endo -75.13 -95.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.511 . . . . 0.0 109.956 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 39.39 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.525 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.77 48.68 1.61 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.14 -0.975 . . . . 0.0 110.247 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.02 179.65 6.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.29 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -153.4 70.05 0.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 37' ' ' ALA . 76.9 mt -80.34 157.93 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.581 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.55 79.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.298 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.589 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 10.0 mmt85 -84.97 173.24 10.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.96 . . . . 0.0 110.05 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.509 ' CE1' HG22 ' A' ' 32' ' ' THR . 6.8 m-85 -112.83 144.87 41.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.938 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 7.0 p90 -144.05 163.61 33.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.737 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 77.5 t80 -96.59 120.22 36.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 111.033 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 45.8 t-20 -89.95 91.99 8.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 109.727 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.17 -27.33 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.415 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -75.62 -24.77 56.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.675 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.23 -36.01 12.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.739 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.0 65.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.566 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 1.1 mp -125.84 -146.67 0.35 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.039 -1.271 . . . . 0.0 109.638 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.38 149.02 44.38 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.528 -0.733 . . . . 0.0 110.118 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 97.4 mt-30 -139.34 178.27 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.901 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.509 HG22 ' CE1' ' A' ' 21' ' ' TYR . 44.2 p -105.07 147.75 27.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.784 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 21.0 p90 -142.43 163.79 31.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.574 -0.703 . . . . 0.0 110.004 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' THR . 83.0 t -75.16 110.46 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 4.7 t80 -94.07 144.56 25.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 110.322 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.76 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -76.95 4.98 51.68 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.104 -0.997 . . . . 0.0 110.901 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.5 -1.98 2.78 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.201 -1.176 . . . . 0.0 111.294 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.448 ' N ' ' CZ ' ' A' ' 35' ' ' TYR . 21.7 p -150.47 174.37 12.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.952 -1.093 . . . . 0.0 110.199 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' CYS . 1.3 mtt-85 42.92 52.82 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 109.799 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -91.08 140.67 29.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 111.096 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.65 -165.63 1.28 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 108.923 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -70.04 -36.6 75.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.07 . . . . 0.0 110.13 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 7.8 t-20 -76.06 54.49 0.86 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.158 -0.964 . . . . 0.0 109.905 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.544 ' ND2' ' HB1' ' A' ' 40' ' ' ALA . 41.8 t-20 -155.79 69.13 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.592 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 12.4 m-85 -89.83 166.07 13.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.741 . . . . 0.0 110.238 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -92.1 -9.33 42.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.216 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -148.51 155.22 40.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.622 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.45 -26.75 68.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.647 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 5.1 mt-10 -72.33 -32.87 66.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.6 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 39.8 t0 -70.65 -36.55 73.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.98 -44.49 65.87 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.436 ' O ' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -63.52 -59.63 4.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.591 -0.693 . . . . 0.0 109.997 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -43.23 -26.37 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 0.0 109.695 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.5 m -97.89 -36.36 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.48 -179.788 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.571 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 6.3 p90 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.14 0.495 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 2.1 m -80.88 -26.97 36.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 0.0 109.265 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.58 -18.18 42.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.466 -0.771 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 159.52 83.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.962 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.38 171.96 16.62 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.01 1.532 . . . . 0.0 110.434 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.3 Cg_endo -71.74 166.26 30.01 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.932 1.491 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 5.3 t80 -123.0 94.03 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -0.973 . . . . 0.0 111.048 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.492 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.48 -22.25 66.91 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 56.6 166.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 14' ' ' CYS . 50.7 Cg_endo -72.86 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.961 1.506 . . . . 0.0 109.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' PRO . 3.1 m 38.62 -160.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 42.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.021 . . . . 0.0 110.116 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.27 150.83 35.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -0.859 . . . . 0.0 110.215 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.92 83.27 2.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.122 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mt -106.54 158.83 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.054 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.84 89.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.194 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -91.28 173.93 7.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.351 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.518 ' CE1' ' CG2' ' A' ' 32' ' ' THR . 30.7 m-85 -115.6 150.45 36.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 111.176 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.33 154.66 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.533 -0.73 . . . . 0.0 109.487 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.505 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 66.5 t80 -85.34 116.47 23.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.593 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 63.8 t-20 -89.28 93.96 9.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.013 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -21.7 1.42 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.753 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -81.05 -22.87 38.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.861 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -97.57 -28.06 14.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.237 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.51 -10.13 69.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -134.25 -146.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -1.167 . . . . 0.0 109.523 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.67 ' O ' HD12 ' A' ' 29' ' ' LEU . 60.8 m -116.04 154.62 29.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.779 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -142.0 154.91 45.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.484 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 18.9 p -83.49 144.86 29.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.626 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.2 p90 -140.97 164.2 30.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.351 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' THR . 22.9 t -74.37 125.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.402 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.695 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -106.13 147.65 28.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 0.0 110.413 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -90.77 -4.1 70.17 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.72 5.46 5.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.161 -1.2 . . . . 0.0 110.845 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.8 p -157.49 164.32 37.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.883 -1.136 . . . . 0.0 110.855 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER 50.63 34.72 10.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.328 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -84.63 164.69 18.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.74 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -121.5 -159.69 0.82 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.569 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 2.7 mtm180 -77.51 -8.86 58.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.098 . . . . 0.0 109.766 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -94.11 59.39 2.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.694 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.581 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 14.8 t-20 -165.23 84.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.9 m-85 -93.97 150.71 20.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.708 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 16.4 mtpt -81.51 -12.24 58.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -142.45 156.52 45.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.296 -0.878 . . . . 0.0 110.186 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . . . -74.12 -22.56 59.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.852 . . . . 0.0 109.953 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 5.1 tp10 -70.68 -35.95 73.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 110.482 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 54' ' ' THR . 0.4 OUTLIER -78.76 -35.44 44.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.668 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.557 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.3 t -67.97 -44.19 77.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 39.1 tpp -64.35 -61.05 2.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.573 -0.705 . . . . 0.0 110.514 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.49 -18.97 21.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.54 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.7 m -88.12 -45.62 9.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.1 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.498 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 19.1 p90 . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 121.137 0.494 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -80.85 -19.0 45.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.735 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 18.4 mt -74.38 -24.68 59.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 7.2 mt-10 -79.04 161.61 67.71 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 41.7 Cg_endo -69.76 168.28 22.02 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.108 1.583 . . . . 0.0 110.359 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.621 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.8 Cg_endo -71.08 156.98 58.87 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.963 1.507 . . . . 0.0 110.517 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.6 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 40.9 t80 -121.39 94.26 4.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.261 -0.9 . . . . 0.0 110.883 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -56.05 -23.5 33.9 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.6 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 63.27 -178.12 6.64 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 45.7 Cg_endo -72.24 -155.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.175 1.618 . . . . 0.0 110.685 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 11.9 m 64.24 154.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 6.34 46.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.22 169.21 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 110.102 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.94 102.37 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.641 HG21 ' NH2' ' A' ' 20' ' ' ARG . 28.6 mt -134.23 145.99 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.844 . . . . 0.0 110.059 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.401 HG23 ' HB ' ' A' ' 32' ' ' THR . 41.2 mm -90.37 85.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.641 ' NH2' HG21 ' A' ' 18' ' ' ILE . 9.1 mmt-85 -91.02 176.91 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.927 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 71.6 m-85 -114.0 154.18 28.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 111.528 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 11.8 p90 -153.0 154.43 34.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.405 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 89.1 t80 -83.99 106.88 15.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.269 -0.894 . . . . 0.0 111.013 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 55.3 t-20 -80.24 98.54 7.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -50.86 -23.35 2.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.976 -1.077 . . . . 0.0 109.559 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.402 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -77.81 -23.71 49.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.448 -0.782 . . . . 0.0 110.209 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -99.79 -14.52 18.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.69 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.02 1.75 85.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 30' ' ' CYS . 1.8 pp -144.27 -147.35 0.21 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.383 -1.069 . . . . 0.0 109.102 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.671 ' N ' HD12 ' A' ' 29' ' ' LEU . 79.4 m -121.96 162.2 21.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 110.607 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 95.7 mt-30 -144.87 -175.36 4.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.607 -0.683 . . . . 0.0 109.395 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 25.2 p -103.13 144.15 31.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.994 -1.066 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.8 p90 -141.8 160.53 40.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.929 . . . . 0.0 110.056 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.7 t -74.05 122.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.035 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.669 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.7 t80 -101.26 141.33 34.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.753 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.57 -0.53 79.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.563 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.4 -1.37 2.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.191 -1.182 . . . . 0.0 111.074 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 39' ' ' ARG . 15.8 p -140.68 163.09 33.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.822 -1.174 . . . . 0.0 111.03 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.442 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER 41.77 45.5 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 110.911 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -73.78 146.66 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.751 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' HB2' ' A' ' 10' ' ' TYR . 42.5 mtpt -95.06 -159.91 0.75 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 8.3 mtt-85 -85.55 -22.73 27.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.146 -0.971 . . . . 0.0 109.869 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.488 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 21.0 t-20 -89.07 53.86 2.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 0.0 110.14 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 3.9 t-20 -143.93 84.55 1.78 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 43' ' ' ASN . 23.8 m-85 -99.6 153.34 19.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 110.552 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -76.24 -20.93 56.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.579 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.9 p -137.67 156.65 47.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 110.614 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.01 68.53 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.582 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.97 -38.52 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.414 -0.804 . . . . 0.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -62.04 -34.41 76.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.084 -1.01 . . . . 0.0 108.557 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.9 t -71.17 -43.18 67.99 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -50.45 33.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.36 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -22.96 25.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.019 -1.051 . . . . 0.0 109.629 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.566 HG22 ' SG ' ' A' ' 55' ' ' CYS . 16.4 m -94.37 -45.85 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.532 -0.73 . . . . 0.0 109.914 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 54' ' ' THR . 56.7 m . . . . . 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 110.501 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.74 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 14.9 p90 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.321 0.581 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.5 -8.3 58.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.022 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.664 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 27.5 mt -76.59 -23.28 53.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 109.953 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -81.8 174.38 6.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.349 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.78 165.85 30.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.872 1.459 . . . . 0.0 110.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.599 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.3 Cg_endo -71.62 -175.99 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.967 1.509 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 67.6 t80 -127.63 93.88 3.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.699 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.46 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -65.83 -22.62 66.56 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 60.32 151.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.16 82.54 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.97 1.51 . . . . 0.0 110.513 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.46 175.88 10.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 110.155 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -108.9 -1.03 19.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.31 160.67 28.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.14 68.47 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.72 153.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 110.075 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -98.01 86.39 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 110.37 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.56 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 mmt180 -86.59 173.15 9.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 64.5 m-85 -112.69 151.12 30.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.09 -1.006 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 8.3 p90 -150.56 163.63 38.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.66 -0.65 . . . . 0.0 109.403 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 70.7 t80 -87.2 132.14 33.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 34.8 t-20 -102.89 87.9 3.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.815 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.13 -32.34 1.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.005 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 1.9 mptp? -72.84 -24.51 60.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.865 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -98.2 -33.69 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.88 . . . . 0.0 110.16 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.01 -12.37 58.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -127.91 -144.23 0.29 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.8 m -121.69 157.24 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 6.6 mt-30 -140.23 -177.51 5.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 19.8 p -102.37 144.4 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.046 -1.034 . . . . 0.0 110.546 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.6 p90 -141.57 160.28 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.79 108.34 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.249 -0.907 . . . . 0.0 110.832 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.984 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -87.44 146.22 25.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.72 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.65 -4.44 85.34 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.68 12.45 7.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.147 -1.207 . . . . 0.0 110.314 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 39' ' ' ARG . 27.0 p -150.11 162.88 39.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.1 mtt-85 40.65 44.42 1.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.984 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -62.64 155.11 27.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.551 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 2.4 mtpp -121.03 -157.8 0.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.368 -0.832 . . . . 0.0 109.578 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.74 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -83.23 -22.5 33.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 0.0 109.978 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 1.7 t-20 -90.13 54.29 2.75 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.768 0.794 . . . . 0.0 109.04 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.586 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 19.4 t-20 -157.5 76.5 0.82 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 22.9 m-85 -87.74 134.78 33.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.433 -0.792 . . . . 0.0 109.849 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -65.71 -16.61 63.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.287 -0.883 . . . . 0.0 111.34 -178.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 99.2 p -143.43 158.02 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 110.434 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -64.8 -29.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.066 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.66 -25.37 56.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.646 -0.659 . . . . 0.0 109.812 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.485 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 39.2 t0 -78.64 -30.59 46.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 109.514 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.547 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 39.9 t -78.65 -43.96 24.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.225 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 48' ' ' ALA . 72.9 mmm -66.28 -49.39 67.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.484 -0.76 . . . . 0.0 110.309 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -62.23 -14.52 39.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 109.849 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.505 HG22 ' HZ ' ' A' ' 4' ' ' PHE . 47.6 m -92.14 -53.56 4.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.575 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 57.6 m . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 110.687 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.513 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 37.7 p90 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.536 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 1.7 m -85.54 -19.47 31.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.714 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 15.1 mt -82.77 -19.03 38.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 110.837 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -86.1 169.86 14.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.93 -1.106 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.94 163.71 36.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.889 1.468 . . . . 0.0 110.183 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.604 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.6 Cg_endo -71.41 163.51 38.83 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.947 1.498 . . . . 0.0 110.516 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.437 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 17.5 t80 -120.77 93.88 4.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.32 -0.863 . . . . 0.0 110.269 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.2 m -50.62 -23.44 2.6 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.92 -176.17 21.99 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.512 ' CG ' ' HG3' ' A' ' 39' ' ' ARG . 48.8 Cg_endo -79.21 -153.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.075 1.566 . . . . 0.0 109.992 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 32.1 m 63.05 170.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.114 -0.991 . . . . 0.0 110.535 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -116.23 10.12 14.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 110.344 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 159.1 7.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.679 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -130.64 78.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.31 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.757 HD11 ' HB2' ' A' ' 37' ' ' ALA . 6.0 mt -104.31 156.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.883 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.439 HG23 ' HB ' ' A' ' 32' ' ' THR . 44.3 mm -99.77 80.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 109.984 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.572 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 9.0 mmt180 -85.95 174.61 9.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -114.27 143.69 44.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 110.864 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 20.5 p90 -138.19 152.14 48.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 62.8 t80 -79.19 106.11 10.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.342 -0.849 . . . . 0.0 111.253 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' ALA . 53.0 t-20 -79.14 84.84 5.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.476 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.714 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.56 -26.03 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.925 -1.109 . . . . 0.0 109.439 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.67 64.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 109.579 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.5 -24.11 16.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.463 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.34 1.26 60.9 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -149.44 -142.2 0.12 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.319 -1.106 . . . . 0.0 109.227 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 m -117.55 164.2 15.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.129 0.966 . . . . 0.0 112.209 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 24.7 mt-30 -147.67 160.86 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.2 p -79.7 144.15 33.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 111.13 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 13.5 p90 -144.08 160.73 40.38 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 11' ' ' THR . 9.1 t -74.01 129.25 36.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 110.19 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.893 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -113.84 146.58 39.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 0.0 109.359 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.713 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.34 4.41 84.22 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.757 ' HB2' HD11 ' A' ' 18' ' ' ILE . . . 68.96 4.59 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.94 -1.329 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 7.9 p -145.01 159.27 43.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.415 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.512 ' HG3' ' CG ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER 51.47 33.12 9.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.215 -0.928 . . . . 0.0 110.794 179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.893 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -59.77 142.13 53.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 110.46 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -102.79 -170.29 1.78 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.063 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.565 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 2.6 mtt-85 -71.73 -25.33 62.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.083 -1.01 . . . . 0.0 109.782 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 11.3 t-20 -92.91 54.38 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 109.982 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.472 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 22.6 t-20 -153.43 70.39 0.85 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.565 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 13.1 m-85 -88.2 146.25 25.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 ttmt -76.89 -18.95 58.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 110.59 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.9 p -136.24 152.34 50.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 110.398 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.38 67.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.5 -0.75 . . . . 0.0 109.907 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.506 ' N ' ' OE1' ' A' ' 49' ' ' GLU . 3.4 mp0 -73.4 -19.87 60.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.675 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.5 t0 -83.32 -29.64 28.13 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 108.722 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.66 -45.97 56.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.41 0.624 . . . . 0.0 109.5 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -54.55 41.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.349 -0.845 . . . . 0.0 110.865 -178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -53.09 -19.1 2.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.608 HG22 ' SG ' ' A' ' 55' ' ' CYS . 40.9 m -97.28 -59.61 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.12 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.608 ' SG ' HG22 ' A' ' 54' ' ' THR . 57.1 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.651 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.628 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 42.5 p90 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.816 0.341 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.598 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 94.8 m -82.84 -25.15 32.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.9 -1.125 . . . . 0.0 109.248 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.401 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.7 mt -80.25 -22.93 41.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 109.485 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 5.9 mm-40 -73.07 154.85 90.63 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.19 167.04 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.927 1.488 . . . . 0.0 110.401 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.615 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.7 Cg_endo -69.22 159.05 55.33 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.027 1.541 . . . . 0.0 110.062 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 30.1 t80 -122.78 94.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.479 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 62.76 172.31 1.68 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 14' ' ' CYS . 45.9 Cg_endo -72.74 -93.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.983 1.517 . . . . 0.0 110.277 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.7 m 39.99 -162.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.208 -0.932 . . . . 0.0 110.61 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -141.61 8.98 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' O ' ' CD ' ' A' ' 17' ' ' ARG . . . -93.16 173.54 7.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.024 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' CD ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -150.08 81.97 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.2 mp -95.53 164.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.983 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.3 mm -100.87 89.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.519 HH21 HG21 ' A' ' 18' ' ' ILE . 3.6 mmt85 -95.42 177.27 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.948 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.526 ' CE1' HG23 ' A' ' 32' ' ' THR . 51.1 m-85 -116.09 151.03 36.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 0.0 111.156 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 11.9 p90 -147.72 158.92 44.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.523 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.627 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 68.8 t80 -88.89 107.7 19.14 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.281 -0.887 . . . . 0.0 110.895 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 62.4 t-20 -83.77 89.59 7.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 110.014 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.38 -24.99 0.57 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.001 -1.062 . . . . 0.0 109.535 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -75.53 -25.97 57.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.835 . . . . 0.0 109.714 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.61 -28.9 15.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.57 -10.31 59.22 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 29' ' ' LEU . 1.3 pt? -140.52 -147.05 0.21 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.25 -1.147 . . . . 0.0 109.841 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 99.4 m -115.69 156.92 25.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 110.551 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.521 HE22 ' HB2' ' A' ' 27' ' ' ALA . 45.3 mt-30 -144.02 178.69 7.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.566 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.526 HG23 ' CE1' ' A' ' 21' ' ' TYR . 3.3 p -95.93 144.6 26.11 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.418 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.4 p90 -143.53 165.06 28.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.488 -0.757 . . . . 0.0 109.83 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.457 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 63.2 t -75.16 132.08 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.984 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.671 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -112.71 146.81 38.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 109.864 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -99.72 1.96 57.0 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.7 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.59 1.73 3.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.007 -1.29 . . . . 0.0 110.971 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 39' ' ' ARG . 22.3 p -149.53 172.43 15.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 0.0 110.482 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 1.5 mpt_? 40.63 30.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -73.49 156.97 37.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 111.031 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HD2' ' HB2' ' A' ' 10' ' ' TYR . 7.5 mtpt -110.33 -169.8 1.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.443 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.628 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 2.7 mtt-85 -76.7 -15.65 59.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.26 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 15.1 t-20 -90.39 53.79 2.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 109.473 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.0 t-20 -147.74 77.64 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 51' ' ' CYS . 17.9 m-85 -94.32 143.84 26.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.793 . . . . 0.0 110.24 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 110.294 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -136.53 157.65 46.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 110.414 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -24.88 66.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.956 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.15 -23.71 63.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.026 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 46.9 t0 -90.18 -24.7 20.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.542 ' HB2' ' CD1' ' A' ' 45' ' ' PHE . 29.7 t -82.15 -43.96 17.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 109.808 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.2 mtp -66.81 -50.25 63.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 0.0 110.547 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -17.59 2.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -110.76 -42.14 4.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.627 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.3 m . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.624 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 14.5 p90 . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 121.195 0.521 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.6 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 6.4 m -85.3 -22.45 28.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 110.646 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.71 -2.78 47.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.74 -1.225 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.47 170.61 7.91 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 110.603 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.01 166.79 28.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.152 1.606 . . . . 0.0 110.35 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.588 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 43.3 Cg_endo -70.78 -173.13 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.883 1.465 . . . . 0.0 109.595 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.59 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 65.5 t80 -154.65 93.92 1.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.912 -1.117 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.402 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -58.68 -23.18 58.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.59 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 66.19 155.68 0.34 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.07 66.38 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.05 1.553 . . . . 0.0 110.31 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.491 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 23.0 m -121.7 -174.91 2.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.729 . . . . 0.0 109.825 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -120.68 12.33 11.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.114 -0.991 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.96 166.69 11.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 110.268 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -144.0 68.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.005 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 35' ' ' TYR . 61.4 mt -87.46 155.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.432 -0.792 . . . . 0.0 110.123 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.1 mm -93.5 89.0 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.557 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.8 mmt85 -99.52 -179.19 4.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 110.383 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.536 ' CZ ' HG23 ' A' ' 32' ' ' THR . 10.7 m-85 -116.81 153.46 32.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 111.328 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 15.5 p90 -149.06 176.77 10.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.519 -0.738 . . . . 0.0 109.361 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.8 OUTLIER -95.03 100.57 12.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' ALA . 48.8 t-20 -86.11 69.46 10.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.656 -1.278 . . . . 0.0 108.337 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.78 -26.04 0.87 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.435 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -62.08 -37.28 84.44 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -83.58 -31.86 26.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.587 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.09 -10.71 10.05 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.625 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.32 -141.89 0.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.754 -1.439 . . . . 0.0 109.889 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 96.2 m -107.2 151.93 24.77 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.499 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 5.7 mt-30 -141.59 179.38 6.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 110.467 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.536 HG23 ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -91.54 148.14 22.5 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.394 -0.817 . . . . 0.0 109.877 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.592 ' HB3' ' CD1' ' A' ' 22' ' ' PHE . 13.4 p90 -148.14 166.08 28.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 110.483 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.452 ' CG1' ' HG3' ' A' ' 17' ' ' ARG . 13.2 t -74.64 122.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.37 -0.831 . . . . 0.0 110.275 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -103.66 142.7 33.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.412 -0.805 . . . . 0.0 109.658 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.754 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.42 -0.98 78.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.545 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.6 0.81 3.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -1.194 . . . . 0.0 110.176 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -153.9 173.55 15.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 44.72 26.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -63.52 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.538 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.9 mtpp -95.83 -162.99 1.0 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.381 -0.825 . . . . 0.0 109.243 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.624 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.3 mtm180 -84.65 -9.33 58.36 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.002 -1.061 . . . . 0.0 109.979 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -96.97 53.99 1.24 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.561 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 13.6 t-20 -144.26 84.2 1.75 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 27.8 m-85 -101.21 164.51 11.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -91.99 -16.23 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.277 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.507 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 97.8 p -141.5 154.81 45.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.87 66.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.588 -0.695 . . . . 0.0 110.001 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -15.04 60.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.726 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.557 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 21.3 t70 -94.58 -25.39 16.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.599 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 7.3 t -73.84 -49.12 26.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.833 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.417 ' O ' ' C ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.67 -49.02 70.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.52 -0.738 . . . . 0.0 110.442 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -45.26 -29.32 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.892 -1.13 . . . . 0.0 109.472 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.462 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 1.2 m -104.56 -31.55 9.38 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.699 0.761 . . . . 0.0 109.083 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.639 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 92.9 m . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.612 -0.68 . . . . 0.0 110.92 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.573 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 5.1 p90 . . . . . 0 N--CA 1.498 1.943 0 CA-C-O 121.786 0.803 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 2.2 t -77.91 -29.27 50.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.691 -0.631 . . . . 0.0 109.793 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 13.1 mt -87.7 -10.09 52.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 109.51 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.27 153.32 84.16 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.647 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 43.2 Cg_endo -70.56 174.45 10.19 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.979 1.516 . . . . 0.0 110.071 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.7 Cg_endo -73.05 155.42 52.58 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.841 1.443 . . . . 0.0 109.813 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 24.3 t80 -118.72 93.95 4.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 111.102 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.469 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -59.88 -23.43 63.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.43 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 64.05 164.83 0.78 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -80.96 89.85 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 124.231 1.648 . . . . 0.0 110.027 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.35 171.25 18.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.056 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -14.02 17.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.19 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.76 169.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.481 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -152.0 69.3 0.9 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.02 155.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 110.365 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.3 mm -94.18 87.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.329 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 mmt85 -90.79 175.09 7.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 110.508 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.593 ' CE2' HG23 ' A' ' 32' ' ' THR . 57.5 m-85 -117.13 148.6 41.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -0.776 . . . . 0.0 111.389 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 17.8 p90 -148.41 161.16 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 69.1 t80 -90.05 108.85 19.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.965 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 26' ' ' LYS . 25.8 t-20 -80.87 87.18 5.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.252 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.26 -26.49 0.51 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.99 -1.069 . . . . 0.0 109.556 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 6.0 tttt -70.95 -29.13 65.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.667 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -91.57 -35.71 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.13 56.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -140.0 -144.74 0.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -1.165 . . . . 0.0 109.036 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.7 m -116.71 150.98 37.33 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 110.572 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 87.1 mt-30 -139.52 167.2 22.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.593 HG23 ' CE2' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -96.78 146.94 24.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.114 -0.991 . . . . 0.0 110.881 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -142.74 161.61 37.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.581 -0.699 . . . . 0.0 110.118 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' THR . 70.4 t -75.28 107.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.313 -0.867 . . . . 0.0 110.395 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.813 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.1 t80 -85.0 146.01 27.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.402 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.686 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.56 2.85 83.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 67.55 13.36 9.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.108 -1.231 . . . . 0.0 110.613 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ARG . 31.3 p -156.36 170.59 21.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.94 . . . . 0.0 110.399 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.85 37.96 0.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -74.89 147.96 40.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.417 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -116.75 -165.3 1.05 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.581 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 6.2 mtt-85 -68.75 -20.12 64.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.268 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 1.7 t-20 -91.48 54.21 2.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.056 -1.028 . . . . 0.0 110.178 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.544 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -156.29 76.05 0.89 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 108.945 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.0 m-85 -91.13 147.59 22.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 110.677 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 0.0 OUTLIER -78.25 -21.36 50.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 110.349 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.491 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 91.8 p -135.8 156.57 48.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 0.0 110.492 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.12 -25.46 68.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.527 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 1.7 tp10 -73.79 -26.22 60.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 25.9 t0 -77.38 -31.77 54.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.265 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.587 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.3 t -82.48 -47.87 11.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.592 -0.692 . . . . 0.0 109.193 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.8 ttm -65.74 -44.44 85.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 109.993 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -58.12 -25.33 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.674 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -90.17 -42.32 11.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.448 -0.783 . . . . 0.0 109.767 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 110.815 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.576 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 4.4 p90 . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.302 0.573 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -82.13 -28.88 31.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.6 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -82.02 -19.31 40.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 109.724 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.94 158.37 85.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.823 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 44.1 Cg_endo -71.84 174.83 10.57 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.853 1.449 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.606 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -71.55 169.74 20.24 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.902 1.475 . . . . 0.0 110.48 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.597 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 63.5 t80 -129.1 94.25 3.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.835 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.401 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -56.29 -23.39 36.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 58.44 -172.8 3.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.0 Cg_endo -73.63 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.17 1.616 . . . . 0.0 110.466 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 28.6 m 63.12 173.33 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -133.52 27.19 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.01 -168.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.102 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 38.8 ttm180 -150.69 73.81 1.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.162 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 82.1 mt -109.99 146.61 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.518 HG23 ' HB ' ' A' ' 32' ' ' THR . 43.9 mm -92.43 82.45 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -81.67 169.24 17.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.919 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 47.2 m-85 -112.44 149.87 31.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 111.492 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 13.0 p90 -150.12 156.81 42.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 47.7 t80 -83.6 116.3 22.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.125 -0.984 . . . . 0.0 110.486 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 26.9 t-20 -91.24 88.48 6.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.874 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.58 -37.72 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.735 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 10.2 tptp -64.91 -27.99 69.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.586 ' O ' HD12 ' A' ' 29' ' ' LEU . . . -92.66 -23.58 18.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.4 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 91.22 -11.29 72.6 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 27' ' ' ALA . 1.7 mp -132.76 -142.53 0.21 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -1.138 . . . . 0.0 109.521 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 66.3 m -119.57 154.67 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.579 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 3.3 mt-30 -138.61 172.3 13.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.499 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.518 ' HB ' HG23 ' A' ' 19' ' ' ILE . 8.5 p -98.59 144.45 27.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 110.506 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -137.82 157.08 47.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.042 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.37 101.33 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.207 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.817 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 10.7 t80 -80.58 149.24 29.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.491 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.741 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -84.56 -1.68 89.11 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.26 6.69 5.22 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 20.2 p -149.77 171.91 15.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 110.456 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 39.34 47.17 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.486 -0.759 . . . . 0.0 110.645 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.817 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -69.28 156.07 39.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -120.47 -162.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.301 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.528 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.6 mtm-85 -80.11 -6.13 57.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 109.978 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.8 t-20 -110.25 54.59 0.66 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.86 . . . . 0.0 109.64 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.584 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 30.1 t-20 -155.41 82.49 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -94.49 142.65 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 111.099 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 11.2 tmtt? -71.92 -23.46 61.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.496 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 97.0 p -134.26 159.02 42.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 110.502 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.23 64.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.78 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -74.23 -28.68 61.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 110.236 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.491 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 56.4 t0 -78.86 -32.56 46.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.559 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.3 t -74.78 -43.98 51.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -48.92 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.253 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -64.69 -11.93 41.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 109.717 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.465 HG22 ' SG ' ' A' ' 5' ' ' CYS . 1.8 m -106.43 -38.79 6.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.885 . . . . 0.0 110.16 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.6 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.648 ' CB ' ' CD ' ' A' ' 42' ' ' ARG . 9.0 p90 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.984 0.421 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.577 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -72.96 -29.66 63.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.072 -1.018 . . . . 0.0 109.658 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.731 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 39.5 mt -78.31 -20.36 51.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.743 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 45.0 mt-10 -81.55 165.37 44.46 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 47.7 Cg_endo -72.87 163.0 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.937 1.493 . . . . 0.0 110.564 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.489 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 43.6 Cg_endo -71.79 -159.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.968 1.509 . . . . 0.0 110.456 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 45.5 t80 -146.43 93.68 2.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 109.946 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -58.67 -22.82 58.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.593 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 61.12 174.87 1.39 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.5 Cg_endo -81.55 -96.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.903 1.475 . . . . 0.0 110.658 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' PRO . 2.0 m 38.91 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.235 -0.915 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -142.54 17.2 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.832 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.01 -179.76 4.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 110.027 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.06 71.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.612 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 3.7 mp -85.84 156.58 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.681 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 32' ' ' THR . 22.1 mm -93.74 80.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.113 -0.992 . . . . 0.0 110.602 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 7.8 mmt180 -81.35 175.04 10.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.702 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.538 ' CD1' ' HA ' ' A' ' 47' ' ' SER . 89.8 m-85 -116.23 151.8 35.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.037 -1.039 . . . . 0.0 111.285 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.511 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 15.7 p90 -150.35 161.87 41.64 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 72.6 t80 -86.33 107.81 18.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.968 -1.082 . . . . 0.0 110.963 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' ALA . 37.5 t-20 -84.99 90.84 7.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.997 . . . . 0.0 109.86 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.53 -28.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.525 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.485 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -71.09 -27.14 63.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.333 -0.855 . . . . 0.0 109.762 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.41 -18.5 19.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.002 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 -3.04 87.54 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.665 HD12 ' O ' ' A' ' 30' ' ' CYS . 1.1 pp -144.1 -145.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.16 -1.2 . . . . 0.0 109.36 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.665 ' O ' HD12 ' A' ' 29' ' ' LEU . 84.3 m -114.76 151.12 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 111.031 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -137.61 176.95 8.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.359 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.532 ' HB ' ' CG2' ' A' ' 19' ' ' ILE . 25.4 p -93.46 144.29 25.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 7.8 p90 -144.48 161.52 38.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 55.5 t -74.72 135.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 0.0 110.231 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.827 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -122.27 141.63 51.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.787 . . . . 0.0 109.775 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -75.39 -1.76 65.9 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 71.2 1.89 4.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -1.127 . . . . 0.0 110.485 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 6.0 p -142.5 157.02 45.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.008 -1.058 . . . . 0.0 110.058 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 4.9 mtp85 56.72 35.6 26.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.827 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -55.03 149.9 11.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.505 ' CE ' ' HB2' ' A' ' 10' ' ' TYR . 2.1 mtmp? -124.86 -170.57 2.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.648 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 6.7 ptp180 -65.05 -32.93 74.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 111.278 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.9 t-20 -88.46 54.66 3.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.822 -1.174 . . . . 0.0 109.449 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.482 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 54.1 t-20 -158.55 76.34 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 23.1 m-85 -85.86 136.72 33.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 110.589 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -61.34 -26.96 68.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.848 . . . . 0.0 110.076 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.538 ' HA ' ' CD1' ' A' ' 21' ' ' TYR . 89.3 p -145.29 162.03 38.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 -20.43 66.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.906 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 2.7 tp10 -70.68 -34.47 72.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.3 t0 -79.28 -32.95 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.375 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.579 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 44.4 t -69.87 -44.43 69.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.765 . . . . 0.0 109.208 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.401 ' O ' ' C ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -65.37 -55.39 18.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.499 -0.751 . . . . 0.0 109.522 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 2.2 ttp180 -46.08 -31.82 2.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' SG ' ' A' ' 55' ' ' CYS . 85.3 m -79.27 -59.44 2.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -0.786 . . . . 0.0 109.445 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.441 ' SG ' HG22 ' A' ' 54' ' ' THR . 59.2 m . . . . . 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.388 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.552 ' CB ' ' HD3' ' A' ' 42' ' ' ARG . 3.5 p90 . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 121.525 0.679 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 3.7 t -84.55 -25.17 28.91 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.873 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 6' ' ' LEU . 7.3 mt -86.96 -15.28 39.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.904 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.43 163.88 56.92 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 168.44 24.5 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.111 1.585 . . . . 0.0 110.187 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.619 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.9 Cg_endo -70.73 169.76 19.38 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.017 1.535 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 38.8 t80 -126.25 94.27 4.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 111.131 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.478 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -67.39 -22.64 65.54 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.83 171.8 0.56 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.6 Cg_endo -80.51 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.877 1.462 . . . . 0.0 110.333 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 41.52 -164.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 110.569 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -134.41 26.41 3.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 110.201 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.55 5.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.17 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 2.2 ptp180 -153.82 73.64 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.125 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 19' ' ' ILE . 4.1 mt -90.26 165.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.275 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.445 ' N ' HG22 ' A' ' 18' ' ' ILE . 29.4 mm -102.79 92.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.549 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.555 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 4.2 mmt180 -94.48 -179.39 4.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.846 . . . . 0.0 110.038 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.557 ' CE2' HG22 ' A' ' 32' ' ' THR . 72.6 m-85 -117.03 146.2 43.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.084 . . . . 0.0 111.06 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.7 p90 -145.69 163.38 35.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.482 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 86.9 t80 -92.26 124.33 36.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.742 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 59.8 t-20 -96.69 96.54 8.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -0.956 . . . . 0.0 109.929 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.6 -36.31 10.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -68.57 -25.5 64.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.776 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -96.36 -24.91 15.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 86.43 -8.72 73.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -129.68 -146.3 0.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.247 -1.149 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 63.1 m -123.48 150.02 44.42 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.729 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.589 HE22 ' HB2' ' A' ' 27' ' ' ALA . 36.3 mt-30 -137.31 160.96 37.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.558 -0.714 . . . . 0.0 109.21 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.557 HG22 ' CE2' ' A' ' 21' ' ' TYR . 40.5 p -82.97 144.23 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.3 p90 -140.62 166.22 25.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.442 -0.787 . . . . 0.0 109.865 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.448 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 3.6 t -74.88 133.84 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.083 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.723 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.6 t80 -112.88 147.09 37.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 0.0 110.324 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.749 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -87.34 -4.16 81.06 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 74.37 -4.54 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.445 -1.032 . . . . 0.0 111.113 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 39' ' ' ARG . 29.3 p -146.7 170.35 17.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 110.441 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.536 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.2 ttt180 42.78 51.76 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.723 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -95.23 157.82 15.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 0.0 110.905 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 4.6 mttp -118.59 -161.48 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.348 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.552 ' HD3' ' CB ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -74.55 -23.98 58.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.1 t-20 -80.19 54.26 1.93 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.919 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.594 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 25.2 t-20 -162.41 74.31 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 20.3 m-85 -85.46 143.7 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.446 -0.783 . . . . 0.0 110.788 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -68.91 -25.11 64.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 0.0 110.096 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -136.39 157.11 47.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 0.0 110.543 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.51 -22.87 66.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.071 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 4.1 mt-10 -75.28 -27.86 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.599 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 14.6 t0 -72.85 -35.85 67.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.526 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.2 t -71.43 -44.52 64.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.7 mmt -67.69 -53.8 24.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.475 -0.766 . . . . 0.0 109.395 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -53.38 -22.43 7.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -96.22 -39.38 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 109.728 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.343 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.748 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 6.6 p90 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.158 0.504 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 53.4 m -84.19 -20.94 31.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 178.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.692 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 15.7 mt -73.75 -22.82 59.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -70.52 160.37 81.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 110.141 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.7 170.28 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.017 1.535 . . . . 0.0 110.208 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.39 178.47 6.1 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.833 1.439 . . . . 0.0 110.153 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 11.0 t80 -139.56 93.86 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.91 . . . . 0.0 110.428 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -59.54 -22.74 62.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.39 144.94 0.03 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.54 65.47 4.65 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.958 1.504 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.488 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 18.5 m -117.56 170.83 8.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 4.49 53.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.357 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.53 175.55 5.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 109.998 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 13.5 ptp180 -155.08 71.97 0.81 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.575 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 mt -81.17 157.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.809 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 19' ' ' ILE . 4.3 mm -94.18 88.49 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.018 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.611 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.2 mmt180 -92.42 -175.65 4.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.338 -0.851 . . . . 0.0 110.034 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.623 ' CE2' HG23 ' A' ' 32' ' ' THR . 69.0 m-85 -119.37 144.82 46.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 111.434 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 14.4 p90 -142.14 166.52 24.47 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 55' ' ' CYS . 73.0 t80 -95.95 111.59 23.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 110.835 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 28.3 t-20 -84.32 91.83 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -47.07 -24.27 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -79.25 -22.93 44.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.407 -0.808 . . . . 0.0 109.823 179.421 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -93.56 -28.47 16.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 -0.6 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -151.26 -151.62 0.4 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -1.163 . . . . 0.0 109.851 179.677 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.58 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 95.4 m -109.99 153.75 24.13 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.871 0.843 . . . . 0.0 111.43 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -143.51 174.25 10.92 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.623 HG23 ' CE2' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -96.54 144.29 26.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.712 -1.243 . . . . 0.0 110.669 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -138.79 162.38 34.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.765 . . . . 0.0 109.583 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 17' ' ' ARG . 53.3 t -75.99 99.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 111.283 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.7 t80 -81.49 144.78 31.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.509 -0.745 . . . . 0.0 109.505 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.778 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -87.06 3.59 86.83 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.392 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 78.55 -24.5 0.21 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.467 -1.019 . . . . 0.0 111.169 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.44 168.35 19.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.898 -1.126 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.77 43.73 27.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 109.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.594 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -85.76 164.48 17.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.353 -0.842 . . . . 0.0 111.198 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.4 mttt -116.23 -166.3 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.748 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -76.88 -19.78 57.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.865 -1.147 . . . . 0.0 110.183 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.434 ' H ' ' HD2' ' A' ' 42' ' ' ARG . 3.8 t-20 -92.07 53.67 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.908 0.861 . . . . 0.0 109.341 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.466 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 17.8 t-20 -149.49 71.06 1.09 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.6 m-85 -84.89 141.21 30.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.531 -178.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 4.7 tttt -66.02 -23.12 66.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.477 -0.764 . . . . 0.0 110.911 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -143.38 153.85 43.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 110.418 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -56.86 -29.86 63.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.705 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.6 tt0 -64.68 -34.02 77.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.82 . . . . 0.0 110.363 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' ' HB ' ' A' ' 54' ' ' THR . 22.5 t0 -79.25 -29.18 42.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.622 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 37.6 t -82.9 -44.2 15.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.429 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.5 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -67.98 -49.95 58.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.956 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -59.97 -23.7 63.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 0.0 109.42 179.295 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.509 HG23 ' HZ ' ' A' ' 4' ' ' PHE . 2.5 m -94.32 -44.3 8.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.559 -0.713 . . . . 0.0 109.824 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 55.8 m . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 -179.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.585 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 28.6 p90 . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.258 0.551 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 20.0 m -83.64 -26.43 29.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.075 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 6' ' ' LEU . 5.3 mt -81.43 -18.24 46.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.721 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.27 162.25 57.14 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.934 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.04 168.97 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.932 1.491 . . . . 0.0 110.108 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.602 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -70.59 175.2 9.12 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.998 1.526 . . . . 0.0 110.667 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -133.91 93.9 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 0.0 110.389 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.72 -22.69 66.63 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 11' ' ' THR . . . 57.94 171.8 0.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.3 Cg_endo -74.68 -97.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.913 1.481 . . . . 0.0 110.453 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 42.96 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.044 -1.035 . . . . 0.0 110.739 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -133.23 15.75 4.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 110.08 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.11 172.43 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 71.13 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 110.284 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -98.35 153.78 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 32' ' ' THR . 14.5 mm -96.64 87.67 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 32' ' ' THR . 8.2 mmt85 -88.67 177.31 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.535 ' CE1' HG23 ' A' ' 32' ' ' THR . 49.2 m-85 -113.39 152.89 29.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 111.082 -179.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -150.58 158.49 44.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.623 -0.673 . . . . 0.0 109.337 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.61 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 44.9 t80 -87.33 113.64 23.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.319 -0.863 . . . . 0.0 110.774 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.621 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 45.3 t-20 -86.27 83.31 7.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.47 -29.09 1.03 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.027 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -27.3 62.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.427 -0.795 . . . . 0.0 109.706 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.98 -26.33 16.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.239 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.48 -10.53 65.0 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.45 -144.11 0.21 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.188 -1.183 . . . . 0.0 109.571 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 95.1 m -121.83 153.97 37.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.703 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 20.0 mt-30 -140.38 160.45 39.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.484 -0.76 . . . . 0.0 109.383 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.535 HG23 ' CE1' ' A' ' 21' ' ' TYR . 2.0 p -84.6 144.56 28.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.009 -1.057 . . . . 0.0 110.723 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.9 p90 -139.15 162.3 35.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.92 179.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' THR . 11.8 t -74.67 122.6 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.797 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -99.79 147.09 25.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -0.88 . . . . 0.0 110.223 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -91.84 -4.38 67.41 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.95 -2.09 2.83 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.265 -1.138 . . . . 0.0 110.902 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 39' ' ' ARG . 28.3 p -146.3 172.24 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.991 -1.068 . . . . 0.0 110.182 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 38' ' ' CYS . 16.4 mtt-85 42.33 28.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.974 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.797 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -63.92 163.5 11.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -127.3 -171.04 2.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.557 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -69.56 -19.62 63.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.953 -1.092 . . . . 0.0 109.834 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 3.3 t-20 -88.25 67.03 8.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 109.695 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 39.0 t-20 -168.43 82.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 109.271 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.561 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 18.0 m-85 -96.42 148.8 22.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.585 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -69.22 -28.34 66.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.871 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -136.56 158.56 44.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -68.14 -20.45 64.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.067 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 5.3 tt0 -65.74 -42.0 91.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.01 -40.24 71.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 34.7 t -64.91 -43.99 91.04 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.656 0.741 . . . . 0.0 109.41 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -67.39 -61.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.726 . . . . 0.0 110.685 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -55.41 -19.25 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.036 -1.04 . . . . 0.0 110.617 -179.441 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.508 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 45.9 m -95.61 -56.0 2.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.07 -1.019 . . . . 0.0 110.172 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.61 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 44.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.929 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.6 ' CG ' ' HB2' ' A' ' 42' ' ' ARG . 10.9 p90 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.221 0.534 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.516 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -83.68 -22.04 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.388 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 19.3 mt -82.36 -16.97 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.467 -0.771 . . . . 0.0 109.842 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.493 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -84.78 160.89 54.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.088 179.838 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD2' ' HG3' ' A' ' 7' ' ' GLU . 44.1 Cg_endo -72.53 165.05 33.82 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.931 1.49 . . . . 0.0 110.071 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.6 Cg_endo -70.67 159.32 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.906 1.477 . . . . 0.0 110.712 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -116.33 94.33 4.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -0.836 . . . . 0.0 110.655 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.485 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -62.66 -22.87 66.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.5 170.25 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' CYS . 48.0 Cg_endo -73.58 -92.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.917 1.482 . . . . 0.0 110.941 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 44.26 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.052 -1.03 . . . . 0.0 110.313 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.09 8.27 3.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 -177.15 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 109.707 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -152.27 82.97 1.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.016 -1.052 . . . . 0.0 110.68 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.1 mt -96.87 157.92 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.752 HG23 ' HB ' ' A' ' 32' ' ' THR . 7.9 mm -104.54 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.153 -0.967 . . . . 0.0 110.242 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.8 mmt85 -88.51 179.97 6.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 62.1 m-85 -110.87 153.83 24.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 110.712 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.7 p90 -152.78 161.94 41.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.43 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 76.5 t80 -92.91 115.31 28.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 110.951 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 40.3 t-20 -90.5 98.55 11.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 0.0 110.01 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -52.24 -20.2 2.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.89 -19.09 29.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.982 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -96.53 -29.77 13.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.908 . . . . 0.0 110.231 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.72 72.45 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.64 -145.2 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.106 -1.232 . . . . 0.0 109.641 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.4 m -121.45 150.46 41.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.895 . . . . 0.0 110.97 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.48 179.65 6.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.752 ' HB ' HG23 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -99.45 144.47 28.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.893 -1.129 . . . . 0.0 111.156 -179.213 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.9 p90 -136.83 158.75 43.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.584 -0.697 . . . . 0.0 109.17 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 11' ' ' THR . 60.6 t -75.28 99.66 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.291 -0.881 . . . . 0.0 111.055 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.636 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 6.1 t80 -78.75 141.5 37.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.23 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.757 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -84.7 5.52 81.52 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.94 0.58 3.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -1.07 . . . . 0.0 111.0 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 39' ' ' ARG . 12.6 p -148.86 176.0 10.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.855 -1.153 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 41.56 44.55 2.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -83.35 137.27 34.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.94 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -103.0 -164.38 1.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.772 . . . . 0.0 109.433 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -69.55 -14.23 62.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.041 -1.037 . . . . 0.0 109.611 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.2 t-20 -94.39 55.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.471 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 16.8 t-20 -160.71 80.27 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 0.0 108.99 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.574 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -92.06 153.19 19.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.858 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -78.67 -23.18 45.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.446 -0.784 . . . . 0.0 110.16 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.1 p -142.68 161.44 38.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.27 -0.894 . . . . 0.0 110.296 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.87 -21.29 65.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -27.19 60.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.405 -0.809 . . . . 0.0 110.173 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.85 -30.81 31.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.348 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.574 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 43.6 t -78.64 -44.61 23.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.602 -0.686 . . . . 0.0 109.622 179.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -46.8 75.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 110.293 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -63.72 -29.43 70.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.05 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.616 HG22 ' SG ' ' A' ' 55' ' ' CYS . 5.4 m -73.85 -50.17 21.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.125 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.616 ' SG ' HG22 ' A' ' 54' ' ' THR . 77.3 m . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 1.0 ' HD2' HD21 ' A' ' 6' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.642 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 38.2 Cg_endo -66.07 165.92 22.54 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.761 1.401 . . . . 0.0 111.123 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.496 ' HA ' HD12 ' A' ' 6' ' ' LEU . 6.5 t70 -99.39 -18.55 17.44 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.491 -0.756 . . . . 0.0 110.1 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.642 ' CE2' ' HB2' ' A' ' 2' ' ' PRO . 21.1 p90 -66.07 -21.18 66.36 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.976 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.55 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 1.4 m -85.3 -21.98 28.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.348 -0.845 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.0 HD21 ' HD2' ' A' ' 1' ' ' ARG . 48.1 mt -74.06 -24.37 59.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.356 -0.84 . . . . 0.0 108.807 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' CG ' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -79.74 164.02 55.5 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.606 -0.684 . . . . 0.0 109.466 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.533 ' HD2' ' CG ' ' A' ' 7' ' ' GLU . 46.5 Cg_endo -74.03 167.36 27.38 Favored 'Trans proline' 0 C--N 1.302 -1.875 0 O-C-N 123.736 1.387 . . . . 0.0 109.965 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.563 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.5 Cg_endo -70.17 172.34 13.23 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.785 1.413 . . . . 0.0 110.127 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.567 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 36.1 t80 -140.76 93.59 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.092 -1.005 . . . . 0.0 110.406 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.452 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -52.67 -23.12 6.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.567 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 65.53 -170.23 27.72 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -72.71 -155.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.092 1.575 . . . . 0.0 110.214 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 23.0 m 62.29 -168.69 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 110.243 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.42 20.78 2.05 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.232 -0.918 . . . . 0.0 109.985 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.24 167.94 0.4 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.97 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -142.36 69.2 1.31 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.354 -0.841 . . . . 0.0 109.811 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.519 HG22 ' HG2' ' A' ' 20' ' ' ARG . 3.5 mt -107.32 148.64 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.468 HG23 ' HB ' ' A' ' 32' ' ' THR . 17.9 mm -94.33 78.52 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 0.0 109.865 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 18' ' ' ILE . 4.1 mmt180 -83.53 -176.55 6.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 109.886 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 45' ' ' PHE . 57.6 m-85 -118.55 144.45 46.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.976 -1.077 . . . . 0.0 111.276 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.55 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -139.43 163.36 32.71 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.55 ' CG ' ' HB3' ' A' ' 5' ' ' CYS . 57.2 t80 -93.44 117.2 29.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.003 -1.061 . . . . 0.0 111.837 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 42.9 t-20 -91.07 92.17 8.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.331 -0.856 . . . . 0.0 108.86 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -44.58 -29.5 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.891 -1.131 . . . . 0.0 110.183 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -75.2 -23.93 57.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.198 -0.939 . . . . 0.0 109.811 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.77 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -92.96 -16.83 24.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 110.507 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.13 -5.72 75.15 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.77 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -145.84 -143.43 0.14 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -1.162 . . . . 0.0 109.286 179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.3 m -117.44 163.33 16.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.277 -0.89 . . . . 0.0 111.687 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 5.9 mt-30 -143.8 166.56 24.55 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.468 ' HB ' HG23 ' A' ' 19' ' ' ILE . 82.5 p -82.97 144.29 30.08 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 110.555 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 7.6 p90 -145.45 171.73 14.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.559 -0.713 . . . . 0.0 109.659 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.4 t -85.71 122.54 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.06 -1.025 . . . . 0.0 110.838 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 7.7 t80 -99.77 148.88 23.92 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.523 -0.736 . . . . 0.0 109.911 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.742 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -96.89 -3.9 59.06 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.641 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.41 -2.81 2.49 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.184 -1.186 . . . . 0.0 111.066 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.423 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 26.0 p -139.81 152.49 46.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.886 -1.134 . . . . 0.0 110.637 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.407 ' HD3' ' HG3' ' A' ' 13' ' ' PRO . 0.2 OUTLIER 49.04 42.99 21.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 110.379 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -70.81 149.87 46.4 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.201 -0.937 . . . . 0.0 110.668 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -101.1 -164.4 1.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.731 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.559 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 12.2 mtt-85 -82.79 -12.81 57.2 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.135 -0.978 . . . . 0.0 110.047 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 6.7 t-20 -95.48 54.12 1.55 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 109.901 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.585 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 15.7 t-20 -152.73 84.93 1.23 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.389 -0.819 . . . . 0.0 109.303 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.588 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 14.7 m-85 -98.5 154.67 17.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -0.813 . . . . 0.0 110.156 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -81.69 -18.64 43.72 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.229 -0.919 . . . . 0.0 110.611 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.422 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 95.3 p -142.18 155.67 45.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -0.942 . . . . 0.0 110.531 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.74 -28.53 70.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.472 -0.768 . . . . 0.0 109.493 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -75.93 -23.83 55.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.437 -0.789 . . . . 0.0 109.717 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 44.6 t0 -74.29 -33.98 63.39 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.588 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 0.4 OUTLIER -71.69 -48.51 46.88 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.437 ' O ' ' N ' ' A' ' 56' ' ' GLY . 1.3 mmt -56.01 -57.55 11.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.494 -0.754 . . . . 0.0 110.141 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.26 -24.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.986 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.8 m -99.54 -63.72 1.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 0.0 110.694 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.49 ' SG ' ' HG2' ' A' ' 2' ' ' PRO . 56.7 m -103.68 34.09 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 0.0 110.584 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -87.2 44.89 3.34 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -110.08 50.36 0.78 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.246 -1.149 . . . . 0.0 110.187 -179.944 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 2' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.646 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 39.8 Cg_endo -70.64 158.82 54.72 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.045 1.55 . . . . 0.0 111.338 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -98.61 -25.44 14.72 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.681 -0.637 . . . . 0.0 109.412 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 53.5 p90 -67.48 -21.16 65.53 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.141 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.577 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 97.9 m -77.07 -24.2 51.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.423 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.731 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 22.8 mt -83.63 -19.46 35.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.536 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -82.04 163.97 50.64 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.435 -0.79 . . . . 0.0 109.938 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.75 160.25 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.856 1.45 . . . . 0.0 110.294 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.593 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.1 Cg_endo -71.4 -178.39 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.939 1.494 . . . . 0.0 110.546 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 86.1 t80 -132.15 93.35 3.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 110.128 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.27 -23.03 66.93 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' O ' HG22 ' A' ' 11' ' ' THR . . . 59.9 176.5 1.21 Allowed Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.8 Cg_endo -79.9 -93.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.927 1.488 . . . . 0.0 110.357 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.5 m 42.77 -168.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.235 -0.916 . . . . 0.0 110.632 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -138.72 13.09 2.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 110.067 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.58 164.35 11.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.228 -0.92 . . . . 0.0 109.959 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 -128.85 71.28 1.41 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 68.0 mt -77.88 151.9 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.374 -0.829 . . . . 0.0 109.772 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 26.2 mm -96.38 89.19 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 0.0 110.671 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -90.06 172.98 8.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.366 -0.833 . . . . 0.0 110.327 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.731 ' CE1' HG23 ' A' ' 32' ' ' THR . 7.6 m-85 -114.41 144.73 42.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.902 . . . . 0.0 110.706 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 10.1 p90 -144.7 154.2 42.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.649 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 67.3 t80 -83.0 112.87 20.15 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.382 -0.824 . . . . 0.0 110.876 -179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.664 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 61.1 t-20 -84.81 86.07 7.39 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.059 -1.025 . . . . 0.0 109.98 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -46.29 -25.39 0.62 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.06 -1.025 . . . . 0.0 109.741 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -76.07 -26.01 56.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.339 -0.851 . . . . 0.0 109.55 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.664 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.12 -25.49 17.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 110.161 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.77 78.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.478 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -137.99 -145.16 0.19 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.138 -1.213 . . . . 0.0 109.588 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' TYR . 95.5 m -119.16 150.6 39.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.919 . . . . 0.0 111.048 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.408 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 24.7 mt-30 -140.48 160.4 40.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.726 . . . . 0.0 109.391 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.731 HG23 ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -89.2 146.87 24.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.069 -1.019 . . . . 0.0 110.588 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.593 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.8 p90 -138.08 162.27 34.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.806 . . . . 0.0 110.045 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' THR . 97.5 t -74.26 106.15 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.484 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.894 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 10.4 t80 -88.17 148.86 24.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.368 -0.833 . . . . 0.0 109.992 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.754 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -86.84 -1.35 85.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 75.42 -6.23 2.01 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.463 -1.022 . . . . 0.0 110.8 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.3 p -136.07 165.76 24.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.0 109.893 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 4.7 mtt180 45.75 52.81 9.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.141 -0.974 . . . . 0.0 110.013 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.894 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -72.79 156.73 38.61 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.269 -0.895 . . . . 0.0 110.55 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -119.53 -162.62 0.93 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.872 . . . . 0.0 110.292 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.598 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 17.7 mtm180 -81.03 -26.07 36.67 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.002 -1.061 . . . . 0.0 109.964 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -93.0 53.92 2.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 109.156 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.503 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.7 t-20 -146.56 74.51 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.506 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 8.6 m-85 -92.95 163.6 13.61 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.419 -0.801 . . . . 0.0 110.586 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -91.45 -14.69 30.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.107 -0.995 . . . . 0.0 110.086 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 80.4 p -145.95 160.46 41.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.447 -0.783 . . . . 0.0 110.212 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.63 -22.45 64.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 109.828 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -74.72 -26.4 59.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 110.102 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 65.1 m-20 -83.01 -30.69 27.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -0.85 . . . . 0.0 109.37 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.506 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.5 t -74.2 -44.04 54.82 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.412 -0.805 . . . . 0.0 109.699 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.513 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -66.29 -57.04 8.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.757 . . . . 0.0 110.356 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.18 -21.36 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.1 -1.0 . . . . 0.0 110.231 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.496 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 2.1 m -101.39 -39.71 7.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -0.895 . . . . 0.0 110.048 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 65.4 m -96.19 -45.98 6.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 110.126 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -55.17 106.11 0.5 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.78 64.5 0.02 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.33 -1.1 . . . . 0.0 110.143 -179.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.498 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.614 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 37.6 Cg_endo -65.01 160.24 42.53 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.878 1.462 . . . . 0.0 111.062 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.71 -20.85 28.74 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.53 -0.731 . . . . 0.0 110.331 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.639 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 3.5 p90 -66.23 -19.71 65.91 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.203 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.578 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 4.6 m -71.23 -31.14 67.2 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.837 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 25' ' ' ALA . 28.0 mt -80.33 -16.07 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.278 -0.889 . . . . 0.0 110.257 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -79.87 162.01 64.04 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 110.111 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.13 170.53 17.94 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.954 1.502 . . . . 0.0 110.414 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.62 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 41.0 Cg_endo -72.01 172.03 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.002 1.527 . . . . 0.0 110.598 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.485 ' CD2' ' HD2' ' A' ' 41' ' ' LYS . 17.7 t80 -130.84 94.31 3.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.258 -0.901 . . . . 0.0 110.683 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -51.74 -23.11 4.13 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 72.69 151.3 1.41 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 39' ' ' ARG . 46.3 Cg_endo -73.98 93.3 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.073 1.565 . . . . 0.0 110.222 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.2 m -154.76 -163.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.225 -0.922 . . . . 0.0 109.981 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HD3' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -127.32 -6.95 5.86 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.324 -0.86 . . . . 0.0 110.189 179.706 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . -83.11 -176.8 6.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 109.776 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -155.01 76.26 0.98 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.02 -1.05 . . . . 0.0 110.674 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 19' ' ' ILE . 19.6 mt -90.44 164.78 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.627 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.45 ' N ' HG22 ' A' ' 18' ' ' ILE . 32.2 mm -105.31 92.7 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.112 -0.993 . . . . 0.0 110.785 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.61 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.74 177.87 5.77 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.268 -0.895 . . . . 0.0 109.786 179.368 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.728 ' CE2' HG23 ' A' ' 32' ' ' THR . 67.1 m-85 -114.88 151.9 33.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.935 -1.103 . . . . 0.0 111.124 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.401 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 23.7 p90 -144.62 153.77 42.11 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.526 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 30.3 t80 -76.11 100.25 4.91 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.171 -0.956 . . . . 0.0 111.15 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.7 t-20 -75.28 71.67 2.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.804 -1.185 . . . . 0.0 109.081 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.511 ' HB2' HD23 ' A' ' 6' ' ' LEU . . . -47.74 -24.53 0.97 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.148 -0.97 . . . . 0.0 109.042 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.4 mtpp -70.55 -31.31 68.3 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -92.15 -21.7 20.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.466 -0.771 . . . . 0.0 109.583 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.2 5.18 60.81 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -150.72 -142.5 0.12 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.058 -1.26 . . . . 0.0 109.713 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.502 ' O ' HD12 ' A' ' 29' ' ' LEU . 92.1 m -125.14 147.79 48.87 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 110.346 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -135.83 178.06 7.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.491 -0.756 . . . . 0.0 109.256 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.728 HG23 ' CE2' ' A' ' 21' ' ' TYR . 1.5 p -101.78 144.21 30.74 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.947 -1.096 . . . . 0.0 110.633 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.62 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 24.2 p90 -133.04 162.89 30.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.631 -0.668 . . . . 0.0 109.335 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 94.0 t -75.4 97.21 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.204 -0.935 . . . . 0.0 111.146 -178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 1.009 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 11.4 t80 -80.06 145.63 32.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 0.0 109.606 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.777 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -83.48 1.29 88.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.777 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 79.74 -27.33 0.15 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.622 -0.928 . . . . 0.0 110.852 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 0.5 OUTLIER -127.23 169.63 13.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.96 -1.087 . . . . 0.0 109.672 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 17.1 mmt180 57.27 33.76 23.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.37 -0.831 . . . . 0.0 110.414 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 1.009 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -69.87 161.31 30.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.05 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.485 ' HD2' ' CD2' ' A' ' 10' ' ' TYR . 17.0 mtpt -137.04 -160.92 1.11 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.093 -1.004 . . . . 0.0 110.419 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.639 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.1 ptp180 -66.99 -32.04 73.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.363 -0.835 . . . . 0.0 111.452 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.4 t-20 -90.63 61.72 4.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.731 -1.23 . . . . 0.0 109.748 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.563 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 33.1 t-20 -161.92 76.19 0.48 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.571 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 24.6 m-85 -85.69 134.56 33.97 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.388 -0.82 . . . . 0.0 110.155 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HA ' ' CZ ' ' A' ' 20' ' ' ARG . 39.3 mttt -65.23 -16.49 63.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.371 -0.831 . . . . 0.0 110.53 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.6 p -149.6 159.34 44.4 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.17 -0.956 . . . . 0.0 110.34 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.59 -20.36 66.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.295 -0.878 . . . . 0.0 110.007 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.32 -31.9 64.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 0.0 110.226 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -77.66 -33.98 53.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.88 . . . . 0.0 109.625 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 18.6 t -72.85 -44.61 61.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.427 -0.796 . . . . 0.0 109.066 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLY . 48.1 tpp -69.61 -44.49 70.6 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.547 -0.721 . . . . 0.0 109.389 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -60.26 -24.03 64.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.873 . . . . 0.0 109.662 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.765 HG22 ' SG ' ' A' ' 55' ' ' CYS . 4.5 m -85.38 -51.6 6.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.371 -0.83 . . . . 0.0 109.945 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.765 ' SG ' HG22 ' A' ' 54' ' ' THR . 73.1 m -133.35 46.91 2.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.221 -0.924 . . . . 0.0 110.545 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -102.67 -164.95 26.17 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.95 30.29 1.99 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.175 -1.191 . . . . 0.0 110.228 179.931 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.664 ' NH2' ' HB2' ' A' ' 58' ' ' ALA . 7.0 ptt-85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.792 0.33 . . . . 0.0 110.127 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.643 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 39.6 Cg_endo -68.45 161.52 44.6 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.077 1.567 . . . . 0.0 111.159 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -89.68 -21.28 22.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.561 -0.712 . . . . 0.0 110.232 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.643 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 6.0 p90 -65.7 -14.05 60.48 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.916 -1.114 . . . . 0.0 109.783 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.559 ' O ' ' CB ' ' A' ' 23' ' ' TYR . 1.7 m -78.63 -22.64 46.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.449 -0.782 . . . . 0.0 110.354 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.629 HD21 ' HE ' ' A' ' 1' ' ' ARG . 19.8 mt -92.06 -10.29 39.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.677 -1.264 . . . . 0.0 109.592 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.76 156.57 82.68 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.385 -0.822 . . . . 0.0 110.074 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 47.2 Cg_endo -73.85 174.4 12.39 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.93 1.489 . . . . 0.0 110.221 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.627 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 45.4 Cg_endo -72.97 -178.36 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.02 1.537 . . . . 0.0 110.357 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 14.4 t80 -155.25 94.18 1.59 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.147 -0.971 . . . . 0.0 110.85 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -53.5 -23.2 9.67 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.8 152.4 2.38 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.27 60.88 4.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.951 1.5 . . . . 0.0 110.08 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.441 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 15.5 m -123.03 -164.53 1.21 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -122.5 0.24 9.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.295 -0.878 . . . . 0.0 110.083 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . -78.69 171.49 15.07 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.376 -0.828 . . . . 0.0 110.436 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.419 ' NH2' HD11 ' A' ' 19' ' ' ILE . 6.9 ttt-85 -149.21 69.22 1.05 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.069 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 35' ' ' TYR . 12.8 mt -95.52 163.95 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.875 . . . . 0.0 109.988 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.579 HG23 ' HB ' ' A' ' 32' ' ' THR . 15.4 mm -104.98 86.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 110.254 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -88.93 179.76 6.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.911 . . . . 0.0 109.845 179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.584 ' CE1' ' HB2' ' A' ' 48' ' ' ALA . 36.6 m-85 -115.3 149.3 38.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 110.942 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 14.2 p90 -144.11 -179.03 6.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.57 -0.706 . . . . 0.0 109.771 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.683 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.7 OUTLIER -95.8 98.53 10.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.927 -1.108 . . . . 0.0 110.92 -179.113 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.57 ' O ' ' N ' ' A' ' 27' ' ' ALA . 47.5 t-20 -81.46 63.92 5.97 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.956 -1.098 . . . . 0.0 108.149 177.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -47.25 -26.98 1.35 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.15 -1.02 . . . . 0.0 108.324 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -35.42 80.9 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -88.09 -17.89 30.06 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.23 10.73 60.62 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.519 ' H ' HD23 ' A' ' 29' ' ' LEU . 1.0 OUTLIER -163.19 -179.13 6.42 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.131 -1.217 . . . . 0.0 108.951 179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 85.3 m -82.5 150.45 26.99 Favored 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.566 -0.709 . . . . 0.0 110.019 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -140.78 169.11 18.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 0.0 109.824 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.579 ' HB ' HG23 ' A' ' 19' ' ' ILE . 19.6 p -88.64 144.38 26.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.146 -0.971 . . . . 0.0 110.098 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.627 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.1 p90 -140.02 165.28 27.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.436 -0.79 . . . . 0.0 110.203 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 11' ' ' THR . 24.4 t -74.68 124.96 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.367 -0.833 . . . . 0.0 110.221 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.881 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -109.46 147.43 32.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -0.848 . . . . 0.0 109.985 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -93.77 -2.08 65.22 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 120.964 -1.085 . . . . 0.0 110.406 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.79 -0.83 3.21 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.123 -1.222 . . . . 0.0 110.794 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.66 152.29 28.48 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.01 -1.056 . . . . 0.0 109.923 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.69 29.97 16.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 109.67 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.881 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -75.27 175.06 8.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.526 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.427 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 22.2 mtpt -121.46 -174.38 2.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.511 -0.743 . . . . 0.0 109.548 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.5 mtt-85 -70.26 -16.76 63.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.077 . . . . 0.0 109.3 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.504 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 2.1 t-20 -93.45 62.96 3.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.881 . . . . 0.0 109.898 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.512 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 8.7 t-20 -154.84 80.22 1.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 17.1 m-85 -95.5 155.64 16.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 0.0 110.578 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.404 ' HG2' ' NH1' ' A' ' 20' ' ' ARG . 0.6 OUTLIER -77.97 -22.8 48.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.332 -0.855 . . . . 0.0 110.33 -179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 98.9 p -134.17 157.97 44.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 110.591 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . . . -74.04 -24.38 59.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.488 -0.757 . . . . 0.0 109.615 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' HA ' ' OE1' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -74.97 -17.57 60.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.482 -0.761 . . . . 0.0 110.032 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.482 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 4.2 t0 -93.5 -30.2 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.447 -0.783 . . . . 0.0 109.207 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 1.7 t -66.89 -52.57 41.68 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' GLY . 3.4 tpt -66.04 -49.43 67.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.641 -0.662 . . . . 0.0 109.846 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -41.47 -41.25 2.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 109.283 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.5 m -91.83 -45.22 8.51 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.835 0.826 . . . . 0.0 109.131 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.683 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 72.8 m -86.21 28.78 0.8 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.742 -0.598 . . . . 0.0 111.396 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -123.92 131.1 7.87 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 155.72 42.38 0.02 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.664 ' HB2' ' NH2' ' A' ' 1' ' ' ARG . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.16 -1.2 . . . . 0.0 110.142 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.47 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 1.6 ptt-85 . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 38.0 Cg_endo -66.27 160.15 46.53 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.833 1.439 . . . . 0.0 111.026 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -16.27 17.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.55 -0.719 . . . . 0.0 110.355 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.735 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 4.1 p90 -65.79 -17.65 64.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.916 -1.115 . . . . 0.0 110.681 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.33 -14.31 46.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 110.927 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.552 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 54.6 mt -75.51 -27.93 58.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.965 -1.084 . . . . 0.0 110.182 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.477 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -64.68 166.57 11.35 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.33 -0.857 . . . . 0.0 110.283 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 7' ' ' GLU . 46.2 Cg_endo -74.7 168.68 24.27 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.121 1.59 . . . . 0.0 110.448 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.7 Cg_endo -71.54 -170.41 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.02 1.537 . . . . 0.0 110.711 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CE1' ' HE3' ' A' ' 41' ' ' LYS . 43.0 t80 -145.62 93.39 2.35 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.254 -0.904 . . . . 0.0 110.611 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.466 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.4 m -64.73 -22.89 67.08 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.23 158.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.14 81.1 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.036 1.545 . . . . 0.0 110.582 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.457 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -147.45 167.37 24.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 0.0 110.235 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -107.53 14.53 25.7 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.261 -0.899 . . . . 0.0 110.366 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.26 152.66 23.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.3 -0.875 . . . . 0.0 110.058 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.37 77.89 1.61 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 110.473 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.51 HG22 ' HG2' ' A' ' 20' ' ' ARG . 70.0 mt -103.13 138.13 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.57 81.1 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.082 -1.011 . . . . 0.0 110.264 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -86.54 173.25 9.71 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 109.852 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 61.9 m-85 -114.24 154.29 28.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.145 -0.972 . . . . 0.0 111.373 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.487 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 9.1 p90 -150.56 156.97 42.44 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.576 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 49.5 t80 -83.14 115.69 22.01 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.135 -0.978 . . . . 0.0 111.266 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.588 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 60.5 t-20 -91.91 87.78 6.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.616 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.552 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.37 -25.42 0.4 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.052 -1.03 . . . . 0.0 109.721 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -24.02 52.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.362 -0.836 . . . . 0.0 109.978 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -95.52 -33.54 12.38 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 110.492 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 102.12 -10.69 56.96 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.435 ' HG ' ' C ' ' A' ' 28' ' ' GLY . 1.1 mt -134.45 -143.99 0.21 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.387 -1.066 . . . . 0.0 109.092 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 68.2 m -120.24 145.68 46.8 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.421 -0.8 . . . . 0.0 109.76 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -129.24 161.05 31.07 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.535 -0.728 . . . . 0.0 109.301 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 6.3 p -86.98 144.48 26.9 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.049 -1.032 . . . . 0.0 110.984 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.4 p90 -140.44 161.89 36.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.589 -0.694 . . . . 0.0 109.933 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 11' ' ' THR . 63.5 t -74.47 111.08 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.196 -0.94 . . . . 0.0 110.499 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 1.071 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.2 t80 -91.94 147.65 22.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.484 -0.76 . . . . 0.0 110.017 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.706 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.8 -4.12 85.25 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 68.59 12.48 8.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 110.089 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 10.2 p -147.3 147.31 30.24 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.888 . . . . 0.0 110.454 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 51.89 44.77 29.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.315 -0.866 . . . . 0.0 110.168 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 1.071 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -67.78 146.13 54.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -0.864 . . . . 0.0 110.579 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 10' ' ' TYR . 26.5 mttm -109.55 -160.53 0.72 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.653 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.735 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -80.87 -22.21 40.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.042 -1.036 . . . . 0.0 110.351 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.487 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 9.6 t-20 -91.31 53.32 2.28 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.906 0.86 . . . . 0.0 109.048 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.5 t-20 -159.82 75.41 0.62 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 23.4 m-85 -85.18 134.23 34.17 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.524 -0.735 . . . . 0.0 110.414 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.1 tptm -60.42 -20.85 61.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.77 . . . . 0.0 111.325 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.4 p -142.52 162.22 36.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.976 -1.077 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.595 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -66.32 -27.04 67.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.378 -0.826 . . . . 0.0 109.118 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' CG ' ' A' ' 53' ' ' ARG . 82.1 mt-10 -75.26 -28.04 59.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.535 -0.728 . . . . 0.0 109.854 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -76.21 -31.27 58.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.493 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 54.0 t -80.58 -44.01 19.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.452 -0.78 . . . . 0.0 109.46 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.529 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.99 -45.89 59.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.452 -0.78 . . . . 0.0 110.246 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -60.81 -15.15 26.9 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.976 -1.078 . . . . 0.0 109.141 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.449 HG22 ' SG ' ' A' ' 55' ' ' CYS . 61.9 m -94.99 -54.79 3.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.521 -0.737 . . . . 0.0 110.144 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.449 ' SG ' HG22 ' A' ' 54' ' ' THR . 58.1 m -114.71 25.75 10.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 110.688 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -75.33 -172.33 31.11 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.54 -10.43 10.58 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.351 -1.087 . . . . 0.0 110.305 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.898 ' CD ' HD21 ' A' ' 6' ' ' LEU . 12.6 ttm105 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.964 0.411 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.61 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 38.5 Cg_endo -67.04 155.3 71.45 Favored 'Trans proline' 0 C--N 1.303 -1.862 0 O-C-N 124.478 1.778 . . . . 0.0 111.421 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 4' ' ' PHE . 19.1 p30 -76.16 -29.67 57.83 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.919 -0.713 . . . . 0.0 109.775 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.61 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 4.1 p90 -67.64 -16.52 64.2 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.689 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.6 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 4.5 t -78.68 -29.76 45.77 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.595 -0.691 . . . . 0.0 109.734 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.898 HD21 ' CD ' ' A' ' 1' ' ' ARG . 27.7 mt -95.47 -9.02 33.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.254 -0.904 . . . . 0.0 109.631 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 7' ' ' GLU . 3.9 mm-40 -75.1 160.85 79.46 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.913 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.89 162.13 39.93 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.916 1.482 . . . . 0.0 110.266 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.575 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.5 Cg_endo -70.15 171.76 14.28 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.034 1.544 . . . . 0.0 110.342 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.597 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 37.4 t80 -133.24 94.45 3.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.133 -0.979 . . . . 0.0 111.019 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -59.55 -22.91 62.38 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 70.85 143.97 0.27 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.92 60.95 5.51 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.049 1.552 . . . . 0.0 110.348 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -126.13 -169.75 2.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.249 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -105.71 -31.7 8.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 110.333 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.16 154.77 12.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 110.143 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 12.7 ptt85 -143.05 77.6 1.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 109.91 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 mt -92.14 160.29 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 110.238 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.528 HG23 ' HB ' ' A' ' 32' ' ' THR . 46.7 mm -91.93 83.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.834 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.607 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -80.82 175.49 10.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 110.054 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 45' ' ' PHE . 51.3 m-85 -115.25 147.72 40.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 110.95 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 15.3 p90 -147.39 156.26 42.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.567 -0.708 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 72.8 t80 -81.42 114.57 20.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.294 -0.878 . . . . 0.0 110.808 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 30.6 t-20 -82.06 82.11 7.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.794 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -45.67 -26.61 0.65 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.166 -0.959 . . . . 0.0 109.993 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 36.8 mmtm -78.05 -23.04 48.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 0.0 109.861 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -98.28 -26.83 14.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.183 -0.948 . . . . 0.0 110.227 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.78 -3.1 57.29 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -141.58 -142.49 0.14 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 99.2 m -121.74 159.45 26.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.496 -0.753 . . . . 0.0 110.731 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 4.7 mt-30 -143.2 169.08 18.28 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.509 -0.745 . . . . 0.0 109.32 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.528 ' HB ' HG23 ' A' ' 19' ' ' ILE . 1.5 p -91.54 144.27 25.72 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.386 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 14.1 p90 -143.39 166.57 24.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.505 -0.747 . . . . 0.0 109.778 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 11' ' ' THR . 65.1 t -74.41 128.3 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.185 -0.947 . . . . 0.0 110.452 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -112.27 145.83 39.27 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.482 -0.761 . . . . 0.0 110.064 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -96.93 7.98 65.17 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 120.046 -1.073 . . . . 0.0 110.742 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.61 ' HA ' ' CE2' ' A' ' 35' ' ' TYR . . . 58.99 12.47 2.38 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.02 -1.283 . . . . 0.0 110.899 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 39' ' ' ARG . 17.9 p -152.34 164.58 37.17 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.043 -1.036 . . . . 0.0 110.494 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.509 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 98.7 mtt180 42.56 38.43 1.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.233 -0.917 . . . . 0.0 109.922 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.572 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -79.88 157.58 26.93 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -122.02 -168.15 1.66 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.369 -0.832 . . . . 0.0 109.63 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.54 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.6 mtm-85 -71.56 -19.16 62.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.022 -1.049 . . . . 0.0 110.152 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 5.1 t-20 -86.23 54.7 3.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.186 -0.946 . . . . 0.0 109.988 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.536 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -163.03 80.87 0.48 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.36 -0.837 . . . . 0.0 109.227 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.534 ' CD2' ' SG ' ' A' ' 51' ' ' CYS . 19.8 m-85 -87.8 146.34 25.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 0.0 110.398 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -70.79 -25.45 62.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.758 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.44 ' HA ' ' CE2' ' A' ' 21' ' ' TYR . 97.5 p -140.47 160.4 40.09 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.15 -0.969 . . . . 0.0 110.563 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -23.57 67.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 0.0 109.666 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.57 -28.69 61.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.379 -0.826 . . . . 0.0 109.988 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 1.1 m-20 -80.83 -30.62 35.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.616 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 45' ' ' PHE . 42.7 t -79.37 -44.64 21.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 0.0 109.333 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.436 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.7 ttm -67.45 -50.28 59.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.304 -0.873 . . . . 0.0 109.48 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -58.32 -19.06 31.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.417 -0.802 . . . . 0.0 109.889 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -90.72 -47.48 7.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.386 -0.821 . . . . 0.0 110.131 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.4 t -126.98 45.93 2.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.454 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -101.98 13.96 57.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.27 63.09 4.48 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.221 -1.164 . . . . 0.0 110.179 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.473 ' NH2' ' OH ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.85 0.357 . . . . 0.0 110.221 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.637 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 40.1 Cg_endo -71.37 159.79 50.59 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.008 1.531 . . . . 0.0 110.631 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -95.32 -26.28 15.98 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.355 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.637 ' CE2' ' HB2' ' A' ' 2' ' ' PRO . 52.1 p90 -67.99 -27.32 66.47 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.627 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 53.4 m -68.15 -29.47 68.37 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 109.31 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' N ' HD23 ' A' ' 6' ' ' LEU . 8.3 mt -77.09 -13.64 59.92 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.883 . . . . 0.0 109.69 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.44 ' OE1' ' HD2' ' A' ' 8' ' ' PRO . 1.0 OUTLIER -79.48 165.01 51.02 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.405 -0.81 . . . . 0.0 110.286 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.44 ' HD2' ' OE1' ' A' ' 7' ' ' GLU . 44.4 Cg_endo -71.97 160.19 48.29 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 123.995 1.524 . . . . 0.0 110.15 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.619 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.6 Cg_endo -70.2 166.56 27.75 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.975 1.513 . . . . 0.0 110.612 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.414 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 67.2 t80 -117.49 94.1 4.42 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.243 -0.911 . . . . 0.0 110.692 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.515 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -63.3 -22.75 67.07 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 63.54 169.34 1.35 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 14' ' ' CYS . 46.7 Cg_endo -75.01 -93.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.961 1.506 . . . . 0.0 110.453 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' C ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 40.37 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.32 -0.863 . . . . 0.0 110.326 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.464 ' HD3' ' C ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -143.13 18.24 1.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.228 -0.92 . . . . 0.0 110.204 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.68 172.3 6.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 110.468 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.703 ' HG2' HG13 ' A' ' 34' ' ' VAL . 8.4 ttp180 -134.74 73.06 1.47 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.349 -0.845 . . . . 0.0 110.001 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.7 HD12 ' HB2' ' A' ' 37' ' ' ALA . 97.1 mt -88.56 155.74 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.277 -0.89 . . . . 0.0 110.383 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 19' ' ' ILE . 15.4 mm -102.01 92.15 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.343 -0.848 . . . . 0.0 110.611 -179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.609 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.6 mmp_? -92.48 -179.92 5.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.696 179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.584 ' CE1' HG23 ' A' ' 32' ' ' THR . 47.6 m-85 -112.26 150.25 31.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.578 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -151.74 157.75 42.43 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.568 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 47.0 t80 -83.8 110.99 18.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.279 -0.888 . . . . 0.0 110.951 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 41.7 t-20 -88.52 87.52 7.3 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.844 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.16 -33.82 2.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.969 -1.082 . . . . 0.0 109.411 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -28.95 69.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 0.0 109.549 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.671 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -94.87 -17.57 21.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 109.993 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.38 -9.5 70.22 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -135.19 -143.11 0.19 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.228 -1.16 . . . . 0.0 109.426 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.4 m -116.95 145.39 43.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -0.852 . . . . 0.0 110.621 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.578 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 mt-30 -128.86 162.79 26.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.795 . . . . 0.0 109.595 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.584 HG23 ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -86.38 148.9 25.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.121 -0.987 . . . . 0.0 110.88 -179.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.6 p90 -143.59 161.74 37.71 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.537 -0.727 . . . . 0.0 109.994 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.703 HG13 ' HG2' ' A' ' 17' ' ' ARG . 70.1 t -74.92 97.49 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.327 -0.858 . . . . 0.0 110.857 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.821 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.9 t80 -79.26 146.45 33.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.367 -0.833 . . . . 0.0 110.356 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -80.0 0.58 82.68 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.95 -1.39 3.08 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.441 -1.035 . . . . 0.0 110.995 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 19.8 p -143.6 168.94 18.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.917 -1.115 . . . . 0.0 110.708 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.8 mtp85 48.97 37.87 11.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 110.64 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.821 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -65.31 144.55 57.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 109.672 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -127.68 -155.6 0.7 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.953 . . . . 0.0 110.704 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.616 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 14.7 ptp180 -70.69 -30.6 67.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.326 -0.858 . . . . 0.0 111.829 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.7 t-20 -93.92 54.27 1.92 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.64 -1.288 . . . . 0.0 109.79 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.4 t-20 -164.12 79.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.595 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 40.1 m-85 -85.46 148.78 25.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.273 -0.892 . . . . 0.0 110.041 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 15.3 mttt -97.02 7.03 47.54 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.037 -1.04 . . . . 0.0 110.665 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.539 ' OG ' ' CB ' ' A' ' 50' ' ' ASP . 51.7 p -134.97 161.44 35.26 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.2 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.77 27.44 0.63 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.583 0.706 . . . . 0.0 111.069 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -160.6 -16.66 0.05 Allowed 'General case' 0 C--N 1.289 -2.063 0 O-C-N 121.602 -0.686 . . . . 0.0 111.616 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.539 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 12.1 t0 -70.76 -25.11 62.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.711 -1.243 . . . . 0.0 108.055 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.595 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.8 t -71.49 -43.91 65.67 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.538 ' CE ' ' HB2' ' A' ' 29' ' ' LEU . 7.7 mtt -67.9 -50.82 54.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.65 -0.656 . . . . 0.0 109.764 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.83 -19.35 2.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 110.088 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -104.5 -43.51 5.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 110.258 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 56.7 m -85.0 -61.27 1.81 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.833 . . . . 0.0 110.514 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 52' ' ' MET . . . -144.46 -118.31 1.23 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 52' ' ' MET . . . 168.84 123.59 0.68 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.209 -1.171 . . . . 0.0 110.062 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.462 ' CD ' HD21 ' A' ' 6' ' ' LEU . 2.1 ttp-105 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.943 0.401 . . . . 0.0 110.054 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.646 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 38.3 Cg_endo -68.09 159.29 53.7 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 124.244 1.654 . . . . 0.0 111.082 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.11 -28.15 17.3 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.209 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.646 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 49.0 p90 -67.97 -26.56 65.99 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.655 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 26.5 m -70.29 -30.35 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 0.0 109.36 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 16.6 mt -75.77 -23.08 55.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.703 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' HG2' ' HD2' ' A' ' 8' ' ' PRO . 3.7 mt-10 -75.31 160.93 78.82 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.428 -0.795 . . . . 0.0 109.715 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD2' ' HG2' ' A' ' 7' ' ' GLU . 44.0 Cg_endo -71.46 169.36 21.08 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.832 1.438 . . . . 0.0 109.958 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.4 Cg_endo -71.13 173.86 11.54 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.898 1.472 . . . . 0.0 110.461 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.492 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 36.6 t80 -135.07 94.08 3.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.0 110.62 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -62.52 -23.29 66.88 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.51 -163.44 3.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 48.8 Cg_endo -74.92 -156.3 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.152 1.606 . . . . 0.0 110.493 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 20.2 m 63.09 147.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.201 -0.937 . . . . 0.0 110.398 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 10.79 39.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.91 165.66 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.192 -0.942 . . . . 0.0 110.558 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -146.61 65.98 1.18 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.909 179.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.1 mt -97.53 152.18 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.509 -0.745 . . . . 0.0 110.04 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.472 HG23 ' HB ' ' A' ' 32' ' ' THR . 39.2 mm -89.25 84.62 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 110.462 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -85.0 168.14 15.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.801 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 37.1 m-85 -110.04 149.8 29.47 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.121 -0.987 . . . . 0.0 110.952 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -152.67 160.57 43.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.581 -0.7 . . . . 0.0 109.501 178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.488 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 72.6 t80 -90.09 127.82 36.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.285 -0.884 . . . . 0.0 110.654 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 27' ' ' ALA . 43.7 t-20 -101.78 87.55 3.16 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.68 -24.88 0.4 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 109.665 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.06 -26.41 59.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.779 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.56 -37.05 10.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 110.254 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.86 -11.31 38.08 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.0 mp -133.97 -144.17 0.22 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.156 -1.202 . . . . 0.0 109.968 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 65.9 m -116.36 156.43 26.73 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.438 -0.789 . . . . 0.0 110.903 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 18.2 mt-30 -144.62 167.59 22.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.505 -0.747 . . . . 0.0 109.575 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.4 p -96.41 144.9 26.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.05 -1.031 . . . . 0.0 110.784 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 24.0 p90 -139.37 165.42 27.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.441 -0.787 . . . . 0.0 110.231 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -75.72 113.59 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.295 -0.878 . . . . 0.0 110.475 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.986 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 8.6 t80 -93.42 148.0 22.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.328 -0.857 . . . . 0.0 109.855 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.736 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.95 -2.24 75.23 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.736 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.43 8.34 5.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.063 -1.257 . . . . 0.0 110.541 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.44 ' O ' ' C ' ' A' ' 39' ' ' ARG . 25.4 p -153.16 174.08 14.69 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.202 -0.936 . . . . 0.0 110.294 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.7 32.3 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.385 -0.822 . . . . 0.0 110.36 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.986 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -64.01 157.52 24.93 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.18 -0.95 . . . . 0.0 110.633 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.492 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 79.7 mttt -126.71 -159.45 0.93 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 109.683 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.58 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -77.54 -19.24 56.06 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.689 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.2 t-20 -92.94 64.48 3.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 0.0 109.711 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.58 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 31.1 t-20 -169.18 80.76 0.13 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.463 -0.773 . . . . 0.0 109.411 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.549 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.8 m-85 -91.71 157.59 16.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.076 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -85.82 -15.17 42.81 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 0.0 110.536 -179.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 94.2 p -144.5 158.4 43.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.227 -0.921 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -65.9 -24.14 66.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.784 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 32.6 mm-40 -75.2 -29.83 60.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.394 -0.816 . . . . 0.0 110.184 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -76.58 -32.58 58.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 109.525 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.549 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 35.9 t -75.02 -43.73 52.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.51 -0.744 . . . . 0.0 109.238 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -37.28 77.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.63 -0.669 . . . . 0.0 110.529 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 12.6 mtp85 -70.83 -20.95 62.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.043 -1.036 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -102.25 -42.45 6.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.271 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.2 m -87.7 -40.55 14.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 110.254 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -45.19 165.57 0.05 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.71 46.0 0.36 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.181 -1.188 . . . . 0.0 110.19 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.448 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 4.0 ttp-105 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.924 0.393 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.534 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 41.8 Cg_endo -69.67 157.3 61.06 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.192 1.628 . . . . 0.0 110.727 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -85.58 -22.71 27.92 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.419 -0.801 . . . . 0.0 110.059 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.647 ' CG ' ' HG3' ' A' ' 42' ' ' ARG . 4.0 p90 -67.13 -21.3 65.84 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.634 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.572 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 3.9 m -68.25 -32.88 73.37 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.15 -0.968 . . . . 0.0 109.465 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.795 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 7.5 mt -84.56 -12.08 54.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.412 -0.805 . . . . 0.0 109.826 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -80.44 168.1 28.06 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.392 -0.818 . . . . 0.0 110.206 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.14 159.18 47.98 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.926 1.488 . . . . 0.0 110.371 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.602 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.4 Cg_endo -70.78 174.1 10.89 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.006 1.529 . . . . 0.0 110.335 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.592 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 89.7 t80 -121.85 93.81 4.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -0.978 . . . . 0.0 110.696 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.519 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.05 -23.12 67.21 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.592 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 64.09 147.56 0.03 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -76.9 81.95 2.46 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.141 1.6 . . . . 0.0 110.596 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.92 168.56 19.97 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.224 -0.923 . . . . 0.0 110.066 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -94.45 3.76 54.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.245 -0.91 . . . . 0.0 110.105 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . -89.7 163.24 15.19 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 110.158 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 16' ' ' ALA . 27.1 mtp180 -142.75 73.96 1.43 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.256 -0.902 . . . . 0.0 110.202 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG21 ' CZ ' ' A' ' 20' ' ' ARG . 51.5 mt -86.95 155.7 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.193 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.463 HG22 HG22 ' A' ' 32' ' ' THR . 27.4 mm -97.71 87.95 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.892 . . . . 0.0 109.993 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.546 ' CZ ' HG21 ' A' ' 18' ' ' ILE . 5.7 mmp_? -91.07 177.59 6.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 110.142 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 38.6 m-85 -112.63 145.43 40.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.217 -0.927 . . . . 0.0 110.92 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 13.9 p90 -145.04 156.7 44.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.654 -0.654 . . . . 0.0 109.302 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.572 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 57.4 t80 -85.08 106.2 16.38 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.286 -0.884 . . . . 0.0 110.903 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 39.5 t-20 -81.3 87.94 6.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.105 -0.997 . . . . 0.0 109.452 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.795 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -44.87 -27.4 0.52 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.05 -1.031 . . . . 0.0 109.787 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.39 -24.5 57.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.758 ' O ' HD23 ' A' ' 29' ' ' LEU . . . -95.97 -17.47 20.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.222 -0.924 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.29 0.87 89.66 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -143.9 -146.28 0.18 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.275 -1.132 . . . . 0.0 109.543 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.54 ' O ' HD12 ' A' ' 29' ' ' LEU . 81.2 m -120.77 147.59 45.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.436 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 15.7 mt-30 -135.22 159.46 41.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.496 -0.752 . . . . 0.0 109.289 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER -80.43 143.88 33.07 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.038 -1.038 . . . . 0.0 110.328 -179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 19.8 p90 -138.32 161.84 35.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.414 -0.804 . . . . 0.0 109.733 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' THR . 12.2 t -74.82 110.36 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.358 -0.839 . . . . 0.0 110.692 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.879 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 11.6 t80 -91.39 150.56 21.21 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.365 -0.834 . . . . 0.0 110.063 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.725 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.36 -4.59 85.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.4 7.04 6.06 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.144 -1.209 . . . . 0.0 110.242 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.3 p -144.58 163.27 34.4 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 47.81 35.06 4.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 110.587 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.879 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -48.76 151.78 1.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 9.1 mttm -131.38 -161.54 1.14 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.177 -0.952 . . . . 0.0 110.325 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.647 ' HG3' ' CG ' ' A' ' 4' ' ' PHE . 12.9 ptt180 -75.71 -32.52 60.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.298 -0.876 . . . . 0.0 111.14 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -89.15 67.71 8.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.928 -1.108 . . . . 0.0 109.252 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.636 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 47.0 t-20 -169.1 74.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.537 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.1 m-85 -84.84 139.69 31.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 0.0 110.279 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.22 -21.33 58.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -0.99 . . . . 0.0 110.304 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -134.15 156.31 48.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 0.0 110.173 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.46 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -67.54 -24.77 65.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.407 -0.808 . . . . 0.0 109.83 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -74.33 -32.57 62.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.504 -0.748 . . . . 0.0 109.968 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -70.75 -37.16 73.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.898 . . . . 0.0 109.201 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.537 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 52.6 t -73.21 -44.35 59.82 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.503 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -61.86 -51.74 66.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.48 -0.763 . . . . 0.0 109.707 179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.0 mtm180 -52.55 -23.98 7.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.279 -0.888 . . . . 0.0 109.612 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.874 HG22 ' SG ' ' A' ' 55' ' ' CYS . 6.4 m -89.18 -48.96 7.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.437 -0.789 . . . . 0.0 109.82 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.874 ' SG ' HG22 ' A' ' 54' ' ' THR . 72.2 m -141.81 51.4 1.53 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.253 -0.905 . . . . 0.0 110.411 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -102.48 -179.52 27.05 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.03 105.67 0.03 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.195 -1.179 . . . . 0.0 110.284 -179.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.465 ' HG2' ' SG ' ' A' ' 55' ' ' CYS . 12.9 mtt85 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.615 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 37.8 Cg_endo -69.56 149.49 68.25 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.94 1.494 . . . . 0.0 110.726 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.97 -31.39 71.93 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.726 -0.789 . . . . 0.0 110.147 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 9.1 p90 -68.39 -22.16 64.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.895 -1.128 . . . . 0.0 110.487 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 5.0 t -82.34 -24.59 34.49 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.82 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 2' ' ' PRO . 20.4 mt -90.83 -14.61 31.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.277 -0.89 . . . . 0.0 109.587 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.533 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 0.3 OUTLIER -78.01 156.63 79.5 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.419 -0.801 . . . . 0.0 109.624 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.21 163.68 35.22 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.77 1.405 . . . . 0.0 110.071 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.532 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.8 Cg_endo -67.65 -176.45 0.94 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.876 1.461 . . . . 0.0 110.158 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -146.34 93.76 2.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.135 -0.978 . . . . 0.0 110.848 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.503 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -60.31 -22.67 63.46 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.14 170.62 1.05 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' CYS . 49.5 Cg_endo -75.13 -95.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.97 1.511 . . . . 0.0 109.956 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 39.39 -160.97 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.185 -0.947 . . . . 0.0 110.525 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.77 48.68 1.61 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.14 -0.975 . . . . 0.0 110.247 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -137.02 179.65 6.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 110.29 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -153.4 70.05 0.84 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.781 . . . . 0.0 109.577 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.488 HD12 ' HA ' ' A' ' 37' ' ' ALA . 76.9 mt -80.34 157.93 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.581 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.55 79.02 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.339 -0.85 . . . . 0.0 110.298 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.589 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 10.0 mmt85 -84.97 173.24 10.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.165 -0.96 . . . . 0.0 110.05 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.509 ' CE1' HG22 ' A' ' 32' ' ' THR . 6.8 m-85 -112.83 144.87 41.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.906 . . . . 0.0 110.938 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 7.0 p90 -144.05 163.61 33.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.522 -0.737 . . . . 0.0 109.186 178.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.605 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 77.5 t80 -96.59 120.22 36.5 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.049 -1.032 . . . . 0.0 111.033 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.631 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 45.8 t-20 -89.95 91.99 8.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.127 -0.983 . . . . 0.0 109.727 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.17 -27.33 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.102 -0.999 . . . . 0.0 109.737 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.415 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -75.62 -24.77 56.51 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.675 179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.23 -36.01 12.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.739 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.96 -9.0 65.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.566 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 1.1 mp -125.84 -146.67 0.35 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.039 -1.271 . . . . 0.0 109.638 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 99.1 m -122.38 149.02 44.38 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.528 -0.733 . . . . 0.0 110.118 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 97.4 mt-30 -139.34 178.27 7.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.384 -0.823 . . . . 0.0 109.901 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.509 HG22 ' CE1' ' A' ' 21' ' ' TYR . 44.2 p -105.07 147.75 27.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 110.784 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.532 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 21.0 p90 -142.43 163.79 31.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.574 -0.703 . . . . 0.0 110.004 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 11' ' ' THR . 83.0 t -75.16 110.46 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 4.7 t80 -94.07 144.56 25.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.354 -0.841 . . . . 0.0 110.322 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.76 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -76.95 4.98 51.68 Favored Glycine 0 N--CA 1.497 2.704 0 O-C-N 121.104 -0.997 . . . . 0.0 110.901 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.76 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.5 -1.98 2.78 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.201 -1.176 . . . . 0.0 111.294 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.448 ' N ' ' CZ ' ' A' ' 35' ' ' TYR . 21.7 p -150.47 174.37 12.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.952 -1.093 . . . . 0.0 110.199 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' CYS . 1.3 mtt-85 42.92 52.82 5.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.232 -0.917 . . . . 0.0 109.799 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -91.08 140.67 29.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 111.096 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.65 -165.63 1.28 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.442 -0.786 . . . . 0.0 108.923 178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -70.04 -36.6 75.14 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.987 -1.07 . . . . 0.0 110.13 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 7.8 t-20 -76.06 54.49 0.86 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.158 -0.964 . . . . 0.0 109.905 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.544 ' ND2' ' HB1' ' A' ' 40' ' ' ALA . 41.8 t-20 -155.79 69.13 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.592 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 12.4 m-85 -89.83 166.07 13.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.515 -0.741 . . . . 0.0 110.238 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.0 mttt -92.1 -9.33 42.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.047 -1.033 . . . . 0.0 110.216 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -148.51 155.22 40.88 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.622 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.45 -26.75 68.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.647 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 5.1 mt-10 -72.33 -32.87 66.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.455 -0.778 . . . . 0.0 109.6 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 39.8 t0 -70.65 -36.55 73.45 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 0.0 108.866 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 13.0 t -70.98 -44.49 65.87 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.545 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -63.52 -59.63 4.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.591 -0.693 . . . . 0.0 109.997 179.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -43.23 -26.37 0.17 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.01 -1.056 . . . . 0.0 109.695 179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.436 ' N ' ' O ' ' A' ' 52' ' ' MET . 1.5 m -97.89 -36.36 10.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.539 -0.726 . . . . 0.0 109.815 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.465 ' SG ' ' HG2' ' A' ' 1' ' ' ARG . 2.3 t -136.58 47.74 2.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.48 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -92.01 132.9 11.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 58' ' ' ALA . . . 157.04 -140.92 7.48 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 57' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.379 -1.071 . . . . 0.0 110.34 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.4 Cg_endo -70.0 156.68 62.13 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.065 1.56 . . . . 0.0 110.405 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -79.26 -26.95 42.31 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.772 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.626 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 6.3 p90 -67.74 -19.46 65.13 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.279 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 2.1 m -80.88 -26.97 36.5 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 0.0 109.265 179.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.58 -18.18 42.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.466 -0.771 . . . . 0.0 109.801 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.57 159.52 83.2 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 109.962 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -73.38 171.96 16.62 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.01 1.532 . . . . 0.0 110.434 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.626 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.3 Cg_endo -71.74 166.26 30.01 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.932 1.491 . . . . 0.0 110.169 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 5.3 t80 -123.0 94.03 4.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.143 -0.973 . . . . 0.0 111.048 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.492 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -64.48 -22.25 66.91 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 56.6 166.32 0.06 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 14' ' ' CYS . 50.7 Cg_endo -72.86 -96.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.961 1.506 . . . . 0.0 109.733 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.47 ' O ' ' O ' ' A' ' 13' ' ' PRO . 3.1 m 38.62 -160.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.271 -0.893 . . . . 0.0 110.496 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.24 42.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.066 -1.021 . . . . 0.0 110.116 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.27 150.83 35.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.325 -0.859 . . . . 0.0 110.215 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.92 83.27 2.02 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.122 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mt -106.54 158.83 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.912 . . . . 0.0 110.054 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.1 mm -99.84 89.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.194 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -91.28 173.93 7.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.92 . . . . 0.0 110.351 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.518 ' CE1' ' CG2' ' A' ' 32' ' ' THR . 30.7 m-85 -115.6 150.45 36.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 111.176 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -153.33 154.66 34.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.533 -0.73 . . . . 0.0 109.487 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.505 ' HB2' ' SG ' ' A' ' 55' ' ' CYS . 66.5 t80 -85.34 116.47 23.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.386 -0.821 . . . . 0.0 110.528 -179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.593 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 63.8 t-20 -89.28 93.96 9.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 0.0 110.013 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -50.17 -21.7 1.42 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.753 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.477 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.3 OUTLIER -81.05 -22.87 38.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.28 -0.887 . . . . 0.0 109.861 179.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.593 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -97.57 -28.06 14.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.237 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.51 -10.13 69.06 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.67 HD12 ' O ' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -134.25 -146.11 0.25 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.216 -1.167 . . . . 0.0 109.523 179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.67 ' O ' HD12 ' A' ' 29' ' ' LEU . 60.8 m -116.04 154.62 29.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -0.934 . . . . 0.0 110.779 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -142.0 154.91 45.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.484 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 18.9 p -83.49 144.86 29.27 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.167 -0.958 . . . . 0.0 110.2 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.626 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.2 p90 -140.97 164.2 30.92 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 0.0 110.351 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' THR . 22.9 t -74.37 125.63 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.402 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.695 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -106.13 147.65 28.74 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 0.0 110.413 -178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.758 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -90.77 -4.1 70.17 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.758 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.72 5.46 5.22 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.161 -1.2 . . . . 0.0 110.845 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.8 p -157.49 164.32 37.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.883 -1.136 . . . . 0.0 110.855 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 0.2 OUTLIER 50.63 34.72 10.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 0.0 110.328 -179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -84.63 164.69 18.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.305 -0.872 . . . . 0.0 110.74 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -121.5 -159.69 0.82 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.373 -0.829 . . . . 0.0 109.637 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.569 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 2.7 mtm180 -77.51 -8.86 58.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.944 -1.098 . . . . 0.0 109.766 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -94.11 59.39 2.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.339 -0.851 . . . . 0.0 109.694 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.581 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 14.8 t-20 -165.23 84.01 0.37 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.557 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.9 m-85 -93.97 150.71 20.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 110.708 -178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.495 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 16.4 mtpt -81.51 -12.24 58.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.354 -0.841 . . . . 0.0 109.945 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -142.45 156.52 45.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.296 -0.878 . . . . 0.0 110.186 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.441 ' HB2' ' CE1' ' A' ' 21' ' ' TYR . . . -74.12 -22.56 59.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.852 . . . . 0.0 109.953 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 5.1 tp10 -70.68 -35.95 73.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.355 -0.841 . . . . 0.0 110.482 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 54' ' ' THR . 0.4 OUTLIER -78.76 -35.44 44.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 0.0 109.668 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.557 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 13.3 t -67.97 -44.19 77.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.338 -0.851 . . . . 0.0 109.282 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.451 ' SD ' ' HA2' ' A' ' 56' ' ' GLY . 39.1 tpp -64.35 -61.05 2.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.573 -0.705 . . . . 0.0 110.514 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.49 -18.97 21.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.54 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.7 m -88.12 -45.62 9.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.292 -0.88 . . . . 0.0 110.116 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 23' ' ' TYR . 58.1 m -99.6 -50.4 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.285 -0.884 . . . . 0.0 110.498 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.451 ' HA2' ' SD ' ' A' ' 52' ' ' MET . . . 46.89 -160.83 0.27 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.48 62.93 0.83 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.308 -1.113 . . . . 0.0 110.237 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.848 0.356 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.633 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 43.7 Cg_endo -72.74 169.81 21.09 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.145 1.603 . . . . 0.0 110.95 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -91.93 -23.42 19.6 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.509 -0.744 . . . . 0.0 109.574 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.633 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 19.1 p90 -68.05 -21.79 64.98 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.557 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.487 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -80.85 -19.0 45.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.677 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.735 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 18.4 mt -74.38 -24.68 59.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 7.2 mt-10 -79.04 161.61 67.71 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 110.32 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 41.7 Cg_endo -69.76 168.28 22.02 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.108 1.583 . . . . 0.0 110.359 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.621 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.8 Cg_endo -71.08 156.98 58.87 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.963 1.507 . . . . 0.0 110.517 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.6 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 40.9 t80 -121.39 94.26 4.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.261 -0.9 . . . . 0.0 110.883 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.2 m -56.05 -23.5 33.9 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.6 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 63.27 -178.12 6.64 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.345 -1.102 . . . . 0.0 110.345 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 45.7 Cg_endo -72.24 -155.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 124.175 1.618 . . . . 0.0 110.685 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 11.9 m 64.24 154.77 0.06 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 110.324 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.97 6.34 46.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.188 -0.945 . . . . 0.0 109.986 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.22 169.21 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 110.102 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.94 102.37 2.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.838 . . . . 0.0 109.847 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.641 HG21 ' NH2' ' A' ' 20' ' ' ARG . 28.6 mt -134.23 145.99 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.349 -0.844 . . . . 0.0 110.059 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.401 HG23 ' HB ' ' A' ' 32' ' ' THR . 41.2 mm -90.37 85.58 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 110.162 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.641 ' NH2' HG21 ' A' ' 18' ' ' ILE . 9.1 mmt-85 -91.02 176.91 6.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 109.927 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 71.6 m-85 -114.0 154.18 28.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 111.528 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 11.8 p90 -153.0 154.43 34.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.651 -0.656 . . . . 0.0 109.405 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 89.1 t80 -83.99 106.88 15.99 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.269 -0.894 . . . . 0.0 111.013 -178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.524 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 55.3 t-20 -80.24 98.54 7.42 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.244 -0.91 . . . . 0.0 109.938 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -50.86 -23.35 2.74 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.976 -1.077 . . . . 0.0 109.559 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.402 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -77.81 -23.71 49.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.448 -0.782 . . . . 0.0 110.209 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -99.79 -14.52 18.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.892 . . . . 0.0 110.69 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.02 1.75 85.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.671 HD12 ' N ' ' A' ' 30' ' ' CYS . 1.8 pp -144.27 -147.35 0.21 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.383 -1.069 . . . . 0.0 109.102 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.671 ' N ' HD12 ' A' ' 29' ' ' LEU . 79.4 m -121.96 162.2 21.5 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 110.607 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 21' ' ' TYR . 95.7 mt-30 -144.87 -175.36 4.65 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.607 -0.683 . . . . 0.0 109.395 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 25.2 p -103.13 144.15 31.68 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.994 -1.066 . . . . 0.0 110.501 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.621 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.8 p90 -141.8 160.53 40.0 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.213 -0.929 . . . . 0.0 110.056 178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.7 t -74.05 122.35 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.035 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.669 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.7 t80 -101.26 141.33 34.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 110.105 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.753 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.57 -0.53 79.03 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 120.09 -1.052 . . . . 0.0 110.563 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.753 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.4 -1.37 2.96 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.191 -1.182 . . . . 0.0 111.074 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.405 ' O ' ' C ' ' A' ' 39' ' ' ARG . 15.8 p -140.68 163.09 33.82 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.822 -1.174 . . . . 0.0 111.03 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.442 ' HB2' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER 41.77 45.5 3.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.465 -0.772 . . . . 0.0 110.911 179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.669 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -73.78 146.66 44.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.751 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HD3' ' HB2' ' A' ' 10' ' ' TYR . 42.5 mtpt -95.06 -159.91 0.75 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.26 -0.9 . . . . 0.0 109.535 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 8.3 mtt-85 -85.55 -22.73 27.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.146 -0.971 . . . . 0.0 109.869 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.488 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . 21.0 t-20 -89.07 53.86 2.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 0.0 110.14 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.518 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 3.9 t-20 -143.93 84.55 1.78 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.488 ' CE1' ' HA ' ' A' ' 43' ' ' ASN . 23.8 m-85 -99.6 153.34 19.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 110.552 -178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -76.24 -20.93 56.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.409 -0.807 . . . . 0.0 110.579 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.9 p -137.67 156.65 47.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.38 -0.825 . . . . 0.0 110.614 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.01 68.53 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.465 -0.772 . . . . 0.0 109.582 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.97 -38.52 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.414 -0.804 . . . . 0.0 110.464 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -62.04 -34.41 76.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.084 -1.01 . . . . 0.0 108.557 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 53.9 t -71.17 -43.18 67.99 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.535 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.13 -50.45 33.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.524 -0.735 . . . . 0.0 110.36 -179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.67 -22.96 25.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.019 -1.051 . . . . 0.0 109.629 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.566 HG22 ' SG ' ' A' ' 55' ' ' CYS . 16.4 m -94.37 -45.85 7.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.532 -0.73 . . . . 0.0 109.914 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.566 ' SG ' HG22 ' A' ' 54' ' ' THR . 56.7 m -116.75 38.06 3.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.39 -0.819 . . . . 0.0 110.501 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -91.92 25.3 17.26 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.06 -68.0 1.29 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.346 -1.091 . . . . 0.0 110.458 -179.647 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.481 ' HG3' ' HD2' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.613 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 39.2 Cg_endo -68.08 163.17 36.96 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.003 1.528 . . . . 0.0 110.456 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.411 ' HA ' ' HG ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -105.3 -15.2 15.11 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.939 179.81 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.74 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 14.9 p90 -66.27 -17.03 64.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.048 -1.033 . . . . 0.0 110.23 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.531 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -85.5 -8.3 58.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.185 -0.947 . . . . 0.0 110.022 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.664 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 27.5 mt -76.59 -23.28 53.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.439 -0.788 . . . . 0.0 109.953 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -81.8 174.38 6.19 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.35 -0.844 . . . . 0.0 110.349 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.78 165.85 30.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 O-C-N 123.872 1.459 . . . . 0.0 110.31 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.599 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.3 Cg_endo -71.62 -175.99 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.967 1.509 . . . . 0.0 110.26 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 67.6 t80 -127.63 93.88 3.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.699 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.46 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -65.83 -22.62 66.56 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 11' ' ' THR . . . 60.32 151.79 0.01 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.16 82.54 1.79 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.97 1.51 . . . . 0.0 110.513 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -146.46 175.88 10.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.874 . . . . 0.0 110.155 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -108.9 -1.03 19.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -0.927 . . . . 0.0 110.144 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -68.31 160.67 28.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.23 -0.919 . . . . 0.0 110.101 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.14 68.47 1.44 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.308 -0.87 . . . . 0.0 109.943 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 53.0 mt -96.72 153.11 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 110.075 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 28.9 mm -98.01 86.39 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.303 -0.873 . . . . 0.0 110.37 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.56 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 3.3 mmt180 -86.59 173.15 9.74 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 110.105 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 48' ' ' ALA . 64.5 m-85 -112.69 151.12 30.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.09 -1.006 . . . . 0.0 110.954 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 8.3 p90 -150.56 163.63 38.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.66 -0.65 . . . . 0.0 109.403 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 70.7 t80 -87.2 132.14 33.97 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.027 -1.046 . . . . 0.0 110.718 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.743 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 34.8 t-20 -102.89 87.9 3.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.158 -0.964 . . . . 0.0 109.815 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.664 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.13 -32.34 1.77 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.093 -1.005 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 1.9 mptp? -72.84 -24.51 60.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.374 -0.829 . . . . 0.0 109.865 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.743 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -98.2 -33.69 11.02 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.88 . . . . 0.0 110.16 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.01 -12.37 58.96 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -127.91 -144.23 0.29 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.301 -1.117 . . . . 0.0 109.504 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 97.8 m -121.69 157.24 31.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.559 -0.713 . . . . 0.0 110.535 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 30' ' ' CYS . 6.6 mt-30 -140.23 -177.51 5.05 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.444 -0.785 . . . . 0.0 109.51 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 19.8 p -102.37 144.4 30.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.046 -1.034 . . . . 0.0 110.546 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.599 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.6 p90 -141.57 160.28 40.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.79 108.34 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.249 -0.907 . . . . 0.0 110.832 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.984 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -87.44 146.22 25.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.447 -0.783 . . . . 0.0 109.962 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.72 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -85.65 -4.44 85.34 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.68 12.45 7.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.147 -1.207 . . . . 0.0 110.314 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 39' ' ' ARG . 27.0 p -150.11 162.88 39.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.152 -0.968 . . . . 0.0 110.294 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.575 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.1 mtt-85 40.65 44.42 1.81 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.984 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -62.64 155.11 27.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.551 ' HD2' ' CD1' ' A' ' 10' ' ' TYR . 2.4 mtpp -121.03 -157.8 0.73 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.368 -0.832 . . . . 0.0 109.578 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.74 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -83.23 -22.5 33.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 0.0 109.978 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 1.7 t-20 -90.13 54.29 2.75 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.768 0.794 . . . . 0.0 109.04 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.586 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 19.4 t-20 -157.5 76.5 0.82 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 22.9 m-85 -87.74 134.78 33.6 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.433 -0.792 . . . . 0.0 109.849 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -65.71 -16.61 63.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.287 -0.883 . . . . 0.0 111.34 -178.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.485 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 99.2 p -143.43 158.02 43.99 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.002 -1.062 . . . . 0.0 110.434 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' ' CE2' ' A' ' 21' ' ' TYR . . . -64.8 -29.08 70.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -0.865 . . . . 0.0 109.066 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.66 -25.37 56.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.646 -0.659 . . . . 0.0 109.812 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.485 ' HB2' ' OG ' ' A' ' 47' ' ' SER . 39.2 t0 -78.64 -30.59 46.49 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.347 -0.846 . . . . 0.0 109.514 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.547 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 39.9 t -78.65 -43.96 24.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.412 -0.805 . . . . 0.0 109.225 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.504 ' O ' ' N ' ' A' ' 56' ' ' GLY . 72.9 mmm -66.28 -49.39 67.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.484 -0.76 . . . . 0.0 110.309 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -62.23 -14.52 39.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 109.849 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.505 HG22 ' HZ ' ' A' ' 4' ' ' PHE . 47.6 m -92.14 -53.56 4.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.162 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.575 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 57.6 m -110.89 20.41 17.56 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.332 -0.855 . . . . 0.0 110.687 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -66.27 -177.54 7.95 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 58' ' ' ALA . . . 117.75 -126.88 7.1 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 57' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.235 . . . . 0.0 110.154 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.475 ' HD2' HD21 ' A' ' 6' ' ' LEU . 2.1 ttp-105 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.655 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 38.5 Cg_endo -67.87 169.1 16.98 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 124.039 1.547 . . . . 0.0 111.115 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.45 -18.01 13.63 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.55 -0.719 . . . . 0.0 109.942 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.655 ' CE2' ' HB2' ' A' ' 2' ' ' PRO . 37.7 p90 -66.35 -24.09 66.46 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 118.671 -1.212 . . . . 0.0 109.877 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.536 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 1.7 m -85.54 -19.47 31.08 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.887 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.714 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 15.1 mt -82.77 -19.03 38.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.203 -0.936 . . . . 0.0 110.837 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -86.1 169.86 14.31 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 120.93 -1.106 . . . . 0.0 109.864 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.94 163.71 36.52 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.889 1.468 . . . . 0.0 110.183 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.604 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 41.6 Cg_endo -71.41 163.51 38.83 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.947 1.498 . . . . 0.0 110.516 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.437 ' HB3' ' HG3' ' A' ' 41' ' ' LYS . 17.5 t80 -120.77 93.88 4.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.32 -0.863 . . . . 0.0 110.269 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.2 m -50.62 -23.44 2.6 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.92 -176.17 21.99 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.512 ' CG ' ' HG3' ' A' ' 39' ' ' ARG . 48.8 Cg_endo -79.21 -153.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.075 1.566 . . . . 0.0 109.992 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 32.1 m 63.05 170.3 0.14 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.114 -0.991 . . . . 0.0 110.535 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -116.23 10.12 14.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.369 -0.832 . . . . 0.0 110.344 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.98 159.1 7.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.3 -0.875 . . . . 0.0 110.679 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -130.64 78.71 1.86 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 0.0 109.31 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.757 HD11 ' HB2' ' A' ' 37' ' ' ALA . 6.0 mt -104.31 156.14 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.883 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.439 HG23 ' HB ' ' A' ' 32' ' ' THR . 44.3 mm -99.77 80.72 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.455 -0.778 . . . . 0.0 109.984 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.572 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 9.0 mmt180 -85.95 174.61 9.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.098 -1.001 . . . . 0.0 109.674 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -114.27 143.69 44.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.998 -1.064 . . . . 0.0 110.864 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 20.5 p90 -138.19 152.14 48.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.532 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 62.8 t80 -79.19 106.11 10.99 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.342 -0.849 . . . . 0.0 111.253 -178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' ALA . 53.0 t-20 -79.14 84.84 5.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.117 -0.99 . . . . 0.0 109.476 178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.714 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.56 -26.03 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.925 -1.109 . . . . 0.0 109.439 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -28.67 64.26 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.348 -0.845 . . . . 0.0 109.579 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.5 -24.11 16.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 110.463 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' O ' ' HA2' ' A' ' 57' ' ' GLY . . . 96.34 1.26 60.9 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 24' ' ' ASN . 0.6 OUTLIER -149.44 -142.2 0.12 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.319 -1.106 . . . . 0.0 109.227 -179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 1.2 m -117.55 164.2 15.27 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.129 0.966 . . . . 0.0 112.209 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 24.7 mt-30 -147.67 160.86 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 20' ' ' ARG . 2.2 p -79.7 144.15 33.95 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.949 -1.094 . . . . 0.0 111.13 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.604 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 13.5 p90 -144.08 160.73 40.38 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 11' ' ' THR . 9.1 t -74.01 129.25 36.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.263 -0.898 . . . . 0.0 110.19 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.893 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -113.84 146.58 39.77 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.676 -0.64 . . . . 0.0 109.359 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.713 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.34 4.41 84.22 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.757 ' HB2' HD11 ' A' ' 18' ' ' ILE . . . 68.96 4.59 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.94 -1.329 . . . . 0.0 110.207 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.455 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 7.9 p -145.01 159.27 43.21 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.199 -0.938 . . . . 0.0 110.415 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.512 ' HG3' ' CG ' ' A' ' 13' ' ' PRO . 0.4 OUTLIER 51.47 33.12 9.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.215 -0.928 . . . . 0.0 110.794 179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.893 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -59.77 142.13 53.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.086 -1.009 . . . . 0.0 110.46 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.437 ' HG3' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -102.79 -170.29 1.78 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.321 -0.862 . . . . 0.0 110.063 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.565 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 2.6 mtt-85 -71.73 -25.33 62.02 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.083 -1.01 . . . . 0.0 109.782 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' ' 5' ' ' CYS . 11.3 t-20 -92.91 54.38 2.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.914 . . . . 0.0 109.982 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.472 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 22.6 t-20 -153.43 70.39 0.85 Allowed 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.565 ' CZ ' ' O ' ' A' ' 42' ' ' ARG . 13.1 m-85 -88.2 146.25 25.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.442 -0.786 . . . . 0.0 110.126 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 26.7 ttmt -76.89 -18.95 58.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 110.59 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.9 p -136.24 152.34 50.64 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 110.398 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.3 -26.38 67.29 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.5 -0.75 . . . . 0.0 109.907 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.506 ' N ' ' OE1' ' A' ' 49' ' ' GLU . 3.4 mp0 -73.4 -19.87 60.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.675 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.5 t0 -83.32 -29.64 28.13 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.346 -0.846 . . . . 0.0 108.722 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.66 -45.97 56.25 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.41 0.624 . . . . 0.0 109.5 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.555 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -61.64 -54.55 41.29 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.349 -0.845 . . . . 0.0 110.865 -178.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -53.09 -19.1 2.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 110.149 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.608 HG22 ' SG ' ' A' ' 55' ' ' CYS . 40.9 m -97.28 -59.61 1.75 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.12 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.608 ' SG ' HG22 ' A' ' 54' ' ' THR . 57.1 m -112.16 -56.63 2.37 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.0 109.651 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.555 ' CA ' ' HA ' ' A' ' 52' ' ' MET . . . 54.52 167.24 0.03 OUTLIER Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.666 ' O ' ' HB2' ' A' ' 58' ' ' ALA . . . -48.33 -95.33 0.01 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 57' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.142 -1.211 . . . . 0.0 110.205 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.3 mtm-85 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 120.86 0.362 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.622 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.2 Cg_endo -68.61 162.89 39.11 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.965 1.508 . . . . 0.0 110.624 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.62 -25.47 21.27 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.723 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.628 ' CD1' ' HB2' ' A' ' 42' ' ' ARG . 42.5 p90 -68.01 -19.05 64.88 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.871 -1.131 . . . . 0.0 111.248 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.598 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 94.8 m -82.84 -25.15 32.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.9 -1.125 . . . . 0.0 109.248 178.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.401 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.7 mt -80.25 -22.93 41.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.415 -0.803 . . . . 0.0 109.485 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 5.9 mm-40 -73.07 154.85 90.63 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.37 -0.831 . . . . 0.0 109.441 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.19 167.04 24.83 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 123.927 1.488 . . . . 0.0 110.401 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.615 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.7 Cg_endo -69.22 159.05 55.33 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.027 1.541 . . . . 0.0 110.062 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD2' ' O ' ' A' ' 39' ' ' ARG . 30.1 t80 -122.78 94.04 4.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.195 -0.941 . . . . 0.0 111.115 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.479 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 62.76 172.31 1.68 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 14' ' ' CYS . 45.9 Cg_endo -72.74 -93.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.983 1.517 . . . . 0.0 110.277 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.7 m 39.99 -162.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.208 -0.932 . . . . 0.0 110.61 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -141.61 8.98 1.98 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' O ' ' CD ' ' A' ' 17' ' ' ARG . . . -93.16 173.54 7.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.197 -0.939 . . . . 0.0 110.024 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' CD ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -150.08 81.97 1.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 110.354 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.543 ' H ' HD12 ' A' ' 18' ' ' ILE . 3.2 mp -95.53 164.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -0.907 . . . . 0.0 109.983 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.3 mm -100.87 89.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 110.307 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.519 HH21 HG21 ' A' ' 18' ' ' ILE . 3.6 mmt85 -95.42 177.27 5.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.221 -0.924 . . . . 0.0 109.948 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.526 ' CE1' HG23 ' A' ' 32' ' ' THR . 51.1 m-85 -116.09 151.03 36.38 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.079 -1.013 . . . . 0.0 111.156 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 11.9 p90 -147.72 158.92 44.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.507 -0.745 . . . . 0.0 109.523 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.627 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 68.8 t80 -88.89 107.7 19.14 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.281 -0.887 . . . . 0.0 110.895 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.536 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 62.4 t-20 -83.77 89.59 7.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 110.014 179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.38 -24.99 0.57 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.001 -1.062 . . . . 0.0 109.535 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -75.53 -25.97 57.66 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.365 -0.835 . . . . 0.0 109.714 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.61 -28.9 15.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.57 -10.31 59.22 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.491 HD23 ' N ' ' A' ' 29' ' ' LEU . 1.3 pt? -140.52 -147.05 0.21 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.25 -1.147 . . . . 0.0 109.841 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 99.4 m -115.69 156.92 25.05 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.421 -0.799 . . . . 0.0 110.551 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.521 HE22 ' HB2' ' A' ' 27' ' ' ALA . 45.3 mt-30 -144.02 178.69 7.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.476 -0.765 . . . . 0.0 109.566 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.526 HG23 ' CE1' ' A' ' 21' ' ' TYR . 3.3 p -95.93 144.6 26.11 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.127 -0.983 . . . . 0.0 110.418 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.615 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.4 p90 -143.53 165.06 28.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.488 -0.757 . . . . 0.0 109.83 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.457 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 63.2 t -75.16 132.08 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.984 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.671 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -112.71 146.81 38.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 109.864 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.735 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -99.72 1.96 57.0 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.7 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 70.59 1.73 3.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.007 -1.29 . . . . 0.0 110.971 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' C ' ' A' ' 39' ' ' ARG . 22.3 p -149.53 172.43 15.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.9 -1.125 . . . . 0.0 110.482 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.5 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 1.5 mpt_? 40.63 30.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.451 -0.781 . . . . 0.0 110.018 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.671 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -73.49 156.97 37.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.447 -0.783 . . . . 0.0 111.031 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.461 ' HD2' ' HB2' ' A' ' 10' ' ' TYR . 7.5 mtpt -110.33 -169.8 1.53 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.481 -0.762 . . . . 0.0 109.443 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.628 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . 2.7 mtt-85 -76.7 -15.65 59.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.002 -1.061 . . . . 0.0 110.26 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 7' ' ' GLU . 15.1 t-20 -90.39 53.79 2.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.089 -1.007 . . . . 0.0 109.473 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.559 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 12.0 t-20 -147.74 77.64 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 51' ' ' CYS . 17.9 m-85 -94.32 143.84 26.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.432 -0.793 . . . . 0.0 110.24 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 43.6 mttt -64.66 -27.24 68.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.347 -0.846 . . . . 0.0 110.294 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.7 p -136.53 157.65 46.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 0.0 110.414 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.61 -24.88 66.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.369 -0.832 . . . . 0.0 109.956 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -69.15 -23.71 63.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.334 -0.854 . . . . 0.0 110.026 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 46.9 t0 -90.18 -24.7 20.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.852 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.542 ' HB2' ' CD1' ' A' ' 45' ' ' PHE . 29.7 t -82.15 -43.96 17.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 109.808 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.43 ' HA ' ' H ' ' A' ' 56' ' ' GLY . 14.2 mtp -66.81 -50.25 63.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 0.0 110.547 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.09 -17.59 2.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.177 -0.952 . . . . 0.0 110.358 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -110.76 -42.14 4.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.627 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.3 m -99.09 -40.16 8.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.162 -0.961 . . . . 0.0 110.432 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 55' ' ' CYS . . . -41.14 98.56 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.964 -1.254 . . . . 0.0 109.964 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 55' ' ' CYS . . . -100.65 -125.88 5.66 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.198 -1.178 . . . . 0.0 110.247 179.902 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.109 0.481 . . . . 0.0 110.011 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.66 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.7 Cg_endo -69.68 162.01 43.71 Favored 'Trans proline' 0 C--N 1.301 -1.946 0 O-C-N 124.312 1.69 . . . . 0.0 111.193 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -87.35 -24.54 24.23 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.568 -0.707 . . . . 0.0 109.78 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.66 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 14.5 p90 -66.36 -13.94 61.34 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.02 -1.05 . . . . 0.0 110.142 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.6 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 6.4 m -85.3 -22.45 28.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.819 . . . . 0.0 110.646 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.2 mt -95.71 -2.78 47.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.74 -1.225 . . . . 0.0 110.293 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -94.47 170.61 7.91 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.437 -0.789 . . . . 0.0 110.603 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.01 166.79 28.44 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.152 1.606 . . . . 0.0 110.35 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.588 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 43.3 Cg_endo -70.78 -173.13 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.702 0 O-C-N 123.883 1.465 . . . . 0.0 109.595 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.59 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 65.5 t80 -154.65 93.92 1.62 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.912 -1.117 . . . . 0.0 110.691 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.402 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -58.68 -23.18 58.92 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.59 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 66.19 155.68 0.34 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.07 66.38 1.36 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.05 1.553 . . . . 0.0 110.31 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.491 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 23.0 m -121.7 -174.91 2.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.533 -0.729 . . . . 0.0 109.825 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -120.68 12.33 11.41 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.114 -0.991 . . . . 0.0 110.299 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.96 166.69 11.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 110.268 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.452 ' HG3' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -144.0 68.18 1.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 110.005 179.876 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 35' ' ' TYR . 61.4 mt -87.46 155.36 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.432 -0.792 . . . . 0.0 110.123 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.1 mm -93.5 89.0 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.557 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.8 mmt85 -99.52 -179.19 4.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.256 -0.903 . . . . 0.0 110.383 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.536 ' CZ ' HG23 ' A' ' 32' ' ' THR . 10.7 m-85 -116.81 153.46 32.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.125 -0.984 . . . . 0.0 111.328 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.592 ' CD1' ' HB3' ' A' ' 33' ' ' PHE . 15.5 p90 -149.06 176.77 10.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.519 -0.738 . . . . 0.0 109.361 178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD2' ' HB3' ' A' ' 55' ' ' CYS . 0.8 OUTLIER -95.03 100.57 12.38 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.189 -0.944 . . . . 0.0 110.666 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' A' ' 27' ' ' ALA . 48.8 t-20 -86.11 69.46 10.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 120.656 -1.278 . . . . 0.0 108.337 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -46.78 -26.04 0.87 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.435 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' N ' ' C ' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -62.08 -37.28 84.44 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -83.58 -31.86 26.09 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.526 -0.734 . . . . 0.0 109.587 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.09 -10.71 10.05 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.625 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.32 -141.89 0.11 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.754 -1.439 . . . . 0.0 109.889 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 96.2 m -107.2 151.93 24.77 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.466 -0.771 . . . . 0.0 109.595 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.499 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 5.7 mt-30 -141.59 179.38 6.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 110.467 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.536 HG23 ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -91.54 148.14 22.5 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.394 -0.817 . . . . 0.0 109.877 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.592 ' HB3' ' CD1' ' A' ' 22' ' ' PHE . 13.4 p90 -148.14 166.08 28.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.3 -0.875 . . . . 0.0 110.483 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.452 ' CG1' ' HG3' ' A' ' 17' ' ' ARG . 13.2 t -74.64 122.34 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.37 -0.831 . . . . 0.0 110.275 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.6 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.5 t80 -103.66 142.7 33.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.412 -0.805 . . . . 0.0 109.658 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.754 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.42 -0.98 78.94 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.886 -1.15 . . . . 0.0 110.545 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.6 0.81 3.76 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.171 -1.194 . . . . 0.0 110.176 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -153.9 173.55 15.79 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.216 -0.928 . . . . 0.0 109.954 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 44.72 26.34 0.19 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 0.0 109.522 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -63.52 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 110.655 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.538 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.9 mtpp -95.83 -162.99 1.0 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.381 -0.825 . . . . 0.0 109.243 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.624 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 11.3 mtm180 -84.65 -9.33 58.36 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.002 -1.061 . . . . 0.0 109.979 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.528 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 4.2 t-20 -96.97 53.99 1.24 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.561 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 13.6 t-20 -144.26 84.2 1.75 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 27.8 m-85 -101.21 164.51 11.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.313 -0.867 . . . . 0.0 110.443 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -91.99 -16.23 26.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.021 . . . . 0.0 110.277 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.507 ' OG ' ' HB2' ' A' ' 50' ' ' ASP . 97.8 p -141.5 154.81 45.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.577 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.02 -27.87 66.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.588 -0.695 . . . . 0.0 110.001 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.23 -15.04 60.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.726 . . . . 0.0 110.135 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.557 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 21.3 t70 -94.58 -25.39 16.82 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.45 -0.781 . . . . 0.0 109.599 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 55' ' ' CYS . 7.3 t -73.84 -49.12 26.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.366 -0.833 . . . . 0.0 109.402 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.542 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -65.67 -49.02 70.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.52 -0.738 . . . . 0.0 110.442 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.557 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -45.26 -29.32 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.892 -1.13 . . . . 0.0 109.472 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.462 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 1.2 m -104.56 -31.55 9.38 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.699 0.761 . . . . 0.0 109.083 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.639 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 92.9 m -100.6 20.0 15.9 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.612 -0.68 . . . . 0.0 110.92 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -129.1 170.76 20.1 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 109.73 31.3 3.22 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.187 -1.184 . . . . 0.0 110.182 179.969 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 120.922 0.392 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.617 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.2 Cg_endo -70.94 154.8 62.9 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.118 1.588 . . . . 0.0 111.267 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.63 -30.68 64.52 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.506 -0.746 . . . . 0.0 110.061 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 5.1 p90 -67.97 -20.13 65.01 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.892 -1.13 . . . . 0.0 109.565 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.616 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 2.2 t -77.91 -29.27 50.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.691 -0.631 . . . . 0.0 109.793 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.408 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 13.1 mt -87.7 -10.09 52.22 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 109.51 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -76.27 153.32 84.16 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.526 -0.734 . . . . 0.0 109.647 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 43.2 Cg_endo -70.56 174.45 10.19 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 O-C-N 123.979 1.516 . . . . 0.0 110.071 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 42.7 Cg_endo -73.05 155.42 52.58 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.841 1.443 . . . . 0.0 109.813 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 24.3 t80 -118.72 93.95 4.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 0.0 111.102 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.469 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -59.88 -23.43 63.43 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.43 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 64.05 164.83 0.78 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -80.96 89.85 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 124.231 1.648 . . . . 0.0 110.027 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.35 171.25 18.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.056 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.57 -14.02 17.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.134 -0.979 . . . . 0.0 110.19 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.76 169.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.299 -0.876 . . . . 0.0 110.481 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -152.0 69.3 0.9 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.413 -0.804 . . . . 0.0 109.469 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.3 mt -100.02 155.35 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 110.365 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.3 mm -94.18 87.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 110.329 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HB2' ' HB2' ' A' ' 35' ' ' TYR . 1.5 mmt85 -90.79 175.09 7.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 110.508 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.593 ' CE2' HG23 ' A' ' 32' ' ' THR . 57.5 m-85 -117.13 148.6 41.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.458 -0.776 . . . . 0.0 111.389 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 17.8 p90 -148.41 161.16 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.616 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 69.1 t80 -90.05 108.85 19.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.887 -1.133 . . . . 0.0 110.965 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.526 ' OD1' ' CB ' ' A' ' 26' ' ' LYS . 25.8 t-20 -80.87 87.18 5.94 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.252 178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 24' ' ' ASN . . . -45.26 -26.49 0.51 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.99 -1.069 . . . . 0.0 109.556 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 6.0 tttt -70.95 -29.13 65.05 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.393 -0.817 . . . . 0.0 109.667 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -91.57 -35.71 14.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 110.055 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.67 0.13 56.58 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -140.0 -144.74 0.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -1.165 . . . . 0.0 109.036 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 84.7 m -116.71 150.98 37.33 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 110.572 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 87.1 mt-30 -139.52 167.2 22.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.593 HG23 ' CE2' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -96.78 146.94 24.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.114 -0.991 . . . . 0.0 110.881 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.541 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -142.74 161.61 37.62 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.581 -0.699 . . . . 0.0 110.118 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' THR . 70.4 t -75.28 107.54 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.313 -0.867 . . . . 0.0 110.395 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.813 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.1 t80 -85.0 146.01 27.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 110.402 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.686 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -89.56 2.85 83.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.686 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 67.55 13.36 9.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.108 -1.231 . . . . 0.0 110.613 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ARG . 31.3 p -156.36 170.59 21.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.197 -0.94 . . . . 0.0 110.399 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 40.85 37.96 0.59 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.383 -0.823 . . . . 0.0 110.563 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.813 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -74.89 147.96 40.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.326 -0.859 . . . . 0.0 110.417 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -116.75 -165.3 1.05 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.356 -0.84 . . . . 0.0 109.896 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.581 ' O ' ' CZ ' ' A' ' 45' ' ' PHE . 6.2 mtt-85 -68.75 -20.12 64.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.067 -1.02 . . . . 0.0 110.268 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 1.7 t-20 -91.48 54.21 2.47 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.056 -1.028 . . . . 0.0 110.178 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.544 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 15.5 t-20 -156.29 76.05 0.89 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.436 -0.79 . . . . 0.0 108.945 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.587 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.0 m-85 -91.13 147.59 22.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 110.677 -178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.491 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 0.0 OUTLIER -78.25 -21.36 50.01 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 110.349 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.491 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 91.8 p -135.8 156.57 48.59 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 0.0 110.492 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.12 -25.46 68.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.527 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 53' ' ' ARG . 1.7 tp10 -73.79 -26.22 60.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.587 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 25.9 t0 -77.38 -31.77 54.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.354 -0.841 . . . . 0.0 109.265 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.587 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 11.3 t -82.48 -47.87 11.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.592 -0.692 . . . . 0.0 109.193 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.543 ' O ' ' N ' ' A' ' 56' ' ' GLY . 5.8 ttm -65.74 -44.44 85.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 0.0 109.993 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.519 ' CB ' ' O ' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -58.12 -25.33 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.674 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 m -90.17 -42.32 11.11 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.448 -0.783 . . . . 0.0 109.767 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -127.32 44.03 3.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 110.815 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -105.69 -130.91 6.8 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.17 35.32 88.35 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.197 -1.178 . . . . 0.0 110.296 179.931 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.579 ' HD2' HD21 ' A' ' 6' ' ' LEU . 15.7 ttm105 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.913 0.387 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.617 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 38.1 Cg_endo -67.16 157.38 61.99 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 124.182 1.622 . . . . 0.0 110.73 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 4' ' ' PHE . 9.3 p-10 -82.29 -25.71 33.74 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.502 -0.749 . . . . 0.0 109.936 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.617 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 4.4 p90 -67.26 -15.04 63.46 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.11 -0.994 . . . . 0.0 110.44 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 1.8 m -82.13 -28.88 31.94 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.18 -0.95 . . . . 0.0 109.6 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.579 HD21 ' HD2' ' A' ' 1' ' ' ARG . 13.9 mt -82.02 -19.31 40.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.399 -0.813 . . . . 0.0 109.724 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.94 158.37 85.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.46 -0.775 . . . . 0.0 109.823 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' HB2' ' HD2' ' A' ' 9' ' ' PRO . 44.1 Cg_endo -71.84 174.83 10.57 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.853 1.449 . . . . 0.0 110.098 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.606 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -71.55 169.74 20.24 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.902 1.475 . . . . 0.0 110.48 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.597 ' CE2' ' HA2' ' A' ' 12' ' ' GLY . 63.5 t80 -129.1 94.25 3.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.835 -179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.401 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -56.29 -23.39 36.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' A' ' 10' ' ' TYR . . . 58.44 -172.8 3.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 46.0 Cg_endo -73.63 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.17 1.616 . . . . 0.0 110.466 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 13' ' ' PRO . 28.6 m 63.12 173.33 0.15 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.0 110.257 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -133.52 27.19 4.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.0 110.405 -179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -66.01 -168.1 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.963 . . . . 0.0 110.102 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 38.8 ttm180 -150.69 73.81 1.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.287 -0.883 . . . . 0.0 110.162 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 82.1 mt -109.99 146.61 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.935 . . . . 0.0 110.324 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.518 HG23 ' HB ' ' A' ' 32' ' ' THR . 43.9 mm -92.43 82.45 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.916 . . . . 0.0 110.098 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.587 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -81.67 169.24 17.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 0.0 109.919 179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 47.2 m-85 -112.44 149.87 31.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.172 -0.955 . . . . 0.0 111.492 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 31' ' ' GLN . 13.0 p90 -150.12 156.81 42.32 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.6 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 47.7 t80 -83.6 116.3 22.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.125 -0.984 . . . . 0.0 110.486 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.575 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 26.9 t-20 -91.24 88.48 6.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.015 . . . . 0.0 109.874 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -46.58 -37.72 8.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 109.735 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 10.2 tptp -64.91 -27.99 69.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.586 ' O ' HD12 ' A' ' 29' ' ' LEU . . . -92.66 -23.58 18.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.941 . . . . 0.0 110.062 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.4 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 91.22 -11.29 72.6 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 27' ' ' ALA . 1.7 mp -132.76 -142.53 0.21 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.265 -1.138 . . . . 0.0 109.521 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 31' ' ' GLN . 66.3 m -119.57 154.67 33.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 110.492 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.579 ' HB2' ' CE1' ' A' ' 22' ' ' PHE . 3.3 mt-30 -138.61 172.3 13.08 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.411 -0.806 . . . . 0.0 109.499 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.518 ' HB ' HG23 ' A' ' 19' ' ' ILE . 8.5 p -98.59 144.45 27.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.985 -1.072 . . . . 0.0 110.506 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.606 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 22.3 p90 -137.82 157.08 47.17 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -0.881 . . . . 0.0 110.042 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.1 t -74.37 101.33 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.383 -0.823 . . . . 0.0 110.207 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.817 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 10.7 t80 -80.58 149.24 29.99 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.466 -0.771 . . . . 0.0 110.491 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.741 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -84.56 -1.68 89.11 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.26 6.69 5.22 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.271 -1.135 . . . . 0.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 20.2 p -149.77 171.91 15.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 0.0 110.456 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 39.34 47.17 1.44 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.486 -0.759 . . . . 0.0 110.645 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.817 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -69.28 156.07 39.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.283 -0.886 . . . . 0.0 110.236 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -120.47 -162.78 0.96 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.301 -0.874 . . . . 0.0 109.991 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.528 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 1.6 mtm-85 -80.11 -6.13 57.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.118 -0.988 . . . . 0.0 109.978 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.8 t-20 -110.25 54.59 0.66 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.86 . . . . 0.0 109.64 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.584 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 30.1 t-20 -155.41 82.49 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.559 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -94.49 142.65 27.19 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.448 -0.783 . . . . 0.0 111.099 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.496 ' HD3' ' HB3' ' A' ' 47' ' ' SER . 11.2 tmtt? -71.92 -23.46 61.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.496 ' HB3' ' HD3' ' A' ' 46' ' ' LYS . 97.0 p -134.26 159.02 42.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.267 -0.896 . . . . 0.0 110.502 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.74 -22.23 64.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.417 -0.802 . . . . 0.0 109.78 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -74.23 -28.68 61.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.36 -0.837 . . . . 0.0 110.236 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.491 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 56.4 t0 -78.86 -32.56 46.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.283 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.559 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.3 t -74.78 -43.98 51.98 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.438 -0.789 . . . . 0.0 109.498 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.52 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -67.63 -48.92 65.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 110.253 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -64.69 -11.93 41.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.041 -1.037 . . . . 0.0 109.717 179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.465 HG22 ' SG ' ' A' ' 5' ' ' CYS . 1.8 m -106.43 -38.79 6.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.885 . . . . 0.0 110.16 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.6 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 58.6 m -108.26 -0.94 20.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.167 -0.958 . . . . 0.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -49.15 111.41 0.98 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -153.11 20.44 0.75 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.316 -1.108 . . . . 0.0 110.165 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 2' ' ' PRO . 9.0 ttm180 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.1 0.476 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.628 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 44.0 Cg_endo -71.7 162.04 43.33 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 O-C-N 124.292 1.68 . . . . 0.0 110.097 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -86.51 -23.16 26.02 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.259 -0.901 . . . . 0.0 109.772 179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.648 ' CB ' ' CD ' ' A' ' 42' ' ' ARG . 9.0 p90 -67.53 -19.16 65.26 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.039 -1.065 . . . . 0.0 110.623 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.577 ' HB3' ' CD2' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -72.96 -29.66 63.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.072 -1.018 . . . . 0.0 109.658 179.459 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.731 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 39.5 mt -78.31 -20.36 51.64 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.259 -0.9 . . . . 0.0 109.743 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 8' ' ' PRO . 45.0 mt-10 -81.55 165.37 44.46 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.416 -0.803 . . . . 0.0 110.238 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 7' ' ' GLU . 47.7 Cg_endo -72.87 163.0 39.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 123.937 1.493 . . . . 0.0 110.564 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.489 ' HB2' ' CD1' ' A' ' 33' ' ' PHE . 43.6 Cg_endo -71.79 -159.22 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.968 1.509 . . . . 0.0 110.456 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CZ ' ' HA2' ' A' ' 12' ' ' GLY . 45.5 t80 -146.43 93.68 2.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.3 -0.875 . . . . 0.0 109.946 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 36' ' ' GLY . 1.3 m -58.67 -22.82 58.03 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.593 ' HA2' ' CZ ' ' A' ' 10' ' ' TYR . . . 61.12 174.87 1.39 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.5 Cg_endo -81.55 -96.09 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 123.903 1.475 . . . . 0.0 110.658 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 13' ' ' PRO . 2.0 m 38.91 -161.93 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.235 -0.915 . . . . 0.0 110.783 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -142.54 17.2 2.02 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.832 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.01 -179.76 4.51 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 110.027 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -155.06 71.26 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.194 -0.941 . . . . 0.0 110.476 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.612 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 3.7 mp -85.84 156.58 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.681 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 32' ' ' THR . 22.1 mm -93.74 80.44 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.113 -0.992 . . . . 0.0 110.602 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 7.8 mmt180 -81.35 175.04 10.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.245 -0.909 . . . . 0.0 109.702 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.538 ' CD1' ' HA ' ' A' ' 47' ' ' SER . 89.8 m-85 -116.23 151.8 35.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.037 -1.039 . . . . 0.0 111.285 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.511 ' HA ' ' CD2' ' A' ' 45' ' ' PHE . 15.7 p90 -150.35 161.87 41.64 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 72.6 t80 -86.33 107.81 18.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.968 -1.082 . . . . 0.0 110.963 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' ALA . 37.5 t-20 -84.99 90.84 7.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.106 -0.997 . . . . 0.0 109.86 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.731 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.53 -28.01 0.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.525 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.485 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -71.09 -27.14 63.4 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.333 -0.855 . . . . 0.0 109.762 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 24' ' ' ASN . . . -96.41 -18.5 19.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 110.002 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.64 -3.04 87.54 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.665 HD12 ' O ' ' A' ' 30' ' ' CYS . 1.1 pp -144.1 -145.54 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.16 -1.2 . . . . 0.0 109.36 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.665 ' O ' HD12 ' A' ' 29' ' ' LEU . 84.3 m -114.76 151.12 34.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 111.031 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -137.61 176.95 8.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.53 -0.731 . . . . 0.0 109.359 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.532 ' HB ' ' CG2' ' A' ' 19' ' ' ILE . 25.4 p -93.46 144.29 25.49 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.109 -0.994 . . . . 0.0 110.346 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 7.8 p90 -144.48 161.52 38.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.401 -0.812 . . . . 0.0 109.931 179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 55.5 t -74.72 135.07 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 0.0 110.231 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.827 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.3 t80 -122.27 141.63 51.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.442 -0.787 . . . . 0.0 109.775 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -75.39 -1.76 65.9 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 71.2 1.89 4.02 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -1.127 . . . . 0.0 110.485 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 39' ' ' ARG . 6.0 p -142.5 157.02 45.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.008 -1.058 . . . . 0.0 110.058 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 4.9 mtp85 56.72 35.6 26.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 110.419 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.827 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -55.03 149.9 11.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.189 -0.944 . . . . 0.0 110.141 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.505 ' CE ' ' HB2' ' A' ' 10' ' ' TYR . 2.1 mtmp? -124.86 -170.57 2.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.206 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.648 ' CD ' ' CB ' ' A' ' 4' ' ' PHE . 6.7 ptp180 -65.05 -32.93 74.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.284 -0.885 . . . . 0.0 111.278 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.9 t-20 -88.46 54.66 3.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.822 -1.174 . . . . 0.0 109.449 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.482 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 54.1 t-20 -158.55 76.34 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 23.1 m-85 -85.86 136.72 33.19 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -0.866 . . . . 0.0 110.589 -178.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -61.34 -26.96 68.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.342 -0.848 . . . . 0.0 110.076 -179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.538 ' HA ' ' CD1' ' A' ' 21' ' ' TYR . 89.3 p -145.29 162.03 38.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.89 . . . . 0.0 110.226 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.97 -20.43 66.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.307 -0.871 . . . . 0.0 109.906 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 2.7 tp10 -70.68 -34.47 72.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.481 -0.762 . . . . 0.0 110.513 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 22.3 t0 -79.28 -32.95 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.375 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.579 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 44.4 t -69.87 -44.43 69.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.475 -0.765 . . . . 0.0 109.208 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.545 ' HA ' ' CA ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -65.37 -55.39 18.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.499 -0.751 . . . . 0.0 109.522 179.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 2.2 ttp180 -46.08 -31.82 2.53 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' SG ' ' A' ' 55' ' ' CYS . 85.3 m -79.27 -59.44 2.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -0.786 . . . . 0.0 109.445 179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.525 ' SG ' ' CG ' ' A' ' 2' ' ' PRO . 59.2 m -114.1 -47.12 2.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.241 -0.912 . . . . 0.0 110.388 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 52' ' ' MET . . . 43.13 -128.7 5.51 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.07 5.57 68.59 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.179 -1.189 . . . . 0.0 110.227 179.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.76 0.314 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.598 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 40.2 Cg_endo -69.31 154.29 69.75 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.972 1.512 . . . . 0.0 110.867 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -70.12 -31.38 68.89 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.455 -0.778 . . . . 0.0 109.673 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 2' ' ' PRO . 3.5 p90 -67.85 -17.23 64.43 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.224 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.59 ' SG ' ' CD2' ' A' ' 23' ' ' TYR . 3.7 t -84.55 -25.17 28.91 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.46 -0.775 . . . . 0.0 109.873 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 6' ' ' LEU . 7.3 mt -86.96 -15.28 39.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.904 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.43 163.88 56.92 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.337 -0.852 . . . . 0.0 110.032 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 168.44 24.5 Favored 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.111 1.585 . . . . 0.0 110.187 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.619 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.9 Cg_endo -70.73 169.76 19.38 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 124.017 1.535 . . . . 0.0 110.635 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 39' ' ' ARG . 38.8 t80 -126.25 94.27 4.04 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.274 -0.891 . . . . 0.0 111.131 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.478 ' O ' ' CA ' ' A' ' 36' ' ' GLY . 1.3 m -67.39 -22.64 65.54 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.83 171.8 0.56 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 14' ' ' CYS . 53.6 Cg_endo -80.51 -94.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.877 1.462 . . . . 0.0 110.333 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 41.52 -164.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.129 -0.982 . . . . 0.0 110.569 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -134.41 26.41 3.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 110.201 179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.86 174.55 5.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 0.0 110.17 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.429 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 2.2 ptp180 -153.82 73.64 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -0.868 . . . . 0.0 110.125 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 19' ' ' ILE . 4.1 mt -90.26 165.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.276 -0.89 . . . . 0.0 110.275 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.445 ' N ' HG22 ' A' ' 18' ' ' ILE . 29.4 mm -102.79 92.92 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.293 -0.879 . . . . 0.0 110.549 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.555 ' HG3' ' CG ' ' A' ' 35' ' ' TYR . 4.2 mmt180 -94.48 -179.39 4.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.846 . . . . 0.0 110.038 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.557 ' CE2' HG22 ' A' ' 32' ' ' THR . 72.6 m-85 -117.03 146.2 43.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.966 -1.084 . . . . 0.0 111.06 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 30' ' ' CYS . 7.7 p90 -145.69 163.38 35.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 109.482 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.59 ' CD2' ' SG ' ' A' ' 5' ' ' CYS . 86.9 t80 -92.26 124.33 36.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.154 -0.966 . . . . 0.0 110.79 -179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.742 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 59.8 t-20 -96.69 96.54 8.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -0.956 . . . . 0.0 109.929 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -47.6 -36.31 10.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.111 -0.993 . . . . 0.0 109.786 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HB3' ' OD1' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -68.57 -25.5 64.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.776 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.742 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -96.36 -24.91 15.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.231 -0.918 . . . . 0.0 110.013 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' C ' ' HG ' ' A' ' 29' ' ' LEU . . . 86.43 -8.72 73.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 27' ' ' ALA . 1.1 mp -129.68 -146.3 0.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.247 -1.149 . . . . 0.0 109.68 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 63.1 m -123.48 150.02 44.42 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.589 0.709 . . . . 0.0 110.729 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.589 HE22 ' HB2' ' A' ' 27' ' ' ALA . 36.3 mt-30 -137.31 160.96 37.56 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.558 -0.714 . . . . 0.0 109.21 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.557 HG22 ' CE2' ' A' ' 21' ' ' TYR . 40.5 p -82.97 144.23 30.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.059 -1.026 . . . . 0.0 110.438 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.619 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 15.3 p90 -140.62 166.22 25.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.442 -0.787 . . . . 0.0 109.865 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.448 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 3.6 t -74.88 133.84 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 110.083 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.723 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.6 t80 -112.88 147.09 37.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.163 -0.961 . . . . 0.0 110.324 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.749 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -87.34 -4.16 81.06 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 74.37 -4.54 2.29 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.445 -1.032 . . . . 0.0 111.113 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 39' ' ' ARG . 29.3 p -146.7 170.35 17.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.906 -1.121 . . . . 0.0 110.441 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.536 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 3.2 ttt180 42.78 51.76 5.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.279 -0.888 . . . . 0.0 109.933 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.723 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -95.23 157.82 15.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 0.0 110.905 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 4.6 mttp -118.59 -161.48 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.348 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.552 ' HD3' ' CB ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -74.55 -23.98 58.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.012 -1.055 . . . . 0.0 110.335 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 2.1 t-20 -80.19 54.26 1.93 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.031 -1.043 . . . . 0.0 109.919 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.594 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 25.2 t-20 -162.41 74.31 0.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 20.3 m-85 -85.46 143.7 28.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.446 -0.783 . . . . 0.0 110.788 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -68.91 -25.11 64.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.513 -0.742 . . . . 0.0 110.096 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 96.9 p -136.39 157.11 47.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 0.0 110.543 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.51 -22.87 66.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.418 -0.801 . . . . 0.0 110.071 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 4.1 mt-10 -75.28 -27.86 59.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.403 -0.811 . . . . 0.0 109.599 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 45' ' ' PHE . 14.6 t0 -72.85 -35.85 67.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.831 . . . . 0.0 108.896 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.526 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 33.2 t -71.43 -44.52 64.69 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.533 ' O ' ' N ' ' A' ' 56' ' ' GLY . 2.7 mmt -67.69 -53.8 24.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.475 -0.766 . . . . 0.0 109.395 179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -53.38 -22.43 7.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.397 -0.815 . . . . 0.0 109.355 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -96.22 -39.38 9.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 109.728 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 1.8 t -132.6 46.63 2.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.284 -0.885 . . . . 0.0 110.939 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -106.96 158.33 15.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.67 109.55 2.76 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.242 -1.152 . . . . 0.0 110.238 -179.854 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.528 ' NE ' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.736 0.303 . . . . 0.0 110.266 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.589 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . 41.7 Cg_endo -70.97 141.91 41.38 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.939 1.494 . . . . 0.0 110.081 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -75.92 -21.83 56.68 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.316 -0.865 . . . . 0.0 110.264 -179.919 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.748 ' CD1' ' CG ' ' A' ' 42' ' ' ARG . 6.6 p90 -67.01 -16.68 64.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.892 -1.123 . . . . 0.0 110.47 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 53.4 m -84.19 -20.94 31.52 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.114 -0.991 . . . . 0.0 109.479 178.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.692 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 15.7 mt -73.75 -22.82 59.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.413 -0.804 . . . . 0.0 110.25 -179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -70.52 160.37 81.71 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 110.141 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.7 170.28 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.017 1.535 . . . . 0.0 110.208 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.39 178.47 6.1 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.833 1.439 . . . . 0.0 110.153 179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.491 ' CG ' ' HD2' ' A' ' 41' ' ' LYS . 11.0 t80 -139.56 93.86 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.91 . . . . 0.0 110.428 -179.629 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -59.54 -22.74 62.12 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.39 144.94 0.03 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.54 65.47 4.65 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.958 1.504 . . . . 0.0 110.412 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.488 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 18.5 m -117.56 170.83 8.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.847 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.56 4.49 53.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.103 -0.998 . . . . 0.0 110.357 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.53 175.55 5.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.242 -0.911 . . . . 0.0 109.998 179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 13.5 ptp180 -155.08 71.97 0.81 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.158 -0.964 . . . . 0.0 110.575 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.1 mt -81.17 157.7 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.809 179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 19' ' ' ILE . 4.3 mm -94.18 88.49 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.072 -1.018 . . . . 0.0 110.38 -179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.611 ' HG3' ' CD2' ' A' ' 35' ' ' TYR . 1.2 mmt180 -92.42 -175.65 4.07 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.338 -0.851 . . . . 0.0 110.034 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.623 ' CE2' HG23 ' A' ' 32' ' ' THR . 69.0 m-85 -119.37 144.82 46.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.156 -0.965 . . . . 0.0 111.434 -179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 14.4 p90 -142.14 166.52 24.47 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' ' 55' ' ' CYS . 73.0 t80 -95.95 111.59 23.55 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.89 -1.131 . . . . 0.0 110.835 -179.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.617 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 28.3 t-20 -84.32 91.83 7.86 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -47.07 -24.27 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.962 . . . . 0.0 109.564 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' CB ' ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -79.25 -22.93 44.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.407 -0.808 . . . . 0.0 109.823 179.421 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -93.56 -28.47 16.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.32 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 -0.6 70.87 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 29' ' ' LEU . 0.4 OUTLIER -151.26 -151.62 0.4 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.223 -1.163 . . . . 0.0 109.851 179.677 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.58 ' N ' ' HG ' ' A' ' 29' ' ' LEU . 95.4 m -109.99 153.75 24.13 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.871 0.843 . . . . 0.0 111.43 -179.304 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -143.51 174.25 10.92 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.623 HG23 ' CE2' ' A' ' 21' ' ' TYR . 0.9 OUTLIER -96.54 144.29 26.75 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.712 -1.243 . . . . 0.0 110.669 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -138.79 162.38 34.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.477 -0.765 . . . . 0.0 109.583 179.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 17' ' ' ARG . 53.3 t -75.99 99.44 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.263 -0.898 . . . . 0.0 111.283 -178.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.633 ' CE2' ' HA ' ' A' ' 37' ' ' ALA . 6.7 t80 -81.49 144.78 31.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.509 -0.745 . . . . 0.0 109.505 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.778 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -87.06 3.59 86.83 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.845 -1.169 . . . . 0.0 110.392 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 78.55 -24.5 0.21 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.467 -1.019 . . . . 0.0 111.169 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -136.44 168.35 19.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.898 -1.126 . . . . 0.0 109.909 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.77 43.73 27.34 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 109.69 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.594 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . . . -85.76 164.48 17.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.353 -0.842 . . . . 0.0 111.198 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' HD2' ' CG ' ' A' ' 10' ' ' TYR . 14.4 mttt -116.23 -166.3 1.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.748 ' CG ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -76.88 -19.78 57.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.865 -1.147 . . . . 0.0 110.183 179.736 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' H ' ' HD2' ' A' ' 42' ' ' ARG . 3.8 t-20 -92.07 53.67 2.21 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.908 0.861 . . . . 0.0 109.341 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.466 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 17.8 t-20 -149.49 71.06 1.09 Allowed 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.528 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 21.6 m-85 -84.89 141.21 30.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.607 -0.683 . . . . 0.0 110.531 -178.077 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 4.7 tttt -66.02 -23.12 66.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.477 -0.764 . . . . 0.0 110.911 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 98.0 p -143.38 153.85 43.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 110.418 -179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -56.86 -29.86 63.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.786 -0.766 . . . . 0.0 109.705 179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 53' ' ' ARG . 10.6 tt0 -64.68 -34.02 77.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.387 -0.82 . . . . 0.0 110.363 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' O ' ' HB ' ' A' ' 54' ' ' THR . 22.5 t0 -79.25 -29.18 42.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 0.0 109.622 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.528 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 37.6 t -82.9 -44.2 15.67 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.429 179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.511 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -67.98 -49.95 58.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.459 -0.775 . . . . 0.0 109.956 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -59.97 -23.7 63.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.111 -0.993 . . . . 0.0 109.42 179.295 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.509 HG23 ' HZ ' ' A' ' 4' ' ' PHE . 2.5 m -94.32 -44.3 8.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.559 -0.713 . . . . 0.0 109.824 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.592 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 55.8 m -101.13 21.92 13.16 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.457 -0.777 . . . . 0.0 110.09 -179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -67.13 129.77 29.39 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -179.559 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.528 ' HA3' ' NE ' ' A' ' 1' ' ' ARG . . . -140.74 -60.92 0.03 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.2 -1.177 . . . . 0.0 110.156 -179.953 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.495 HH22 ' HB2' ' A' ' 58' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.781 0.324 . . . . 0.0 110.172 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.623 ' HB2' ' CE2' ' A' ' 4' ' ' PHE . 41.3 Cg_endo -70.44 161.01 47.57 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.057 1.556 . . . . 0.0 110.584 179.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -91.38 -25.84 19.18 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.41 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.623 ' CE2' ' HB2' ' A' ' 2' ' ' PRO . 28.6 p90 -67.33 -16.65 64.38 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.359 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.585 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 20.0 m -83.64 -26.43 29.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.075 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.562 HD23 ' N ' ' A' ' 6' ' ' LEU . 5.3 mt -81.43 -18.24 46.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.547 -0.721 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.27 162.25 57.14 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 0.0 109.934 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.04 168.97 22.52 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.932 1.491 . . . . 0.0 110.108 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.602 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 40.8 Cg_endo -70.59 175.2 9.12 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.998 1.526 . . . . 0.0 110.667 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -133.91 93.9 3.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 0.0 110.389 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 1.3 m -65.72 -22.69 66.63 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.41 ' O ' HG22 ' A' ' 11' ' ' THR . . . 57.94 171.8 0.27 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' CYS . 51.3 Cg_endo -74.68 -97.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.913 1.481 . . . . 0.0 110.453 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 42.96 -169.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.044 -1.035 . . . . 0.0 110.739 179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -133.23 15.75 4.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 110.08 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.11 172.43 9.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 110.093 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 71.13 1.02 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 110.284 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -98.35 153.78 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.284 -0.885 . . . . 0.0 110.091 179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.475 HG23 ' HB ' ' A' ' 32' ' ' THR . 14.5 mm -96.64 87.67 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.354 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 32' ' ' THR . 8.2 mmt85 -88.67 177.31 6.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.857 . . . . 0.0 110.181 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.535 ' CE1' HG23 ' A' ' 32' ' ' THR . 49.2 m-85 -113.39 152.89 29.43 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.05 -1.031 . . . . 0.0 111.082 -179.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 31' ' ' GLN . 11.5 p90 -150.58 158.49 44.22 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.623 -0.673 . . . . 0.0 109.337 178.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.61 ' CG ' ' HB3' ' A' ' 55' ' ' CYS . 44.9 t80 -87.33 113.64 23.23 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.319 -0.863 . . . . 0.0 110.774 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.621 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 45.3 t-20 -86.27 83.31 7.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.691 179.33 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -45.47 -29.09 1.03 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.057 -1.027 . . . . 0.0 109.58 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.82 -27.3 62.81 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.427 -0.795 . . . . 0.0 109.706 179.388 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -94.98 -26.33 16.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 110.239 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.48 -10.53 65.0 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.45 -144.11 0.21 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.188 -1.183 . . . . 0.0 109.571 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 95.1 m -121.83 153.97 37.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.262 -0.899 . . . . 0.0 110.703 -179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 20.0 mt-30 -140.38 160.45 39.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.484 -0.76 . . . . 0.0 109.383 179.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.535 HG23 ' CE1' ' A' ' 21' ' ' TYR . 2.0 p -84.6 144.56 28.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.009 -1.057 . . . . 0.0 110.723 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.602 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 18.9 p90 -139.15 162.3 35.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.617 -0.677 . . . . 0.0 109.92 179.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 11' ' ' THR . 11.8 t -74.67 122.6 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.258 -0.902 . . . . 0.0 109.849 -179.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.797 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 7.5 t80 -99.79 147.09 25.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.292 -0.88 . . . . 0.0 110.223 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.756 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -91.84 -4.38 67.41 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -179.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 72.95 -2.09 2.83 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.265 -1.138 . . . . 0.0 110.902 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 39' ' ' ARG . 28.3 p -146.3 172.24 13.78 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.991 -1.068 . . . . 0.0 110.182 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' C ' ' O ' ' A' ' 38' ' ' CYS . 16.4 mtt-85 42.33 28.58 0.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.276 -0.89 . . . . 0.0 109.974 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.797 ' HB2' ' OH ' ' A' ' 35' ' ' TYR . . . -63.92 163.5 11.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.36 -0.837 . . . . 0.0 110.801 -179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -127.3 -171.04 2.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.498 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.557 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -69.56 -19.62 63.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.953 -1.092 . . . . 0.0 109.834 179.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.48 ' OD1' ' HB2' ' A' ' 22' ' ' PHE . 3.3 t-20 -88.25 67.03 8.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 0.0 109.695 179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.596 ' ND2' ' CE1' ' A' ' 35' ' ' TYR . 39.0 t-20 -168.43 82.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 109.271 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.561 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 18.0 m-85 -96.42 148.8 22.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 110.585 -178.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -69.22 -28.34 66.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.314 -0.866 . . . . 0.0 109.871 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.6 p -136.56 158.56 44.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -0.845 . . . . 0.0 110.153 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 52' ' ' MET . . . -68.14 -20.45 64.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.282 -0.886 . . . . 0.0 110.067 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 5.3 tt0 -65.74 -42.0 91.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -71.01 -40.24 71.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.0 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 34.7 t -64.91 -43.99 91.04 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.656 0.741 . . . . 0.0 109.41 179.067 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.532 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -67.39 -61.92 1.67 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.539 -0.726 . . . . 0.0 110.685 -179.546 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -55.41 -19.25 8.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.036 -1.04 . . . . 0.0 110.617 -179.441 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.508 ' N ' ' HG3' ' A' ' 53' ' ' ARG . 45.9 m -95.61 -56.0 2.83 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.07 -1.019 . . . . 0.0 110.172 179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.61 ' HB3' ' CG ' ' A' ' 23' ' ' TYR . 44.6 m -85.56 0.57 52.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.929 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 52' ' ' MET . . . -60.94 -173.57 1.05 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.09 -6.27 25.35 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.495 ' HB2' HH22 ' A' ' 1' ' ' ARG . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.261 -1.14 . . . . 0.0 110.146 179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 5.6 mtm-85 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.885 0.374 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.644 ' CB ' ' CE2' ' A' ' 4' ' ' PHE . 43.6 Cg_endo -73.47 166.29 30.23 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.131 1.595 . . . . 0.0 111.001 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.426 ' OD1' HD12 ' A' ' 6' ' ' LEU . 2.6 t0 -94.03 -22.21 18.68 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.433 -0.792 . . . . 0.0 109.626 179.406 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.644 ' CE2' ' CB ' ' A' ' 2' ' ' PRO . 10.9 p90 -66.67 -20.87 66.08 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.907 179.646 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.516 ' SG ' ' CE1' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -83.68 -22.04 32.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.56 179.388 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 25' ' ' ALA . 19.3 mt -82.36 -16.97 47.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.467 -0.771 . . . . 0.0 109.842 179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.493 ' HG3' ' HD2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -84.78 160.89 54.88 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 110.088 179.838 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD2' ' HG3' ' A' ' 7' ' ' GLU . 44.1 Cg_endo -72.53 165.05 33.82 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.931 1.49 . . . . 0.0 110.071 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.613 ' HB2' ' CD2' ' A' ' 33' ' ' PHE . 39.6 Cg_endo -70.67 159.32 53.12 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.906 1.477 . . . . 0.0 110.712 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -116.33 94.33 4.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.363 -0.836 . . . . 0.0 110.655 -179.249 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.485 ' O ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -62.66 -22.87 66.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.5 170.25 0.55 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 14' ' ' CYS . 48.0 Cg_endo -73.58 -92.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.917 1.482 . . . . 0.0 110.941 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' PRO . 1.3 m 44.26 -169.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.052 -1.03 . . . . 0.0 110.313 -179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.09 8.27 3.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.909 . . . . 0.0 110.356 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.85 -177.15 3.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -0.949 . . . . 0.0 109.707 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.449 ' CG ' ' O ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -152.27 82.97 1.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.016 -1.052 . . . . 0.0 110.68 -179.696 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.1 mt -96.87 157.92 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.276 -0.89 . . . . 0.0 109.914 179.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.752 HG23 ' HB ' ' A' ' 32' ' ' THR . 7.9 mm -104.54 89.01 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.153 -0.967 . . . . 0.0 110.242 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 32' ' ' THR . 5.8 mmt85 -88.51 179.97 6.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.943 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' A' ' 45' ' ' PHE . 62.1 m-85 -110.87 153.83 24.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 110.712 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.473 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.7 p90 -152.78 161.94 41.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.43 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.516 ' CD2' ' HB3' ' A' ' 5' ' ' CYS . 76.5 t80 -92.91 115.31 28.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 110.951 -179.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.767 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . 40.3 t-20 -90.5 98.55 11.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.223 -0.923 . . . . 0.0 110.01 179.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . . . -52.24 -20.2 2.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.89 -19.09 29.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.179 -0.951 . . . . 0.0 109.982 179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.767 ' HB3' ' HB3' ' A' ' 24' ' ' ASN . . . -96.53 -29.77 13.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.908 . . . . 0.0 110.231 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.99 -5.72 72.45 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.64 -145.2 0.17 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.106 -1.232 . . . . 0.0 109.641 179.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 76.4 m -121.45 150.46 41.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.267 -0.895 . . . . 0.0 110.97 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -138.48 179.65 6.34 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.47 -0.769 . . . . 0.0 109.648 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.752 ' HB ' HG23 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -99.45 144.47 28.52 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.893 -1.129 . . . . 0.0 111.156 -179.213 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.613 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 23.9 p90 -136.83 158.75 43.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.584 -0.697 . . . . 0.0 109.17 178.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 11' ' ' THR . 60.6 t -75.28 99.66 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.291 -0.881 . . . . 0.0 111.055 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.636 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 6.1 t80 -78.75 141.5 37.79 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.161 -0.962 . . . . 0.0 110.23 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.757 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -84.7 5.52 81.52 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 36' ' ' GLY . . . 73.94 0.58 3.66 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -1.07 . . . . 0.0 111.0 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.413 ' O ' ' C ' ' A' ' 39' ' ' ARG . 12.6 p -148.86 176.0 10.78 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.855 -1.153 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.413 ' C ' ' O ' ' A' ' 38' ' ' CYS . 0.0 OUTLIER 41.56 44.55 2.62 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -0.763 . . . . 0.0 110.376 179.98 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.636 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . . . -83.35 137.27 34.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.195 -0.94 . . . . 0.0 110.466 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -103.0 -164.38 1.07 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.466 -0.772 . . . . 0.0 109.433 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HB2' ' CG ' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -69.55 -14.23 62.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.041 -1.037 . . . . 0.0 109.611 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 4' ' ' PHE . 3.2 t-20 -94.39 55.38 1.98 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.313 -0.867 . . . . 0.0 109.53 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.471 ' ND2' ' CD1' ' A' ' 35' ' ' TYR . 16.8 t-20 -160.71 80.27 0.64 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.43 -0.794 . . . . 0.0 108.99 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.574 ' CD2' ' HB2' ' A' ' 51' ' ' CYS . 19.6 m-85 -92.06 153.19 19.56 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.297 -0.877 . . . . 0.0 110.858 -178.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -78.67 -23.18 45.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.446 -0.784 . . . . 0.0 110.16 -179.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 84.1 p -142.68 161.44 38.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.27 -0.894 . . . . 0.0 110.296 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.87 -21.29 65.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.791 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -27.19 60.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.405 -0.809 . . . . 0.0 110.173 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.85 -30.81 31.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 109.348 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.574 ' HB2' ' CD2' ' A' ' 45' ' ' PHE . 43.6 t -78.64 -44.61 23.44 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.602 -0.686 . . . . 0.0 109.622 179.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -66.35 -46.8 75.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 0.0 110.293 -179.995 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -63.72 -29.43 70.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 110.05 179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.616 HG22 ' SG ' ' A' ' 55' ' ' CYS . 5.4 m -73.85 -50.17 21.6 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.125 179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.616 ' SG ' HG22 ' A' ' 54' ' ' THR . 77.3 m -119.15 -42.43 2.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 -179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 52' ' ' MET . . . 76.39 -75.63 1.58 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 58' ' ' ALA . . . 97.61 -160.35 21.1 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 57' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.282 -1.128 . . . . 0.0 110.261 -179.959 . . . . . . . . 1 1 . 1 stop_ save_